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The American 
Society of Pharmacognosy 
Annual Meeting
July 21-25, 2018
Hilton Lexington Downtown
Lexington, Kentucky
ENGAGE IN THE CONVO #ASP2018
Welcome to 59th Annual Meeting of the American Society of Pharmacognosy (ASP) 2018 in beautiful downtown 
Lexington, Kentucky! The Local Organizing Committee would like to thank you for joining us for the ASP meeting 
at the Hilton Lexington Downtown. The scientific program includes podium presentations from an impressive and 
diverse group of speakers who will be discussing the latest advances in all areas of natural products discovery and 
development, a series of workshops supporting your technical and professional development, as well as two poster 
sessions to showcase work from around the globe. Additional activities will allow attendees to enjoy Kentucky to 
its fullest including an evening at the majestic Keeneland Racetrack, tours of Horse Farms and Distilleries, and an 
excursion to the Lloyd library and Winkler Center (repository for the founding ASP scientific and societal articles). 
For the Young Members, a fun filled evening event at Buffalo Trace Distillery is planned. Lexington and the Bluegrass 
have a lot to offer. We invite you to enjoy the many restaurants/bars and perhaps take some time to enjoy the natural 
beauty of the Red River Gorge, gain an appreciation for the majestry of the throughbred tradition at the internatio-
nally acclaimed Kentucky Horse Park, and many other attractions surrounding Lexington. We wish you a wonderful 
time in the Bluegrass.
The ASP 2018 Local Organizing Committee:
Jürgen Rohr, Chair
Joe Chappell
Sylvie Garneau-Tsodikova
Pete Spielmann
Jon Thorson
Oleg Tsodikov
Steven Van Lanen
and Laura Stoll, ASP Business Manager
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ASP 2018
Lexington, Kentucky, July 21-25, 2018
ASP 2018 Organizers
Local Organizers
Jürgen Rohr, Chair (University of Kentucky)
Joe Chappell (University of Kentucky)
Sylvie Garneau-Tsodikova (University of Kentucky)
Pete Spielmann (University of Kentucky)
Jon Thorson (University of Kentucky)
Oleg Tsodikov (University of Kentucky)
Steven Van Lanen (University of Kentucky)
 
Scientific Committee
Jürgen Rohr, Chair (University of Kentucky)
John Beutler (National Cancer Institute)
Joe Chappell (University of Kentucky)
Sylvie Garneau-Tsodikova (University of Kentucky)
Mark O’Neil-Johnson (Sequoia Sciences)
Sheo Singh (SBS Pharma Consulting)
Pete Spielmann (University of Kentucky)
Jon Thorson (University of Kentucky)
Oleg Tsodikov (University of Kentucky)
Steven Van Lanen (University of Kentucky)
Chang-Guo Zhan (University of Kentucky)
Meeting Planning and Registration 
Laura Stoll (The American Society of Pharmacognosy)
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2018 ASP ANNUAL MEETING SPONSORS
GOLD SPONSORS
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BRONZE SPONSOR
SUPPORTED BY A GRANT FROM GENENTECH
GENERAL SPONSORS
                      
                                        
The Lynn and Gerry Brady Foundation
6Abstracts | 2018 Annual Meeting of the ASP | July 21-25, 2018 | Lexington, Kentucky, USA
2018 ASP ANNUAL MEETING EXHIBITORS
ACD/Labs
Advion
Biotage
Bruker BioSpin
Gilson
JEOL USA
Lloyd Library and Museum
Mestrelab Research
SCIEX
Teledyne ISCO
Thieme
Waters
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Nature 
Provides
Find the 
answers
To learn more visit:  www.bruker.com
Innovation with Integrity
Natural  Products
Learn More With NMR
Beginning with research for discovery and solving complex structural questions to ultimately 
establishing high-throughput screening methods for quality control, Bruker has the analytical solutions 
you need to give you knowledge and insight that brings authentic, safe and effective natural products 
to consumers.
nat-prod_letter_ad-2018.indd   1 6/11/2018   2:51:20 PM
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College of Pharmacy
YOUR JOURNEY.
YOUR FUTURE.
GRADUATE STUDIES IN PHARMACEUTICAL SCIENCES
Learn more at pharmacy.uky.edu/PhD
Earn your PhD at a top-10 funded institution while engaging in cutting-edge research that 
spans the spectrum of pharmaceutical sciences. All graduate students receive an annual 
stipend of $30,000.
Pharmacology 
and Experimental 
Therapeutics
Clinical and 
Experimental 
Therapeutics
Pharmaceutical 
Outcomes 
and Policy
Medicinal, 
Bioorganic and 
Computational 
Chemistry
Pharmaceutical 
Chemistry and 
Engineering
C
M
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CY
CMY
K
PhD One Page Handout.pdf   1   10/28/16   10:25 AM
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PUBS:
 American Laboratory
American Drug Discovery
American Pharmaceutical Review
Bio Business
Bio IT World
BioTech World
BioTechnology Focus
BioPharm International
BioProcess International
Chemical & Engineering News
Drug Discovery and Dev
Drug Discovery News
Environmental Science & Technology
Food Processing
Food Quality
Food Safety Magazine
Genetic Engineering News (GEN)
Genome Technology
Genomics & Proteomics
Jour of The American Soc for 
       Mass Spectrometry
Lab Asia Media Guide
Lab Business - Jesmar
LCGC Asia
LCGC N. America
LCGC Europe
Molecular and Cellular Protemomics 
Nature Methods
Pharmaceutical Discovery 
       & Development
Pharmaceutical Manufacturing
Pharmaceutical Technology
Pharmaceutical Technology EUROPE
Pharmaceutical Executive
Pharm Form and Quality
Proteomics Journal
Scientific American
Scientific Computing & Instrumentation
Scientific Computing World
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NATURAL 
PRODUCTS
From biomarker and drug discovery to safety, quality control and manufacturing 
e iciency, Waters is equipped and committed to help labs navigate the wonderful 
complexity of natural products. Together as industry pioneers, let ’s embrace 
the challenges and pursue new possibilities that are waiting to be uncovered. 
To learn more about our application-specific, workflow-driven solutions and 
technologies, visit waters.com/naturalwonder
          THE WONDER OF 
    THE NATURAL WORLD.
THE POWER OF NATURAL PRODUCTS. 
               GO SEAMLESSLY. 
©2017 Waters Corporation. Waters and The Science of What’s Possible are registered trademarks of Waters Corporation.
PHARMACEUTICAL   ■    HEALTH SCIENCES   ■    FOOD   ■    ENVIRONMENTAL   ■    CHEMICAL MATERIALS
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ASP Award Winners 2018
Norman R. Farnsworth Research Achievement Award
James Gloer, Ph.D., University of lowa
Varro E. Tyler Prize
Guido Pauli, Ph.D., University of Illinois Chicago
Matt Suffness Young Investigator Award
Marcy Balunas, Ph.D., University of Connecticut
ASP Kilmer Prize
David Gallegos, Oregon State University
Undergraduate Research Award
Mario Augustinovic, University of North Carolina 
Greensboro
Manead Khin, University of North Carolina Greensboro
Malia L. Moore, University of California Berkley
Madison Patrick, Auburn University
Sabrina Ton, University of Oklahoma
Research Starter Grant
Ethan Van Arnam, Ph.D., Claremont McKenna College
Lukasz Ciesla, University of Alabama
Lynn Brady Student Travel Award
Brian Guo, University of Illinois at Chicago 
Paige Mandelare, Oregon State University
Carla Meningatti, University of Sao Paolo
Sara Puckett, University of Connecticut 
Robert Tokarski, Ohio State University
Jerry McLaughlin Student Travel Award
Oluwatofunmilayo Divaolu, University of Aberdeen 
(United Kingdom)
Anupama Tuladhar, Florida International University
David Carew Student Travel Award
Yihue Zhang, Auburn University
Waqar Bhatti Student Travel Award
Samantha Gromek, University of Connecticut
Student Travel Award
Kelsey Alexander, University of California-San Diego 
Anina Buchman, Eberhard Karls University (Germany)
Maria S. Costa, University of Iceland 
Camila M. Crnkovic, University of Illinois, Chicago
Pradeep Dewapriya, University of Queensland (Australia) 
Taise T.H. Fukuda, University Sao Paolo/Harvard 
Gabrielle M. Grandchamp, University of North Carolina-
Chapel Hill
Riley Kirk, University of Rhode Island 
Shamsunnahar Kushi, University of Queensland (Australia)
Sylvia Kunakom, University of Illinois at Chicago 
Preston Manwil, Ohio State University 
Laizuman Nahar, University Queensland (Australia)
George Neuhaus, Oregon State University
Paul Scesa, Florida Atlantic University
Abu Bakar Siddique, University of Louisiana Monroe
Hannah Whitmore, University Surrey (United Kingdom) 
Mario Wibowo, Griffith University (Australia) 
Travel Grant for Active Members
Asmaa Boufridi, Griffith University (Australia)
Jana Braesel, University of Illinois at Chicago 
Narayan Chaurisiya, University of Mississippi
Anne-Clare Limon, University of South Florida
Pencheng Wang, University of Pittsburgh 
Chen Zhang, University of California-San Diego 
2018 Arthur E. Schwarting Award
Sang Kook Lee, Ph.D., SNU Korea
Hwa-Jin Chung, Won Kyung Kim, Jedo Oh, Me-riong 
Kim, Joon-Shik Shin, Jinho Lee, In-Hyuk Ha, and Sang 
Kook Lee.* Anti-Osteoporotic Activity of Harpagoside by 
Upregulation of the BMP2 and Wnt Signaling Pathways 
in Osteoblasts and Suppression of Differentiation in 
Osteoclasts. J. Nat. Prod. 2017, 80(2), 434-442. (DOI: 
10.1021/acs.jnatprod.6b00964).
2018 Jack L. Beal Award
Chambers C. Hughes, Ph.D., University California, San Diego
Daniela Reimer and Chambers C. Hughes.* Thiol-Based 
Probe for Electrophilic Natural Products Reveals 
That Most of the Ammosamides Are Artifacts. J. 
Nat. Prod. 2017, 80(1), 126–133. (DOI: 10.1021/acs.
jnatprod.6b00773).
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The American 
Society of Pharmacognosy 
Annual Meeting
July 21-25, 2018
Hilton Lexington Downtown
Lexington, Kentucky
ENGAGE IN THE CONVO #ASP2018
Program Schedule
Saturday July 21, 2018
8:00 AM – 7:30 PM Registration – Grand Kentucky Ballroom Foyer
9:00 AM – 4:00 PM Executive Committee Meeting (Invitation Only) – 
 Grand Kentucky Ballroom Salon B
9:00 AM – 1:00 PM AMWS1 - Grand Kentucky Ballroom Salon C
 “Introduction to Global Natural Product Social (GNPS) Molecular Networking and 3D 
Visualization of Natural Product Data” with  Dr. Pieter Dorrestein (UCSD) 
9:00 AM – 11:00 AM AMWS2 - Grand Kentucky Ballroom Salon A
 “Grant Writing Strategies” with Dr. D. Craig Hopp (NCCIH, National Institutes of Health)
 2:00 PM – 4:00 PM PMWS1 - Grand Kentucky Ballroom Salon A
 “New Approaches for the Biological Evaluation of Natural Products with Anticancer 
Potential” with Dr. April Risinger (University of Texas, Health Sciences Center, San Antonio)
2:00 PM – 5:00 PM PMWS2 - Grand Kentucky Ballroom Salon C
 “How Can Countercurrent Separation help You with Your Natural Product Research?” with 
CENAPT team, in collaboration with Gregoire Audo (Armen/Gilson)
2:00 PM – 4:00 PM PMWS3 – Grand Kentucky Ballroom Salon D
 “One Carbon Based Unit’s / Computer’s Approach to Structure Elucidation” with Mark 
O’Neil-Johnson, Sequoia Sciences, Inc and Arvin Moser, ACD Labs
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12:00 PM – 5:00 PM Exhibitor Set Up – Grand Kentucky Ballroom Foyer
5:00 PM – 10:00 PM Exhibition – Grand Kentucky Ballroom Foyer
7:00 PM – 10:00 PM President’s Opening Reception - Supported in part by the American Society of 
Pharmacognosy Foundation through a generous donation from the Estate of Gerry and 
Lynn Brady
 Grand Kentucky Ballroom – (Ticketed Event)
Sunday July 22, 2018
6:45 AM – 6:00 PM Registration – Grand Kentucky Ballroom Foyer
6:45 AM – 6:00 PM Exhibition – Grand Kentucky Ballroom Foyer
6:45 AM – 7:45 AM Continental Breakfast – Grand Kentucky Ballroom Foyer
7:45AM – 8:00 AM Welcoming Remarks and Announcements – Grand Kentucky Ballroom
Grand Kentucky Ballroom 
Symposium I – Structural Biology
Chair: Oleg Tsodikov
8:00 AM – 8:40 AM S-01
 Hazel M. Holden (University of Wisconsin – Madison)
 THE BIOSYNTHESIS OF N-FORMYLATED SUGARS IN PATHOGENIC BACTERIA
8:40 AM – 9:20 AM S-02
 George N. Phillips, Jr.  (Rice University)
 STRUCTURAL BIOLOGY OF NATURAL PRODUCT METABOLISM: SOME 
EXAMPLES
9:20 AM – 10:00 AM S-03
 Catherine L. Drennan  (Massachusetts Institute of Technology)
 
 STRUCTURAL ELUCIDATION OF ENZYMES INVOLVED IN OXETANOCIN-A 
BIOSYNTHESIS
10: 00 AM – 10:30 AM Break – Grand Kentucky Ballroom Foyer
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Grand Kentucky Ballroom Salon A&B
Session S-AM1 – Carbohydrates
Chair: Jon Thorson
10:30 AM – 11:10 AM S-04
 Hung-wen Liu  (University of Texas at Austin)
 RADICAL SAM ENZYMES IN THE BIOSYNTHESIS OF SUGAR-CONTAINING 
NATURAL PRODUCTS
11:10 AM – 11:50 AM S-05
 George A. O’Doherty (Northeastern University)
 DE NOVO SYNTHESIS OF NATURAL PRODUCTS FOR MEDICINAL CHEMISTRY
11:50 AM – 12:10 PM O-01
 Chia-Chuan Chang, PhD. (National Taiwan University)
 CHEMICAL INVESTIGATION OF SACCHARIDES OF DENDROBIUM CASSIOPE
12:10 PM – 12:30 PM O-02
 Qingyao Shou (Unigen, Inc.)
 TRITERPENOID SAPONINS FROM THE ROOTS OF GLYCYRRHIZA GLABRA
Grand Kentucky Ballroom Salon C&D
Session S-AM2 – Biosynthesis/Discovery 
Chair: Steven Van Lanen
10:30 AM – 11:10 AM S-06
 Jianhua Ju (South China Sea Institute of Oceanology, Chinese Academy of Sciences)
 ANTI-INFECTIVE NATURAL PRODUCTS DISCOVERY AND BIOSYNTHESIS FROM 
MARINE MICROORGANISMS
11:10 AM – 11:30 AM O-03
 Stephanie Grond (Eberhard Karls Universität Tübingen Institute of Organic Chemistry)
 LUGDUNIN - A NEW ANTIBIOTIC FROM OUR NOSE: STRUCTURE, CHEMICAL 
SYNTHESIS AND BIOACTIVITY
11:30 AM – 11:50 AM O-04
 Hope Ada Igboeli (University of Prince Edward Island)
 DISCOVERY OF A NEW POLYKETIDE VIA CO-TREATMENT WITH AN EPIGENETIC 
MODIFIER AND OSMOTIC STRESS
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11:50 AM – 12:10 PM O-05
 Gina Grammbitter (Goethe-Universität Frankfurt am Main)
 UNCOMMON MECHANISM OF A TYPE II PKS DERIVED ARYL POLYENE PIGMENT 
PRODUCED BY XENORHABDUS DOUCETIAE
12:10 PM – 12:30 PM O-06
 Jana Braesel (University of Illinois at Chicago)
 DIAZAQUINOMYCIN BIOSYNTHESIS IN MARINE AND FRESHWATER 
ACTINOMYCETES
12:30 PM – 2:00 PM Lunch (on your own)
12:30 PM – 2:00 PM Journal of Natural Products Editorial Board Meeting (Invitation Only) Triple Crown
Grand Kentucky Ballroom Salon A&B
Session – S-PM1 - Discovery 
Chair:  Jürgen Rohr
2:00 PM – 2:40 PM S-07
 Chirlei Glienke (Federal University of Parana, Brazil)
 BIODIVERSITY AND BIOTECHNOLOGICAL POTENTIAL OF ENDOPHYTES OF 
THE MEDICINAL PLANTS FROM THE BRAZILIAN BIOMES PANTANAL AND 
CERRADO
2:40 PM – 3:00 PM O-07
 Jaclyn M. Winter (University of Utah)
 EXPLORING THE CHEMICAL POTENTIAL OF GREAT SALT LAKE 
MICROORGANISMS
3:00 PM – 3:20 PM O-08
 Andrés Mauricio Caraballo Rodríguez (University of California - San Diego, Skaggs 
School of Pharmacy and Pharmaceutical Sciences)
 (University of California San Diego)
 MOLECULAR CARTOGRAPHY OF FUNGUS-GROWING ANTS GARDENS REVEALS 
THE PRESENCE OF BIOACTIVE METABOLITES IN SITU
3:20 PM – 3:40 PM O-09
 Serge Fotso 
 (Corteva Agriscience™, Agriculture Division of DowDuPont™)
 
 ANTIFUNGAL PEPTIDES FROM MICROASCUS ALVEOLARIS ACTIVE AGAINST 
PHYTOPATHOGENIC FUNGI
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3:40 PM – 4:00 PM O-10
 David Cole Stevens (University of Mississippi)
 MYXOBACTERIA DEGRADE ACYLHOMOSERINE LACTONE QUORUM SIGNALS 
AND PREVENT PSEUDOMONAS PUTIDA BIOFILM FORMATION
Grand Kentucky Ballroom Salon C&D
Session – S-PM2 – Plant Genetics
Chair: Joe Chappell
2:00 PM – 2:40 PM S-08
 Cathie Martin (John Innes Centre)
 SYNTHESIS OF BIOACTIVE 4’ DEOXYFLAVONES IN SCUTELLARIA BAICALENSIS, 
THE GOLDEN HERB OF THE CHINESE MEDICINAL GARDEN
2:40 PM – 3:00 PM O-11
 Debasis Bagchi, PhD, MACN, CNS, MAIChE 
 (Cepham Inc., University of Houston)
 A RANDOMIZED, PLACEBO-CONTROLLED, CLINICAL TRIAL TO EVALUATE THE 
EFFICACY OF A NOVEL FENUGREEK SEED EXTRACT ON PHYSICAL FITNESS 
AND SPORTS NUTRITION
3:00 PM – 3:20 PM O-12
 Hannah Whitmore (University of Surrey)
 NOVEL HOMOISOFLAVONOIDS AS INHIBITORS OF OCULAR ANGIOGENESIS
3:20 PM – 3:40 PM O-13
 Nga Yi Tsang (Hong Kong Baptist University)
 DISCOVERY OF ANTI-AVIAN INFLUENZA COMPOUNDS FROM EURYA NITIDA 
AND MAESA PERLARIUS
3:40 PM – 4:00 PM O-14
 Anina Buchmann (University of Tuebingen, Germany)
 THE IMMUNOSUPPRESSANT BRASILICARDIN: HETEROLOGOUS EXPRESSION, 
REVISION OF THE GENE CLUSTER AND MUTASYNTHESIS STUDIES
4:00 PM – 7:00 PM Poster Session I – Magnolia, Bluegrass, Crimson Clover, Lilly of the Valley, Black Berry Lilly, 
Lobby and Pre-Function 
 (Poster #’s P-01 – P-140) 
 (All posters need to be picked up by Monday 6:00 AM, ASP is not responsible for lost or 
damaged posters)
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4:00 PM – 7:00 PM Dinner (on your own)
Grand Kentucky Ballroom
Symposium II – Synthesis
Chair: Sylvie Garneau-Tsodikova
7:00 PM – 7:40 PM S-09
 Peter Wipf (University of Pittsburgh)
 ADVENTURES IN THE SYNTHESIS OF POLYCYCLIC ALKALOIDS
7:40 PM – 8:20 PM S-10
 Shahriar Mobashery (University of Notre Dame)
 COMPLEX BIOLOGICAL MACHINERIES: BACTERIAL CELL WALL, ITS TURNOVER 
AND LINK TO ANTIBIOTIC RESISTANCE
8:20 PM – 9:00 PM S-11
 Paul J. Hergenrother (University of Illinois, Urbana-Champaign)
 SYSTEMATIC CONVERSION OF GRAM-POSITIVE-ONLY COMPOUNDS INTO 
BROAD-SPECTRUM ANTIBIOTICS
9:00 PM – 9:40 PM S-12
 Jeroen S. Dickschat (University of Bonn)
 TRACING TERRESTRIAL TERPENES WITH ISOTOPES
Monday July 23, 2018
7:00 AM – 4:30 PM Registration – Grand Ballroom Foyer
7:00 AM – 4:30 PM Exhibition – Grand Ballroom Foyer
7:00 AM – 8:00 AM Continental Breakfast – Grand Ballroom Foyer
Grand Kentucky Ballroom
Symposium III – Discovery Techniques
Chairs: Sylvie Garneau-Tsodikova
8:00 AM – 8:40 AM S-13
 Nathan Magarvey (McMaster University)
 DENDRAL TO DEEP LEARNING IN NATURAL PRODUCT CHEMISTRY
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8:40 AM – 9:20 AM S-14
 Rebecca Goss (University of St Andrews)
 EXPLORING AND EXPLOITING BIOSYNTHESIS TO ACCESS NOVEL NATURAL 
PRODUCTS  
 
9:20 AM – 10:00 AM S-15
 Rebecca A. Butcher (University of Florida)
 
 CHEMICAL SIGNALING IN WORMS
10:00 AM – 10:30 AM Break
Grand Kentucky Ballroom Salon A&B
Session M-AM1 - Biosynthesis
Chair: Jürgen Rohr
10:30 AM– 11:10 AM S-16
 Yi Tang (University of California, Los Angeles)
 DISCOVERING NEW ENZYMES FROM FUNGAL NATURAL PRODUCT 
BIOSYNTHETIC PATHWAYS
11:10 AM – 11:50 AM S-17
 Ben Shen, Ph.D. (The Scripps Research Institute)
 GENOME MINING OF ENEDIYNE NATURAL PRODUCTS PROVIDING NEW 
OPPORTUNITIES FOR ENEDIYNE BIOSYNTHESIS, ENGINEERING, AND DRUG 
DISCOVERY
11:50 AM – 12:10 PM O-15
 Michael J. Smanski (University of Minnesota)
 DESIGNED BIOSYNTHESIS OF A NATURAL PRODUCT OF UNKNOWN ORIGIN
12:10 PM – 12:30 PM O-16
 Timothy A. Wencewicz
 (Washington University in St. Louis, Department of Chemistry) 
 CROSSROADS OF ANTIBIOTIC BIOSYNTHESIS AND RESISTANCE
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Grand Kentucky Ballroom Salon C&D
Session M-AM2 - Discovery
Chair: Oleg Tsodikov
10:30 AM– 11:10 AM S-18
 Robert H. Cichewicz (The University of Oklahoma)
 MAKE NATURAL PRODUCTS GREAT AGAIN: NO COLLUSION; PLENTY OF 
COLLABORATION
11:10 AM – 11:30 AM O-17
 Rob Capon (The University of Queensland)
 METABOLITES FROM A FISH GUT FUNGUS CHALLENGE THE DEFINITION OF 
WHAT IT IS TO BE A NATURAL PRODUCT?
11:30 AM – 11:50 AM O-18
 Jason M. Crawford (Yale University)
 BIOACTIVE POLYKETIDE TRANSFORMATIONS IN BACTERIAL PATHOGENS AND 
IN HUMANS
11:50 AM – 12:10 PM O-19
 Danielle H. Demers (AnalytiCon Discovery)
 NATLIFE 2020: DISCOVERING TASTE MODULATING NATURAL PRODUCTS FOR 
HUMAN HEALTH APPLICATIONS
 
12:10 PM – 12:30 PM O-20
 Patricia M. Van Skaik (Lloyd Library and Museum)
 WHAT’S OLD AND NEW AT THE LLOYD LIBRARY: AMERICA’S INDEPENDENT 
PHARMACOGNOSY LIBRARY
12:30 PM – 2:00 PM Lunch (on your own)
12:30 PM – 2:00 PM Fellows Meeting (Invitation Only)
 Triple Crown Room
Grand Kentucky Ballroom Salon A&B
Session M-PM1 - Marine 
Chair: Jon Thorson
2:00 PM – 2:40 PM S-19
 Kerry McPhail (Oregon State University)
 TARGETING INHIBITORS OF PROTEIN SECRETION FROM MARINE MICROBIAL 
COMMUNITIES
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2:40 PM – 3:00 PM O-21
 Glenroy (Dean) Martin (Fisk University)
 INVESTIGATION OF BIOACTIVE CHEMICAL ENTITIES FROM MARINE 
MICROORGANISMS
3:00 PM – 3:20 PM O-22
 Sandra Loesgen (Oregon State University)
 MENSACARCIN AFFECTS MITOCHONDRIAL FUNCTION SELECTIVELY IN 
MELANOMA CELLS
3:20 PM – 3:40 PM O-23
 Jeremy G. Owen (Victoria University of Wellington)
 METAGENOME SEQUENCING OF THE NEW ZEALAND MARINE SPONGE 
MYCALE HENTSCHELI UNCOVERS THE BIOSYNTHETIC PATHWAYS FOR THE 
CYTOTOXIC POLYKETIDES MYCALAMIDE AND PATEAMINE
3:40 PM – 4:00 PM O-24
 Shugeng Cao (Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo)
 
 NEW NATURAL PRODUCTS FROM HAWAIIAN MARINE AND ENDOPHYTIC 
FUNGI
Grand Kentucky Ballroom Salon C&D
Session M-PM2 – Plant Metabolites
Chair: Steven Van Lanen
2:00 PM – 2:40 PM S-20
 Christopher J. Schofield (University of Oxford)
 ENZYMES THAT MAKE AND BREAK β-LACTAMS
 
2:40 PM – 3:00 PM O-25
 Paul Scesa (Florida Atlantic University)
 A KINETIC DEAROMATIZATION STRATEGY FOR AN EXPEDIENT BIOMIMETIC 
ROUTE TO THE BIELSCHOWSKYSIN SKELETON
 
3:00 PM – 3:20 PM O-26
 Eduardo J. Caro-Diaz 
 (School of Pharmacy, University of Puerto Rico)
 
 HIGHLY CONVERGENT TOTAL SYNTHESIS AND ASSIGNMENT OF ABSOLUTE 
CONFIGURATION OF MAJUSCULAMIDE D, A POTENT CYTOTOXIC METABOLITE 
FROM MOOREA SP.
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3:20 PM – 3:40 PM O-27
 Camila Manoel Crnkovic (University of Illinois at Chicago)
 USING METABOLOMICS TO DISCOVER NATURAL PRODUCTS FROM CULTURED 
CYANOBACTERIA
3:40 PM – 4:00 PM O-28
 Barry R. O’Keefe (National Cancer Institute)
 THE NCI PROGRAM FOR NATURAL PRODUCT DISCOVERY
4:00 PM – 6:00 PM Poster Session II – Magnolia, Bluegrass, Crimson Clover, Lilly of the Valley, Black Berry Lilly, 
Lobby and Pre-Function
 (Poster #’s P-141 - P-275)
 (All posters need to be picked up by Tuesday 6:00 AM
 ASP is not responsible for lost or damaged posters)
6:00 PM Bus Loading for Keenleand
 Hilton Lexington Downtown Lobby
7:00 PM – 10:00 PM An Evening at Keeneland  (Dinner - Ticketed Event)
 4201 Versailles Rd.
 Lexington, KY 40510
 Directions to Keeneland
Tuesday July 24, 2018
7:00 AM – 12:30 PM Registration – Grand Ballroom Foyer
7:00 AM – 12:30 PM Exhibition – Grand Ballroom Foyer
7:00 AM – 8:00 AM Continental Breakfast – Grand Ballroom Foyer
Grand Kentucky Ballroom
Symposium IV- Biosynthesis 
Chair: Joe Chappell
8:00 AM – 8:40 AM S-21
 Tim S. Bugni (University of Wisconsin)
 Waters Award Recipient
 SMALL MOLECULE MEDIATED BACTERIAL INTERACTIONS TRANSCRIPTIONALLY 
ACTIVATE BIOSYNTHETIC GENE CLUSTERS IN A MICROMONOSPORA SP.
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8:40 AM – 9:20 AM S-22
 Michael D. Burkart (University of California, San Diego)
 PROTEIN-PROTEIN AND PROTEIN-SUBSTRATE INTERACTIONS IN FATTY ACID 
AND POLYKETIDE SYNTHASES
9:20 AM – 10:00 AM S-23
 Christian Hertweck (Leibniz Institute for Natural Product Research and Infection Biology 
– Hans Knöll Institute)
 CHEMICAL INNOVATION IN MICROBIAL INTERACTIONS
10:00 AM–10:30 AM Break
Grand Kentucky Ballroom Salon A&B
Session T-AM1 - Discovery
Chair: Steven Van Lanen
10:30 AM – 11:10 AM S-24
 Amy L. Lane (University of North Florida)
 
 HARNESSING BIOSYNTHETIC PATHWAYS TO EXPAND DIKETOPIPERAZINE 
CHEMICAL SPACE
11:10 AM – 11:50 AM S-25
 Sean F. Brady (The Rockefeller University)
 NATURAL PRODUCTS FROM UNCULTURED BACTERIA
11:50 AM – 12:10 PM O-29
 Andrew Osborn (Oregon State University)
 CHARACTERIZATION OF CONSERVED ACTINOBACTERIAL MYCOSPORINE-
LIKE AMINO ACID GENES THROUGH HETEROLOGOUS EXPRESSION
12:10 PM – 12:30 PM O-30
 April L. Risinger, PhD (The University of Texas Health Science Center at San Antonio - UT 
Health)
 OLD DRUGS, NEW TRICKS: NON-MITOTIC EFFECTS OF MICROTUBULE 
TARGETING AGENTS IN CANCER CELLS
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Grand Kentucky Ballroom Salon C&D
Session T-AM2 - Methods
Chair: Jon Thorson
10:30 AM – 11:10 AM S-26
 Roger Linington (Simon Fraser University)
 THE NATURAL PRODUCTS ATLAS; AN OPEN ACCESS DATABASE PLATFORM FOR 
NATURAL PRODUCTS DISCOVERY
 
11:10 AM – 11:30 AM O-31
 Brian Killday (Bruker Biospin)
 TWO-DIMENSIONAL QUANTITATIVE NUCLEAR MAGNETIC RESONANCE FOR 
DETERMINATION OF COMPONENT CONCENTRATIONS IN COMPLEX MIXTURES
 
11:30 AM – 11:50 AM O-32
 Kirk R. Gustafson (Molecular Targets Program, Center for Cancer Research, NCI)
 NMR CHARACTERIZATION OF COMPLEX NATURAL PRODUCTS: NEW TOOLS 
FOR ASSIGNING NOVEL MOLECULAR SCAFFOLDS
11:50 AM – 12:10 PM O-33
 Maria Sofia Ramos da Costa (University of Iceland)
 IDBAC: A MALDI-TOF MS PLATFORM TO CREATE DIVERSE MICROBIAL 
LIBRARIES
12:10 PM – 12:30 PM O-34
 James Hudson Tryon (Northwestern University)
 LEVERAGING METABOLOMICS ACROSS HUNDREDS OF ACTINOMYCETE 
STRAINS TO CALIBRATE EMERGING BIOINFORMATICS PLATFORMS
1:30 PM Bus Loading for Optional Tours to Horse Farm and Distillery
 Hilton Lexington Downtown Lobby
2:00 PM – 5:00 PM Horse Farm and Distillery Tours
2: 00 PM Bus Loading Starting for the Young Members Event
 Hilton Lexington Downtown Lobby
4:00 PM – 8:00 PM Young Members Event (Ticketed Event)
 Buffalo Trace Distillery 
 113 Great Buffalo Trace
 Frankfort, KY 40601
 Directions to Buffalo Trace Distillery
12:30 PM - Free Afternoon and Evening for others not attending Young Members Event or Optional 
Tours
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Wednesday July 25, 2018
7:00 AM – 3:30 PM Registration – Grand Kentucky Ballroom Foyer
7:00 AM – 11:50 AM Exhibition – Grand Kentucky Ballroom Foyer
7:00 AM – 8:00 AM Continental Breakfast – Grand Kentucky Ballroom Foyer
11:50 AM – 3:00 PM Exhibitor Dismantling – Grand Kentucky Ballroom Foyer
Grand Kentucky Ballroom
Symposium V- Discovery
Chair: Jürgen Rohr 
8:00 AM – 8:40 AM S-27
 Jon Clardy (Harvard Medical School)
 TARGETED-INTERACTION SCREENS AND ANTIBIOTIC DISCOVERY
8:40 AM – 9:20 AM S-28
 Taiwo Olayemi Elufioye (University of Ibadan)
 PHYTOCHEMICALS AS NEUROPROTECTIVE AGENTS: THE MULTI-TARGET 
APPROACH 
9:20 AM – 10:00 AM S-29
 Rolf Müller (Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS)
 MYXOBACTERIA: BIODIVERSITY, SYNTHETIC BIOTECHNOLOGY AND 
SECONDARY METABOLOMICS FOR NATURAL PRODUCT DISCOVERY
10:00 AM – 10:30 AM Break – Grand Kentucky Ballroom Foyer
Grand Kentucky Ballroom Salon A&B
Session W-AM1- Enzymes
Chair: Sylvie Garneau-Tsodikova
10:30 AM – 11:10 AM S-30 
 Andrew M. Gulick, Ph.D (University at Buffalo)
 THE STRUCTURAL CYCLE OF NONRIBOSOMAL PEPTIDE SYNTHETASE ENZYMES
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11:10 AM – 11:50 AM S-31
 Sylvie Garneau-Tsodikova (University of Kentucky)
 
 UNDERSTANDING AND ENGINEERING MULTIFUNCTIONAL ENZYMES FOR 
NONRIBOSOMAL PEPTIDE SYNTHESIS
Grand Kentucky Ballroom Salon C&D
Session W-AM2- Symbiosis
Chair: Oleg Tsodikov
10:30 AM – 11:10 AM S-32
 Eric W. Schmidt (University of Utah)
 STRUCTURAL AND BIOCHEMICAL DIVERSITY IN MARINE SYMBIOTIC NATURAL 
PRODUCTS 
11:10 AM – 11:30 AM O-35
 Paige Elizabeth Mandelare (Oregon State University)
 CO-CULTURE OF TWO FORMS OF A MARINE-DERIVED ASPERGILLUS ALLIACEUS 
RESULTS IN THE PRODUCTION OF ALLIANTHRONES A-F
11:30AM – 11:50 AM O-36
 Gabrielle Grandchamp (University of North Carolina at Chapel Hill)
 COCULTURE STIMULATES ANTIBIOTIC BIOSYNTHESIS IN ACTINOMYCETES
11:50 AM – 1:30 PM Lunch (on your own)
Grand Kentucky Ballroom
Award Symposium
1:30 PM – 2:20 PM S-33
 James B. Gloer (Department of Chemistry, University of Iowa)
 Norman R. Farnsworth Research Achievement Award Lecture
 ADVENTURES IN FUNGAL NATURAL PRODUCTS CHEMISTRY--FUNGAL 
ECOLOGY, BIODIVERSITY, AND THE SEARCH FOR NEW BIOACTIVE 
METABOLITES
2:20 PM – 3:00 PM S-35
 Marcy J. Balunas (University of Connecticut)
 Matt Suffness Young Investigator Award Lecture
 INTERACTION-DRIVEN MOLECULE DISCOVERY FROM HOST-MICROE 
SYMBIOSES
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3:00 PM – 5:00 PM ASP Business Meeting – Magnolia Room
6:30 PM – 7:30 PM Closing Reception – Grand Kentucky Ballroom Foyer
7:30 PM – 10:30 PM Closing Ceremony and Banquet – Grand Kentucky Ballroom 
(Ticketed Event)
Thursday July 26, 2018
9:00 AM  Optional Excursion to Lloyd Library 
  
Thank you for your participation in the 2018 ASP Meeting!   
See you in Madison, WI in 2019
Poster Presentations
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Symposium Presentations
S-01
THE BIOSYNTHESIS OF N-FORMYLATED SUGARS IN 
PATHOGENIC BACTERIA
Hazel M. Holden and James B. Thoden
Department of Biochemistry, University of Wisconsin-Madison
Bacteria produce an astonishingly diverse array of carbohydrate-based ma-
cromolecules that serve important physiological roles. Approximately 11 
years ago, my laboratory turned its research attention to those enzymes that 
are involved in the biosynthesis of novel sugars found attached to antibio-
tics, antifungals, anthelmintics, and antitumor agents. In addition to being 
found on natural products, however, unusual sugars have also been obser-
ved on the lipopolysaccharides or LPS of Gram-negative bacteria. There is 
growing evidence that the O-antigens of the LPS play important physiolo-
gical roles including effective colonization of host tissues, protection from 
phagocytosis and serum-mediated killing, and resistance to antimicrobial 
peptides. 
The occurrence of deoxysugars on the bacterial LPS has been known for 
more than 30 years. Due to the increased sensitivities of such techniques as 
NMR, however, it is becoming apparent that the O-antigens are far more 
complicated than originally thought. Recent research has demonstrated 
that some pathogenic Gram-negative bacteria contain quite remarkable N-
formylated dideoxysugars. Indeed, my laboratory has shown that Mycobac-
terium tuberculosis, the causative agent of tuberculosis, has all the necessary 
enzymes to produce N-formylated sugars. Our recent investigations on the 
enzymes involved in the biosynthesis of these sugars will be presented. 
S-02
STRUCTURAL BIOLOGY OF NATURAL PRODUCT 
METABOLISM: SOME EXAMPLES
George N. Phillips, Jr.
Rice University, MS 140, Houston, Tx 77006
Complex natural products are often biosynthesized by modular polyketide 
synthase (PKS) systems, which extend and modify the nascent compound 
through sequential steps.  We have characterized a set of PKS’s that do not 
contain the usual customized  in cis acyl transferase modules but can use 
more generic ones.   This class of PKS have an interesting “variation on 
a theme” and suggest ways for horizontal gene transfer to play a role in 
new natural product pathways.  The set of enzymes that modify the basic 
scaffold produced by the PKS systems, including cyclization, aromatization, 
methylation and glycosylation also exhibit interesting enzymatic activities 
that can be studied at the atomic level by structural biology to reveal 
mechanisms of action. Some of these systems will be reviewed with an 
eye toward the pathways that are involved for enediynes and other natural 
products. Finally, new crystallographic methods also allow time-resolved 
kinetics of natural product degradation to be revealed with near atomic de-
tail  Some results on beta-lactamase will be presented.
Supported by NIH grants GM094585, GM098248, CA106150 and the De-
partment of Energy
S-03
STRUCTURAL ELUCIDATION OF ENZYMES INVOLVED 
IN OXETANOCIN-A BIOSYNTHESIS 
Jennifer Bridwell-Rabb1-3, Aoshu Zhong4,5, Gyunghoon Kang2, Hung-wen 
Liu4,5, and Catherine L. Drennan1-3
1Howard Hughes Medical Institute, 2Department of Chemistry, and 
3Department of Biology, Massachusetts Institute of Technology, Cambridge, 
Massachusetts 02139, 4Division of Chemical Biology and Medicinal 
Chemistry, College of Pharmacy, and 5Department of Chemistry, University 
of Texas, Austin, TX 78712
The natural product oxetanocin-A is a potent antiviral compound produ-
ced by Bacillus megaterium NK84-0128. The biosynthesis of oxetanocin-A 
has been linked to a plasmid-borne gene cluster that contains four genes 
involved in oxetanocin-A production (oxsA and oxsB) and oxetanocin-A 
resistance (oxrA and oxrB). In terms of the biosynthetic enzymes, OxsB 
is a cobalamin (Cbl)-dependent Sadenosylmethionine (SAM) radical en-
zyme, and OxsA is an HD-domain phosphohydrolase enzyme. We have 
determined crystal structures of both OxsA and OxsB, and in this talk, we 
will present our current thinking about how these enzymes work together 
to transform dATP into oxetanocin-A, a process that involves a chemically 
challenging carbon skeletal rearrangement. 
S-04
RADICAL SAM ENZYMES IN THE BIOSYNTHESIS OF 
SUGAR-CONTAINING NATURAL PRODUCTS 
Hung-wen Liu
Division of Chemical Biology and Medicinal Chemistry, College of 
Pharmacy, and Department of Chemistry, University of Texas at Austin, 
Austin, TX 78712, USA
Carbohydrates play a key role in the biological activity of numerous natural 
products. In many instances, their biosynthesis requires radical mediated 
chemical transformations, some of which are catalyzed by radical SAM 
enzymes. DesII is one such enzyme involved in the deamination reaction 
necessary for net C4 deoxygenation of a glucose derivative en route to deso-
samine formation. AprD4 is functionally related to DesII and catalyzes the 
C3 deoxygenation of paromamine, a key step in the biosynthesis of serval 
aminoglycosides. SpeY has been shown to catalyze dioxane ring formation 
in a disaccharide. GenK is a cobalamin-dependent radical SAM enzyme 
that catalyzes the methylation of an unactivated sp3 carbon of GenX2 to pro-
duce the intermediate G418 during the biosynthesis of gentamicin. OxsB 
is another cobalamin-dependent radical SAM enzyme responsible for the 
ring contraction of 2’-deoxyadenosine 5’-monophosphate to yield the four-
membered heterocycle in oxetanocin. These enzymes are representative 
radical SAM enzymes that are involved in carbohydrate biosynthesis. The 
biosynthetic roles of some of these enzymes, their mechanisms of catalysis, 
the questions that have arisen during their study, and the insights they can 
offer for furthering our understanding of radical SAM enzymology will be 
discussed in this presentation. 
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S-05
DE NOVO SYNTHESIS OF NATURAL PRODUCTS FOR 
MEDICINAL CHEMISTRY
George A. O’Doherty
Department of Chemistry Northeastern University, Boston, MA  02115
Over the years, the O’Doherty group has been working in two related areas 
of organic synthesis: carbohydrates and natural products. The unifying the-
me that connects our research in these two areas is our method of synthesis 
(asymmetric catalysis) and target selection (stereochemically complexity 
and biological activity). A recurring theme in the group’s synthetic ap-
proaches to any target is the reliance on asymmetric catalysis and synthetic 
design for the control of asymmetry. The application of these “atom econo-
mical” approaches should allow simple conversion of readily available bulk 
chemicals (e.g., polyenes, furans) to advanced chiral intermediates (e.g., 
polyketides and carbohydrates). Fundamental to our approach is the deve-
lopment of highly efficient routes that transform, via catalysis, inexpensive 
achiral starting materials into enantiopure products, which are poised for 
the conversion into complex molecules with biologically relevant proper-
ties (i.e., enantioselective synthesis of a new “chiral pool” via asymmetric 
catalysis).  Recently, we have found that these approaches have matured to 
the point where we have developed enantioselective routes to these com-
plex molecules in sufficient quantities that are amenable for biomedical 
investigations. 
Scheme 1: Sample target molecules
S-06
ANTI-INFECTIVE NATURAL PRODUCTS 
DISCOVERY AND BIOSYNTHESIS FROM MARINE 
MICROORGANISMS
Jianhua Ju
CAS Key Laboratory of Marine Bio-resources and Ecology, South China Sea 
Institute of Oceanology, Chinese Academy of Sciences, Guangzhou 510301, 
China
Natural  products  play  a  pivotal  role  in  drug  discovery  and development 
initiatives, especially in infectious disease arenas. However, the emergence 
of drug-resistance among human pathogenic bacteria has proven to be an 
increasingly  important  problem, necessitating the discovery of new drug 
candidates with novel structures to circumvent bacterial mechanisms of 
drug resistance. Marine microorganisms have emerged as an exciting re-
source for novel bioactive natural products discovery. Deciphering and en-
gineering the natural product biosynthetic pathway provide an alternative 
strategy to modify the structures of complex natural products. In this talk, 
selected examples will be discussed on: i) isolation and identification of ma-
rine microorganisms from marine habitats; ii) Screening and discovery of 
novel anti-infective natural products as promising drug leads from marine 
microorganisms; and iii) genetic engineering of the biosynthetic pathways 
of the anti-infective polypeptide, polyketide and nucleoside natural pro-
ducts to make new drugable analogues and elucidating novel enzymes ca-
pable of catalyzing new chemistry. 
S-07
BIODIVERSITY AND BIOTECHNOLOGICAL POTENTIAL 
OF ENDOPHYTES OF THE MEDICINAL PLANTS FROM 
THE BRAZILIAN BIOMES PANTANAL AND CERRADO
Chirlei Glienke1, Daiani C. Savi1, Khaled A. Shaaban2,3, Jon S. Thorson2,3, 
Yvelise M. Possiede4, Jürgen Rohr2
1Department of Genetics, Federal University of Paraná, Curitiba, Brazil; 
2Department of Pharmaceutical Sciences, University of Kentucky, Lexington, 
KY, United States; 3Center for Pharmaceutical Research and Innovation, 
University of Kentucky, Lexington, KY, United States; 4Department of 
Biology, Federal University of Mato Grosso do Sul, Campo Grande, Brazil
Multidrug resistant pathogens have been observed with increasing fre-
quency in recent decades, driving the search for new drugs and stimulat-
ing the interest in Natural Products (NP) sources. Endophytes represent 
an important source of novel and useful bioactive compounds. In recent 
years, we have explored endophytes of medicinal plants from two Brazil-
ian biomes, the Pantanal (wetland) and the Cerrado (savannah), known 
as a biodiversity hotspot. We isolated more than 3,000 endophytic strains 
from Vochysia divergens (Pantanal) and Stryphnodendron adstrigens (Cer-
rado) and the molecular phylogenetic analyzes revealed high diversity of 
actinomycetes and fungi. The strains belong to more than 30 genera, and 
about 30% of all isolates correspond to new species and even to new ge-
nera. Several strains are producers of secondary metabolites with high bi-
ological activity against human pathogens such as Staphylococcus aureus, 
methicillin-resistant S. aureus (MRSA), Escherichia coli, Micrococcus luteus, 
Klebssiella pneumoniae (KPC), Candida albicans and Saccharomyces cere-
visiae, and against plant pathogens, such as Colletotrichum abscissum and 
Phyllosticta citricarpa. These compounds belong to several classes of known 
compounds (indoles, b-carbolines, brevianamide, diaporthin, orthosporin, 
cercosporin, isocercosporin and diketopiperazines) and novel compounds, 
such as 3-(sec-butyl)-6-ethyl-4,5-dihydroxy-2-methoxy-6-methylcyclo-
hex-2-enone. Our results indicate that the endophytes of Brazilian medici-
nal plants are producers of bioactive compounds and that their biodiversity 
and biotechnological potential remain underestimated.
S-08
SYNTHESIS OF BIOACTIVE 4’ DEOXYFLAVONES IN 
SCUTELLARIA BAICALENSIS, THE GOLDEN HERB OF 
THE CHINESE MEDICINAL GARDEN.
Cathie Martin1, Meng-Ying Cui2, Dongfeng Yang1,3, Jie Liu2, Jie Li2, Lionel 
Hill1, Lei Yang2, Yonghong Hu2, Xiao-Ya Chen2,4 and Qing Zhao1,2
1Department of Metabolic Biology, John Innes Centre, Norwich, NR4 7UH 
UK; 2Shanghai Key Laboratory of Plant Functional Genomics and Resources, 
Shanghai Chenshan Botanical Garden, Shanghai Chenshan Plant Science 
Research Center, Chinese Academy of Sciences, Shanghai, China; 3College 
of Life Sciences, Zhejiang Sci-Tech University, Key Laboratory of Plant 
Secondary Metabolism and Regulation of Zhejiang Province, Hangzhou 
310018, China; 4State Key Laboratory of Plant Molecular Genetics, CAS 
Center for Excellence in Molecular Plant Sciences, Shanghai Institute of 
Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai, 
China
Scutellaria baicalensis Georgi, known as Huang-Qin or Chinese skullcap, is 
one of the most widely used medicinal plants in traditional Eastern med-
icine. It has been applied in the treatment of inflammation, respiratory 
tract infections, diarrhoea, dysentery, liver disorders, hypertension, haem-
orrhaging, and insomnia. The major bioactive compounds isolated from 
S. baicalensis are 4’deoxyflavones such as baicalin, baicalein, wogonin and 
wogonoside. These flavones have been reported to have several pharmaco-
logical activities, which include anti-cancer, hepatoprotection, antibacterial 
and antiviral, antioxidant, anticonvulsant and neuroprotective effects.
I will describe the elucidation of the complete biosynthetic pathways for 
baicalein and wogonin in S. baicalensis, where new pathways have evolved 
Poster Presentations
28Abstracts | 2018 Annual Meeting of the ASP | July 21-25, 2018 | Lexington, Kentucky, USA
from the classic flavone biosynthetic pathway found in many angiosperms. 
A recently completed genome sequence for S. baicalensis sheds light on how 
this pathway evolved, principally by tandem duplications and neofunction-
alizations. Metabolite profiling shows that different 4’deoxyflavones accu-
mulate in different species of Scutellaria, particularly as a resulting in vary-
ing activity of P450 decorating enzymes. Screening of Scutellaria accessions 
also identified species where 4’ deoxyflavones accumulate to high levels in 
leaves, so offering more sustainable natural sources of these bioactive com-
pounds.
S-09
ADVENTURES IN THE SYNTHESIS OF POLYCYCLIC 
ALKALOIDS
Peter Wipf, Stephanie McCabe, and Liming Cao
Department of Chemistry, University of Pittsburgh, Pittsburgh, PA 15260, 
USA
A significant part of our work over the past two decades has been influen-
ced by explorations of natural products, in particular alkaloids, with no-
vel architectures. Small ring strain and transannular interactions in larger 
ring scaffolds have traditionally been a rich source of serendipity-driven 
discoveries in Chemistry. For example, we have studied the effects of con-
figuration and hybridization of five-membered heterocycles embedded in 
the macrocyclic ring system of Lissoclinum peptides, giving raise to unique 
metal chelation selectivities. In the total synthesis of both enantiomers of 
the Clavine alkaloid cycloclavine, we used the strain of a methylenecyclo-
propene to assemble three consecutive stereocenters in an intramolecular 
Diels-Alder cycloaddition. In the last steps of a synthesis of the 3-aza-[7]-
paracyclophane moiety of the ascidian Aplidium haouarianum metabolite 
haouamine A, an unexpected fragmentation generated a rearranged hete-
rocyclic product.
S-10
COMPLEX BIOLOGICAL MACHINERIES: BACTERIAL 
CELL WALL, ITS TURNOVER AND LINK TO ANTIBIOTIC 
RESISTANCE
Shahriar Mobashery
Department of Chemistry and Biochemistry, University of Notre Dame, 
Notre Dame, IN 46556 USA
Members of Enterobacteriaceae and Pseudomonas aeruginosa have the abi-
lity to sense damage inflicted to their cell wall by β-lactam antibiotics. The 
process involves chemical signaling, which will be a subject of my presen-
tation. A primary mechanism for this sensing and signalling involves the 
events of cell-wall recycling. The cell wall is degraded for recycling and then 
the cell wall is synthesized de novo for the repair function. The recycling 
events get initiated by the functions of a family of 11 lytic transglycosy-
lases in P. aeruginosa, which generate the signalling factors that influence 
transcriptional events in the cytoplasm. The structures and mechanisms of 
these enzymes and those of the early cytoplasmic steps of recycling have 
been the subject of study in my lab, which I will disclose in my presentation. 
S-11
SYSTEMATIC CONVERSION OF GRAM-POSITIVE-ONLY 
COMPOUNDS INTO BROAD-SPECTRUM ANTIBIOTICS
Professor Paul J. Hergenrother
Department of Chemistry, 600 S. Mathews, University of Illinois, Urbana-
Champaign, Urbana, IL 61801
The incidence of multi-drug resistant Gram-negative infections has risen 
sharply in the last decade and is a growing health concern.  This problem is 
exacerbated by the fact that it has been 50 years since the clinical introduction 
of a new antibacterial class for these pathogens.  Central to the problem of 
Gram-negative antibiotic discovery are the challenges small-molecules face 
in traversing the Gram-negative outer membrane.  This lecture will describe 
our guidelines, the “eNTRy rules”, for predicting compound accumulation in 
Gram-negative bacteria.  The successful application of the eNTRy rules to 
the conversion of several different classes of Gram-positive-only compounds 
into versions that have broad-spectrum antibiotic activity will be discussed.
S-12
TRACING TERRESTRIAL TERPENES WITH ISOTOPES
Jeroen S. Dickschat
Kekulé-Institute of Organic Chemistry and Biochemistry, University of Bonn, 
Gerhard-Domagk-Strasse 1, 53121 Bonn, Germany (dickschat@uni-bonn.
de).
Recent advances in genome sequencing have revealed a large number of 
terpene synthases in microorgansisms. During the past years my group 
has synthesised various isotopically labelled terpene precursors that can be 
used to efficiently unravel the cyclisation mechanisms of these astonishing 
enzymes. Their application in mechanistic investigations on the most inte-
resting newly discovered terpene synthases, making the compounds shown 
below, will be discussed.
H H
H
spata-13,17-diene
HH
spiroviolene spiroalbatene
S-13
DENDRAL TO DEEP LEARNING IN NATURAL PRODUCT 
CHEMISTRY
Nathan Magarvey, PhD. 
McMaster University, Biochemistry and Biomedical Sciences & Chemistry 
and Chemical Biology, 1280 Main Street West, Hamilton Canada L8S4L8
Bioactive natural products from microbes discovered from an era defi-
ned through bioactivity guided fractionation lead to many revolutionary 
products. Much history exists in these searches and like in other pursuits 
there is a need to create increased efficiency in mining microbes for new 
bioactive agents. The increase in, and capacities to, sequence microbes and 
microbiomes provides information that now is suggesting the unknown 
chemical dark matter awaiting interrogation in relevant assays/applicati-
ons. Translating genetic information into accurate suggestion of chemistry 
demands computational tools and artificial intelligence. Among the first 
artificial intelligent systems, Dendral, focused on the unknown chemical 
dark matter from other planets. A similar level of ambition will be required 
to define the unknown chemistry encoded within microbial genomes.  In 
this talk an attempt will be made to define the history, current progress and 
prospective future of deep learning and artificial intelligence in microbial 
natural product chemical discovery.   
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S-14
EXPLORING AND EXPLOITING BIOSYNTHESIS TO 
ACCESS NOVEL NATURAL PRODUCTS  
Rebecca J. M. Goss1,2*
1Biomedicinal Ressearch Complex, University of St Andrews, KY16 9ST, 
UK; 2School of Chemistry, University of St Andrews, KY16 9ST, UK
Though natural products represent a treasure trove of medicinally relevant 
compounds, they are commonly misperceived to be unsuitable for me-
dicinal chemistry. We have an interest in the discovery of novel bioactive 
natural products and elucidating the biosynthesis of structurally unusual 
natural products.  We are developing new approaches to natural product 
analogue synthesis by blending together synthetic biology and synthetic 
chemistry. By complementing the biosynthetic machinery encoding an exi-
sting natural product with foreign genes we are able to introduce chemical-
ly orthogonal, reactive and selectable functionalisable handles into natural 
products. We have been developing mild chemical methodologies to enable 
the chemical derivitisation of these handles.
S-15
CHEMICAL SIGNALING IN WORMS
Rebecca A. Butcher
Department of Chemistry, University of Florida, Gainesville, FL  32611, 
USA
Our goal is to develop a comprehensive understanding of the chemical 
structures, biosynthesis, and mechanism of secondary metabolites in ne-
matodes.  This talk will describe our work on two important classes of natu-
ral products from C. elegans, the ascarosides and the nemamides.  C. elegans 
secretes ascarosides, derivatives of the 3,6-dideoxysugar ascarylose, as phe-
romones to control its development and behavior. We are using a multidis-
ciplinary approach, including RNAi-based screens, metabolomics, in vitro 
enzyme assays, organic synthesis of biosynthetic intermediates, and X-ray 
crystallography, to study the ascaroside biosynthetic pathway.  Our work 
has shown how peroxisomal β-oxidation is used to control the production 
of different ascaroside pheromones and how environmental conditions 
influence this process.  In a second area of research, we have used com-
parative metabolomics and NMR spectroscopy to discover the first hybrid 
polyketide-nonribosomal peptides from an animal, the nemamides from 
C. elegans.  We are using CRISPR-Cas9 and comparative metabolomics to 
explore the role of specific enzymatic domains in nemamide biosynthesis. 
Our work is providing insights into the biosynthesis of natural products in 
the context of a complex animal system.  
S-16
DISCOVERING NEW ENZYMES FROM FUNGAL 
NATURAL PRODUCT BIOSYNTHETIC PATHWAYS
Yi Tang
Department of Chemistry and Biochemistry, Department of Chemical 
and Biomolecular Engineering, University of California, Los Angeles, 420 
Westwood Plaza, Los Angeles, CA 90095
Fungal natural products are structurally diverse compounds with pharma-
ceutically relevant bioactivities.  In this talk I will present our work in un-
derstanding the biosynthesis of hybrid polyketide-amino acid compounds 
synthesized by polyketide synthase-nonribosomal peptide synthetases 
(PKS-NRPS).     We will focus on how assembly-line programming rules 
from the PKS-NRPS and novel enzyme activities from tailoring enzymes 
are precisely coordinated to build chemical complexity in a relatively few 
biosynthetic steps.   For example, we discovered pericyclases that catalyze 
Diels-Alder and hetero-Diels Alder reactions are found in these pathways 
to install decalin and pyran rings, respectively.  Other examples that will be 
presented include oxaleimides, a new family of succinimide and maleimide 
containing natural products discovered from genome mining of a cryptic 
PKS-NRPS gene cluster.  
S-17
GENOME MINING OF ENEDIYNE NATURAL PRODUCTS 
PROVIDING NEW OPPORTUNITIES FOR ENEDIYNE 
BIOSYNTHESIS, ENGINEERING, AND DRUG DISCOVERY
Ben Shen
Departments of Chemistry and Molecular Medicine and Natural Products 
Library Initiative at The Scripps Research institute, The Scripps Research 
Institute, Jupiter, Florida, USA
The enediyne family of natural products has had profound impact on 
modern chemistry, biology, and medicine.  Since the neocarzinostatin 
chromophore structure was first unveiled in 1985, the enediyne family 
has grown steadily but remains very small.  Recent advances in microbial 
genomics, however, clearly revealed that the biosynthetic potential of soil 
actinomycetes to produce enediynes is underappreciated.  Our current 
efforts on genome mining of enediyne natural products will be discussed 
to highlight the new opportunities for enediyne biosynthesis, engineering, 
and drug discovery.
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S-18
MAKE NATURAL PRODUCTS GREAT AGAIN: NO 
COLLUSION; PLENTY OF COLLABORATION
Robert H. Cichewicz1
1Natural Product Discovery Group, Department of Chemistry and 
Biochemistry, Institute for Natural Product Applications and Research 
Technologies, University of Oklahoma, Norman, OK 73019
Nature has long served as a source for bioactive molecules with many of 
these compounds ranking among the world’s most renowned and widely 
used organic substances. Numerous examples exist including well-known 
cancer chemotherapeutic agents, insecticides, and antibiotics. The influence 
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that natural products have had on humankind and the chemical sciences is 
undeniable, yet these landmark molecules are the products of past disco-
very efforts, which has raised the question, what do natural products have 
to offer as a resource for bioactive compound discovery in today’s world? 
An approach that has been implemented at the University of Oklahoma to 
transform fungal natural products drug discovery is the creation of a novel 
citizen-science-driven discovery effort called the Citizen Science Soil Coll-
ection Program (https://whatsinyourbackyard.org/). This program is aimed 
at recruiting citizen scientist from all walks of life to join our research team 
and explore the immense biological and natural-product-chemical diver-
sity of fungi from across much of the North American continent. In ad-
dition to enabling the rapid development of one of the world’s largest fun-
gal isolate and natural product chemistry collections, the Citizen Science 
Soil Collection Program provides a grassroots mechanism for promoting 
STEM education. Several unique and promising compounds have already 
emerged through these endeavors, which have reached families and schools 
across America.
S-19
TARGETING INHIBITORS OF PROTEIN SECRETION 
FROM MARINE MICROBIAL COMMUNITIES
Kerry L. McPhail1, David A. Gallegos1, Xinhui Yu1, Xuemei Wan1, Patricia 
M. Flatt2, Eric Isemonger3, Jarmo C.J. Kalinski3, Xavier Siwe Noundou3, 
Samantha Waterworth4, Rosemary A. Dorrington2, Jason Kwan4, Jane E. 
Ishmael1
1Department of Pharmaceutical Sciences, Oregon State University, 
Corvallis, OR 97331, USA, 2Department of Chemistry, Western Oregon 
University, Monmouth, OR 97361, USA, 3Department of Biochemistry and 
Microbiology, Rhodes University, Grahamstown South Africa, 4School of 
Pharmacy, University of Wisconsin, Madison, WI 53705.
The dominant role of “privileged” natural product (NP) structures in 
modern medicine is well established, especially for microbial NPs in the 
treatment of infectious diseases and cancers. Many microbial NP-based 
drugs have arisen from serendipitous discoveries involving relatively limited 
chemical and biological screening, followed by lengthy development paths 
for unanticipated indications. The discovery of extensive NP biosynthetic 
potential in sequenced microbial genomes, has prompted efforts to target 
biosynthetic genes for known NPs in short supply, or that potentially 
represent new chemical entities with new biological mechanisms but remain 
“cryptic”. We have taken advantage of collaborations in metagenomics and 
pharmacology to facilitate our investigations of macrocyclic NPs from 
marine tunicate/microbial symbiont consortia, and microbial communities 
dominated by cyanobacteria, in some cases, linking genomics, 
transcriptomics and secondary metabolomics. Whole-cell functional assays 
are being used for the discovery of substrate-selective inhibitors of cellular 
protein secretion via the Sec61 translocon. In particular, we are targeting 
nonpolar cyclic depsipeptide structures that are consistent with the 
handful of known Sec61 translocon inhibitors, as well as secreted protease 
inhibitors. The protein secretory pathway is an emerging therapeutic target 
due to its central involvement in regulating cellular proteostasis and protein 
folding, and its dysregulation in human disease. 
S-20
ENZYMES THAT MAKE AND BREAK Β-LACTAMS
Christopher J. Schofield
Department of Chemistry, University of Oxford, Mansfield Road, Oxford, 
OX1 3TA, UK
The lecture will describe mechanistic and inhibition studies on enzymes 
involved in β-lactam biosynthesis and hydrolysis.  It will aim to show how 
a desire to understand how these enzymes work led to the identification of 
unanticipated roles for homologues of the bacterial roles in humans, in-
cluding in the regulation of protein biosynthesis and nucleic acid repair. 
Recently, this work has led to the identification of new mechanisms for anti-
biotic resistance.  Work on the inhibition of metallo β-lactamases and other 
enzymes involved in antibiotic resistance will be described.
S-21
SMALL MOLECULE MEDIATED BACTERIAL 
INTERACTIONS TRANSCRIPTIONALLY 
ACTIVATE BIOSYNTHETIC GENE CLUSTERS IN A 
MICROMONOSPORA SP.
Deepa Acharya1, Navid Adnani1, Marc G. Chevrette2, Ian J. Miller1, Shaurya 
Chanana1, Yusi Cui1, Cameron R. Currie2, Lingjun Li1, Jason C. Kwan1, Tim 
S. Bugni1
1Pharmaceutical Sciences Division and 2Department of Bacteriology, 
University of Wisconsin, Madison, Wisconsin 53705
Whole genome sequencing has shown that the biosynthetic potential of 
actinomycetes far exceeds what is observed using standard fermentation 
conditions.  As such, products for many biosynthetic gene clusters are not 
observed under standard laboratory conditions.   In particular, we found 
that members of the Micromonosporaceae, a group of actinomycetes com-
mon in marine environments, rarely produced extracts with antibiotic ac-
tivity, despite evidence for rich biosynthesis capability.  We developed mi-
croscale co-culture platforms to evaluate mixed cultures for induction of 
antibiotic production.  One pair, a Micromonospora sp. and a Rhodococcus 
sp. led the production of an otherwise unattainable bis-nitroglycosylated 
antibiotic that we named keyicin.  Our preliminary studies led to the hypo-
thesis that a small molecule mediated the interaction between these orga-
nisms that activated production of keyicin.  We sequenced the genomes of 
both organisms using PacBio and identified the Micromonospora sp. as the 
producer.  Within the biosynthetic gene cluster, we identified a LuxR with 
homology to those found in Pseudomonas sp.  Combined with evidence 
that the Rhodococcus sp. produced a molecule responsible for activating 
production, we established a working hypothesis that a small molecule led 
to transcriptional activation of the keyicin pathway.  This presentation will 
discuss the data supporting our current hypothesis and a proof of concept 
for extending these studies to other similarly regulated clusters.  
S-22
PROTEIN-PROTEIN AND PROTEIN-SUBSTRATE 
INTERACTIONS IN FATTY ACID AND POLYKETIDE 
SYNTHASES
Michael D. Burkart
Department of Chemistry and Biochemistry, University of California, San 
Diego, 9500 Gilman Dr., La Jolla, CA 92093.
Metabolites from fatty acid synthase (FAS) and polyketide synthase (PKS) 
pathways differ broadly in their identities and functional roles. The for-
mer are considered primary metabolites that are linear hydrocarbon acids, 
while the latter are complex aromatic, partially reduced, or polyunsaturated 
secondary metabolites. Though the study of bacterial FAS has benefitted 
from decades of biochemical and structural investigations, PKSs have re-
mained less understood, primarily due to challenges in protein expression 
and structural biology. Here we will discuss approaches to the study of FAS 
that have highlighted the critical role of the acyl carrier protein (ACP) with 
regard to how it stabilizes intermediates through sequestration and selec-
tively delivers cargo to successive enzymes within these iterative pathways, 
utilizing the specificity conferred by protein-protein interactions to guide 
and organize enzymatic timing and specificity. Analogs of the tools that 
have shown promise in FAS elucidation have found new approaches to both 
type I and type II PKS systems, which will be further elaborated with appli-
cations to structural biology approaches. 
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S-23
CHEMICAL INNOVATION IN MICROBIAL 
INTERACTIONS
Christian Hertweck
Leibniz Institute for Natural Product Research and Infection Biology (HKI), 
Beutenbergstr. 11a, 07745 Jena, Germany; E-mail: christian.hertweck@
leibniz-hki.de
The vast structural diversity of secondary metabolites has evolved over mil-
lions of years to address specific needs of the producing microorganisms in 
their niches. Thus, microbial natural products are not only highly specific 
mediators of microbial interactions, but also a valuable a source of molecu-
lar tools and therapeutics that have been pre-optimized for particular bio-
logical targets. Recent research has led to a massive body of knowledge on 
biosynthetic mechanisms, structures and functions. Yet, we know only very 
little about how structural diversity evolved. We are also perplexed by the 
hugely underestimated biosynthetic potential that remains invisible outside 
of the specific ecological context. This talk will present some compounds 
and pathways from various less explored bacteria, highlight the importance 
of considering ecological aspects in the search for biologically active mole-
cules, and shed light on mechanisms and some evolutionary aspects of na-
tural product biosynthesis. 
S-24
HARNESSING BIOSYNTHETIC PATHWAYS TO EXPAND 
DIKETOPIPERAZINE CHEMICAL SPACE
Amy L. Lane
Chemistry Department, University of North Florida, Jacksonville, FL 32224
Natural products with 2,5-diketopiperazine (DKP) scaffolds offer a broad 
range of bioactivities and chemical structures. The functional and struc-
tural diversity of these cyclodipeptides arises via enzyme-catalyzed con-
struction from a variety of amino acids as well as tailoring of DKP cores. 
For many years, nonribosomal peptide synthetases (NRPSs) were the only 
enzymes recognized as catalysts for DKP assembly. Cyclodipeptide syn-
thases (CDPSs), employing two aminoacyl-tRNAs as substrates for DKP 
assembly, were first reported in 2009. Aminoacyl-tRNAs are uncommon 
players in natural product assembly, making CDPSs intriguing members of 
Nature’s biosynthetic repertoire. Biochemical and bioinformatics analyses 
support that CDPSs are found from at least six bacterial phyla and some 
animals, yet biosynthetic pathways with CDPSs remain understudied rela-
tive to pathways featuring NRPSs or other common biosynthetic enzymes. 
Through studies of bacterial pathways that include CDPSs, my group has 
unveiled novel biosynthetic capabilities and developed tools for the engi-
neered biosynthesis of DKPs. This presentation will highlight our strategies 
for the characterization of these pathways to discover uniquely functiona-
lized DKPs and our development of a platform for the CDPS-catalyzed as-
sembly of novel DKPs from unnatural aminoacyl-tRNA precursors. Our 
results establish the catalytic promise of CDPSs beyond natural cellular 
aminoacyl-tRNAs, and showcase the utility of biosynthetic strategies for 
expanding the breadth of chemical space provided natural products.  
S-25
NATURAL PRODUCTS FROM UNCULTURED BACTERIA 
Sean F. Brady
Rockefeller University, New York NY
One of the key revelations to arise from the large-scale sequencing of bac-
terial (meta)genomic DNA is that traditional approaches used for the dis-
covery of bioactive small molecules have only gained functional access to a 
small fraction of the bacterial biosynthetic gene clusters present in nature. 
Uncultivated environmental bacteria no doubt produce additional undis-
covered secondary metabolites that could serve as molecular probes of bio-
logical processes as well as new therapeutic agents. Although there appears 
to be no easy way to culture this collection of unstudied microorganisms, 
it is possible to isolate large fragments of bacterial DNA directly from envi-
ronmental samples and clone this DNA into model cultured bacteria where 
it can be amplified and studied. We are using both functional and sequence-
based screening strategies to identify bioactive natural products encoded 
by large DNA libraries constructed using DNA extracted from both soil or 
human microbiomes. Bioactive small molecules identified in these studies 
will be discussed.
S-26
THE NATURAL PRODUCTS ATLAS; AN OPEN ACCESS 
DATABASE PLATFORM FOR NATURAL PRODUCTS 
DISCOVERY
Roger G. Linington
Department of Chemistry, Simon Fraser University, Burnaby, BC V5A 1S6, 
Canada.
Data-driven methods are playing an increasing role in many areas of mo-
dern natural products science. However, despite the recognition that these 
tools can greatly accelerate discovery programs, the field still lacks a central 
open access repository containing all known natural products structures. 
Our laboratory has been developing such a platform for all microbially-
derived natural products. This database, termed the Natural Products At-
las, aims to provide a community resource for data pertaining to microbial 
natural products, including structures, names, origins, physicochemical 
data, structural reassignments and corrections, total syntheses and other 
information. It is expected that future versions of the platform will inclu-
de spectral data and information about biological activities. The 2018 ASP 
meeting will be the official launch of this new resource. Attributes, features 
and applications of this new tool will be presented.
             
S-27
TARGETED-INTERACTION SCREENS AND ANTIBIOTIC 
DISCOVERY 
Jon Clardy1, Gleb Pishchany2, Emily Mevers1, Roberto Kolter2
1Department of Biological Chemistry & Molecular Pharmacology, Harvard 
Medical School, Boston, MA 02115, USA, 2Department of Microbiology and 
Immunology, Harvard Medical School, Boston, MA 02115.
The rapid and pervasive appearance of antibiotic resistance has invigorated 
efforts to discover new small molecule antibiotics that could become use-
ful therapeutics. Many of these efforts have involved revisiting traditional 
sources – particularly environmental bacteria – with new methods. This 
lecture reports on one such method, which we have named targeted-inter-
action screens. The method capitalizes on the ability of complex bacterial 
communities to produce small molecules that are not observed when any 
of the single community members is cultured with the same. The discovery 
of amycomicin, a potent and specific antibiotic for Staphylococcus aureus, 
an important human pathogen, from a community of nine Actinomycetes 
will illustrate the method. Amycomicin is active against MRSA (methicillin 
resistant S. aureus) and active in an in vivo mouse skin infection model (see 
Figure).
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S-28
PHYTOCHEMICALS AS NEUROPROTECTIVE AGENTS: 
THE MULTI-TARGET APPROACH
Taiwo Olayemi Elufioye
Department of Pharmacognosy, Faculty of Pharmacy, University of Ibadan, 
Ibadan, Nigeria
Neurodegenerative diseases (NDs) such as Alzheimer’s, Parkinson’s, and 
Huntington’s diseases as well as amyotropic lateral sclerosis affect millions 
of people around the world with the main risk factor being advancing age. 
Each of these diseases involves characteristic pathological and molecular 
features resulting from their effects on specific neurons and/or regions in 
the brain. Neuroprotection refers to the preservation of the structure and 
function of these neurons from insults arising from cellular injuries in-
duced by a variety of agents and/or NDs.
Several in vitro and in vivo study models specific to each ND have been 
employed with the aim of understanding their underlying mechanisms and 
identifying new therapeutic strategies.  Of the most prevalent drug devel-
opment efforts employed in the past few decades, mechanisms implicated 
in the accumulation of protein-based deposits, oxidative stress, neuro-in-
flammation, and certain neurotransmitter deficits such as acetylcholine and 
dopamine have been scrutinized in great detail. 
This presentation will be discussing classical examples of plant-derived 
neuroprotective agents by highlighting their structural class and specific 
mechanisms of action. 
S-29
MYXOBACTERIA: BIODIVERSITY, SYNTHETIC 
BIOTECHNOLOGY AND SECONDARY METABOLOMICS 
FOR NATURAL PRODUCT DISCOVERY 
Rolf Müller
Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), 
Department Microbial Natural Products, Coordinator Research Unit Novel 
Antibiotics, German Center for Infection Research, University Campus E8 1, 
66123 Saarbrücken, Germany
Amongst the well-established bacterial producers myxobacteria have a 
great track record for the discovery of entirely new natural product scaf-
folds exhibiting promsing bioactivities. This is at least in part due to the 
fact that they have been much less studied in the past in comparison to 
other traditional sources such as actinomycetes and bacilli. Nevertheless, 
the issue of rediscovery is a major hurdle for myxobacterial extracts as well. 
I will disucss recent results from our efforts to culture previously uncul-
tured myxobacteria and to connect phylogentically distant clades to novel 
metabolites by metabolome and genome mining. In addition, I will show 
examples of heterologous expression of myxobacterial compounds yielding 
producer strains making production of lead compounds for pharmaceuti-
cal development feasible.
S-30
THE STRUCTURAL CYCLE OF NONRIBOSOMAL 
PEPTIDE SYNTHETASE ENZYMES 
Andrew M. Gulick
Department of Structural Biology, Jacobs School of Medicine and Biomedical 
Sciences, University at Buffalo, Buffalo, NY 14203. Hauptman-Woodward 
Medical Research Foundation, Bufralo, NY.
The Nonribosomal Peptide Synthetases (NRPSs) are a family of large mo-
dular enzymes that are responsible for the production of many pharmaceu-
tically important peptide natural products. During biosynthesis, the NRPSs 
employ an assembly line strategy in which the amino acid and peptide inter-
mediates are covalently bound to a peptidyl carrier protein (PCP) domain. 
This loaded PCP transports the substrates to neighboring catalytic domains 
for substrate activation, modification, polymerization, and release. The core 
NRPS domains include the adenylation domain that activates and loads the 
amino acid substrate, the condensation domain that catalyzes peptide bond 
formation, and the thioesterase domain that catalyzes product release. Ad-
ditional auxiliary domains may catalyze further modifications. Recently, 
insight into the structural mechanisms that govern NRPS choreography 
has been provided through the determination of structures of multidomain 
enzymes that capture the protein in distinct states of the catalytic cycle. In 
particular, a large conformational change that is employed by the NRPS 
adenylation domain is required for the domain to adopt the catalytic con-
formations necessary for both the adenylation and thioester-forming par-
tial reactions. This conformational change also transports the PCP domain 
between the two core domains. We will present our studies with full NRPS 
modules that demonstrate how the adenylation and condensation domains 
simultaneously adopt active conformations, leading to an efficient catalytic 
cycle. Further, the structures illustrate limited interactions between the core 
of the NRPS and the downstream thioesterase domain suggesting limited 
structural constraints between modules. 
S-31
UNDERSTANDING AND ENGINEERING 
MULTIFUNCTIONAL ENZYMES FOR NONRIBOSOMAL 
PEPTIDE SYNTHESIS
Sylvie Garneau-Tsodikova*
* Department of Pharmaceutical Sciences, University of Kentucky, 
Lexington, KY, 40536-0596, USA.
Nonribosomal peptides are natural products biosynthesized by multi-mod-
ular enzymatic assembly-lines comprised of domains performing various 
activities. Adenylating enzymes play a critical role in dictating the identity 
of building blocks to be incorporated in growing peptides during nonri-
bosomal peptide biosynthesis. To increase the structural diversity of the 
products it generates, Nature has evolved unique interrupted adenylating 
enzymes capable of performing both adenylation and methylation reac-
tions. We will present our efforts towards understanding the mechanism by 
which these unique enzymes function and our biochemical and structural 
work towards engineering novel interrupted enzymes with adenylating and 
methylating activities. We will also discuss introduction of diversity into 
natural products via halogenation.
S-32
STRUCTURAL AND BIOCHEMICAL DIVERSITY IN 
MARINE SYMBIOTIC NATURAL PRODUCTS
Eric W. Schmidt
Department of Medicinal Chemistry, University of Utah, Salt Lake City, UT 
84108
Marine animals contain unique compounds with unique scaffolds and 
chemical modifications. Technical advances have improved the direct 
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access to biosynthetic machinery and to active compounds for drug dis-
covery. While many chemicals are produced by the symbiotic microbiota, 
others are made by the animals themselves. Recent advances in characteriz-
ing novel compounds and biochemical reactions from marine animals and 
their symbionts will be described.
S-33
ADVENTURES IN FUNGAL NATURAL PRODUCTS 
CHEMISTRY--FUNGAL ECOLOGY, BIODIVERSITY, AND 
THE SEARCH FOR NEW BIOACTIVE METABOLITES
James B. Gloer. 
Department of Chemistry, University of Iowa, Iowa City, IA 52242, USA
My professional association with fungi and their metabolites began 35 
years ago with a fortuitous opportunity to study the chemistry of an unu-
sual host-selective toxin produced by a plant pathogen.  The structural and 
biological novelty of that system ultimately inspired the development of a 
research program in fungal chemistry that has continued ever since.  At the 
time, it was clear that many ecological groups of fungi were underexplored 
from a chemical standpoint, despite evidence that certain types might be 
fruitful sources of bioactive natural products.  We initiated a program tar-
geting fungi from biodiverse, undersampled communities on the basis of 
several criteria, including hypotheses about roles of chemistry in antagoni-
stic or defensive interactions, as well as the distinctiveness of taxa prevalent 
in those communities.  We proposed that this focus on organism selection 
could reduce redundancy inherent in random screening approaches, while 
shedding light on some fundamental questions about targeted species and 
providing direction for future prioritization strategies.  Many different ef-
forts along these lines were undertaken over the years, including studies 
of marine, freshwater, mycoparasitic, fungicolous, endophytic, coprophi-
lous, and sclerotium-producing fungi, all of which proved to be productive 
sources of bioactive metabolites and other interesting findings to varying 
degrees.  All of these projects have involved close collaborations with out-
standing mycologists whose unique expertise and valuable insights made 
this kind of targeted approach possible.  This presentation will highlight 
some results and observations arising from these collaborative studies over 
the long term, and offer some personal perspective on past and present de-
velopments in this rapidly-evolving field.
S-35
INTERACTION-DRIVEN MOLECULE DISCOVERY FROM 
HOST-MICROBE SYMBIOSES
Marcy J. Balunas1
1Division of Medicinal Chemistry, Department of Pharmaceutical Sciences, 
University of Connecticut, 69 North Eagleville Road, Storrs, CT 06269, USA
Microbial symbioses are increasingly recognized to play an integral role in 
host structure and function. Co-evolution of these benign and/or benefi-
cial relationships has been the focus of numerous microbiology studies, 
although the role of secondary metabolite interactions has received con-
siderably less attention. Small molecule interactions in these host-microbe 
symbioses are likely to contribute to the complex molecular conversations 
occurring between bacterial symbionts, eukaryotic hosts, and their pa-
thogens/prey. Given that these host-microbe associations have naturally 
evolved to select for biologically active bacteria, they provide a source of 
secondary metabolites more likely to have potent medicinal activity and 
thus be poised for future preclinical drug development. We utilize several 
unique host-microbe symbioses to explore interactions between eukaryotic 
hosts and their associated bacteria, integrating natural products and ana-
lytical chemistry, medicinal and synthetic chemistry, microbial chemical 
ecology, and biological screening with advanced molecular biology to pro-
vide a comprehensive understanding of secondary metabolite production 
in these symbioses. Our long-term goal is to use insights gained from these 
host-microbe symbioses to discover and develop new druggable lead com-
pounds for a wide range of human diseases. Recent developments from the-
se studies will be presented including experiments to allow for competitive 
interactions to enhance metabolite production and further our understan-
ding of microbial interactions.
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O-01
CHEMICAL INVESTIGATION OF SACCHARIDES OF 
DENDROBIUM CASSIOPE
Jhih-Jhong Wang1, Mei-Kuang Lu2 and Chia-Chuan Chang1
1School of Pharmacy, National Taiwan University, Taipei 10050, Taiwan, 
R.O.C., 2National Research Institute of Chinese Medicine, Taipei 11221, 
Taiwan, R.O.C.
Dendrobium Cassiope (DC), a hybrid of Dendrobium nobile (♀) and D. 
moniliforme (♂), is a medicinal herb cultivated in Taiwan. Dendrobium 
shows several bioactivities, such as anti-hyperglycemic, beneficial for car-
diovascular diseases, and immunity modulation. The present study utilized 
centrifugal filtration for rapid purification of the polysaccharides (PSs) of 
DC. The PSs were purified by DEAE-cellulose column chromatography 
and characterized by nuclear magnetic resonance spectroscopy (NMR) and 
monosaccharides composition analysis. The major PS (DC-PS1) is an glu-
comannan with a molecular weight over 3 kDa, and the ratio of Man-Glc 
is 100 : 12.5, and with partial 2-O- and 3-O-acetyl groups. The backbone of 
DC-PS1 is β-(1→4)-mannose and β-(1→4)-glucose, with 1,6-α-mannosyl 
branches and β-mannosyl terminals. The molecular weight of DC-PS1 was 
estimated to be 3.308 kDa, and the degree of polymerization (DP) is 20, 
by high performance size exclusion chromatography (HPSEC) and diffu-
sion-ordered NMR (DOSY).
O-02
TRITERPENOID SAPONINS FROM THE ROOTS OF 
GLYCYRRHIZA GLABRA
Qingyao Shou1, Ping Jiao1, Mei Hong1, Qi Jia1, Indra Prakash2*, Sangphyo 
Hong2, Bin Wang2, Gil Ma2, Allison Bechman2
1Unigen USA, 2121 South State St., Suite 400, Tacoma, WA 984052 The 
Coca-Cola Company, One Coca-Cola Plaza North West, Atlanta, GA 30313 
With a rising consumer demand for reduced-sugar in food and beverages, 
the discovery of natural low-/zero- calorie sugar alternatives brings more 
attention to global food industries and researchers. Licorice, the root of Gly-
cyrrhiza species is one of the oldest and well-known sweet materials in the 
world. Its extract is widely used as a flavor in foods, beverages, and dietary 
supplements. Glycyrrhizin as one of the major metabolites obtained from 
Licorice, is up to 50 times as sweet as sucrose, and is approved as a natural 
sweetener and/or flavor in many countries. Except for glycyrrhizin, several 
other triterpene saponins from Licorice plants were identified sweet. This 
drove us to look deep into glycyrrhizin analogs from G. glabra. With the 
strategy of the LC/MS guided mining, ten new oleanane-type triterpeno-
id saponins (Glabasaponin A-J) were isolated from the roots of G. glabra 
together with a known compound Macedonoside A. The structures of the 
compounds 1−10 (Figure 1) were determined based on 1D and 2D NMR, 
as well as the accurate molecular weight from QTOF-MS data analyses, and 
the sugar residues were identified by gas chromatography after hydrolysis.
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O-03
LUGDUNIN – A NEW ANTIBIOTIC FROM OUR NOSE: 
STRUCTURE, CHEMICAL SYNTHESIS AND BIOACTIVITY
Nadine A. Schilling1, Martin C. Konnerth1, Alexander Zipperer2, Hubert 
Kalbacher3, Anne Berscheid2, Heike Brötz-Oesterhelt2, Andreas Peschel2, 
Bernhard Krismer2, Stephanie Grond1
1Institute of Organic Chemistry, 2Interfaculty Institute for Microbiology and 
Infection Medicine Tübingen (IMIT), 3Interfaculty Institute of Biochemistry, 
Eberhard Karls Universität Tübingen, Germany
A Staphylococcus lugdunensis isolate from the human nose produces a 
compound with strong bactericidal activity against multi-resistant Sta-
phylococcus aureus. Structure elucidation by NMR, high resolution mass 
spectrometry and chemical reactions revealed the hydrophobic cyclic hep-
tapeptide, named lugdunin. Peptide synthesis was especially customized 
to form the thiazolidine heterocycle. The thiazolidine ring – for the first 
time in a cyclopeptide – and a tryptophan are crucial for full biological ac-
tivity. With manifold products from our synthesis, SAR (structure activity 
relationship)-studies revealed nature’s architectural concept of the antibac-
terial agent. We discuss that we have not observed resistance development 
yet, and present our current hypotheses of mechanisms underlying the 
structure-activity relationships.
O-04
DISCOVERY OF A NEW POLYKETIDE VIA CO-
TREATMENT WITH AN EPIGENETIC MODIFIER AND 
OSMOTIC STRESS 
Hope Ada Igboeli, Douglas Marchbank, Hebelin Correa, Russell Kerr.
Department of Chemistry, University of Prince Edward Island
Genomic analysis of several filamentous fungi has revealed the presence of 
“silent” biosynthetic pathways which encode for unknown natural prod-
ucts. The number of these silent biosynthetic gene clusters often greatly 
outnumbers the number of commonly expressed natural products. This 
insight has fuelled the development of new strategies for natural products 
discovery in fungi to optimize their biosynthetic potential. Herein we de-
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scribe a new method of natural product biosynthetic gene activation in fun-
gi involving the initiation of both stress and epigenetic pathways to simulta-
neously up-regulate silent or trace natural products. This method has led to 
the discovery of a new polyketide which was isolated from the fermentation 
extract of Asteromyces cruciatus treated with suberoylanilide hydroxamic 
acid and salt. The polyketide was purified by reversed-phase flash column 
chromatography followed by preparative high performance liquid chroma-
tography. The structure of this compound was established using one-and-
two dimensional NMR experiments.
O-05
UNCOMMON MECHANISM OF A TYPE II PKS 
DERIVED ARYL POLYENE PIGMENT PRODUCED BY 
XENORHABDUS DOUCETIAE
Gina L.C. Grammbitter1, Kudratullah Karimi2, Nina Morgner2 and Helge B. 
Bode1,3
1Institut für Molekulare Biowissenschaften, Goethe-Universität Frankfurt, 
60438 Frankfurt, Germany, 2Institut für Physikalische und Theoretische 
Chemie, Goethe-Universität Frankfurt, 60438 Frankfurt, Germany, 
3Buchmann Institute for Molecular Life Sciences, Goethe-Universität 
Frankfurt, 60438 Frankfurt, Germany
Aryl polyene (APE) pigments are a widely distributed class of bacterial po-
lyketides, also present in γ-proteobacteria such as Xenorhabdus doucetiae. 
Nevertheless, little is known about the biosynthesis of these compounds, 
which are produced by an uncommon type II polyketide synthase (PKS) 
mechanism. We started by identifying the major yellow APE from X. dou-
cetiae via HPLC-UV/MS. Co-purification experiments with APE enzymes 
revealed four stable protein complexes, three of them being new for PKS II 
systems. The focus of our work was to investigate the complex biosynthetic 
mechanism of APEs. Therefore, we isolated all enzymes  involved in bio-
synthesis and characterised them in vitro. As a result, we reconstituted the 
whole APE biosynthesis by MS analyses of the ACP-bound intermediates 
of each reaction step. These findings not only shed light on the biosynthetic 
mechanism of this special PKS II system, but also on protein-protein inter-
actions of the multi-enzyme complex.
O-06
DIAZAQUINOMYCIN BIOSYNTHESIS IN MARINE AND 
FRESHWATER ACTINOMYCETES 
Jana Braesel1, Brian T. Murphy1, and Alessandra S. Eustáquio1
1University of Illinois at Chicago, College of Pharmacy, Department of 
Medicinal Chemistry and Pharmacognosy, Chicago, IL 60607
Tuberculosis (TB) remains a global health problem, accounting for 1.7 mil-
lion deaths in 2016 and 6.3 million new cases. The most significant threat 
is multidrug- and extensively drug-resistant strains of Mycobacterium tu-
berculosis, which are resistant to first- and second-line drug regimes. It was 
recently reported that diazaquinomycins show potent and selective inhibi-
tory activity against M. tuberculosis, including a panel of drug-resistant TB 
strains. Understanding of the genetic and molecular basis of diazaquino-
mycin biosynthesis can help generate structural analogs for structure-activ-
ity relationship studies.
To identify the diazaquinomycin biosynthetic gene cluster, the genomes 
of two known diazaquinomycin producers, Streptomyces sp. F001 and Mi-
cromonospora sp. B006, were sequenced. Since automated genome mining 
techniques, such as antiSMASH 4.0, failed to identify a putative diazaquino-
mycin biosynthetic gene cluster, both genomes were compared using pro-
gressive MAUVE alignment. A 22.3 kb continuous region shared between 
the strains F001 and B006 was identified. This presentation will highlight 
our latest results towards confirming the diazaquinomycin biosynthet-
ic gene cluster by deleting the identified region using CRISPR/Cas9. Our 
goal is to further study diazaquinomycin biosynthesis by a combination of 
gene inactivation and biochemical in vitro characterization of pathway en-
zymes. We are especially interested in the molecular basis for the different 
diazaquinomycin analogs produced by each strain. 
O-07
EXPLORING THE CHEMICAL POTENTIAL OF GREAT 
SALT LAKE MICROORGANISMS
Emilio Cortes-Sanchez, Guangwei Wu and Jaclyn M. Winter. 
Department of Medicinal Chemistry, College of Pharmacy, University of 
Utah, Salt Lake City, UT 84112
Biological pressures can influence the chemical diversity of secondary 
metabolites and microorganisms isolated from extreme environments 
have proven to ideal resources for drug discovery efforts and for charac-
terizing novel biosynthetic pathways. The Great Salt Lake, also recognized 
as America’s Dead Sea, is an endorheic hypersaline lake in Utah. Recently, 
we started a natural product drug discovery campaign aimed at interroga-
ting halophilic bacteria isolated from this unique environment. One of our 
strains, Streptomyces sp. GSL-15, was shown to produce BE-5221 D (1) a 
new beta-hydroxy acetamide belonging to the rare class of trialkyl-substi-
tuted aromatic acids. Following de novo genome sequencing and assembly, 
genome mining was used to identify the biosynthetic cluster responsible 
for the synthesis of this unique metabolite. A 57 kb type I polyketide clu-
ster was identified and confirmed to be responsible for the synthesis of 1 
through an engineered CRISPR-Cas9 approach. Feeding experiments with 
various 13C-labeled precursors revealed how the backbone of 1 is biosyn-
thesized and resulted in the identification of a new offloading mechanism 
in polyketide biosynthesis. Investigation into this mechanism, as well as 
the genes responsible for the unusual carbon-carbon bond formation, is 
ongoing. 
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O-08
MOLECULAR CARTOGRAPHY OF FUNGUS-GROWING 
ANTS GARDENS REVEALS THE PRESENCE OF 
BIOACTIVE METABOLITES IN SITU
Andrés Mauricio Caraballo-Rodríguez1, Kathleen E. Kyle2, Sara P. Puckett3, 
Evan Fox2, Ricardo R. da Silva1, Justin J. J. van der Hooft1,4, Madeleine 
Ernst1, Marcy J. Balunas3, Jonathan L. Klassen2, Pieter C. Dorrestein1
1Collaborative Mass Spectrometry Innovation Center, Skaggs School of 
Pharmacy and Pharmaceutical Sciences, University of California, San 
Diego, La Jolla, CA; 2Department of Molecular and Cell Biology, University 
of Connecticut, Storrs, CT, USA; 3Division of Medicinal Chemistry, 
Department of Pharmaceutical Sciences, University of Connecticut, Storrs, 
CT 06269, USA, 4Bioinformatics Group, Department of Plant Sciences, 
Wageningen University, 6708 PB, Wageningen, The Netherlands.
Fungus-growing ants are useful models to study the role of molecules in 
intraspecies interactions. We applied mass spectrometry approaches for 
detecting, identifying and mapping molecules from Trachymyrmex septen-
trionalis and Atta texana fungus gardens. Molecular mapping of Trachy-
myrmex septentrionalis fungus gardens obtained from the Eastern coast 
of USA enabled to visualize geographical distribution of molecules with 
a wide range of biological activities, from antibiosis to anticancer proper-
ties. These included fungal peptides from Trichoderma species; fungal ste-
rols; plant and microbial saponins and bacterial peptides from Pseudomo-
nas species. Molecular mapping of lab reared Atta texana fungus garden 
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enabled us to visualize 3D spatial distribution of flavonoid-related plant 
metabolites, which suggests biotransformation processes occurring in situ. 
Thus, molecular cartography of fungus gardens provided insights into the 
chemical diversity of natural products in situ, a necessary step for revealing 
the biological role molecules play in natural environments.
O-09
ANTIFUNGAL PEPTIDES FROM MICROASCUS 
ALVEOLARIS ACTIVE AGAINST PHYTOPATHOGENIC 
FUNGI.
Serge Fotso1, Paul Graupner1, Quanbo Xiong1, Jeffrey R. Gilbert1, Don 
Hahn1, Avila Adame Cruz1, George Davis1 and Kengo Sumiyoshi2
1Discovery Research, Corteva Agriscience™, Agriculture Division of 
DowDuPont™, 9330 Zionsville Road, Indianapolis, IN 46268, USA. 
2Bioscience Laboratories, Meiji Seika Pharma Co. Ltd., 788 Kayama, 
Odawara-shi, Kanagawa 250-0852, Japan
Agricultural crops face tremendous yield and quality losses due to pests, 
pathogenic diseases and weed damages. In addition, the emergence and 
spread of disease resistance to chemical agents used in modern agricultu-
ral to control pathogens and pests is a growing concern for the farmers 
and scientists. Added to those challenges, the stringent regulatory pressure 
on some synthetic pesticides (withdraw or usage restriction), the modern 
agricultural practice is facing a global food challenge to meet the growing 
need of food production to feed 9 billion people by 2050. Natural products 
can play a crucial role in the discovery of new Ag active molecules. Nature 
produces many compounds with biological activity such as fungicide, in-
secticide and herbicide which may present high acceptable environmental 
and fate profile. The Corteva Natural product (NP) program intent to uti-
lize that advantage of NP to solve these challenges that are facing modern 
agriculture. Through our process, the investigation of the crude extract 
from the fungi Microascus alveolaris strain PF1466 led to the isolation of the 
known scopularide and three new cyclodepsipeptides named alveolarides 
A, B and C. Alveolaride A  provided strong in vitro activity against the plant 
pathogens Pyricularia oryzae, Zymoseptoria tritici and Ustilago maydis. The 
structures and biological activities of these compounds will be presented.
O-10
MYXOBACTERIA DEGRADE ACYLHOMOSERINE 
LACTONE QUORUM SIGNALS AND PREVENT 
PSEUDOMONAS PUTIDA BIOFILM FORMATION
Barbara Adaikpoh, Shukria Akbar, Rachael Pace, and Cole Stevens
Department of Biomolecular Sciences, University of Mississippi School of 
Pharmacy, University, MS  38677-1848
Quorum quenching enzymes such as acylhomoserine lactonases (AHLases) 
are typically associated with Gram-negative bacteria that participate in quo-
rum signaling and facilitate maintenance of acylhomoserine lactone (AHL) 
metabolic flux. We propose that myxobacteria utilize these AHLases, like-
ly acquired via horizontal gene transfer, to disrupt the quorum signaling 
networks of neighboring prey. Investigated AHLases from Archangium sp. 
strain Cb G35 and Cystobacter ferrugineus strain Cfe23 were chosen due to 
their sequence similarity to AHLases associated with the genus Pseudomo-
nas. Both AHLases were capable of degrading a variety of AHLs including 
3-oxo-C12-AHL the regulatory quorum signal involved in Pseudomonas 
putida biofilm formation. Addition of purified AHLase from C. ferrugineus 
to P. putida cultures not only prevented biofilm formation but also pro-
vided denser cultures when compared to AHLase-unexposed controls. We 
propose that predatory myxobacteria utilize quorum quenching enzymes 
to prevent organized, multicellular prey behaviors that are recalcitrant to 
predation such as biofilm formation.
O-11
A RANDOMIZED, PLACEBO-CONTROLLED, CLINICAL 
TRIAL TO EVALUATE THE EFFICACY OF A NOVEL 
FENUGREEK SEED EXTRACT ON PHYSICAL FITNESS 
AND SPORTS NUTRITION 
Anand Swaroop,1 Sreejayan Nair,2 Derek T. Smith,3 Scarlet L. Barnes,3 Boyi 
Dai,3 Timothy J. Robinson,4 Rama P. Nair5 and Debasis Bagchi1,6
1Cepham Inc, Somerset, NJ.,2School of Pharmacy, 3Department of 
Kinesiology and Health, 4WWAMI Medical Education, College of Health 
Sciences, Laramie, WY; 5Nutriwyo LLC, Laramie, WY; 6University of 
Houston, College of Pharmacy, Houston, TX, USA.
Background:  Our previous studies demonstrated that a saponin rich isolate 
from the spice fenugreek (Trigonella foenum-graecum) improved glucose 
tolerance, insulin sensitivity and cardiometabolic parameters in diabetic 
mice. The current study was aimed at evaluating the effect of a novel fenu-
greek seed extract enriched in 20% protodioscin (Furosap®, FS) supplemen-
tation on body mass, serum testosterone levels, cardiorespiratory endur-
ance and muscle strength in healthy human subjects. Methods: A prospec-
tive, double blind, placebo-controlled, randomized trial was performed in 
healthy male human subjects (n= 40, 24.02±3.9 years), who received FS or 
placebo capsules (250 mg, twice daily) for 12 weeks. Prior to and following 
intervention, hand-grip, body fat mass/lean mass/fat distribution, upper 
and lower body strength and maximal graded exercise stress testing were 
determined using a digital hand dynamometer, dual-energy X-ray absorp-
tiometer (DEXA), force plate, and treadmill with open-circuit spirometry, 
respectively. Testosterone levels and C-reactive proteins were determined 
in the serum samples. Results: Mean lean mass, fat-free mass and total se-
rum testosterone levels were significantly elevated in the group receiving 
FS. Furthermore, a tendency towards lowering blood pressure was obser-
ved in the FS-treatment group. No changes were observed in grip-strength, 
jump height, peak jump force and push-up force between the treatment or 
placebo groups. Similarly, measures of cardiorespiratory endurance (heart 
rate, VO2 max, peak and submaximal respiratory exchange ratio), systolic 
and diastolic blood pressures, and fat-mass remained unchanged in both 
groups following intervention. Conclusions: FS supplementation over a 
period of 12 weeks increased lean body mass and total testosterone levels. 
No adverse events were reported. Further long-term studies in larger popu-
lation are necessary to validate these findings.
O-12
NOVEL HOMOISOFLAVONOIDS AS INHIBITORS OF 
OCULAR ANGIOGENESIS 
Hannah Whitmorea, Dulcie Mulhollanda, Sianne Schwikkardb, Timothy 
Corsonc, Kamakshi Sishtlac, Walter Knirschd, Wolfgang Wetschnigd
aDept. of Chemistry, University of Surrey, GU2 7XH, UK; bSchool of Life 
Sciences, Kingston University, KT1 2EE, UK; cDept. of Ophthalmology, IU 
School of Medicine, IN 46202; dInstitute of Plant Sciences, Karl-Franzens-
University, Graz 8010, Austria.
Novel homoisoflavonoids were extracted from Rhodocodon intermedius 
(1,3,5), R. cryptopodus (6), R. rotundus (7), Eucomis autumnalis (8), E. co-
mosa (9,10) and Massonia bifolia (11,12). These, along with acetate deri-
vatives, 2 and 4, have been tested in cell proliferation assays to determine 
their anti-angiogenic abilities, producing excellent results. Anti-angiogenic 
compounds are of interest in the treatment of retinopathy, a major cause 
of blindness in patients with diabetes and ‘wet’ age-related macular dege-
neration. The absolute configuration of compounds 5-7 was found to be S 
at C-3, unusual for 3-benzyl-4-chromanones from the Hyacinthaceae. The 
structures and biological activity of novel natural-source and synthetic ho-
moisoflavonoids will be presented.
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O-13
DISCOVERY OF ANTI-AVIAN INFLUENZA COMPOUNDS 
FROM EURYA NITIDA AND MAESA PERLARIUS
Nga Yi Tsang1, Wan-Fei Li1, Yang Zhao1, Eric Yip2, Yi Guan2, and Hong-Jie 
Zhang1,*
1School of Chinese Medicine, Hong Kong Baptist University, Hong Kong 
SAR, China. 2Centre of Inﬂuenza Research, School of Public Health, The 
University of Hong Kong, Hong Kong SAR, China.
Viral infections cause various human diseases that threaten public health. 
Avian influenza (AIV) refers to influenza caused by viruses adapted to 
birds. The largest and most deadly pandemic in recorded history occurred 
in 1918 with an estimated death toll of more than 40 million people world-
wide, which was caused by an H1N1 subtype influenza A virus. H5N1 
is another deadly pathogenic avian influenza subtypes that cause severe 
disease and death both in human and poultry. Herbal medicines provide 
vast resources for the development of novel antiviral drugs. We have re-
cently identified two anti-bird flu entry active plant leads (Eurya nitida, 
Theaceae; Maesa perlarius, Myrsinaceae) from evaluation of >2,000 plant 
extracts. Bioassay-guided separation of the MeOH extracts of the stems 
of the two plant has led to the identification of a number of anti-avian flu 
compounds. The isolated compounds have been evaluated against the in-
fluenza viruses of H1N1, H3N2, H5N1 and H9N2. Acknowledgements: The 
work described in this paper was supported by the Health and Medical Re-
search Fund (12132161) of the Food and Health Bureau, Hong Kong SAR, 
and the  Hong Kong Baptist University (HKBU) Interdisciplinary  Research 
Matching Scheme (RC-IRMS/15-16/02).
O-14
THE IMMUNOSUPPRESSANT BRASILICARDIN: 
HETEROLOGOUS EXPRESSION, REVISION OF THE 
GENE CLUSTER AND MUTASYNTHESIS STUDIES
Anina Buchmann1, Michael Eitel2, Pierre Koch2, Paul N. Schwarz3, Evi 
Stegmann3, Wolfgang Wohlleben3, Marcin Wolański4, Michał Krawiec4, 
Jolanta Zakrzewska-Czerwińska4, Carmen Méndez5, Alma Botas5, Francisco 
Morís6, Jesus Cortés6, and Harald Gross1
1Department of Pharmaceutical Biology, University of Tübingen, Tübingen, 
Germany, 2Department of Pharmaceutical Chemistry, University of 
Tübingen, Tübingen, Germany, 3Department of Microbiology and 
Biotechnology, University of Tübingen, Tübingen, Germany, 4Department 
of Molecular Microbiology, University of Wroclaw, Wroclaw, Poland, 
5Department of Functional Biology, University of Oviedo, Oviedo, Spain, 
6EntreChem SL, Oviedo, Spain.
Brasilicardin A (BcA) is a novel and potent immunosuppressant consi-
sting of a unique diterpene anti/syn/anti-perhydrophenanthrene skeleton 
with two sugar residues, an amino acid-like portion, and a hydroxyben-
zoate moiety, which is produced in low quantity by the human pathogen 
Nocardia terpenica. BcA is comparable in potency with standard immuno-
suppressants such as cyclosporine or tacrolimus, but is less toxic due to a 
novel mode of action. In order to develop a safe biotechnological platform 
for the production of brasilicardin analogs in high yields, a fosmid contai-
ning the putative brasilicardin gene cluster was introduced into more than 
70 bacterial strains belonging to the risk group 1. Heterologous expressi-
on of the putative brasilicardin gene cluster led to the production of non-
glycosylated or rhamnosylated brasilicardins in most of the strains tested, 
with one strain producing ~300 mg/L of rhamnosylated brasilicardins. 
Subsequent genetic engineering measures led to gram-scale production of 
brasilicardins. In order to gain insight into the biosynthesis of brasilicar-
din, the genome of the natural producer was sequenced and a systematic 
gene deletion study was conducted. This led to the revision of the so far 
proposed brasilicardin biosynthetic pathway and opened up the possibility 
for mutasynthetic studies. Application of the latter strategy, yielded a broad 
spectrum of 17 new brasilicardin derivatives.
O-15
DESIGNED BIOSYNTHESIS OF A NATURAL PRODUCT 
OF UNKNOWN ORIGIN
Suzie Hsu, Dimitri Perusse, Thomas Hougard and Michael J. Smanski
Department of Biochemistry, Molecular Biology, and Biophysics and 
BioTechnology Institute, University of Minnesota – Twin Cities, Saint Paul, 
MN, 55108, USA
Serofendic acid (SA) is a natural product isolated from fetal calf serum 
with a chemical structure that suggests plant or microbial origin. Initial-
ly isolated due to its nanomolar neuroprotective activity, SA shows potent 
activity preventing damage from myocardial and cerebral ischemia. It is a 
preclinical lead for the development of drugs to treat victims of stroke or 
heart attack. Here we report the design and validation of a synthetic meta-
bolic pathway that affords a late stage intermediate, ent-atiserenoic acid in a 
Streptomyces host, at titers exceeding 500 mg/L titers. We demonstrated the 
utility of this platform by synthesizing SA and analogs that are more potent 
than clinically approved anti-apoptotic compound, ursodeoxycholic acid. 
O-16
CROSSROADS OF ANTIBIOTIC BIOSYNTHESIS AND 
RESISTANCE
Timothy A. Wencewicz
Department of Chemistry, Washington University in St. Louis, St. Louis, MO 
63130, USA
Antibiotic biosynthetic gene clusters (BGCs) often contain genes encoding 
for self-protection mechanisms employed during antibiotic production. 
These self-protection genes can become antibiotic resistance genes (ARGs) 
in human pathogens following horizontal gene transfer. We recently disco-
vered an emerging family of tetracycline ARGs encoding for tetracycline 
inactivating enzymes (“tetracycline destructases”) using functional screens 
of metagenomic samples. The tetracycline destructases are flavin monooxy-
genases (FMOs) that covalently inactivate tetracycline antibiotics via scaf-
fold oxidation. We determined the structural and mechanistic basis for te-
tracycline oxidation by several tetracycline destructases, which suggests an 
evolutionary origin for these resistance enzymes in tailoring FMOs from 
type II polyketide BGCs of polycyclic natural product scaffolds with a high 
degree of C-hydroxylation. The story of the tetracycline destructases will 
be presented to highlight how the delicate balance between enzymatic con-
struction (biosynthesis) and destruction (resistance) of antibiotics can dri-
ve microbial selection and inspire clinical solutions for antibiotic resistance.
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O-17
METABOLITES FROM A FISH GUT FUNGUS 
CHALLENGE THE DEFINITION OF WHAT IT IS TO BE A 
NATURAL PRODUCT? 
Osama G. Mohamed,1 Zeinab G. Khalil1 and Robert J. Capon1
1Institute for Molecular Bioscience, The University of Queensland, St Lucia, 
Queensland 4072, Australia 
Cultivation trials on a fungus, Trichoderma sp. CMB-F563, isolated from 
the gastrointestinal tract of a mullet purchased from a local market, re-
vealed a remarkable level of chemical diversity. The prolinimines A-D, 
observed exclusively on rice media, were identified as an unprecedented 
set of N-amino-L-proline methyl ester (hydrazine) Schiff bases. Structures, 
inclusive of absolute configuration, were assigned by detailed spectroscopic 
analysis, chemical degradation and total synthesis, with dimeric and trime-
ric prolinimines C-D identified as isolation artefacts of monomeric prolini-
mines A-B. Intrigued by this structure class, we developed chemical probes 
to detect the putative biosynthetic precursor, N-amino-L-proline methyl 
ester. These studies revealed an unexpected level of chemical reactivity and 
biosynthetic complexity, challenging our perceptions on the relationship 
between microbes and culture media, and prompting a re-evaluation of the 
very definition of what is to be a natural product. 
O-18
BIOACTIVE POLYKETIDE TRANSFORMATIONS IN 
BACTERIAL PATHOGENS AND IN HUMANS
Hyun Bong Park1,2, Tyler Goddard1,2, Joonseok Oh1,2, Corey E. Perez1,2, 
Brandon Mercado1, and Jason M. Crawford1,2,3*
1Department of Chemistry, Yale University, New Haven, CT 06520   
2Chemical Biology Institute, Yale University, West Haven, CT 06516  
3Department of Microbial Pathogenesis, Yale School of Medicine, New 
Haven, CT 06536 
Gammaproteobacterial pathogens belonging to the  Photorhabdus  genus 
participate in a multilateral symbiosis with nematodes, insects, and in some 
cases, humans. P. luminescens establishes an infection in the circulatory fluid 
of insect larvae, whereas P. asymbiotica can also cause systemic infections 
in humans, such as bloodstream infections (bacteremia and sepsis). Under 
cellular stress cultivation conditions mimicking host pathogenesis, we ob-
served the stimulation of a novel polyketide harboring a complex 6,6,5,3,6 
pentacyclic core, which we named the carbocyclinone core. We also identi-
fied a conserved Photorhabdus oxidase that initiates an oxidative cyclization 
sequence – an electrocyclization followed by a Diels Alder cyclization 
– utilizing two achiral aromatic polyketide substrates en route to product 
formation. The resulting product contains 6-stereocenters and includes a 
strained cyclopropane in conjugation with quinone and pseudo-quinone 
moieties. Humans contain a distant homolog of the oxidase, and whole 
blood could similarly catalyze carbocyclinone conversion. Other related 
polyketides, including ones found in dietary plants and are known to access 
the bloodstream, also served as suitable substrates. Model chemical studies 
demonstrated that the cyclopropane serves as an electrophilic site, likely 
underscoring its mode of action. Through structural and biological consid-
erations, we speculated that the carbocyclinones might inhibit blood coag-
ulation. Coagulation participates in innate immunity and pathogen defense 
in both insects and humans.  In a Mycobacterial model of coagulation, the 
product was more potent than the anticoagulant drug warfarin, yet it did 
not display eukaryotic cytotoxicity in our assays. We discuss the structure, 
biosynthesis, genetics, and biomedical implications of the carbocyclinones 
from insects to humans.
O-19
NATLIFE 2020: DISCOVERING TASTE 
MODULATING NATURAL PRODUCTS FOR 
HUMAN HEALTH APPLICATIONS
Danielle H. Demers1, Dietmar Wolf1, Karsten Siems2, Katja Riedel3, Michael 
Krohn3
1AnalytiCon Discovery, LLC, 9601 Medical Center Drive, Rockville, MD 
20850, USA, 2AnalytiCon Discovery GmbH, Hermannswerder Haus 17, 
14473 Potsdam, Germany, 3BRAIN AG, Darmstaedter Str. 34-36, 64673 
Zwingenberg, Germany
Contemporary dietary patterns, including the overconsumption of salt, su-
gar, and fats, have paved a new landscape of nutrition and health science. 
Numerous salt, sugar, and fat replacing ingredients have been discovered, 
however a vast majority are curtailed by undesirable off-tastes or untenable 
production pathways. As part of the NatLifE 2020 strategic alliance, fun-
ded in part by the German Federal Ministry for Education and Research 
(BMBF), AnalytiCon Discovery is looking to the natural products of edib-
le plants in order to discover and develop a new generation of sustainably 
produced taste modulating ingredients. This case study describes the high 
throughput screening of natural compounds for bitter masking properties, 
and the discovery of a lead compound which blocks the bitter off-notes of 
important sugar replacing ingredients such as saccharin and acesulfam K.  
O-20
WHAT’S OLD AND NEW AT THE LLOYD LIBRARY: 
AMERICA’S INDEPENDENT PHARMACOGNOSY 
LIBRARY
Patricia Van Skaik
Executive Director of the Lloyd Library and Museum
Lloyd Brothers Start a Pharmacognosy Library (1870s)
• Pharmacognosy in the 19th Century (Eclectic Medicine)
• Lloyd Collections Off the Beaten Path
• Research, Development & Manufacture of Natural Pharmaceuticals
• Research Publications
Fast Forward 140 Years-Grow, Connect, Sustain and Impact
• Developing and preserving collections for today and tomorrow
• Supporting researchers from around the world
Poster Presentations
39Abstracts | 2018 Annual Meeting of the ASP | July 21-25, 2018 | Lexington, Kentucky, USA
• Reference Service
• Website-Finding Aids/Catalog
• Document Delivery
• Digital Content
• Advancing Scholarship-Fellows 
• Educating through Lectures & Exhibits
• Forming Partnerships & Celebrating
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INVESTIGATION OF BIOACTIVE CHEMICAL ENTITIES 
FROM MARINE MICROORGANISMS
Glenroy Martin, and Dustin Gibson
Department of Life and Physical Sciences, Fisk University, Nashville, TN 
37208, USA
The marine environs consist of a rich untapped biodiversity that has shown 
to produce a wide range of natural products with novel structural features 
and interesting biological activities.  The marine microorganisms, for ex-
ample, have yielded compounds with new structural classes and bioactivi-
ties. A few of these include FDA approved drugs with antibiotic, antiviral 
and antitumor activities. In our previous work, we have isolated 12 marine 
microorganisms that have exhibited antimicrobial activities.  Of the twelve, 
the extracts of two (GM03 and GM06) displayed activities against triple ne-
gative breast cancer (TNBC) cell lines.  Additionally, coculture experiments 
were carried out with microorganisms GM01 and GMN6 that exhibited 
antimicrobial activities in mixed cultures.  The purification and identifica-
tion of the bioactive chemical entities from the above extracts are currently 
under investigation. 
O-22
MENSACARCIN AFFECTS MITOCHONDRIAL FUNCTION 
SELECTIVELY IN MELANOMA CELLS
Elizabeth N. Kaweesa, Birte Plitzko, Sandra Loesgen
Department of Chemistry, Oregon State University, Corvallis, OR 97331, 
USA.
Mensacarcin is a highly produced bacterial natural product with unique 
cytotoxic and cytostatic effects. A combination of molecular and cell-based 
assays was used to provide insight into mensacarcin cytotoxicity and selec-
tive induction of cell death in melanoma. First, different cell proliferation 
and cytotoxicity assays as well as western blot analysis show that mensa-
carcin induces caspase depending apoptosis in melanoma cells but not in 
the non-sensitive colon carcinoma cells. Secondly, subcellular compart-
mentalization studies using confocal microscopy was used to determine 
mensacarcin’s site of action. Fluorescently-labeled mensacarcin retains acti-
vity and co-localizes in mitochondria within minutes where it affects ener-
gy metabolism. Finally, live cell bioenergetic flux experiments were used to 
determine how mensacarcin induces mitochondrial dysfunction.
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METAGENOME SEQUENCING OF THE NEW ZEALAND 
MARINE SPONGE MYCALE HENTSCHELI UNCOVERS 
THE BIOSYNTHETIC PATHWAYS FOR THE CYTOTOXIC 
POLYKETIDES MYCALAMIDE AND PATEAMINE
Matthew A. Storey1, David F. Ackerley1, Robert A. Keyzers2, Peter T. 
Northcote3 and Jeremy G. Owen1∗
1 School of Biological Sciences, Victoria University of Wellington, New 
Zealand; 2 School of Chemical and Physical Sciences, Victoria University of 
Wellington, New Zealand; 3 Ferrier Research Institute, Victoria University of 
Wellington, New Zealand.
The New Zealand marine sponge Mycale hentscheli is the source of the cyto-
toxic polyketides pateamine, peloruside and mycalamide. By using a com-
bination of Illumina and PacBio sequence data, coupled to metagenome 
binning and hybrid assembly, we have resolved complete genomes for the 
major sponge symbiotic bacteria living in association with a M. hentscheli 
specimen. Here we describe the primary and secondary metabolic charac-
teristics of the microbiome of M. hentscheli, and present complete biosyn-
thetic pathways for mycalamide and pateamine.
O-24
NEW NATURAL PRODUCTS FROM HAWAIIAN MARINE 
AND ENDOPHYTIC FUNGI
Chunshun Li, Shugeng Cao*
Department of Pharmaceutical Sciences, Daniel K. Inouye College of 
Pharmacy, University of Hawai’i at Hilo, HI, USA
The Hawaiian Islands are the most remote dry land on earth. They are loca-
ted almost 2,400 miles from California, 3,800 miles from Japan, and 2,400 
miles from the Marquesas Islands, from which the first settlers arrived in 
Hawaii around 300-400 AD. The natural resources of Hawai`i are unique 
due to its mid-oceanic environment with ecologically rich habitats, which 
present a wide variety of terrestrial ecosystems including tropical rain fo-
rests, coastlines, and marine life. From literature and unpublished sources, 
approximately 21,383 species have been recorded from the Hawaiian Is-
lands and surrounding waters, of which 8,759 are endemic to the Hawai-
ian Islands, and 4,532 are nonindigenous species. Of these, approximately 
15,000 species are terrestrial, 300 are found in freshwater, and 5,500 are 
marine-inhabiting. Literature search also revealed that Hawaiian microor-
ganisms, especially marine and endophytic fungi are under-explored. In-
vestigation of Hawaiian fungi isolated from marine and plants led to the 
discovery of many new and diverse secondary metabolites, for examples 
peyronellins and paraphaeosphaerides.
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A KINETIC DEAROMATIZATION STRATEGY FOR 
AN EXPEDIENT BIOMIMETIC ROUTE TO THE 
BIELSCHOWSKYSIN SKELETON
Paul Scesa1, Medhi Wangpaichitr2, Niramol Savaraj2, Lyndon West1, and 
Stephane Roche1
1Department of Chemistry and Biochemistry, Florida Atlantic University, 
Boca Raton, Florida 33431, USA, 2University of Miami School of Medicine, 
1475 NW 12 Ave, Miami, FL 33136 USA
Bielschowskysin (1), the flagship of the furanocembranoid diterpene fami-
ly, has attracted attention from chemists owing to its intriguing and daunt-
ing polycyclic architecture and medicinal potential against lung cancer. 
The high level of functionalization of 1 poses a considerable challenge to 
synthesis. Herein, a stereoselective furan dearomatization strategy of fu-
ranocembranoids was achieved via the intermediacy of chlorohydrins. The 
stereochemical course of the kinetic dearomatization was established, and 
the C3 configuration of the resulting exo‐enol ether intermediates proved 
to be essential to complete the late‐stage transannular [2+2] photocycload-
dition. Overall, this biomimetic strategy starting from the natural product 
acerosolide (4) featured an unprecedented regio‐ and highly stereoselective 
furan dearomatization, which provided rapid access to the pivotal exo‐enol 
ethers en route to the intricate bielschowskyane skeleton.
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HIGHLY CONVERGENT TOTAL SYNTHESIS AND 
ASSIGNMENT OF ABSOLUTE CONFIGURATION 
OF MAJUSCULAMIDE D, A POTENT CYTOTOXIC 
METABOLITE FROM MOOREA SP.
Eduardo J.E. Caro-Diaz1, Fred Valeriote2, and William H. Gerwick1,3
1Center for Marine Biotechnology and Biomedicine, Scripps Institution of 
Oceanography, University of California at San Diego, La Jolla, CA 92037, 
USA, 2Division of Hematology and Oncology, Department of Internal 
Medicine, Henry Ford Hospital, Detroit, Michigan 48202, United States , 
3Skaggs School of Pharmacy and Pharmaceutical Sciences, University of 
California San Diego, California 92093, USA
We describe the first total synthesis of majusculamide D, a lipopentapep-
tide isolated from Moorea sp.  that has shown potent anti-cancer activity. 
Our strategy was to produce large amounts of compound  via  a scalable 
synthesis taking advantage of a convergent route and minimal number of 
purifications by making use of simple work-ups for the production of large 
amounts of synthetic intermediates. We have also determined the absolute 
configuration of the 1,3-dimethyloctanamide motif and achieved by an ele-
gant synthesis of this buliding block via ZACA chemistry.
N
O N
O
OH
O
N
MeO
OH
N
OAc
N
Me OO
majusculamide D
O
OH
ZACA-vinyl/oxid
tandem
O
N
MeO
OH
N
OAc
N
Me O
OH
Boc
HN
O
N
O
OH
Peptide 
couplings
imidate 
coupling
PANC-1
IC50
 = 320 pm
assigned (R,R)
4 silica column 
purifications
O-27
USING METABOLOMICS TO DISCOVER NATURAL 
PRODUCTS FROM CULTURED CYANOBACTERIA 
Camila M. Crnkovic1, Aleksej Krunic1, Daniel S. May1, Diana Kao2, Tyler A. 
Wilson3, James R. Fuchs3, Joanna E. Burdette1, Nicholas H. Oberlies2, Jimmy 
Orjala1
1Department of Medicinal Chemistry and Pharmacognosy, University 
of Illinois at Chicago, Chicago, IL 60612, 2Department of Chemistry & 
Biochemistry, University of North Carolina Greensboro, Greensboro, NC 
27402, 3Division of Medicinal Chemistry and Pharmacognosy, The Ohio 
State University, Columbus, OH 43210
The discovery of natural products has been traditionally based on bioas-
say-guided approaches. Recently, omics techniques have added new tools 
to the field of natural product discovery. Cyanobacteria are chemically 
rich organisms shown to produce valuable metabolites. In this study, we 
applied two strategies using mass spectrometry metabolomics to explore 
the chemical diversity of cultured cyanobacteria. In the first strategy, in 
situ metabolomics using a droplet–liquid microjunction–surface sampling 
probe (droplet probe) coupled with UPLC-UV-HRMS/MS led to the dis-
covery of calothrixamides A and B from strain Calothrix sp. UIC 10520. In 
the second approach, comparative metabolomics using UPLC-HRMS was 
applied to analyze three strains growing in four liquid media that contained 
different levels of phosphate and nitrate. Among many relevant observa-
tions, these experiments revealed a new linear peptide, named scytoamide, 
produced in increased amounts by strain Scytonema sp. UIC 10036 under 
low nitrate and high phosphate conditions. Calothrixamides A-B and scy-
toamide were elucidated by HRMS, MS/MS, and 1D and 2D NMR, along 
with chemical degradation and derivatization reactions.
O-28
THE NCI PROGRAM FOR NATURAL PRODUCT 
DISCOVERY
Christopher C. Thornburg1, John R. Britt1, Jason R. Evans1,2, Rhone K. Akee1, 
James A. Whitt1, Spencer K. Trinh1, Matthew J. Harris1, Jerell R. Thompson1, 
Teresa L. Ewing1, Suzanne M. Shipley1, Paul G. Grothaus3, David J. 
Newman3, Tanja Grkovic1, and Barry R. O’Keefe3,4
1Natural Products Support Group, Leidos Biomedical Research, Inc., 
Frederick National Laboratory for Cancer Research, Frederick, MD 21702, 
2Data Management Services, Inc., Frederick National Laboratory for Cancer 
Research, Frederick, MD 21702, 3Natural Products Branch, Developmental 
Therapeutics Program, Division of Cancer Treatment and Diagnosis, 
National Cancer Institute, Frederick, MD 21702, 4Molecular Targets 
Program, Center for Cancer Research, National Cancer Institute, Frederick, 
MD 21702.
The US National Cancer Institute’s Natural Product Repository is one of the 
world’s largest, most diverse collections of natural products containing over 
230,000 unique extracts derived from plant, marine and microbial organis-
ms that have been collected from biodiverse regions throughout the world. 
Importantly, this national resource is available to the research communi-
ty for the screening of extracts and the isolation of bioactive natural pro-
ducts. However, despite the success of natural products in drug discovery, 
compatibility issues that make crude natural product extracts challenging 
have reduced enthusiasm for the high-throughput screening (HTS) of cru-
de natural product extract libraries in targeted assay systems. To address 
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these limitations and make the NCI’s Natural Products Repository more 
amenable to HTS, we have initiated the prefractionation of extracts using 
an automated, high-throughput robotics platform capable of generating a 
library of 1,000,000 partially purified extracts. The talk will discuss this and 
other efforts to increase the utility of the NCI Natural Products Repository. 
O-29
CHARACTERIZATION OF CONSERVED 
ACTINOBACTERIAL MYCOSPORINE-LIKE AMINO ACID 
GENES THROUGH HETEROLOGOUS EXPRESSION
Andrew R. Osborn and Taifo Mahmud
Department of Pharmaceutical Sciences, Oregon State University, Corvallis, 
OR 97331, USA.
Mycosporine-like amino acids (MAAs) are sunscreen compounds identi-
fied in algae, bacteria, and marine invertebrates. MAAs are formed by a 
four-step pathway that uses sedoheptulose 7-phosphate as substrate where 
it undergoes cyclization, methylation, and two amino acid condensations. 
Over 30 MAAs have been identified, yet the known pathway cannot ex-
plain all this diversity. Genome mining identified three putative genes en-
coding a haloacid dehalogenase, a taurine dioxygenase (TauD-like), and a 
membrane protein conserved within actinobacterial MAA operons. The 
Rhodococcus fascians D188 MAA operon was cloned into fragments with 
and without the putative genes to determine their function by heterolo-
gous expression in Streptomyces coelicolor M1152. The MAA shinorine was 
found in all cultures, but expressions that contained the tauD-like gene also 
formed the MAAs palythine and palythine-serine. Thus, the TauD-like en-
zyme is needed for cleaving the amino acid C-N bond to form palythines, 
whose biosynthesis was previously unknown.
O-30
OLD DRUGS, NEW TRICKS: NON-MITOTIC EFFECTS OF 
MICROTUBULE TARGETING AGENTS IN CANCER CELLS
April L. Risinger, Nicholas F. Dybdal-Hargreaves, Roma Kaul, and Susan L. 
Mooberry
Department of Pharmacology and Mays Cancer Center, UT Health San 
Antonio, 7703 Floyd Curl Drive, San Antonio, TX, 78229, USA.
The discovery and development of microtubule targeting agents (MTAs), 
including the taxanes, vinca alkaloids, ixabepilone, and eribulin, represent 
some of the most notable success stories for natural products drug discove-
ry. The clinical anticancer efficacy of these drugs has long been attributed 
strictly to their antimitotic activities and they are commonly referred to as 
“antimitotics.” However, increasing evidence of the non-mitotic effects of 
MTAs on oncogenic signaling has prompted a reevaluation of their mecha-
nisms of action. The finding that individual patients can respond differently 
to the 4 classes of MTAs used to treat breast cancer prompted evaluations 
into the distinct effects of these drugs on oncogenic signaling pathways. We 
evaluated early events that link MTA-induced microtubule disruption to 
the signaling pathways involved in the epithelial-mesenchymal transition 
(EMT), an important event in oncogenesis. Striking differences were iden-
tified among MTAs in their ability to disrupt Src-dependent E-cadherin 
internalization and TGF-β signaling. Within 2 h of treatment, eribulin has 
unique effects on the localization of E-cadherin. Additionally, eribulin and 
vinorelbine inhibit expression of key transcription factors that drive EMT 
as compared to a taxane. These findings demonstrate the ability of diver-
se MTAs to rapidly and differentially alter non-mitotic oncogenic signa-
ling. Identification of differences among MTAs might facilitate the rational 
selection of specific drugs depending on tumor characteristics. These stu-
dies highlight the importance of continually revisiting the mechanisms of 
action of compounds, particularly in light of clinical observations. Studies 
were funded by Eisai Inc. 
O-31
TWO-DIMENSIONAL QUANTITATIVE NUCLEAR 
MAGNETIC RESONANCE FOR DETERMINATION 
OF COMPONENT CONCENTRATIONS IN COMPLEX 
MIXTURES
K. Brian Killday1, Christian Fischer2, and Kimberly L. Colson1
1Bruker BioSpin Corp., Billerica, MA, USA and 2Bruker BioSpin GmbH, 
Rheinstetten, Germany
Numerous applications of Nuclear Magnetic Resonance Spectroscopy 
(NMR) for quantitative analyses of chemical mixtures have been utilized. 
1D 1H-NMR typically provides the highest sensitivity analyses with 
excellent linear response to component concentrations which can be 
converted to absolute concentrations by reference to an internal standard 
(including the solvent) or an external reference via the PULCON method. 
Analyses of complex mixtures via 1D-NMR however are often hindered by 
resonance overlap. Utilization of 1H-13C heteronuclear correlation (HSQC) 
provides excellent dispersion along the 13C chemical shift dimension, 
thereby greatly reducing peak overlap.  The added dispersion along with 
the high reproducibility of NMR enables molecular identification with 
high confidence even with closely related molecules.  The HSQC cross-
peak intensity responses are influenced by resonance-specific signal 
attenuation and therefore the volumes for different cross peaks from the 
same molecule can vary. Nevertheless, by utilizing the same experimental 
parameters for any set of standards and unknowns, the areas for the 
corresponding resonances scales linearly with molar concentrations. 
This study investigates the quantitative accuracy of HSQC on synthetic 
model mixtures.  In addition, it will be demonstrated that Quantitation 
via Heteronuclear Multiple Bond Correlation (Q-HMBC) experiments 
can be performed utilizing the PULCON method.  Applications to natural 
product extracts and formulations and implementation into automated 
analysis methods will be presented.
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NMR CHARACTERIZATION OF COMPLEX NATURAL 
PRODUCTS: NEW TOOLS FOR ASSIGNING NOVEL 
MOLECULAR SCAFFOLDS
Kirk R. Gustafson,1 Keke Li,1 Yizhou Liu,2 R. Thomas Williamson,2 Gary E. 
Martin2
 1Molecular Targets Program, Center for Cancer Research, National Cancer 
Institute-Frederick, Frederick, MD, USA, 2Structure Elucidation Group, 
Process and Analytical Research and Development, Merck & Co. Inc., 
Rahway, NJ, USA
NMR provides powerful structural elucidation tools that are particularly 
well suited for natural products studies.  Comprehensive spectroscopic 
characterization of a native metabolite may be sufficient to fully assign a 
planar structure.  However, assignment of the relative and absolute con-
figuration of a molecule when there are multiple stereogenic centers often 
requires the development and application of additional experimental strat-
egies.  Many successful approaches in this regard rely on the formation of 
appropriate derivatives for more detailed NMR study.  Since natural prod-
ucts are often obtained in very limited quantities, micro-scale chemical ma-
nipulations and the ability to analyze the structure of the resulting products 
is often key to the complete structural and configurational assignment of 
complex metabolites.  Anisotropic NMR parameters such as residual dipo-
lar coupling (RDC) and residual chemical shift anisotropy (RCSA) provide 
a powerful and complementary means to help assign and verify structures 
deduced from conventional NMR analyses. Application of a wide spectrum 
of NMR techniques and methodologies will be described in the structural 
elucidation of two novel natural product scaffolds, each of which contain 
multiple stereogenic centers.
O-33
IDBAC: A MALDI-TOF MS PLATFORM TO CREATE 
DIVERSE MICROBIAL LIBRARIES
Maria S. Costa1,2, Chase Clark2, Sesselja Omarsdottir1, Laura M. Sanchez2, 
Brian T. Murphy2,3
1University of Iceland, Reykjavik, Iceland, 2Department of Medicinal 
Chemistry and Pharmacognosy, 3Institute for Tuberculosis Research, College 
of Pharmacy, University of Illinois at Chicago, Chicago
In the course of a nearly century-long global effort to discover new bacte-
rial-derived antibiotics from the environment, there have been few innova-
tions to the way that researchers have collected samples and subsequently 
created microbial libraries sourced for therapeutic discovery. As a result, 
it is difficult to discover novel antibiotic scaffolds due to the degree of ta-
xonomic and chemical redundancy that exists in these strain libraries. To 
address the need for isolating novel taxa from environmental samples, we 
developed a high-throughput matrix assisted laser desorption ionization 
mass spectrometry (MALDI-TOF MS) technique that allows us to readily 
group bacterial colonies by putative taxonomic identity and further discri-
minate them based on in situ natural product production. In May 2017, we 
embarked on a collection expedition to Iceland, which has a unique geo-
logy and geographical position in the North Atlantic Ocean. Using SCU-
BA and sampling off of vessels, we collected eighty-six samples from thirty 
sites. After purifying 1,607 strains from the samples that we collected, we 
acquired consecutive protein and specialized metabolite MS spectra from 
single colonies of these strains. In approximately four hours we are able to 
prepare, acquire data for, and visualize 384 colonies using our semi-auto-
mated, freely available IDBac bioinformatics pipeline. This pipeline will be 
presented.
O-34
LEVERAGING METABOLOMICS ACROSS HUNDREDS 
OF ACTINOMYCETE STRAINS TO CALIBRATE 
EMERGING BIOINFORMATICS PLATFORMS
James H. Tryon1, Jorge C. Navarro-Muñoz2, Elizabeth Parkinson3, Michael 
Mullowney1, Nelly Selem-Mojica4, Emmanuel L.C. De Los Santos5, Marnix 
Medema2, Francisco Barona-Gomez4, Regan Thompson1, William Metcalf3, 
Neil L. Kelleher1.
1Dept. of Chemistry, Northwestern University, Evanston, IL, 2Bioinformatics 
Group, Wageningen University, Wageningen, The Netherlands, 3Institute for 
Genomic Biology, University of Illinois, Urbana, IL, 4Langebio, Guanajuato, 
Mexico, 5Warwick Integrative Synthetic Biology Centre, University of 
Warwick, Coventry, United Kingdom
Bioinformatic analyses of microbial genome sequences have unveiled lar-
ge numbers of uncharacterized natural product biosynthetic gene clusters 
(BGCs). Despite growing interest in studying natural products across large 
datasets, no publicly available tool exists that provides in-depth BGC com-
parisons across massive genome libraries. During the development of BiG-
SCAPE, a tool to provide the field with these analyses, we became interested 
in applying a large library of untargeted LC-MS/MS metabolomics data 
collected from hundreds of actinomycete strains to calibrate BiG-SCAPE 
BGC comparison metrics. A benchmarking strategy was developed using 
a subset of known natural products and their characterized BGCs within 
our dataset. Analysis of these benchmark compounds as well as correlation 
score distributions for thousands of unknown compounds within our da-
taset has been used to demonstrate the potential of BiG-SCAPE to enable 
large-scale genome mining efforts. 
O-35
CO-CULTURE OF TWO FORMS OF A MARINE-
DERIVED ASPERGILLUS ALLIACEUS RESULTS IN THE 
PRODUCTION OF ALLIANTHRONES A-F
Paige E. Mandelare, Donovon A. Adpressa, Elizabeth N. Kaweesa, Lev N. 
Zakharov, Sandra Loesgen
Department of Chemistry, Oregon State University, Corvallis, OR 97331
Two developmental forms of marine alga-derived Aspergillus alliaceus 
were explored as sources of new metabolites. The asexual (conidial) and 
the sclerotial form of this endophytic fungus can be separated and each 
produce their own, distinct secondary metabolite profile. After combining 
both fungal phenotypes in a co-culture experiment, nalgiolaxin, a chlori-
nated anthraquinone pigment was more abundant and bianthrones were 
newly produced. The structures of allianthrones A-F were determined by 
extensive NMR spectroscopic analysis, and supported by chiroptical pro-
perties, and X-ray crystallography. Allianthrone A and exhibited moderate 
cytotoxic activity against colorectal carcinoma (HCT-116) and melanoma 
(SK-Mel-5) and allianthrones A and D were subjected to the NCI-60 cell 
line panel.
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COCULTURE STIMULATES ANTIBIOTIC BIOSYNTHESIS 
IN ACTINOMYCETES
Gabrielle Grandchamp1, Nikolas Stasulli1, Elizabeth Shank1,2
1Department of Microbiology & Immunology, The University of North 
Carolina at Chapel Hill, Chapel Hill, NC, 2Department of Biology, The 
University of North Carolina at Chapel Hill, Chapel Hill, NC
Actinomycetes are one of the largest producers of specialized metabolites, 
including many commonly used antibiotics. Under laboratory conditions, 
most actinomycetes only produce a fraction of the metabolites they are pre-
dicted to synthesize. The signals that activate expression of these cryptic 
biosynthetic gene clusters are unknown, although other bacteria may pro-
vide these signals. Based on this hypothesis, we are using coculture to mi-
mic interactions that occur in native environments to elicit specialized me-
tabolite production and identify novel antibiotics. We isolated actinomyce-
tes from individual soil particles to capture interactions that could feasibly 
occur in the environment. We tested 11 isolates in all 55 possible pairwise 
combinations for antibiotic activity against Staphylococcus aureus using an 
antibiotic overlay assay. We identified multiple actinomycete pairs that dis-
played coculture-specific antibiotic activity, some of which were also active 
against a beta-lactam resistant strain of S. aureus. Using bioassay-guided 
fractionation we have obtained a semi-pure active fraction from one of the 
active cocultures. We are now using liquid-chromatography-mass spectro-
metry and NMR to identify the active compound. Our results indicate that, 
in microbial coculture, secreted metabolites can serve as signals that alter 
the expression of antibiotic biosynthetic genes. Exploring the metabolic 
consequences of microbial coculture may therefore allow us to identify no-
vel antibiotics with potential therapeutic applications as well as reveal how 
bacteria communicate in native settings.
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CO-CULTURING OF TROPICAL MARINE 
CYANOBACTERIA OF MOOREA AND LEPTOLYNGBYA 
SPECIES
Evgenia Glukhov, Aurora Guild, Alankrta Annapurni Venkatesh, Bahar 
Teke and William H Gerwick
Center for Marine Biotechnology and Biomedicine, Scripps Institution of 
Oceanography, University of California San Diego, La Jolla, California 
92093
Antagonistic interaction between co-cultured organisms has been a pro-
ductive method by which to activate normally silent secondary metabo-
lite biosynthetic gene clusters. To this end, we performed a four week long 
co-culture experiment using four isolated, non-axenic, tropical filamentous 
cyanobacteria cultures. As identified by 16S rRNA sequencing, two of the 
cultures were Leptolynbya species while other two were Moorea producens. 
All four cultures were isolated from original field collections made in shal-
low waters near Jamaica, Palmyra atoll, American Samoa and Sulawesi. 
These cultures have been established as producers of potent natural prod-
ucts such as hectochlorin, jamaicamides, palmyramide A, leptochaelin, 
fagaaluamides and phormidolide. The biomass and media of each sample 
were harvested, dried and extracted to produce crude extracts with yields 
of 5-40%. We tracked the progress of the co-culture process using light mi-
croscopy, and recorded that Moorea filaments in Moorea and Leptolynbya 
co-cultures were dying, thus indicating an impact of the one species on the 
other. The addition of diluted crude extracts of Leptolyngbya or its cocul-
ture with Moorea did not kill Moorea filaments, suggesting a non-chemical 
reason for this phenomenon. The crude extracts of each of the experiments 
will be analyzed by mass spectrometry, MS2 molecular networking, UV ab-
sorbance and biological activity to cancer cells. 
P-002
NEW ALCYOPTEROSINS AND STEROIDS ISOLATED 
FROM AN UNDESCRIBED ANTARCTIC CORAL
Anne-Claire D. Limon,1 Nerida G. Wilson,2 Bill J. Baker1.
1Department of Chemistry, University of South Florida, Tampa, FL 33620, 
USA, 2Western Australia Museum and University of Western Australia 
Perth, Western Australia, Australia 
Marine invertebrates from Antarctica have been investigated for their po-
tential natural product chemistry. Often sessile, these organisms must de-
velop chemical protective mechanisms to survive and defend themselves 
against predators. The biodiversity of these organisms is of particular in-
terest due to the extremely low temperatures and the circumpolar current 
around the Antarctic continent serving as an ecological isolating shield. The 
chemodiversity that emanates from these organisms can be a significant 
source of novel chemistry to be further developed into new drugs. The che-
mical investigation of an undescribed Gersemia sp. Antarctic coral has led 
to the isolation of two different kinds of bioactive compounds. After lyophi-
lization of the organism, two different extractions were performed: the first 
one used a methylene chloride: methanol (1:1) solvent mixture, and the 
second one used methylene chloride only as solvent in a Soxhlet extraction. 
After a partition followed by normal phase Medium Pressure Liquid Chro-
matography, stages of normal phase and reverse phase High Performance 
Liquid Chromatography purifications were performed and revealed two 
kinds of new bioactive compounds: new acetylated sesquiterpenoids with 
alcyopterosin scaffolds from the first process and new acetylated steroids 
from the second. One and two-dimensional nuclear magnetic resonance, 
mass spectrometry, X-ray crystallography, and circular dichroism were the 
methods performed to elucidate and confirm the structures. Furthermore, 
biological testing against Leishmania sp. and ESKAPE pathogens, Zika vi-
rus, Clostridium difficile, and HeLa cancer cells were performed to extend 
the scope of drug discovery potential. 
P-003
INVESTIGATING THE CYTOTOXIC SECONDARY 
METABOLITES OF AN AMERICAN SAMOAN MARINE 
CYANOBACTERIA LEPTOLYNGBYA SP.
Kelsey L. Alexander1, Brendan M. Duggan2, Eduardo Caro-Diaz3, C. 
Benjamin Naman3,4, Evgenia Glukhov3, and William H. Gerwick2,3 
1Department of Chemistry and Biochemistry, University of California, San 
Diego, La Jolla, CA 92093. 2Skaggs School of Pharmacy and Pharmaceutical 
Sciences, University of California, San Diego, La Jolla, California 
92093.3Scripps Institution of Oceanography, University of California, 
San Diego, La Jolla, CA 92093. 4Li Dak Sum Marine Biopharmaceutical 
Research Center, College of Marine Sciences Ningbo University, Ningbo, 
Zhejiang 315211, China
Marine cyanobacteria have emerged as one of the most prolific producers 
of structurally unique and biologically active marine natural products. 
In this regard, living collections of the cyanobacterium Leptolyngbya sp. 
ASX22JUL14-1 were made in American Samoa and maintained in labora-
tory culture. The secondary metabolites of this culture were determined to 
be of interest due to in vitro cytotoxicity of the organic extract against NCI-
H460 lung cancer cells. After extended culture efforts to produce adequate 
biomass, LC-MS/MS based molecular networking, various forms of NMR, 
and cancer cell bioassay were used to guide the isolation of a novel natural 
product. Accelerated NMR techniques were used for faster data collection, 
and its structure was determined using the full assortment of spectroscopic 
methods.
P-004
NEW BIOACTIVE COMPOUNDS FROM SINGAPORE’S 
MARINE CYANOBACTERIA AND SPONGE-ASSOCIATED 
ACTINOMYCETES
Chi Ying Gary Ding,1 Ji Fa Marshall Ong,1 Gurjeet Singh Kohli,2 Liang 
Yang,2 Evgenia Glukhov,3 William Gerwick,3 and Lik Tong Tan1*
1National Institute of Education, Nanyang Technological University, 1 
Nanyang Walk, Singapore 637616, 2Singapore Centre for Environmental 
Life Sciences Engineering, Nanyang Technological University, 60 Nanyang 
Drive Singapore 637551 3Center for Marine Biotechnology and Biomedicine, 
Scripps Institution of Oceanography, University of California San Diego, La 
Jolla, CA, USA *E-mail: liktong.tan@nie.edu.sg
Filamentous marine cyanobacteria and bacteria, such as actinomycetes, are 
well known to be prolific sources of novel bioactive natural products for 
drug discovery and development.  As part of a drug discovery research pro-
gram in Singapore, a new cyclic depsipeptide, benderamide A, was isolated 
from a marine cyanobacterial bloom collected from St. John’s Island.  Its 
planar structure was deduced based on extensive 1D and 2D NMR spectro-
scopy while the stereochemistry was determined using Marfey’s analysis. 
In addition to five amino acid-derived residues, benderamide A contained 
a polyketide unit, 2-2-dimethyl-3-hydroxyoctynoic acid (Dhoya).  Prelimi-
nary biological result revealed benderamide A to exhibit 100% toxicity in 
the brine shrimp toxicity assay when tested at 10ppm.  Cytotoxicity data of 
the new cyclic depsipeptide will also be presented in this study.  We have 
recently embarked research on drug discovery from marine bacteria asso-
ciated with a number of deep water marine sponge species collected at the 
Singapore Straits.  Using culture-dependent method, a total of 187 marine 
actinomycetes were isolated and identified based on 16S rRNA gene se-
quences.  About 3% of the bacterial extracts showed anti-quorum sensing 
activity in a dose dependent manner.  Furthermore, the bacterial extracts 
were subjected to MS-based molecular networking analysis for dereplica-
tion and their bacterial genome analysed for the presence of novel biosyn-
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thetic gene clusters.  Both the metabolomic and genomic data of a marine 
bacterial strain #52 are presented here to illustrate the use of innovative 
techniques for the discovery of novel bioactive compounds.
Acknowledgments: This project is supported by the NRF MSRDP P-15 
grant.
P-005
MINING NOVEL LINEAR AND CYCLIC PEPTIDES 
FROM AN AUSTRALIAN MARINE TUNICATE-DERIVED 
FUNGUS, TALAROMYCES SP. CMB-TU011. 
P. Dewapriya1, P. Prasad1, Z. Khalil1, P. Cruz-Morales2,3, A.A. Salim1, E. 
Marcellin2, and R.J. Capon1
1Institute for Molecular Bioscience, 2Australian Institute for Bioengineering 
and Nanotechnology, The University of Queensland, St Lucia, QLD 
4072, Australia, 3Joint BioEnergy Institute, Lawrence Berkeley National 
Laboratory, California, USA
An Australian marine tunicate-derived fungus, Talaromyces sp. 
CMB-TU011, was subjected to analytical (MATRIX) cultivations to 
identify optimal conditions for the production of four new extensively 
N-methylated linear peptides, talaropeptides A-D (shown), and an 
unprecedented cyclic peptide hydroxamate, talarolide A. Identification 
of these peptides was achieved by detailed spectroscopic analysis, and 
chemical methods (C3 and 2D C3 Marfey’s). Genomic analysis identified 
the talaropeptide NPRS, the 2nd largest described to date, as similar to 
cyclosporine.
P-006
MARINE DERIVED PROTEINS WITH POTENT 
BIOACTIVTY
Carter A. Mitchell1, Emily V. Reagle1, Barry R. O’Keefe1,2
1Molecular Targets Program, Center for Cancer Research, National Cancer 
Institute, Frederick, MD 21702; 2Natural Products Branch, Developmental 
Therapeutics Program, DCTD, National Cancer Institute, Frederick, 21702
Natural product extracts represent a substantial repository of bioactive 
compounds that have resulted in treatments currently used in numerous 
therapeutic regimens. These drugs have largely been discovered by natural 
product chemists investigating the small organic solvent-soluble compo-
nents of these extracts. However, clinically approved biologics from natu-
ral sources provide evidence that the discovery of novel bioactive proteins 
from nature can lead to viable, clinically relevant therapeutics. We exami-
ned the proteinaceous components of aqueous marine extracts from the 
Natural Products Branch repository for proteins with potent anticancer 
or antiviral activities using the NCI-60 cancer-cell panel and an in-house 
anti-HIV-1 assay. Extracts with activities concentrated in the proteinaceous 
fraction were further characterized to identify the proteins of interest. Here 
we report the isolation, characterization, and initial sequencing efforts of 
two lectins from marine aqueous extracts. Proteins isolated from both the 
sponge Vagocia sp. and the sea cucumber Isostichopus badionotus that dis-
played nanomolar bioactivities against HIV-1 and NCI-60 cancer cell lines, 
respectively, will be discussed. 
P-007
DISCOVERY OF ANTILEISHMANIAL NATURAL 
PRODUCTS FROM ACTINOBACTERIA ASSOCIATED TO 
BRAZILIAN FUNGUS-GROWING ANTS
Humberto E. Ortega1, Tim S. Bugni2, Leonardo L. Gomes Ferreira3, Adriano 
D. Andricopulo3, Jon Clardy4 and Mônica T. Pupo1
1School of Pharmaceutical Sciences of Ribeirão Preto, University of São 
Paulo, Ribeirão Preto-SP, Brazil, 2School of Pharmacy, University of 
Wisconsin, Madison, WI, USA, 3Physics Institute of São Carlos, University 
of São Paulo, São Carlos-SP, Brazil, 4Harvard Medical School, Boston, MA, 
USA
In the quadripartite symbiosis in the fungus-growing ant ecosystem bet-
ween three mutualist (Attine ant, fungal garden and symbiotic actinomy-
cetes) and one parasite (specialized pathogenic fungus Escovopsis sp) some 
interspecies interactions are mediated by small molecules. The actinobacte-
ria associated to the ant host produce secondary metabolites to inhibit this 
pathogen but not the crop fungus. This specific ecological function can gui-
de the discovery of natural products potentially active against human pa-
thogens. Indeed, Interesting bacterial-derived natural products have been 
reported with a wide spectrum of biological activities. In an ongoing ICBG 
project, we have isolated several actinobacteria strains from the exoskeleton 
of fungus-growing ants to prospect for active compounds against protozo-
an parasites such as Leishmania donovani. The bioassay guided fractiona-
tion of active extracts led to the isolation of antibiotics Mer-A2026B (1), 
Piericidin-A1 (2) and Nigericin (3), from cultures of Candidatus Streptomy-
ces philanthi bv. triangulum ICBG292, which showed IC50 of 37 µM, 42 µM 
and 334 nM against L. donovani, respectively. The compounds were also 
active against Escovopsis. Dimeric dinactin (4), produced by Streptomyces 
puniceus AB10, showed potent anti-L. donovani activity with an IC50 of 55 
nM. Compounds 3 and 4 were more active than positive control, miltefo-
sine (IC50 of 7.26 µM). Structures of additional leishmanicidal compounds 
are currently being established. Therefore, the ecological function of natu-
ral products from bacterial symbionts of attine ants can be aligned pharma-
cological activities.
P-008
CACOLIDES A-L, UNPRECEDENTED SESTERTERPENE 
BUTENOLIDES FROM A SOUTHERN AUSTRALIAN 
MARINE SPONGE, CACOSPONGIA SP. 
S. Khushi1, A. A. Salim1 and R. J. Capon1
1Division of Chemistry and Structural Biology, Institute for Molecular 
Bioscience, University of Queensland, QLD 4072, Australia
Preliminary HPLC-DAD-MS and 1H NMR analysis of triturated fractions 
prepared from an extract of a southern Australian marine sponge, Caco-
spongia sp. (CMB-03404), suggested the presence of secondary metabolites 
belonging to the variabilin-like class of sesterterpene tetronic acid (high-
lighted in red). As this sponge-specific structure class is well represented 
in the scientific literature, initial thoughts were that this extract had little to 
offer in the way of structure novelty. However, a closer examination using 
a molecular networking (GNPS) approach, followed by careful fraction-
ation and structure elucidation using detailed 1D and 2D NMR spectro-
scopic analysis, identified an array of fourteen new metabolites, spanning 
cacolides A-L and cacolic acids A-B. Of note, none of the cacolides were 
tetronic acids, but many possessed an isomeric, and very rare γ-substituted 
γ-hydroxybutenolide moiety (highlighted in blue). 
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cacolide A
P-009
DEEP-SEA ACTINOBACTERIA AS AN ATTRACTIVE 
SOURCE FOR NATURAL PRODUCTS 
Guojun Wang Ph.D. 
Harbor Branch Oceanographic Institute, Florida Atlantic University, 5600 
US Highway 1 North, Fort Pierce, FL 34946
Though natural products (NPs) derived from terrestrial actinobacteria are 
the major source of current antibiotics, the less-exploited deep-sea Actino-
bacteria may serve as an unprecedented source of novel NPs. In a prelimi-
nary study of 50 Actinobacteria isolated from diverse deep-sea sponges or 
unique environmental niches, we found more than half of the tested strains 
(27) were identified as active in at least one anti-microbial assay. We also 
proved the rare earth salt lanthanum chloride (LaCl3) is an effective elicitor. 
Of the 27 strains, the anti-microbial activity of 15 (>50%) were induced or 
enhanced by the addition of LaCl3. Here, we report the identification of new 
metabolites (except R6-1-1) isolated from R818, a deep-sea Streptomyces 
sp. (the R series of compounds) and J378, a deep-sea Nocardiopsis sp. (the 
J series of angucyclines). A brominated derivative (structure not shown) 
of J6-1 showed an anti-MRSA activity at least 160-fold higher than that of 
J6-1. The genome of both strains were determined. Genome- and structure-
guided biosynthesis of these metabolites are now being studied. 
 
 
 
 
P-010
FACILE SYNTHESIS AND MICROBIAL METABOLISM OF 
PRENYLQUERCETINS
Fubo Han1, Deborah K.B. Runyoro2, Olipa D. Ngassapa2, and Ik-Soo Lee1
1College of Pharmacy and Research Institute of Drug Development, 
Chonnam National University, Gwangju 61186, Republic of Korea, 2School 
of Pharmacy, Muhimbili University of Health and Allied Sciences, P.O. Box 
65013, Dar-Es-Salaam, Tanzania
Quercetin, one of the major constituents of propolis, was found to show 
various biological activities. Enhancement of bioactivity of flavonoids has 
often been closely associated with nuclear prenylation, and thus three pre-
nylated derivatives of quercetin were synthesized through Claisen rearran-
gement in the presence of boron trifluoride etherate. Microbial metabolism 
studies were carried out in order to identify microbial metabolites of pre-
nylquercetins with increased water solubility and improved bioavailability. 
During the screening process, it was revealed that the fungus M. hiemalis 
is capable of metabolizing prenylquercetins into more polar metabolites. 
Antioxidant activity of the prenylated quercetin derivatives and microbial 
metabolites were evaluated by DPPH assay. Synthesis, isolation, structure 
elucidation and bioassay of the prenylquercetins and their metabolites will 
be presented.
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P-011
BIOGENESIS OF HALOGENATED AMINO ACID 
BUILDING BLOCKS IN THE BIOSYNTHESIS OF THE 
LIPOPEPTIDE ANTIBIOTIC TAROMYCIN
Hanna Luhavaya, Renata Sigrist, Jonathan R. Chekan, Shaun M. K. 
McKinnie, and Bradley S. Moore
Center for Marine Biotechnology and Biomedicine, Scripps Institution of 
Oceanography, University of California San Diego, La Jolla, CA, 92093, USA
An orphan biosynthetic gene cluster from the marine actinomycete 
Saccharomonospora sp. CNQ-490 was successfully captured, engineered, 
and heterologously expressed, which resulted in the isolation of two novel 
lipopeptide antibiotics, taromycin A and B. Both molecules are highly sim-
ilar to the clinically used antibiotic daptomycin, but have several structural 
differences. The two aromatic amino acid residues in taromycins, tryp-
tophan (Trp) and kynurenine (Kyn), are chlorinated. Although 6-Cl-Trp 
has been reported in other peptides, 4-Cl-Kyn has not been previously ob-
served in nature. The work to be presented describes in vivo and in vitro 
studies that elucidated the unique enzymology underlying the formation 
of these residues. Tar14, a new member of flavin-dependent tryptophan 
halogenases, was biochemically characterized and its crystal structure was 
solved. Tar13 (tryptophan 2,3-dioxygenase, TDO) and Tar16 (kynurenine 
formamidase, KF), have been identified as the enzymes that perform the 
unprecedented transformation of 6-Cl-Trp to 4-Cl-Kyn. Tar13 and Tar16 
fall into a separate new subgroup in the phylogenetic tree of known TDO 
and KF homologues. The characterization of these enzymes enriches the 
functional diversity of TDO  and KF families and provides a new strategy 
for discovering novel halogenated natural products by genome mining. 
P-013
CHEMICAL CHARACTERIZATION, POTENTIAL 
ANTIOXIDANT AND NEUROPROTECTIVE ACTIVITIES 
OF POLYSACCHARIDES OF SOME SEAWEEDS
Tosin A. Olasehinde1, Leonard V. Mabinya1, Ademola O. Olaniran, and 
Anthony I. Okoh1. 
Applied and Environmental Microbiology Research Group, Department of 
Biochemistry and Microbiology, University of Fort Hare, Alice, South Africa1, 
Discipline of Microbiology, School of Life Sciences, College of Agriculture, 
Engineering and Science, University of Kwazulu-Natal, Durban, South 
Africa2
This study sought to characterize and determine the antioxidant and 
neuroprotective potentials of polysaccharides from Ecklonia maxima, 
Ulva rigida and Gelidium Pristoides. The antioxidant activity of the poly-
saccharides was determined via their ability to scavenge 2,2-diphenyl -1- 
picrylhydrazyl (DPPH), 2,2-azinobis 3-ethylbenzothiazoline-6-sulfonate 
(ABTS) and hydroxyl (OH) radicals. The effect of the polysaccharides was 
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also tested on acetylcholinesterase (AChE), butyrylcholinesterase (BChE) 
and beta-amyloid (Aβ1-42) protein. Sugars such as D-xylose, D-ribose, 
D-galactose, D-arabinose and L-rhamnose and L-fucose were identified 
in the polysaccharides via Gas Chromatography-Mass Spectrometry. The 
polysaccharides exhibited ABTS, DPPH and OH radical scavenging activ-
ities. The polysaccharides also reduced AChE and BChE activities in vitro. 
Electron micrographs from the transmission electron microscope revealed 
that polysaccharides from the seaweeds incubated with Aβ1-42 at different 
intervals (0-96 h) were devoid of protein fibrils or showed very low levels 
of fibrils compared to the control. The observed antioxidant activity and 
inhibitory effects of the polysaccharides on AChE, BChE and beta-amy-
loid aggregation suggest that they are potential neuroprotective agents and 
could be explored for the treatment and management of Alzheimer’s dis-
ease.
P-014
ANTIMICROBIAL SECONDARY METABOLITES FROM 
MARINE-INVERTEBRATE ASSOCIATED BACTERIA.
René F. Ramos A.1, Fan Zhang1, Miao Zhao2, Gabriel Cornilescu3, Douglas 
Braun1, Thomas Wyche4, Megan Duster2, Jeff Piotrowski5, Travis De Wolfe6, 
David Andes2, Scott Rajski1, Tim Bugni1
1School of Pharmacy, University of Wisconsin-Madison, Madison, WI 
53705; 2School of Medicine and Public Health, University of Wisconsin 
Madison, WI 53705; 3National Magnetic Resonance Facility at Madison, 
Department of Biochemistry, University of Wisconsin-Madison, Madison, 
WI 53706; 4Merck Research Labs, Boston, MA 02115, 5Yumanity 
Therapeutics, Cambridge, MA 02139; 6Department of Food Science, 
University of Wisconsin-Madison, Madison, WI 53706
C. difficile infections (CDIs) and methicillin-resistant S. aureus (MRSA) in-
fections constitute a major health threat worldwide emphasizing the need 
for new drug entities. Within this scope, ecteinamycin (1) was isolated from 
a marine Actinomadura sp. Ecteinamycin demonstrated potent activity 
against C. difficile NAP1/B1/027 (MIC = 59 ng/μL), as well as other toxi-
genic and non-toxigenic strains. Chemical genomics using E. coli barcoded 
deletion mutants revealed particularly sensitive mutants such as those de-
ficient in trkA and kdpD (potassium cation transport-related genes) sug-
gesting that 1 likely exerts antibacterial activity via its ionophoric activity. 
Also, a potent bioactive spiro-napthoquinone (2) was isolated from a mari-
ne Micromonospora sp. Compound 2 demonstrated potent activity against 
MSSA and MRSA strains, with MICs of 0.25 μg/mL. Further in vivo testing 
and MOA studies are being pursued.
P-015
CHARACELLA PACHASTRELLOIDES; TREASURE OF THE 
IRISH DEEP-SEA
Sam Afoullouss1,2, Kevin Calabro1, Christine Morrow2, Rob Nesbitt1,2, Claire 
Laguionie-Marchais2, Ryan Young1,2, Bill Baker 3, Louise Allcock2, Olivier P. 
Thomas1
1Marine Biodiscovery. School of Chemistry and Ryan Institute, National 
University of Ireland Galway University Road, H91TK33 Galway, Ireland.  
2Zoology, School of Natural Sciences and Ryan Institute, NUI Galway, 
University Road, Galway, Ireland. 3Department of Chemistry and Centre for 
Drug Discovery and Innovation, University of South Florida, Tampa, Fl., 
USAP
We are investigating the chemical diversity of deep-sea sponges collected 
from the Irish continental shelf. Sampled from between 1000 – 3000 m, 
these sponges inhabit a rarely explored cornucopia of biodiverse fauna. 
Due to the extreme physical conditions, these organisms have developed 
unique secondary metabolites with previously unseen chemical structures 
and characteristics. We aim to isolate these new compounds and determi-
ne their potential to be developed into new marine drugs. Our search for 
new compounds begins with a chemical screening process. This technique 
gives an overall view of the chemical diversity present in each sponge and 
increases our probability of finding novel compounds.
We report herein the isolation and structure elucidation of two novel epimer 
peptides from the sponge Characella pachastrelloides (Carter, 1876). Both of 
them (867 Da) consist of three separate moieties, a tripeptide (O-Me-Tyr, 
Asp, Thr), a ten-member alkyl chain capped with dimethyl substituted cy-
clic tetrahydropyran bonded to the α-carbon of the threonine and 2-α-ami-
nopyranuronamide connected to the tripeptide via a O-glycosidic linkage. 
Both compounds are epimers which only differ with the sugar moieties, 
where the 2-α-glucuronamide replaces a 2-α-galacturonamide.  
P-016
A NEW CYCLOPENTAPEPTIDE ISOLATED FROM THE 
MARINE-FACULTATIVE ASPERGILLUS SP. (MEXU 27854)
Manuel A. Aparicio-Cuevas1, Tyler Graf2, Nicholas Oberlies2, and Mario 
Figueroa1
1Facultad de Química, Universidad Nacional Autónoma de México, CDMX, 
04510, Mexico. 2Department of Chemistry and Biochemistry, University of 
North Carolina at Greensboro, Greensboro, NC, 26170
Reinvestigation of the marine-facultative Aspergillus sp. (MEXU 27854) 
yielded the known dioxomorpholine PF 1233A, along with a new cyclic 
N-methyl amino acid-containing cyclopentapeptide (1). Their structures 
were established by 1D and 2D NMR and spectrometric analysis, and the 
absolute configuration of 1 was elucidated via the Marfey’s method on a 
UPLC-PDA-HRESIMS-MS/MS system.
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P-017
BIOACTIVE COMPOUNDS PRODUCED BY 
ACTINOBACTERIA ASSOCIATED WITH ACROMYRMEX 
ANTS
Carla Menegatti1, Weilan G. P. Melo1, Cameron R. Currie2, Leonardo L. G. 
Ferreira3, Adriano D. Andricopulo3, Jon Clardy4, and Mônica T. Pupo1
1School of Pharmaceutical Sciences of  Ribeirão Preto, University of São 
Paulo, Ribeirão Preto, SP, Brazil, 2Department of Bacteriology, University of 
Wisconsin, Madison, WI, USA, 3Physics Institute of São Carlos, University of 
São Paulo, São Carlos, SP, Brazil, 4Department of  Biological Chemistry and 
Molecular Pharmacology, Harvard Medical School, Boston, MA, USA
Microbial symbionts are sources of novel and bioactive natural products. 
The ancient and complex relationship established between Attini ants and 
fungi cultivated by them for food is one of the best-known symbiotic asso-
ciations. This association can be harmed by pathogenic fungi of the genus 
Escovopsis. Based on this ecological evidence, this work aims to study nat-
ural products biosynthesized by symbiotic microorganisms associated with 
Acromyrmex leaf-cutter ants collected in remaining areas of Atlantic For-
est in Brazil. We have screened bacterial strains against the specific fungal 
pathogen Escovopsis and the parasites Trypanosoma cruzi and Leishmania 
donovani. Two actinobacteria identified by 16S rRNA gene sequencing as 
Streptomyces luridiscabiei ICBG 328 and Streptomyces nodosus ICBG 197 
showed antifungal activity in antagonism assay and their extracts displayed 
antiprotozoal activity against T. cruzi and L. donovani.  Bioguided frac-
tionation of the extracts by SPE and HPLC led to the identification of six 
analogous polyketides and a polyene macrolide produced by S.  luridisca-
biei ICBG 328 and S. nodosus ICBG 197, respectively. Analyses of HR-ESI-
MS data, 1D and 2D NMR data, and searches on databases, allowed the 
structure determination of compounds known as chromomycins A2-3G, 
A3, AP, A2, 02-3D, 4B-A3 and Nystatin, the polyene macrolide. Nystatin 
showed antifungal activity against two Escovopsis strains whereas chromo-
mycins displayed significant antiprotozoal activity against L. donovani.
P-018
DISCOVERY OF MARINE NATURAL PRODUCT 
INHIBITORS OF NEW DELHI METALLO BETA-
LACTAMASE 1
Chris S. Thomas1, Doug R. Braun1, Gregory A. Ellis1, Vlad Vinnik2, Michael 
G. Thomas2, Tim S. Bugni1
1Pharmaceutical Sciences Division, University of Wisconsin-Madison, 777 
Highland Ave., Madison, WI 2Department of Bacteriology, University of 
Wisconsin-Madison, Madison, WI 
Carbapenem Resistant Enterobacteriaceae (CRE) is a growing health con-
cern in desperate need of new treatment options. New Delhi metallo beta 
lactamase 1 (NDM-1) is the newest member of the metallo beta lactamase 
(MBL) family of carbapenemase enzymes that contribute to CRE antibiotic 
resistance to beta lactam antibiotics. NDM-1 is the most prevalent MBL 
CRE infection in the United States, and at present, there are no clinically 
relevant inhibitors for NDM-1. Our group sought to identify new inhibitors 
of NDM-1 from our fractionated libraries of marine natural product ex-
tracts. Expression of the NDM-1 gene on a pBAD33 plasmid in BW27749 
E. coli cells was tightly regulated through arabinose incorporation in the 
media. A cell-based screen was developed from these cells to screen for in-
hibitors of NDM-1.  Promising fractions were assessed via an LC/MS-based 
screen. Pure compounds were analyzed in pure protein inhibition assays 
with nitrocefin. Assay-guided fractionation of active fractions coupled with 
HRMS and NMR has led us to the discovery of new natural product inhib-
itors of NDM-1. 
P-019
ACID-CATALYZED RING CONTRACTION OF THE 
MACROLACTONE RHIZOXIN 
Adam C. Carter1,2, Cora L. Petersen3, April L. Risinger3, Susan L. 
Mooberry3,4, Robert H. Cichewicz1,2
1Natural Product Discovery Group, Institute for Natural Product 
Applications and Research Technologies, University of Oklahoma, Norman, 
OK 73019, 2Department of Chemistry and Biochemistry, University of 
Oklahoma, Norman, OK 73019, 3Department of Pharmacology, The 
University of Texas Health Science Center at San Antonio, San Antonio, TX 
78229, 4Cancer Therapy & Research Center, The University of Texas Health 
Science Center at San Antonio, San Antonio, TX 78229
The macrolactone rhizoxin (1) and several analogues (2-6) were isolated 
from a Rhizopus microsporus isolate, which contained an endosymbiotic 
bacterium, Burkholderia rhizoxinica. Compound 4 contains an unprece-
dented 15-membered macrolactone rather than the 16-membered macro-
lactone present in all previously reported metabolites in this family. Investi-
gation into the formation of 4 led to the hypothesis that the formation of the 
new rhizoxin analogues is dependent on the mildly acidic nature of the cul-
ture medium. Specifically, 4 is proposed to arise through a Meinwald-like 
rearrangement of the allylic epoxide to yield the contracted macrolactone. 
This report details the formation of these rhizoxin analogues and discusses 
their biological activities.
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P-020
SCREENING IRISH DEEP-SEA INVERTEBRATES 
FOR BIOACTIVE COMPOUNDS AGAINST THE 
APOPTOSOME. 
Ryan M. Young1, Amin Tashakor2, Howard O. Fearnhead2, Mark Johnson1, 
Bill J. Baker3 and A. Louise Allcock1
1 Ryan Institute & School of Natural Sciences, National University of Ireland, 
Galway, Ireland; 2Pharmacology and Therapeutics, National University of 
Ireland, Galway, Ireland; 3 Department of Chemistry, University of South 
Florida, Tampa, USA
Although 95% of the sea floor is deeper than 1000 m, marine metabolites 
of deep-sea origin only account for 2% of described marine metabolites. 
With the development of new technologies we can now access and collect 
in these biodiverse and species-rich habitats.  Ireland’s territorial waters are 
among the largest in mainland Europe (c.a. 880 000 km2), and its continen-
tal margin has a high prevalence of submarine canyons and highly diverse 
corals mounds, dominated by Porifera and Cnidaria. We have sampled the-
se environments using the ROV Holland aboard the R/V Celtic Explorer in 
support of our biodiscovery program.
Among our screening priorities is a targeted approach focused on pro-
grammed cell death (PCD). PDC occurs in many pathological situations 
from inflammation to ischaemia. It is also the mechanism through which 
many anti-cancer therapies act.  Screening the extracts of our deep-sea or-
ganisms in a primary caspase-3 screen identified three extracts of interest. 
The activity of these extracts was confirmed utilizing a novel split-luciferase 
apoptosome secondary screen designed to identify both activators and in-
hibitors of this protein complex.  Bioguided fractionation of the most ac-
tive extract originating from a deep-sea zoanthid yielded a bromotyrosine 
metabolite.  The structure was elucidated using contemporary 1D and 2D 
NMR spectroscopy and HRMS.  Further work is ongoing into the mode of 
action as well as isolation and elucidation of additional bioactive metabo-
lites from this zoanthid.
P-021
GENOME MINING OF FRESHWATER CYANOBACTERIA 
FOR RARE METABOLITES
Kyle Mathes1, Jimmy Orjala, Alessandra S. Eustaquio
University of Illinois at Chicago, College of Pharmacy, Department of 
Medicinal Chemistry and Pharmacognosy, and Center for Biomolecular 
Sciences, Chicago, IL, USA
Freshwater cyanobacteria are producers of metabolites of biomedical and 
ecological significance. Among the natural products that cyanobacteria 
produce are polyketides biosynthesized by type III polyketide synthases 
(T3PKSs). For example, a T3PKS is involved in the biosynthesis of the 
cytotoxic molecules known as cyclophanes. The Orjala lab has built a lar-
ge collection  freshwater cyanobacteria strain collection at UIC. We have 
sequenced the genome of Nostoc sp. strain UIC 10110, a merocyclophane 
producer. We used the gene sequence coding for the merocyclophane T3P-
KS to find homologs using BLAST, and designed a degenerate primer pair 
to probe the strain library for T3PKSs by PCR. After screening 449 strains, 
11 strains were identified to contain type III PKSs. Based on phylogenetic 
analysis, three hits appear to encode novel polyketides, whereas eight are 
probable cyclophane producers. This work will ultimately expand the cur-
rent knowledge of cyanobacterial chemistry and has the potential to disco-
ver new molecules that may be of biomedical relevance. 
P-022
LANTIPEPTIDE VITILEVUAMIDE AND CO-
METABOLITES FROM SOUTH AFRICAN DIDEMNID 
TUNICATES
David Gallegos1, Xinhui Yu1, Xuemei Wan1, Jeffrey Serrill1, Shirley Parker-
Nance2, Rosemary Dorrington3, Eric Schmidt4, Jane Ishmael1, Kerry 
McPhail1
1Department of Pharmaceutical Sciences, Oregon State University, Corvallis, 
OR 97331, USA,2SAEON and Nelson Mandela University, Port Elizabeth 
6031, South Africa,3Department of Biochemistry and Biotechnology Rhodes 
University, Grahamstown 6140, South Africa, 4Deparment of Medicinal 
Chemistry, University of Utah, Salt Lake City, UT 84112, USA..
Unique populations of endemic, biologically diverse sessile marine orga-
nisms that contain may house specific microbial consortia represent criti-
cal opportunities to discover new chemistry. We have targeted “gelatinous” 
didemnid tunicates found in Algoa Bay, South Africa, as a potential source 
of diverse suites of metabolites with potent biological activities. A bioassay-
guided isolation approach yielded the known natural product vitilevuami-
de from several new species of didemnid tunicates.  Vitilevuamide (1602 
Da) was previously isolated from two tunicates collected from Papua New 
Guinea,ref1 and was described as an anti-tubulin agent with an unknown 
specific mechanism,ref1,2 although its molecular structure could not be cha-
racterized fully. With assistance from biosynthetic pathway predictions, we 
have assigned the absolute configuration of this nonribosomal peptide. Re-
markably, we have also characterized low molecular weight polyketide co-
metabolites that appear to associate closely with vitilevuamide, and which 
may enhance the cytotoxicity of vitilevuamide, as well as additional large 
peptide congeners. Our further bBiological investigation to date, including 
submission to the NCI60 cell line panel, has confirmed the inhibition of 
tubulin polymerization by vitilevuamide, and cytotoxicity of the associated 
polyketides. 
P-023
GUANIDINE ALKALOIDS FROM TWO MARINE 
SPONGES OF GENUS MONANCHORA WITH 
ANTIFUNGAL ACTIVITY AGAINST CRYPTOCOCCUS SP.
Mohamed M. Radwan1, Ali E. Raslan1,2, Amira S. Wanas1, Safwat A. 
Ahmed3, Alaa M. Nafady2, Siddharth K. Tripathi1, Melissa R. Jacob1, 
Hashim A. Hassanean3, Mahmoud A. ElSohly1,4
1National Center for Natural Products Research, School of Pharmacy, 
University of Mississippi, MS 38677, USA, 2Department of Pharmacognosy, 
Faculty of Pharmacy, Al-Azhar University, Assiut 71524, Egypt, 
3Department of Pharmacognosy, Faculty of Pharmacy, Suez Canal 
University, Ismailia 41522, Egypt, 4Department of Pharmaceuitcs and Drug 
Delivery, School of Pharmacy, University of Mississippi, MS 38677, USA
Crambescidic acid-671 (1), a new guanidine alkaloid along with the known 
alkaloids: crambescidin 800 (2), crambescidin 826 (3), crambescidin 359 
(4), and formiamycalin (5) were isolated from the marine sponges Monan-
chora clathrata and Monanchora unguiculata. Compounds 1-4 isolated 
from M. clathrata and Compounds 2-5 isolated from M. unguiculata. Com-
pounds 1-3 and 5 showed potent antifungal activity against three Crypto-
coccus strains with IC50 values ranging from 0.04 μM to 1.20 μM, MIC val-
ues ranging from 0.24 μM to 1.27 μM, and MFC values ranging from 0.24 
μM to 2.55 μM, comparable to the positive control Amphotericin B. 
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P-024
BUTUANIMIDES: NOVEL HALOGENATED NRPS-PKS 
COMPOUNDS FROM A PHILIPPINE SHIPWORM 
ASSOCIATED BACTERIUM
Bailey W. Miller1, Jose-Miguel Robes2, Marvin A. Altamia2, Hiroaki Naka3, 
Albebson Lim2, Eric Schmidt1, Gisela P. Concepcion2, Margo Haygood1,3
1Department of Medicinal Chemistry, University of Utah, Salt Lake City, 
Utah, USA, 2Marine Science Institute, University of the Philippines, Quezon 
City, Philippines. 3Institute of Environmental Health, Oregon Health and 
Science University, Portland, Oregon, USA
The marine wood-boring bivalve mollusks of the family Teredinidae, also 
know as shipworms, play host to cellulolytic symbionts, primarily of the 
genus Teredinibacter. A novel species of Teredinibacter was isolated from 
the gill homogenate of Bactronophorus sp. collected in a mangrove forest in 
the southern Philippines. A series of compounds bearing structural resem-
blance to andrimid and moiramide, herein named the butuanimides, were 
isolated from the organic extract of this strain. Similar to the known com-
pounds, butuanimides have a methyl succinidmide moiety conjugated to 
valine. However, this series lacks the B-phenylalanine subunit found in the 
known compounds, and the PKS-derived tail portion is halogenated and 
includes a highly unstable, epoxyalcohol-containing six-membered ring. 
Preliminary bioassay data shows activity against both a strain of MRSA and 
P. aeruginosa, without cytotoxicity to the mammalian cell lines MDCK or 
HCT-116. Furthermore, the genome of this symbiont was obtained and a 
biosynthetic pathway will be proposed.
P-025
DITERPENOIDS DERIVED FROM THE ANTARCTIC 
SPONGE DENDRILLA MEMBRANOSA DISPLAY POTENT 
ACTIVITY IN INFECTIOUS DISEASE SCREENING
Andrew J. Shilling1, Alexandre M. Bory1, Jessie Adams2, Ala Azhari3, 
Christopher Rice4, Alison Roth3, Christopher G. Witowski1, J. Alan Maschek1, 
Lindsey N. Shaw2, John H. Adams3, Dennis E. Kyle4, Charles D. Amsler5, 
James B. McClintock5, Bill J. Baker1
1Department of Chemistry, 2Department of Cell Biology, Microbiology, 
and Molecular Biology, 3Department of Global Health, College of Public 
Health, University of South Florida, Tampa, FL 33620, USA, 4Department of 
Infectious Diseases, Department of Cellular Biology, University of Georgia, 
Athens, GA 30602, USA, 5Department of Biology, University of Alabama at 
Birmingham, Birmingham, AL 35294, USA
The Antarctic sponge Dendrilla membranosa was found to contain diter-
penoid secondary metabolites with activity in a screening campaign fo-
cused on Leishmania donovani, Naegleria fowlerii and the ESKAPE patho-
gens. In total, 12 natural products and 12 semi-synthetic derivatives were 
isolated or derived from this cold-water poriferan resulting in a library of 
21 compounds, with 3 compounds being both isolated directly from the 
sponge as well as alternatively obtained via semi-synthetic routes. Seven of 
the 21 compounds within the library are previously unreported structures. 
P-026
ANTIMICROBIAL NATURAL PRODUCTS FROM SOUTH 
AFRICAN MARINE ALGAE
Jameel Fakee1, Edmund Mabande2, Omolola Afolayan2, Marilize le Roes-
Hill3, John J. Bolton4 and Denzil R. Beukes2
1Faculty of Pharmacy, Rhodes University, Grahamstown, 6140, South Africa, 
2School of Pharmacy, University of the Western Cape, Bellville, 6535, South 
Africa, 3Biocatalysis and Technical Biology Research Group, Cape Peninsula 
University of Technology, Bellville, 7535, South Africa, 4Department of 
Biological Sciences, University of Cape Town, Rondebosch, 7700, South 
Africa
Natural products remain the leading source of new antibiotics against pa-
thogenic microorganisms.  However, the rapid development of resistance 
against common antibiotics combined with the slow pace of new antimi-
crobial drug discovery present a significant risk to human health.  We have 
therefore initiated a programme to explore the antimicrobial potential of 
South African marine organisms. In the current study, we screened a libra-
ry of more than 200 marine algal extracts for activity against Acinetobacter 
baumannii, Enterococcus faecalis, Escherichia coli, Staphylococcus aureus 
subsp. aureus and Candida albicans.  The natural products with the most 
promising antimicrobial activities were isolated and their structures deter-
mined using standard spectroscopic methods. 
In this paper we will present the structures and antimicrobial activities of 
representative examples of more than 50 natural products.
P-027
PHYTOCHEMICAL COMPARISM AND GENOTOXICITY 
STUDIES OF TWO SELECTED GASTROPODS SHELL 
SPECIES
Alaribe Chinwendum, S1. Susan Idowu1 and Toye T. Emuejevoke2
1Dept of Pharmaceutical Chemistry, Faculty of Pharmacy, University of 
Lagos, Nigeria. 2Biologix Support Services, Anthony Village, Maryland, 
Ikeja, Lagos 
Nature continues to be an attractive source of new therapeutic agent since 
a tremendous chemical diversity is found in millions of species of plants, 
animals, marine organisms and microorganisms. However, their safety is of 
paramount important both at the cellular and molecular level. In order to 
stress how important lower animals are which can be sources of pharma-
cological substances, as well as the level at which they can be safe for use 
motivates the drive of this research more so the fact that they are extincting 
species. The objectives of study are to investigate the genotoxic, cytotoxic 
and phytochemical properties of Land and Marine snail, Achatina achatina 
and Thais clavigera, respectively.
The n-hexane extracts from each powdered shells Achatina achatina (AaH) 
and Thais clavigera (TcH) were subjected to GC-Mass spectrometry, Di-
phenylamine Assay and Gel Electrophoresis Assay for Phytochemical and 
Genotoxic assays respectively.   
The GC-MS results revealed the presence of two toxins in n hexane ex-
tracts of Thais clavigera; dibutyl phthalate, an endocrine disruptor and Bis 
(2-ethylhexyl) phthalate, a carcinogen and a teratogen while the n hexane 
extracts of the Achatina achatina showed aromatic hydrocarbons ; p-cyme-
ne; 1,3,8-p-menthatriene and dimethoxyethybenzene. 
The genotoxic properties of the extracts, AaH and TcH evaluated on liver 
and testis tissues of mice, using Diphenylamine Assay and Gel Electropho-
resis assay showed that the DNA fragmentation in the was insignificant 
with AaH and TcH in the liver (0 % ) and testis (36 %). This finding suggests 
that the two extracts may play protective role in the genomic DNA of the li-
ver and testis cells. The Cytotoxic properties of two extracts were evaluated 
using brine shrimp lethality. Findings revealed that n hexane extract of the 
Thais clavigera was the most toxic. 
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Figure 1: Gel Electrophoresis assay of AaH and TcH
P-028
ABSOLUTE STEREOSTRUCTURES OF ALKALOIDS 
AND AMINO ALCOHOLS FROM TWO MARINE 
INVERTEBRATES
Tadeusz F. Molinski,1,2 Xiaxia Di,3 Sesselja Ómarsdóttir3 A. Norrie Pearce4 
and Brent R. Copp4
1Department of Chemistry and Biochemistry, and 2Skaggs School of 
Pharmacy and Pharmaceutical Sciences, University of California, San Diego, 
La Jolla, CA 92093, USA. 3University of Iceland, Faculty of Pharmaceutical 
Sciences, Hagi, Hofsvallagata 53 Reykjavik IS-107, Iceland. 4University of 
Auckland, School of Chemical Sciences, University of Auckland, Private Bag 
92019, Auckland 1142, New Zealand
The structures of indole alkaloids and sphingoid bases from marine orga-
nisms often deviate from conventional patterns of functionalization found 
in the plant Kingdom, and present challenges to assignment of their ab-
solute stereochemistry. We describe, here, the absolute stereostructure of 
the new dioxindole 1, from a sub-Arctic specimen of Geodia baretti, and 
re-evaluation of barettin (2) and dihydrobarettin (3) using ECD and the 
new Marfey’s-type reagent, L-Na-(1-fluoro-2,4-dinitrophenyl)tryptophana-
mide (L-FDPT, 4). Finally, (S)-distaminolyne A (5), from the New Zealand 
ascidian, Pseudodistoma opacum, is re-evaluated against 6 and 7 obtained 
by asymmetric synthesis.
P-029
DISCOVERY OF NOVEL NATURAL PRODUCTS FROM A 
CONSORTIUM OF PANAMANIAN CYANOBACTERIAL 
STRAINS
Hyukjae Choi1, and Willim H. Gerwick2
1College of Pharmacy, Yeungnam University, Gyeongsan, Gyeongbuk 
38541, Korea, 2Center for Marine Biotechnology and Biomedicine, Scripps 
Institution of Oceanography, University of California, San Diego, La Jolla, 
California 92093, United States
Marine microorganisms are rich sources of structurally intriguing natural 
products and a number of marine microbial secondary metabolites have 
been reported with potent anti-cancer activities. As a part of on-going re-
search to discover new bioactive natural products from marine microorga-
nisms, chemical investigation on an extract of environmental collection of 
Panamanian cyanobacteria Symploca sp. with Scytolyngbya sp. were perfor-
med. Based-on MS-based dereplication and MS2-based molecular networ-
king study on the extract showed the presence of a series of novel secondary 
metabolites. Four new natural products were isolated by normal-phase va-
cuum liquid chromatography (NP-VLC) followed by reversed-phase high 
performance liquid chromatography (RP-HPLC). Their structures were de-
termined by spectroscopic data analyses and absolute configurations were 
proposed from the biosynthetic speculation. Among four compounds, a 
compound with 4-O-methyl β-ribofuranose showed most potent cytoto-
xicity against H-460 human lung cancer cells (23% cell survival at 7.5 μM).
P-030
ISOLATION OF METABOLITES FROM ANTARCTIC 
SPONGE ARTEMISINA PLUMOSA FOR POTENTIAL DNA 
TOPOISOMERASE I INHIBITION BIOACTIVITY
Joshua Welsch1, Paola Fiorani2, Charles D. Amsler3, James B. McClintock3, 
and Bill J. Baker1
1Department of Chemistry, University of South Florida, Tampa, FL 33620, 
2Institute of Translational Pharmacology, National Research Council, Via 
Del Fosso del Cavaliere, Rome 00133, 3Department of Biology, University of 
Alabama at Birmingham, Birmingham, AL 35294
Studies of the plant alkaloid camptothecin isolated from Camptotheca 
acuminata have shown the antitumoral potential of compounds that inhibit 
mammalian DNA Topoisomerase I activity. Topoisomerases are necessary 
for cellular functions such as DNA replication, transcription, and recombi-
nation, hence disruption of this activity poses a viable mechanism for drugs 
that target the need for innovative anticancer agents. It is well established 
that marine sponges represent a rich source for novel secondary metaboli-
tes, with approximately 30% of all marine natural products isolated to date 
being derived from sponges. This vast diversity of secondary metabolites 
combined with the historical success of natural products as anticancer 
drugs makes marine sponges ideal candidates for new compounds capable 
of Topoisomerase I inhibition.
Freeze-dried samples of the Antarctic sponge Artemisina plumosa were ex-
tracted using solutions of 1:1 dichloromethane:methanol, and subsequent 
extraction with 1:1 methanol:water. These extracts were fractionated using 
MPLC. A bioassay was conducted on the MPLC fractions to determine 
DNA relaxation activity, with 9 positive results, which was used in paral-
lel with Nuclear Magnetic Spectroscopy (NMR) to guide separation of the 
samples using HPLC. Through this sequence of isolation and separation on 
sponge extracts preliminary results indicate a potential for DNA Topoiso-
merase I inhibition bioactivity.
P-031
AN OVERVIEW OF DELITPYRONES: Α-PYRONE 
DERIVATIVES FROM A FRESHWATER DELITSCHIA SP.
Jacklyn M. Gallagher1, José Rivera-Chávez1, Tamam El-Elimat2, Tyler N. 
Graf1, Jacques Fournier3, Gati K. Panigrahi4, Gagan Deep4, Rick L. Bunch5, 
Huzefa A. Raja1, Nicholas H. Oberlies1
1Department of Chemistry and Biochemistry, University of North Carolina 
at Greensboro, Greensboro, NC 27402, USA. 2Department of Medicinal 
Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of 
Science and Technology, Irbid 22110, Jordan. 3Los Muros, Rimont 09420, 
France. 4Department of Cancer Biology and Comprehensive Cancer Center, 
Wake Forest Baptist Medical Canter & Wake Forest School of Medicine, 
Winston-Salem, NC, USA. 5Department of Geography, Environment, and 
Sustainability, University of North Carolina at Greensboro, Greensboro, NC 
27402, USA.
Of the approximately 120,000 identified species of fungi (3-8%) within the 
2.2-3.8 million that is estimated within the kingdom, limited research has 
been conducted on freshwater ascomycetes with only 675 species described. 
Interestingly, less than 250 metabolites have been reported from freshwater 
ascomycetes.  Our group’s research on these fungi has established that fur-
ther investigation into their chemical space is paramount.  Using an eight 
step procedure, a peak library was constructed and screened against the 
African American prostate cancer cell line E006AA-hT as this population 
encounters higher rates of incidence and mortality.  Cytotoxity and derep-
lication results of a Delitschia sp. designated as G858, lead to the isolation 
of 8 new α-pyrone derivatives, 1 new dihydronaphthalenone, and 8 known 
fungal compounds. Of these 17 isolated compounds, 14 were tested against 
the prostate cancer cell line E006AA-hT, with one compound showing a 
promising lead.
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P-032
NEW SECONDARY METABOLITES FROM AN 
ANTARCTIC TUNICATE
Sofia Kokkaliari,1 Charles D. Amsler,2 Alexander D. Crawford,3 James B. 
McClintock,2 Bill J. Baker1
1Department of Chemistry, University of South Florida, University of South 
Florida, Tampa, Fl 33620; 2Department of Biology, University of Alabama 
at Birmingham, Birmingham,  Al 35249-1170; 3Luxembourg Centre for 
Systems Biomedicine, Université du Luxembourg, Belvaux, Luxembourg; 
4Theracule S.á r.l., Belval, Luxembourg; 5Faculty of Veterinary Medicine, 
Norwegian University of Life Sciences, Oslo, Norway
Marine organisms have attracted the interest of the scientific commu-
nity in the past few decades, followed by the discovery of new and novel 
compounds. An area of great interest has been marine organisms native 
to Antarctica, which due to the circumpolar current have created a uni-
que ecosystem. In this project, we worked with a Synoicum sp. from which 
new compounds were isolated. The new compounds belong to the family 
of indole alkaloids and have been subjected to various bioassays in order to 
determine their activity. 
P-033
STRUCTURAL INTERROGATION OF MICROBIAL 
DYNEMICIN BIOSYNTHETIC ENZYMES
Alvarado SK 1, Van Lanen S 3, Thorson JS 3,4, Phillips GN Jr. 1,2
1Department of BioSciences, Rice University, Houston, TX 77005, 
2Department of Chemistry, Rice University, Houston, TX 77005, 
3Department of Pharmaceutical Sciences, University of Kentucky College of 
Pharmacy, Lexington, KY 40536, 4Center for Pharmaceutical Research and 
Innovation, University of Kentucky College of Pharmacy, Lexington, KY 
40536
Dynemicin is a 10-membered enediyne isolated from a soil microbe, Mi-
cromonospora chersin, employed for bacterial defense. The enediynes, in-
cluding dynemicin, have also distinguished themselves as promising can-
didates for antibacterial or cancer therapeutics due to their unparalleled 
cytotoxicity via chromosomal double-stranded DNA cleavage. Dynemicin 
possesses an unusual and complex molecular architecture; the enediyne 
comprises the characteristic bicyclo “warhead” group and a distinctive 
anthraquinone peripheral moiety that acts as the anchor governing the 
bicyclo group’s positioning for hydrogen abstraction. The dynemicin an-
thraquinone group is synthesized and assembled by an extensive host of 
enzymes. DynU16, a putative cyclase, DynA1 and DynA2, putative oxida-
ses were selected for pioneering structural efforts to facilitate decoding of 
the elaborate anthraquinone molecular assembly. Structural determination 
and analysis via X-ray crystallography will provide high-resolution struc-
tures exposing the biocatalytic features that enable regio-, chemo- and 
stereo-selectivity of the enzymes. Moreover, synergistic biochemical and 
structural efforts have the promising potential to reveal paradigm-shifting 
biological chemistry. If the proposed objectives are achieved, structural 
characterization of the dynemicin biosynthetic machinery will afford valu-
able perspectives into the intricate enediyne molecularassembly.
Supported by a training fellowship from the Gulf Coast Consortia, on the 
Houston Area Molecular Biophysics Program (Grant No. T32GM008280) 
and  National Cancer Institute, R01-CA217255. 
P-034
MODEL ACTINOCIN PROVIDES INFORMATION FOR 
ACTINOMYCIN SUBSTRUCTURE FORMATION AND 
PROMOTION OF ANTIBIOTIC ACTIVITY
Matt McErlean, Wenlong Cai, Abhisek Mandal, Khaled Shaaban, Aubree 
Zimmer, Jürgen Röhr, Jon Thorson, Steven Van Lanen
College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA
The actinomycin scaffold remains the gold standard to measure DNA bind-
ing. However, since its discovery in 1949, several other families of actino-
mycin have been discovered, some containing an unusual β-ring heterocy-
cle. Though there is evidence the formation of this substructure drastically 
changes the biological activity of the molecule, little is known how these 
β-ring heterocycles form. Furthermore, it is unclear how the mechanism 
of activity changes in these actinomycins to produce this unique activity. 
Herein, we synthesized a model actinocin to (1) probe the mechanism of 
β-ring heterocycle formation and (2) probe for a change in activity. The in-
formation gleaned from our model was applied to actinomycins we believe 
could undergo this structural transformation.
P-035
ENGINEERING MULTIFUNCTIONAL ENZYMES 
CAPABLE OF ADENYLATING AND SELECTIVELY 
METHYLATING THE SIDE CHAIN OR CORE OF AMINO 
ACIDS 
Taylor A. Lundy1, Shogo Mori1, Jarrod W. Creameans1, and Sylvie Garneau-
Tsodikova1
1Department of Pharmaceutical Sciences, College of Pharmacy, University of 
Kentucky, Lexington, KY 40536-0596, USA
Nonribosomal peptides (NRPs) are a large class of natural products with 
therapeutic relevance. These NRPs are synthesized by mega-enzymes 
called nonribosomal peptide synthetases (NRPSs). NRPSs are subdivided 
into catalytic domains (adenylation (A), condensation (C), and thiolation 
(T)) and auxiliary domains (e.g., methyltransferase (M)). NRPSs string 
together amino acids to yield a final NRP product. These NRPs can then 
be decorated with additional chemistry by auxiliary domains. Nature has 
added further diversity to NRPSs by embedding auxiliary domains into A 
domains, most commonly an M domain, to yield an interrupted A domain. 
A domains are key targets for NRPS engineering as they dictate the amino 
acids incorporated into NRPs. We aim to emulate and expand what Nature 
has created. To investigate this, we generated two fully functional artificial 
interrupted A domains by inserting different noncognate M domains into a 
naturally occurring uninterrupted A domain. These engineered A domains 
were capable of selectively methylating the amino acid in accordance with 
the natural M domain specificity. Additionally, we added a backbone meth-
ylating M domain to an already interrupted A domain that naturally con-
tains a side chain methylating M domain to create a trifunctional A domain 
that can methylate the amino acid in two different locations. This provides 
an exciting proof-of-concept for generating interrupted A domains as fu-
ture tools to modify NRPSs and increase their NP diversity. 
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P-036
HOW ARE NONRIBOSOMAL PEPTIDES METHYLATED? 
A TALE OF INTERRUPTED ADENYLATION DOMAINS
Shogo Mori1, Allan H. Pang1, Taylor A. Lundy1, Atefeh Garzan1, Oleg V. 
Tsodikov1*, and Sylvie Garneau-Tsodikova1*
1Department of Pharmaceutical Sciences, College of Science, University of 
Kentucky, Lexington, KY 40536, USA. 
Natural products (NPs) are one of the most important sources of drugs. 
They are produced by various enzymes including nonribosomal peptide 
synthetases (NRPSs) that assemble amino acids into small peptide NPs. 
NRPSs are modular enzymes that contain multiple catalytic domains in 
each module. Each domain normally has a specific function, whose or-
chestrated actions synthesize complex peptide NPs. However, the adenyla-
tion (A) domains sometimes embed another functional domain within 
their structures. Such A domains, called interrupted A domains, play an 
important role in tailoring the NP structures. We have now biochemically 
and structurally characterized interrupted A domains found in the biosyn-
thetic pathway of the bisintercalator NP, thiocoraline. Thiocoraline and its 
analogous NP, thiochondrilline A, contain unique N,S-dimethyl-l-cysteine 
residues, whose dimethylation was proposed to be catalyzed by two dif-
ferent methylation (M) domains embedded in two different interrupted 
A domains. We identified the pathway for constructing the residue out of 
12 possible pathways by a series of radiometric assays. We also solved the 
structure of one interrupted A domain involved in thiocoraline biosynthe-
sis and doing so gained insight into the mechanism by which interrupted 
bifunctional A domains work. We are now using the information gathered 
by these studies to guide our effort towards combinatorial biosynthesis of 
methylated NRPs.
P-037
PRENYLATED FLAVONE DERIVATIVES FROM THE 
TWIGS OF ARTOCARPUS HETEROPHYLLUS
Sirada Boonyaketgoson1, Vatcharin Rukachaisirikul2, Souwalak 
Phongpaichit3, Kongkiat Trisuwan1*
1Department of Chemistry and Center of Excellence for Innovation 
in Chemistry, Faculty of Science, Chiang Mai University, Chiang Mai 
50200, Thailand, 2Department of Chemistry and Center of Excellence for 
Innovation in Chemistry, Faculty of Science, Prince of Songkla University, 
Hat Yai, Songkla 90112, Thailand, 3Department of Microbiology and 
Natural Product Research Center of Excellence, Faculty of Science, Prince of 
Songkla University, Hat Yai, Songkla 90112, Thailand
The chromatographic separation of the methanolic crude extract from the 
twigs of Artocarpus heterophyllus led to the isolation of six known pre-
nylated flavones named artocarpesin (1), noratocarpin (2), cudraflavone C 
(3), artocarpin (4) brosimone I (5) and cycloartocarpin (6). Their structu-
res were identified on the basis of spectroscopic data, mainly 1D and 2D 
NMR data. Compounds 2, 4 and 5 exhibited cytotoxicity against oral hu-
man carcinoma (KB), human breast carcinoma (MCF-7), small lung carci-
noma (NCI-H187) and noncancerous cell lines with the IC50 values in the 
range of 10 - 37.9 µM. In addition, compound 6 showed cytotoxicity against 
NCI-H187 with an IC50 value of 44.2 µM.
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P-038
TOWARD AN ENZYME-COUPLED, BIOORTHOGONAL 
PLATFORM FOR METHYLTRANSFERASES
Tyler D. Huber1,2, Brooke R. Johnson1,2, Yang Liu1,2, Jonathan A. Clinger,3 
Fengbin Wang,3 Shanteri Singh1,2,4, Jianjun Zhang1,2,5, Jürgen Rohr2, Steven 
G. Van Lanen2, Andrew J. Morris6, George N. Phillips, Jr.,3,7 and Jon S. 
Thorson1,2
1Center for Pharmaceutical Research and Innovation, College of 
Pharmacy, University of Kentucky, Lexington, KY, USA, 2Department of 
Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 
Lexington, KY, USA, 3Department of Biosciences, Rice University, Houston, 
TX, USA, 4current address: Department of Chemistry and Biochemistry, 
University of Oklahoma, Norman, OK, USA, 5current address: Alcami 
Corporation, Germantown, WI, USA, 6Division of Cardiovascular 
Medicine, Gill Heart Institute, University of Kentucky, Lexington, KY, USA, 
7Department of Chemistry, Rice University, Houston, TX, USA
Methyl group transfer from S-adenosyl-l-methionine (AdoMet) to va-
rious substrates including DNA, proteins, and natural products (NPs), is 
accomplished by methyltransferases (MTs). Analogs of AdoMet, bearing 
an alternative S-alkyl group can be exploited, in the context of an array of 
wild-type MT-catalyzed reactions, to differentially alkylate DNA, proteins, 
and NPs. This technology provides a means to elucidate MT targets by the 
MT-mediated installation of chemoselective handles from AdoMet analogs 
to biologically relevant molecules and affords researchers a fresh route to 
diversify NP scaffolds by permitting the differential alkylation of chemical 
sites vulnerable to NP MTs that are unreactive to traditional, synthetic or-
ganic chemistry alkylation protocols. We present novel chemoenzymatic 
strategies that employ methionine adenosyltransferases (MATs) and me-
thionine (Met) analogs to synthesize AdoMet analogs in vitro, which are 
utilized in a one-pot reaction by MTs for the alkylrandomization of NP 
scaffolds. We will also present the development, use, and results of a high-
throughput screen to identify mutant-MAT/Met-analog pairs suitable for 
postliminary bioorthogonal applications.
P-040
UTILIZATION OF AROMATIC PRENYLTRANSFERASES 
FOR ALKYL-DIVERSIFICATION OF NATURAL 
PRODUCTS
Chandrasekhar Bandari, Erin M. Scull and Shanteri Singh
Institute for Natural Products Applications and Research Technologies, 
Department of Chemistry and Biochemistry, University of Oklahoma, 101 
Stephenson Parkway Norman Oklahoma 73019, USA
The structural diversification of natural products (NPs) presents an important 
means for generating novel biologically active molecules. While the system-
atic diversification of structurally complex NPs using conventional chemical 
synthesis can be challenging, a chemoenzymatic method of diversification 
provides a promising alternative for regio- and stereo- selective NP-diversifi-
cation. To this end, NP tailoring enzymes are known to exhibit relaxed sub-
strate specificity towards their substrates and some of these tailoring enzymes 
such as glycosyltransferases, acyltransferases etc. have been successfully used 
for selective late stage modification of NPs. A class of highly promiscuous NP 
late stage modification enzymes are soluble aromatic prenyltransferases (PTs) 
that catalyze the transfer of prenyl groups from their corresponding activated 
donors onto aromatic moieties. While several promiscuous PTs have been 
characterized to date, their utility towards alkyl-diversification of NPs largely 
remains unexplored. Herein, we present representative examples of utility of 
PTs for alkyl-diversification of NPs using synthetic unnatural alkyl-donors. 
In addition, we demonstrate the substrate specificity of PTs can be modulated 
via rational-engineering of the PTs. Thus, this study provides a basis for fur-
ther investigation of chemoenzymatic utility of PTs for alkyl-diversification of 
therapeutically important molecules towards the generation of alkyl-derivat-
ized molecules with altered activity.
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P-041
CINNAMIC ACID DERIVATIVES FROM 
BAILLONELLA TOXISPERMA EXTRACT DISLAYING 
ANTIHYPERALGESIC AND ANTIINFLAMMATORY 
ACTIVITIES IN VIVO 
Stacy-Ann J. Parker†, Seth Stelma†, Telesphore B. Nguelefack‡, Kevin J. 
Tidgewell†
†Department of Medicinal Chemistry, Duquesne University, Pittsburgh, PA 
15282, United States. ‡Faculty of Science, University of Dschang, Dschang, 
Cameroon 
Decoctions of the aerial plant parts of Baillonella toxisperma in Cameroon, 
has long been used in traditional medicine for pain-relief, as well as for 
their anti-inflammatory properties. Corroborating the ethnomedicinal 
uses, the stem bark methanol extract of B. toxisperma showed significant 
antihyperalgesic and antiinflammatory properties in in vivo rat models of 
acute and chronic pain. To identify the compounds responsible for the ob-
served activities, the extract was subjected to a series of partitioning and 
chromatographic techniques which led to the discovery of cinnamic acid 
(1) and its α-amyrin hybrid, 2, a new chemical entity. The isolation and 
characterization of 2 from this bioactive fraction will be discussed. 
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P-042
CHARACTERIZATION OF THE CALICHEAMICIN 
ORSELLATE FLAVIN-DEPENDENT HALOGENASE CALO3
Zhaoshuai Wang1,2, Yang Liu1,2, and Jon S. Thorson*1,2
1Center for Pharmaceutical Research and Innovation, College of 
Pharmacy, University of Kentucky, Lexington, KY, USA, 2Department of 
Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 
Lexington, KY, USA.
While a number of flavin-dependent halogenases involved in the bromina-
tion or chlorination of microbial secondary metabolites have been charac-
terized, corresponding flavin-dependent iodinases remain largely unstu-
died. We report on the preliminary in vitro characterization of the putative 
flavin-dependent halogenase CalO3 responsible for iodination or bromina-
tion of the calicheamicin orselinate moiety.  Studies to be discussed include 
heterologous CalO3 overproduction in E. coli, CalO3 purification and SAR 
studies [using a series of synthetic orselinate SNAC esters in the absence or 
presence of the other key calicheamicin orselinate modifying enzymes (oxi-
dase CalO2, methytransferase CalO6 and CalO1)]. These studies will help 
clarify the timing and fundamental details of the uniquely-substitued cali-
cheamicin orselinate moiety and may also pave the way to understanding 
the molecular features that define halogen selectivity in flavin-dependent 
halogenases. 
P-043
NEW AQUEOUS-SOLUBLE PEPTIDIC ALKALOIDS AND 
SIDEROPHORES FROM PENICILLIUM SOLITUM IS1-A 
FROM THE ANTARCTIC CONTINENT
Julie P.G. Rodriguez1, Raquel P. Morais-Urano1, Jairo I. Bulla1, Antonio G. 
Ferreira2, Raquel A. Santos3, Lara D. Sette4, Roberto G. S. Berlinck1.
1 Instituto de Química de São Carlos, Universidade de São Paulo, São 
Carlos, SP, Brazil, 2Departamento de Química, Universidade Federal de São 
Carlos, São Carlos, SP, Brazil, 3Núcleo de Pesquisas em Ciências Exatas e 
Tecnológicas, Universidade de Franca, Franca, SP, Brazil, 4Departamento de 
Bioquímica e Microbiologia, Instituto de Biociências, Universidade Estadual 
Paulista “Júlio de Mesquita Filho”, , Campus Rio Claro, Avenida 24-A, 1515, 
Rio Claro, SP, Brazil.
Water-soluble secondary metabolites represent a smallest fraction of inve-
stigated natural products, allegedly due to the difficulty of handling water-
soluble extracts. Since the investigation of very polar metabolites is rather 
neglected, we developed a new strategy for the investigation of water-so-
luble extracts. The hydrophilic fraction from the growth media of Penicilli-
um solitum IS1-A isolated from a marine isopod collected at the Antarctic 
Continent displayed cytotoxic activity and was investigated using several 
separation approaches. A series of novel water-soluble peptidic alkaloids 
and siderophores have been isolated, whose structures and bioactivities will 
be presented and discussed.
Funding FAPESP, CAPES and CNPq.
P-045
BACTERIAL-DERIVED EXTRACELLULAR ELECTRON 
SHUTTLE
Emily Mevers1, Jose Cornejo2, Gleb Pishchany3, Lin Su2, Moshe Baruch2, 
Roberto Kolter3, Caroline Ajo-Franklin2 and Jon Clardy1
1Department of Biological Chemistry & Molecular Pharmacology, Harvard 
Medical School, Boston, MA 02115 USA; Molecular Foundry, Lawrence 
Berkeley National Laboratory, Berkeley, CA 94720 USA; 3Department of 
Microbiology and Immunobiology, Harvard Medical School, Boston, MA, 
02115
Shewanella oneidensis MR-1 is a facultative anaerobic γ-proteobacterium 
that has the ability to utilize a diverse suite of terminal electron acceptors, 
including insoluble solid metal oxides. The mechanisms underlying how 
MR-1 indirectly shuttles electrons to these solid substrates are poorly un-
derstood. In 2000 chemical analyses of MR-1’s spent supernatant revealed 
that MR-1 excretes a small labile molecule that has the ability to recover an-
aerobic respiration of mutants on solid substrates, but the active metabolite 
was never identified. Revisiting this lack of identity with specialized resin, 
HR-LCMS analysis, and total synthesis, led to its identification as 2-ami-
no-3-carboxy-naphthoquinone (ACNQ). ACNQ potently recovers anaero-
bic respiration in a mutant strain (ΔmenC: menaquinone mutant) on solid 
substrates (EC50 of 25 nM) and can significantly increase current generation 
in Mtr-expressing E. coli strains. ACNQ is derived non-enzymatically from 
a primary metabolite, 1,4-dihydroxy-2-naphthoic acid (DHNA) and is pro-
duced by all other anaerobic bacteria (facultative and obligate) investigated. 
In summary, the discovery of ACNQ provides a better understanding as 
to how MR-1 shuttles electrons to insoluble terminal electron acceptors. 
This discovery has several potential applications, including medical uses 
like treatment of mitochondrial disease and bioenergy. 
Poster Presentations
55Abstracts | 2018 Annual Meeting of the ASP | July 21-25, 2018 | Lexington, Kentucky, USA
P-046
NEW ANTI-CRYPTOCOCCUS WORTMANNIN 
DERIVATIVES FROM A NIESSLIA SP. PREVIOUSLY 
KNOWN ONLY FROM THE METAGENOME
Nicole M. Krausert,1 Lijian Xu,2  Yan Li,2 Gerald F. Bills,2 and James B. 
Gloer.
1Department of Chemistry, University of Iowa, Iowa City, IA, 52242, USA, 
2Texas Therapeutic Institute, The Brown Foundation Institute of Molecular 
Medicine, University of Texas Health Science Center at Houston, Houston, 
TX, 77054, USA 
In the course of our studies of coprophilous (dung-colonizing) fungi 
as sources of antifungal agents, strain TTI-426 was obtained from horse 
dung collected at Lake Houston in Montgomery County, Texas.  The cru-
de extract of a fermentation of this strain grown in YES medium showed 
activity against Cryptococcus neoformans and Candida albicans and was 
therefore selected for chemical investigation.  rDNA sequences of TTI-426 
were identical to sequences of an undescribed Niesslia sp. from soil meta-
genomes in northern Texas. The strain was later identified as a new species 
of the genus Niesslia, based on morphology and sequence analysis.  Silica 
gel column chromatography and reversed phase HPLC afforded two new 
anti-Cryptococcus wortmannin derivatives, as well as additional new related 
compounds.  The structures of these metabolites were established mainly 
by analysis of HRESIMS and 2D NMR data.  Relative configurations were 
assigned using NOESY data, and the structure assignments were supported 
by NMR comparison with similar compounds.  
P-047
CHALLENGES IN ABSOLUTE CONFIGURATION – 
NEW POLYKETIDES FROM MARINE-ASSOCIATED 
ASPERGILLUS POROSUS
George F. Neuhaus1, Donovon A. Adpressa1, Torsten Bruhn2, Sandra 
Loesgen*1
1Department of Chemistry, Oregon State University, Corvallis, OR 97331, 
USA, 2Bundesinstitut für Risikobewertung, Max-Dohrn-Str. 8-10, 10609 
Berlin, Germany
Fungal natural products have inspired and enabled countless modern 
therapeutics. We found Aspergillus porosus to produce novel polyketides 
with interesting structural features alongside known cytotoxins. Chemical 
screening revealed the presence of novel, dynamic secondary metabolites of 
polyketide origin. Structural elucidation was performed primarily with 1D 
and 2D NMR techniques. Mosher’s ester analysis along with a J-based con-
formational analysis, utilizing C-H coupling constants measured via HET-
LOC, established the absolute configuration of two asymmetric carbons. 
Further comparative analysis of experimental NMR and electronic circular 
dichroism spectra with computed spectra, along with isotope exchange stu-
dies support the assignment of the remaining asymmetric centers.
P-048
FOUR CLASSES OF SECONDARY METABOLITES 
FROM AN ENDOPHYTIC FUNGUS COLLETOTRICHUM 
GLOEOSPORIOIDES JS0417
Changyeol Lee1, Soonok Kim 2, and Sang Hee Shim 1,*
1College of Pharmacy, Duksung Women’s University, Seoul 01369, South 
Korea 2National Institute of Biological Resources, Incheon 22689, South 
Korea
Endophytic fungus Colletotrichum gloeosporioides JS0417 was isolated 
from roots of Suaeda japonica Makino and cultivated on rice media, and 
then extracted with ethyl acetate (EtOAc). Chemical investigation of the 
EtOAc extracts led to the isolation of four classes of secondary metabo-
lites including five cyclic lipodepsipeptides (1-5), two chaetiacandins (6-7), 
three α-pyrones (8-10) and six indoles (11-16). Their chemical structures 
were elucidated based on chemical methods including Mosher’s method, 
advanced Marfey’s method as well as spectroscopic data. Nine metabolites 
(1-9) were first reported from this fungal strain. Details of isolation and 
structure determination are presented.
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P-049
A NEW GLYCOSYLATED CYCLIC LIPODEPSIPEPTIDE 
FROM A HALOPHYTE-ASSOCIATED FUNGUS, 
COLLETOTRICHUM GLOEOSPORIOIDES JS419
Sunghee Bang1, Changyeol Lee1, Soonok Kim2, Ki Sung Kang3 and Sang Hee 
Shim1,*
1College of Pharmacy, Duksung Women’s University, Seoul 01369, South 
Korea,2National Institute of Biological Resources, Incheon 22689, South 
Korea, 3College of Korean Medicine, Gachon University, Seongnam 13120, 
South Korea
A novel glycosylated cyclic lipodepsipeptide was isolated from cultures of a halo-
phyte Sueda japonica-associated fungus, Colletotrichum gloeosporioides JS419. 
Spectroscopic analysis revealed that its planar structure is a glycosylated cyclic 
lipodepsipeptide, in which 3,5-dihydroxy-2,6-dimethyl-11-O-mannosyl dodeca-
noic acid was linked to a phenylalanine and an N-methyl isoleucine. Its relative 
and absolute stereochemistry were established by ROESY, J-based configuration 
analysis and chemical reaction such as modified Mosher’s method, advanced 
Marfey’s method, and sugar derivatization. Despite of the precedent of the 
polyketide-derived lipid moiety with 14 carbons in two cases, its relative 
as well as absolute stereochemistry was elucidated in this study for the first 
time. It exhibited mild anti-proliferative effect in MCF-7 cells by blocking nuclear 
translocation of estrogen receptor-α.
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P-050
ISOLATION OF ANTIFUNGAL ACTIVE SUBSTANCES 
FROM BOESENBERGIA PULCHERRIMA AGAINST 
FUSARIUM WILT (FUSARIUM OXYSPORUM)
Chan-joo Park1, Hyan-sang Kim1, Dong Woon Lee2, Yong-hwa Choi1,*
1School of Ecology and Environmental System, Kyungpook National 
University, Sangju 37224, Republic of Korea, 2School of Ecological 
Environment and Tourism, Kyungpook National University, Sangju 37224, 
Republic of Korea, *Corresponding author: ychoi@knu.ac.kr
With the aim of developing environment-friendly agricultural products 
with antifungal activity against Fusarium oxysporum f. sp. lycopersici, a cau-
sative agent of Fusarium wilt, active substances from Boesenbergia pulcher-
rima roots were isolated. The hexane fraction from B. pulcherrima root 
extract was analyzed by GC/MS. The main peaks were estimated and iden-
tified to be methyl eugenol, methyl isoeugenol, elemicin, α-asarone, and 
1,2-dimethoxy-4-(2-methoxyethenyl)benzene based on the Wiley library 
and by comparing retention times and mass spectra with their correspon-
ding standards using GC/MS. For the identification of the compound in 
peak D that was estimated to be 1,2,4-trimethoxy-5-vinylbenzene, for 
which no reference standard was available, the hexane fraction was pro-
cessed by column chromatography before NMR analysis. The result con-
firmed the compound to be 1,2,4-trimethoxy-5-vinylbenzene. Almost all 
compounds showed antifungal activity against F. oxysporum based on bio-
assays, and α-asarone had the highest activity. 
P-051
COMBATING MICROBIAL DRUG RESISTANCE: 
IDENTIFICATION AND SAR STUDY OF INDOLE-
FUNCTIONALISED POLYAMINES AS ANTIBIOTIC 
ENHANCERS.
Melissa M. Cadelis1, Elliot I. W. Pike1, Steven A. Li1, Marie-Lise Bourguet-
Kondracki2, Marine Blanchet3, Jean-Michel Brunel3 and Brent R. Copp1
1School of Chemical Sciences, The University of Auckland, Private 
Bag 92019, Auckland 1142, New Zealand, 2Laboratoire Molécules de 
Communication et Adaptation des Micro-organismes, UMR 7245 CNRS, 
Muséum National d’Histoire Naturelle, 57 rue Cuvier (C.P. 54), 75005 Paris, 
France, 3Aix-Marseille Université, Centre de Recherches en Cancérologie de 
Marseille (CRCM), CNRS, UMR7258, 13385 Marseille, France.
Antibiotics have been the cornerstone of modern medicine saving lives 
by virtue of being able to cure infectious diseases. The combination of in-
creased incidence of drug-resistant strains of bacteria, with a lack of novel 
drugs in development, creates an urgency for antibiotics with new mecha-
nisms of action. An attractive strategy for overcoming bacterial resistance 
is to identify compounds that can enhance the activity of antibiotics that are 
becoming ineffective. Initial screening of compounds from our in-house 
library identified a lead indole-functionalised polyamine that restored acti-
vity of the antibiotic doxycycline towards the drug-resistant Gram-negative 
bacterium, P. aeruginosa while also exhibiting intrinsic antibacterial acti-
vity. SAR studies were conducted and a number of novel analogues were 
identified as potent doxycycline enhancers towards P. aeruginosa, E. coli 
and K. pneumoniae. The results of a comprehensive SAR on the observed 
doxycycline enhancing activity along with the mechanism of action of the 
more potent compounds and their ability to enhance the activity of other 
classes of antibiotics towards drug-resistant bacteria will be presented.
P-052
ANTIMALARIAL AND ANTIOXIDANT PROPERTIES OF 
THE LEAVES OF ALAFIA BARTERI
1Owolabi MA, 1Oribayo OO, 1Ukpo GE, 2Francis. O. Shode, 3Ola Duncan
1Natural Product Laboratory, Department of Pharmaceutical Chemistry, 
Faculty of Pharmacy, College of Medicine Campus, University of Lagos, 
Nigeria. 2Department of Biotechnology and Food Technology, Faculty 
of Applied Sciences, Durban University of Technology, South Africa. 
3Department of Physiology, Faculty of Basic Medical Science, College of 
Medicine Campus, University of Lagos, Nigeria.
High resistance and cost to available antimalarials and free radicals involve-
ment in the development of complication caused by malaria has arouse the 
need to explore plant materials that have antioxidant activity and contain 
new chemical compounds that can treat this deadly disease. Thus we investi-
gated a popularly used plant for its antioxidant activity and its effectiveness 
in the treatment of malaria. Dried and powdered leaves of Alafia barteri 
was extracted in hexane, dichloromethane, ethyl acetate and methanol. 
Fractionation of dichloromethane extract yielded Compound 1; methanol 
extract yielded compounds 2 and 3. The in-vivo antimalarial activity of the 
compounds aganist P. berghei (NK-65) were evaluated. The antioxidant ac-
tivity investigation included various radicals and oxidation systems (FRAP, 
ABTS• + and ORAC). Methanol extract of the leaves of A. barteri, possessed 
significant chemo suppressive activity and exhibited good clearance against 
chloroquine resistant Plasmodium Berghei (NK-65). Compound 1 showed 
significant antimalarial activity compared to compounds 2 and 3.  The lea-
ves of A. barteri presented a good antioxidant activity and can be explored 
as therapeutic agents in the attenuation of free radical as well as in the treat-
ment of malaria disease. 
P-053
GRAM SCALE PRODUCTION OF THE ANTIFUNGAL 
POLYENE SELVAMICIN
Kenneth J. Barns1, René F. Ramos1, Fan Zhang1, Doug R. Braun1, Cameron 
R. Currie2, Jon Clardy3, and Tim S. Bugni1
1Pharmaceutical Sciences Division, University of Wisconsin—Madison, 
Madison, Wisconsin 53705, United States; 2Department of Bacteriology, 
University of Wisconsin-Madison, Madison, WI 53706; 3Department of 
Biological Chemistry and Molecular Pharmacology, Harvard Medical 
School, Boston, MA 02115
Fungal infections are associated with high mortality rates. Recent outbreaks 
of pan resistant strains of Candida auris demonstrate the dire need for new 
antifungal agents. Selvamicin was discovered as a new polyene antifungal 
agent that does not bind ergosterol like amphotericin suggesting a different 
mechanism of action. Additionally, selvamicin shows better solubility and 
activity towards Candida auris. The promising characteristics of selvamicin 
combined with a putative new mechanism of action have led us to pursue 
further evaluation of this promising antifungal agent. As a prerequisite to 
preclinical evaluation, we pursued production of gram-scale quantities of 
the antifungal polyene selvamicin. We tested a range of media conditions 
aiming for minimal production of molecules aside from selvamicin in par-
allel with optimizing isolation and purification. Following just two iterati-
ons of HPLC on the crude product yields ~0.5-1 g of selvamicin, at a purity 
>95%. This poster will highlight aspects of how gram scale production was 
achieved.
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P-054
ANNONACEAE FAMILY AND THEIR ACTIVITY 
TOWARDS NRF-2/ARE PATHWAY
Claire Tran1, Shabana I. Khan1,2, Ikhlas A. Khan1,2
1Department of Biomolecular Sciences, 2National Center for Natural 
Products Research, School of Pharmacy, University of Mississippi, University, 
MS, 38677
Annonaceae family or custard apple family has over a hundred genera and 
thousands of species. This family is distributed worldwide and some spe-
cies have been used traditionally for medicinal effects. The purpose of this 
investigation is to study the anti-cell proliferative effects of a collection of 
Annonaceae plant extracts in colon cancer cells (HCT-116 and HT-29) and 
to determine their effects against inflammation via Nrf-2 activation path-
way. A collection of 85 Annonaceae plant extracts (16 genera, 32 species) 
from the repository of the NCNPR was screened for anti-cell proliferative 
activity and their effects on the activation of Nrf-2/ARE pathway. The cell 
proliferation was determined by a colorimetric method based on tetra-
zolium salts WST-8 in which viable cells are able to reduce WST-8 salts to 
water-soluble dye. Reporter gene assay was employed to determine Nrf-2 
activation. The results indicated that of the 85 extracts, 25 extracts inhibited 
cell proliferation of colon cancer cells at the concentration of 50 μg/ml or 
less; five extracts showed Nrf-2 activation of greater than two fold at 100 μg/
mL in HCT-116 cells. 
P-055
MACROLACTONIZATION OF MULTIPLE MICROVIRIDIN 
CORE PEPTIDES WITHIN A SINGLE POLYPEPTIDE 
SUBSTRATE BY AN ATP-GRASP LIGASE
Yi Zhang1, Kunhua Li2, Guang Yang1, Joshua L. McBride1, Steven D. 
Bruner2, Yousong Ding1
1Department of Medicinal Chemistry, Center for Natural Products, Drug 
Discovery and Development, College of Pharmacy, University of Florida, 
Gainesville, Florida, 32610, USA, 2Department of Chemistry, University of 
Florida, Gainesville, Florida, 32611, USA. 
Ribosomally synthesized and post-translationally modified peptides 
(RiPPs) are an important family of natural products. Their biosynthesis fol-
lows a common scheme in which the leader peptide of a precursor peptide 
guides the modifications of a single core peptide. Here we describe bio-
chemical studies of the processing of multiple core peptides within a pre-
cursor peptide, rare in RiPP biosynthesis. In a cyanobacterial microviridin 
pathway, an ATP grasp ligase, AMdnC, installs up to two macrolactones 
on each of the three core peptides within AMdnA. The enzyme catalysis 
occurs in a distributive fashion and follows an unstrict N-to-C overall di-
rectionality. Furthermore, AMdnC is catalytically versatile to process un-
natural substrates carrying one to four core peptides, and kinetic studies 
provide insights into its catalytic properties. Collectively, our results reveal 
a distinct biosynthetic logic of RiPPs, opening up the possibility of modular 
production via synthetic biology approaches. 
P-056
ENEDIYNE NATURAL PRODUCTS BIOSYNTHESIS
Minakshi Bhardwaj, Steven Van lanen, Jon Thorson
University of Kentucky
Enediyne natural products are secondary metabolites produced by soil and 
marine microorganisms (Actinomycetes). Enediyne natural products are 
the most cytotoxic molecules and use as anticancer drugs. Various antibo-
dy–drug conjugates (ADCs) have shown great clinical success in anticancer 
therapy.
Enediynes have complex structures that are unusual among naturally oc-
curring natural products. The structure is characterized by an unsaturated 
core with two acetylenic groups conjugated to a double bond with a 9- or 
10-membered ring. The enediyne part of the structure leads to interesting 
questions about their biosynthesis in Actinomyces.
We are working on synthesizing potential precursor for the enediyne na-
tural product. It has been observed that knockout of polyketide synthase 
resulted in hampering in the production of enediyne compounds. The po-
tential precursors will be fed to polyketide synthase mutant and production 
of enediyne will be monitored. This will help us to decipher the precursors 
for the enediyne natural product.
P-057
DELINEATING THE BIOSYNTHESIS OF CAPURAMYCIN-
TYPE ANTIBIOTICS
Ashley Biecker and Steven Van Lanen
Department of Pharmaceutical Science, College of Pharmacy, University of 
Kentucky
Mycobacterium tuberculosis (TB) has been significant global concern for 
centuries despite the advances in modern medicine. The standard thera-
peutic regimen against TB remains a long process involving an extensive 
drug cocktail, and the prominence of various drug resistant strains further 
complicates the treatment of TB. Thus, it is imperative to discover and de-
velop new antibiotic compounds that will improve upon the therapeutic 
regimen and circumvent resistance mechanisms. An underexplored class 
of nucleoside natural products—the capuramycins—have excellent anti-TB 
properties and have been shown to potently inhibit MraY, a ubiquitous and 
essential enzyme that functions in bacterial cell wall biosynthesis. Howev-
er, the capuramycins’ mechanism of action against MraY is not yet under-
stood, and are key for improving that activity. The biosynthetic pathway of 
capuramycin has been proposed, but many steps remain uncharacterized. 
We have chosen to investigate the enzymatic activities of the putative meth-
yltransferase, CapK, and the putative glycosyltransferase, CapG, found 
in the gene cluster of capuramycin-type compound A-503083 in order to 
clarify the biosynthetic pathway further. Based on our findings, we aim to 
exploit the activities of CapK and CapG in order to diversify the capuramy-
cin scaffold and assemble a library of novel capuramycins with favorable 
anti-TB properties: moderate potency, maintained target specificity, and no 
resistance.
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P-058
OPTIMIZATION OF THE BIOSYNTHESIS 
OF VERTICILLINS AND USE OF EXPANSILE 
NANOPARTICLES FOR IN VITRO STUDIES.
Chiraz Soumia M. Amrine1, Aaron H. Colby2, Mark W. Grinstaff2, Julia R. 
Austin3, Joanna E. Burdette3, Cedric J. Pearce4, Nicholas H. Oberlies1
1Department of Chemistry and Biochemistry, University of North Carolina 
at Greensboro, Greensboro, NC 27402, 2Nanotechnology Innovation Center, 
Boston University, Boston, MA 02215, 3Department of Medicinal Chemistry 
and Pharmacognosy. University of Illinois at Chicago, Chicago, IL 60612. 
4Mycosynthetix, Inc., 505 Meadowlands Drive, Suite 103, Hillsborough, NC 
27278.
Verticillins are members of the epipolythiodioxopiperazine (ETP) alkaloid 
class of fungal metabolites and are known as potent cytotoxic agents with 
IC50 values lower than 10 nM. Studies showed that verticillin A has activi-
ty as a selective histone methyl transferases inhibitor with important anti-
cancer properties. However, two major challenges slow down moving this 
class forward. Initially, the reliable supply was the first challenge to provide 
amounts required for preclinical advancement of these leads. Thus, having 
a rapid way to probe a suite of fermentation conditions was desired, so as to 
optimize the biosynthesis of the ETPs resulting in the selection of the best 
fungal strain, the best medium for growth and the optimum growth time. 
The other challenge, like many natural products, these analogues are poorly 
soluble, which makes their administration a challenging process. Encapsu-
lating verticillin A inside expansile nanoparticles (eNPs) enhanced greatly 
their solubility in physiologic conditions, thereby facilitating in vivo studies. 
eNPs were prepared in a 5% loading, within a range of 70-80% of the initial 
amount encapsulated. The verticillin A loaded eNPs showed promising re-
sults in vitro against triple negative MDA-MB-231 breast cancer cells and 
is currently being tested in vivo against ovarian cancer in murine models.
P-059
DECRYPTING ORPHAN BIOSYNTHETIC GENE 
CLUSTERS IN BACTERIAL CO-CULTURES THROUGH 
CHEMICAL AND BIOINFORMATIC ANALYSES 
Deepa Acharya1, Ian Miller1, Doug Braun1, Yusi Cui1, Marc Chevrette2, 
Mark Berres3, Cameron Currie2 Lingjun Li1, Jason Kwan1, Tim Bugni1
1School of Pharmacy, University of Wisconsin-Madison, 777 Highland 
Ave., Madison, WI 53705, 3Bioinformatics Resource Center, University of 
Wisconsin-Madison, 425 Henry Mall, Madison, WI 53706
We have developed methods of co-cultivation as a means to unlock the 
potential of orphan gene clusters in marine Actinobacteria. We discove-
red that a Micromonospora sp. (WMMB235) produced a new antibiotic, 
keyicin, when co-cultured with a Rhodococcus sp. (WMMA185)1”ISSN” : 
“1554-8929”, “abstract” : “Advances in genomics and metabolomics have 
made clear in recent years that microbial biosynthetic capacities on Earth 
far exceed previous expectations. This is attributable, in part, to the rea-
lization that most microbial natural product (NP. We performed global 
transcriptomics and quantitative proteomics on the producing organism 
WMMB235 in co-culture and mono-culture to delineate the scope of inter-
species interactions for gene activation. We found significant increases in 
gene expression not only for the kyc gene cluster responsible for keyicin, 
but also a number of other biosynthetic gene clusters (BGCs) encoding pu-
tative novel molecules. Moreover, we observed that semi-crude extracts of 
Rhodococcus sp. are sufficient to activate the production of Keyicin. This 
suggests that the two species communicate via small molecule chemical 
signaling akin to quorum sensing. Very little is known about the quorum 
sensing mechanisms in Actinobacteria, and lesser still about the mechanis-
ms regulating cryptic BGCs. Taken together, these studies show co-culture 
is an effective approach to access orphan BGCs and shed light on new quo-
rum sensing signaling pathways in Actinobacteria.
P-060
ELUCIDATION OF THE COMPLETE NARGENICIN 
BIOSYNTHETIC GENE CLUSTER FROM A HUMAN 
PATHOGENIC NOCARDIA ISOLATE
Sacha J. Pidot1, Marion Herisse1, Jessica L. Porter1, Torsten Seemann1,2, 
Benjamin P. Howden1,2,3, Timothy P. Stinear1,3
1Department of Microbiology and Immunology at the Peter Doherty 
Institute, University of Melbourne, VIC, Australia, 2Microbiological 
Diagnostic Unit, University of Melbourne, VIC, Australia, 3Doherty Applied 
Microbial Genomics, University of Melbourne, VIC, Australia
As part of our antibiotic discovery program, we isolated a human patho-
genic Nocardia arthritidis isolate that produced an antibiotic highly active 
against Gram positive bacteria, including methicillin resistant Staphylococ-
cus aureus and vancomycin resistant Enterococci. Upon further investiga-
tion, the isolated compound was identified as nargenicin, a 28-membered 
macrolide containing a unique ether bridge, which is also known to have 
antineoplastic activity. Shortly after its discovery in the 1980s, nargenicin 
was found to be of polyketide origin. However, the biosynthetic gene cluster 
responsible for nargenicin production and the tailoring enzymes involved 
have remained unidentified. We performed Pacbio SMRT sequencing of 
our N. arthritidis isolate, which allowed rapid and complete assembly of a 
putative nargenicin biosynthetic gene cluster (nar), whose polyketide syn-
thase architecture matched the known nargenicin structure. To show con-
clusively that nar is responsible for nargenicin production, we inactivated 
the nar gene cluster in the producing strain, abolishing nargenicin produc-
tion. Furthermore, we investigated the biosynthetic tailoring enzymes that 
form part of the nar gene cluster to determine their precise roles in narge-
nicin biosynthesis. The identification of the nar gene cluster paves the way 
for heterologous expression and biosynthetic engineering studies to derive 
future bioactive compounds based on the nargenicin scaffold. 
P-061
ISOLATION OF MURAYMYCIN CONGENERS AND SAR 
STUDY
Zheng Cui,1 Xiachang Wang,2,3 Stefan Koppermann,4 Patrick D. Fischer,4 
Jannine Ludwig,4 Jon S. Thorson,2 Christian Ducho,4 and Steven G. Van 
Lanen.*,1
1 Department of Pharmaceutical Sciences and 2 Center for Pharmaceutical 
Research and Innovation, College of Pharmacy, University of Kentucky, 789 
S. Limestone Street, Lexington, KY 40536 USA, 3 Jiangsu Key Laboratory 
for Functional Substance of Chinese Medicine, School of Pharmacy, Nanjing 
University of Chinese Medicine, Nanjing 210023, People’s Republic of China,4 
Department of Pharmacy, Pharmaceutical and Medicinal Chemistry, 
Saarland University Campus C2 3, 66123 Saarbrücken, Germany
Three new muraymycin congeners, named B8, B9, and C6, as well as six 
known muraymycin congeners were isolated from three mutant muray-
mycin producer strains using new media conditions.  Structures of these 
compounds were elucidated by HRMS and NMR. The entirety of the NMR 
data is reported in the public for the first time. Muraymycin B8 and B9 with 
an elongated terminally branched fatty acid side chain, had picomolar IC50 
values against Staphylococcus aureus and showed good antibacterial activity 
against S. aureus.  Muraymycin C6, with an N-acetyl modification of the 
primary amine of the disaccharide core showed greatly reduced antibac-
terial activity. SAR investigation on four representative muraymycin sub-
groups A-D was studied.
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P-062
TESTOSTERONE BOOSTING EFFICACY OF A NOVEL 
CURCULIGO ORCHIOIDES EXTRACT IN MALE RATS 
Kanwaljit Chopra1, Anand Swaroop2, Pawan Kumar3, Manashi Bagchi2 and 
Debasis Bagchi2,4
1University Institute of Pharmaceutical Sciences, Panjab University, 
Chandigarh, India; 2Cepham Research Center, Piscataway, NJ, USA; 
3Chemical Resources, Panchkula, Panjab, India; 4Dept of Pharmacological 
and Pharmaceutical Sciences, University of Houston College of Pharmacy, 
Houston, TX, USA.
Curculigo orchioides Gaertn (family Hypoxidaceae, also known as black or 
kali musli), is an endangered medicinal plant used for diverse medicinal 
purposes including impotency, aphrodisiac, diuretic, tonic, jaundice, and 
skin ailments. Phytochemical investigations of rhizomes revealed the pres-
ence of a novel phenolic glycoside, curculigoside, triterpenoid, saponins, 
flavones, cellulose, hemicellulose, and calcium oxalate. We developed a 
novel extract of Curculigo orchioides (BlamusTM, standardized to 30% cur-
culigosides) and assessed its dose- and time-dependent efficacy (0, 10, 25 
and 50 mg/kg body weight p.o.) on body weight, serum free and total tes-
tosterone levels in male rats (200-230 grams; n = 6) over a period of 28 days. 
Blamus didn’t cause any marked elevation in serum free testosterone levels 
at either 10 or 25 mg/kg body weight doses, however, a 50 mg/kg body 
weight dose of showed a significant increase in serum free testosterone level 
(*p < 0.0001). However, no significant increases were observed in serum to-
tal testosterone levels at 0, 10, 25 or 50 mg/kg body weight doses of Blamus. 
Extensive testicular histopathological analyses including investigations on 
the seminiferous tubules, spermatogenesis, sperm cell morphology, Leydig 
cells and Sertoli cells following treatment with either 0, 10, 25 or 50 mg/kg 
body weight doses of Blamus demonstrated dose-dependent improvement 
in structural integrity. Furthermore, no significant changes were observed 
in serum SGOT, SGPT, BUN and creatinine levels following treatment with 
any of the given doses, which demonstrated its safety profiles. Thus our data 
ascertained that Blamus may serve as a safe and novel, natural testosterone 
booster and provide broad spectrum application is sports nutrition, muscle 
building and exercise pathophysiology.
P-063
IDENTIFICATION OF POTENT AHR LIGANDS FROM 
HUMAN-ASSOCIATED BACTERIA BY STRUCTURE-
GUIDED GENOME MINING 
Lihan Zhang1 and Emily Balskus1
1Department of Chemistry and Chemical Biology, Harvard University, 12 
Oxford St., Cambridge, MA, 02138
Aryl hydrocarbon receptor (AhR) is a ligand-activated transcriptional fac-
tor that regulates inflammation and cell proliferation in response to aro-
matic hydrocarbons. Recent studies reported that human microbiota are 
capable of metabolizing tryptophan to indole-derived compounds that ac-
tivate AhR signaling pathway; however, whether microbiota can de novo 
biosynthesize AhR ligands remains poorly understood. In this study we 
investigated AhR ligands from human microbiota by genome mining tar-
geted on biosynthetic genes that produce polyaromatic secondary metab-
olites. By searching for genes responsible for β-carboline biosynthesis, we 
isolated oxopropaline, streptonigrin, and a new derivative from a gut-asso-
ciated Streptomyces strain. An assay for AhR signaling activation revealed 
that oxopropaline has stronger AhR signaling induction than tryptophan 
metabolites such as diindolylmethane. These results will aid the discovery 
and design of drugs targeting AhR signaling pathway. 
P-064
INSIGHT INTO THE BIOSYNTHETIC PATHWAY OF A 
NOVEL NUCLEOSIDE ANTIBIOTIC
Jonathan Overbay1, Zheng Cui1, Zhaoyong Yang2, Christian Ducho3, Steven 
Van Lanen1
1Department of Pharmaceutical Sciences, College of Pharmacy, University 
of Kentucky, Lexington, KY 40506, 2Key Laboratory of Biotechnology of 
Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of 
Medical Science & Peking Union Medical College, Beijing 1000050, China, 
3Department of Pharmacy, Pharmaceutical and Medicinal Chemistry, 
Saarland University, 66123 Saarbrucken, Germany
Antibiotic-resistance has become a widespread problem in the United 
States and across the globe. Meanwhile, new antibiotics are entering the 
clinic at an alarmingly low rate. Highly-modified nucleosides, a class of 
natural products often produced by actinobacteria, target MraY bacterial 
translocase I. MraY is a clinically unexploited enzyme target that is ubiq-
uitous and essential to peptidoglycan cell wall biosynthesis. The nucleoside 
antibiotics known vary in efficacy and the functionalities contributing to 
improved activity is poorly understood. Sphaerimicin, a newly discovered 
modified nucleoside, has potent inhibitory activity with an IC50 of 13.65 
nM against MraY. In general, sphaerimicin is primarily effective against 
gram-positive bacteria (MIC ranges from 2-16 μg/mL against Enterococcus 
faecium and Staphylococcus aureus), but little is known about the biosynthe-
sis and mechanism of action. Sphaerimicin has highly unusual structural 
features, including a heavily modified ribosylated glycl-uridine disaccha-
ride core that is appended to a dihydroxylated piperidine ring. The novel 
biosynthesis of these features was investigated, leading to the functional 
characterization of six enzymes critical for the disaccharide core formation 
from uridine monophosphate. Recently, a unique S-adenosylmethionine- 
and PLP-dependent alpha-aminobutyric acid transferase and a nonheme 
Fe(II)- and alpha-ketogluterate-dependent hydroxylase from the sphaeri-
micin biosynthetic pathway were characterized. This part of the pathway 
extends the carbon scaffold, which will be crucial for formation of the 
piperidine ring. Not only does this study provide new chemical entities to 
help better understand MraY as a target, it could potentially reveal new en-
zymatic chemistries that will power innovative chemoenzymatic synthesis 
and genome mining to uncover new natural products.
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P-065
1,2,4-TRIAZINE CONTAINING NATURAL PRODUCTS: 
INVESTIGATIONS INTO THE BIOSYNTHESIS, SELF-
RESISTANCE AND GENOME MINING.
Khaled H. Almabruk1, Michael K. Fenwick2, Brenda T. Shaffer3, Qing Yang3, 
Joyce E. Loper3, Steven E. Ealick2, Benjamin Philmus1
1Department of Pharmaceutical Sciences, Oregon State University, Corvallis, 
OR 97331, USA. 2Department of Chemistry and Chemical Biology, Cornell 
University, Ithaca, NY, USA. 3Department of Botany and Plant Pathology, 
Oregon State University, Corvallis, OR, USA.
Triazine containing natural products constitute a small set of known me-
tabolites including toxoflavin (1), a virulence factor produced by the plant 
pathogenic bacteria Burkholderia glumae and nostocine A (2), an alleo-
chemical produced by the cyanobacterium Nostoc spongiaeforme. Here we 
present our lab’s findings involving the biosynthetic route used by Pseudo-
monas protegens Pf-5 to form the 1,2,4-triazine ring which goes through 
5-amino-6-(5-phospho-D-ribitylamino)uracil (3), an intermediate shared 
by the riboflavin biosynthetic pathway. In addition, we have looked at the 
self-resistance that P. protegens Pf-5 utilizes to prevent self-toxicity. By 
screening microbial genomic sequences available publically, we have also 
identified multiple biosynthetic gene clusters suggesting that they have a 
common core of enzymes that we have postulated synthesize a common 
intermediate (4) that is then diversified into a larger chemical space then 
previously appreciated.
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P-066
ELUCIDATING THE BIOSYNTHESIS OF PENILUMAMIDE 
AND IDENTIFYING NEW THERAPEUTIC TARGETS FOR 
ANTIBIOTIC DEVELOPMENT 
Stephanie C. Heard and Jaclyn M. Winter
While resistance mechanisms continue to rise among disease-causing bac-
teria, the number of effective antibiotics is quickly being depleted. One 
particular pathway we are targeting for developing new antibiotic agents 
is folate metabolism. We searched the literature for natural products con-
taining structural components similar to intermediates in the folate path-
way and found the lumazine-containing peptide penilumamide, which was 
isolated from a marine-derived Aspergillus sp. This small nonribosomal 
peptide contains an unprecedented 1,3-dimethyl-lumazine-6-carboxamide 
functional group coupled to methionine sulfoxide and anthranilic acid. The 
lumazine functional group is extremely rare and has only been reported 
in three natural products, to date. Penilumamide therefore is an excellent 
candidate for biosynthetic interrogation and for revealing not only how this 
unprecedented monomer is synthesized, but if the pterin-like core possess-
es antimicrobial activity. The 33 Mbp genome of the penilumamide-pro-
ducing fungal strain A. ﬂavipes CNL-338 was sequenced and assembled, 
revealing 66 biosynthetic clusters of which 21 are nonribosomal pep-
tide-related. Four nonribosomal peptide synthetases (NRPSs) were located 
adjacent to a suite of genes dedicated to pterin biosynthesis. Independent 
inactivation of all four NRPS genes within close proximity of this putative 
lumazine-producing operon confirmed that only a single module-contain-
ing enzyme is required for penilumamide production. The biosynthesis of 
the lumazine building block will be presented, as well as gene inactivation 
studies and reconstitution of the nonribosomal peptide synthetase. 
P-067
IDENTIFICATION OF THE BIOSYNTHETIC GENE 
CLUSTER OF TRIACSINS
Wenlong Cai1, Fredrick Twigg1, Wei Huang1, Joyce Liu1, and Wenjun 
Zhang1,2
1Department of Chemical and Biomolecular Engineering, University 
of California, Berkeley, CA 94720; and 2Chan Zuckerberg Biohub, San 
Francisco, CA 94158
Triacsins, having been discovered for over three decades from Streptmyces 
aureofaciens, are widely used today as potent acyl-CoA synthetase inhi-
bitors. Triacsins are notable for their unique a unique N-hydroxytriazene 
moiety at the terminus which is not found in any other natural products. 
Simpler conjugated nitrogen-nitrogen bonds are found in a variety of na-
tural products while only a handful of biosynthetic pathways have been 
characterized. We have recently identified the biosynthetic gene cluster for 
triacsins in Streptomyces aureofaciens via genome mining and gene inacti-
vation. Further genome mining effort led to the discovery of an additional 
Streptomyces producer of triacsins. Our in vivo and in vitro characterizati-
on of candidate biosynthetic genes and possible intermediates revealed new 
biosynthetic insights regarding triacsin biosynthesis in Streptomyces.
P-068
BIOSYNTHESIS OF THE RIPP TROJAN HORSE 
ANTIBIOTIC MICROCIN C IS DIRECTED BY THE 
N-FORMYL PEPTIDE SUBSTRATE
Shi-Hui Dong‡,§, Alexey Kulikovsky‡,†, Svetlana Dubiley†, Konstantin 
Severinov†, and Satish K. Nair‡,§,&,*
‡Department of Biochemistry, §Institute for Genomic Biology, and &Center 
for Biophysics and Quantitative Biology, University of Illinois at Urbana-
Champaign, Illinois, USA. †Institute of Gene Biology, Russian Academy of 
Science, 34/5 Vavilo str. 11934 Moscow, Russia 
Microcin C7 (McC) is a ribosomally produced heptapeptide that is subse-
quently modified by the linkage of the terminal Asp α-carboxylate to AMP 
via a phosphoramidate bond. Post-translational modification on the hep-
tapeptide precursor is carried out by MccB, which consumes two equiva-
lents of ATP to generate the P-N linkage. Here, we demonstrate that MccB 
only efficiently processes the precursor heptapeptide that retains the N-
formylated initiator Met (fMet). Binding studies and kinetic measurements 
evidence the role of the N-formyl moiety, and structural studies reveal sub-
strate bound in a productive mode. Structural data show that the N-formyl 
peptide binding results in an ordering of residues in the “crossover loop”, 
which dictates specificity in homologous ubiquitin activating enzymes. Im-
portantly, the N-formyl peptide exhibits substrate inhibition, and cannot 
be displaced from MccB by the desformyl counterpart. Such substrate in-
hibition may be a strategy to avert the unwanted buildup of McC and avoid 
toxicity in the cytoplasm of producing organisms.
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P-069
DESIGN AND SYNTHESIS OF PHYLLANTHUSMIN 
ANALOGUES TO IMPROVE PHARMACOLOGICAL 
PROPERTIES
Andrew C. Huntsman1, Alexandria Young2, John L. Woodard1, Hee-Byung 
Chai1, Yulin Ren1, Mitch A. Phelps3, A. Douglas Kinghorn1, Joanna E. 
Burdette2, James R. Fuchs1
1Medicinal Chemistry and Pharmacognosy, The Ohio State University 
2Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago 
3Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University.
Structure activity relationship studies on the phyllanthusmin class of na-
tural products have led to a novel lead compound (PHY-34) with potent 
antiproliferative activity. Its design has facilitated additional functionali-
zation to further explore pharmacological properties, such as selectivity, 
solubility, and potency. In brief, this work has provided insight into key 
structural motifs and chemical transformations that may be able to be ex-
ploited to overcome additional challenges associated with the development 
of this class, including toxicity. Our current focus is on identification of the 
molecular target, addressing metabolic liabilities, and mediating potential 
off-target effects. 
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P-070
ANTIMALARIAL AND ANTIMICROBIAL ACTIVITIES OF 
Α-(2-PIPERIDYL)-2-ALKYL-4-QUINOLINEMETHANOL 
ANALOGS
H. M. T. Bandara Herath, H. Ranjith W. Dharmaratne, Melissa Jacob, N. P. 
Dhammika Nanayakkara
National Center for Natural Product Research, School of Pharmacy, 
University of Mississippi, MS 38677
Mefloquine, a currently used antimalarial drug, is an analogs of the high-
ly effective antimalarial alkaloid, quinine. A related analog, SN-10275, had 
better prophylactic and therapeutic activities than quinine against Plasmo-
dium vivax malaria in humans, potent in vitro activity against Staphylococ-
cus aureus and Cryptococcus neoformans, and strong in vivo antischisto-
somal activity in a mouse model. However, drug-induced phototoxicity 
remains the major drawback in development of this compound. The ob-
served photosensitivity of SN-10275 has been attributed to the increased 
resonance conjugation from the 2-aryl group. A subsequent study has 
shown that WR166391 also has potent antimicrobial activity. In our study, 
we prepared a number of WR166391 analogs with bulky alkyl groups (t-
butyl, cyclohexyl, adamantyl) at the 2-position and different substitutions 
on the quinoline ring. Some of them showed potent in vitro activity against 
C. neoformans, methicillin-resistant S. aureus (MRSA) and Mycobacterium 
intercellulare.
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P-071
ISOLATION, CHARACTERIZATION AND SYNTHESIS 
OF SECONDARY METABOLITES DERIVED FROM THE 
MIRACLE TREE (MORINGA OLEIFERA) LEAVES
Omer I. Fantoukh1,2,3,  Mohamed Albadry1,2, Mohammed F. Hawwal1,2,3, 
Abidah Parveen1,2, Taghreed Majrashi1,2, Zulfiqar Ali1, Amar G. 
Chittiboyina1,2, Ikhlas A. Khan1,2 
1National Center for Natural Products Research, 2Division of 
Pharmacognosy, Department of BioMolecular Sciences, School of Pharmacy, 
University of Mississippi, University, MS 38677, USA, 3Department of 
Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi 
Arabia
Moringa oleifera Lam. is known as the miracle vegetable because all parts of 
Moringa have been exploited to treat a variety of ailments. It shows antihy-
pertensive, antimicrobial, antidiabetic, anticancer, and anti-inflammatory 
activities. In this study, phytochemical investigation of M.oleifera leaves re-
sulted in the isolation and characterization of one new compound in addi-
tion to fifteen known secondary metabolites from several chemical classes 
including flavonoids, terpenoids, lignans and phenyl propanoids. Because 
of the low yields and limited supply, the new compound and niazirin were 
successively synthesized for anticancer activity screening.
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P-072
ISOFORM SELECTIVITY OF HARMINE CONJUGATED 
1,2,3-TRIAZOLES AGAINST HUMAN MONOAMINE 
OXIDASE
Saqlain Haider1, Manal Alhusban1, Narayan Chaurasiya1, Babu L. 
Tekwani1,2, Amar G. Chittiboyina1, and Ikhlas A Khan1,2
1National Center for Natural Products Research, 2Division of 
Pharmacognosy, Department of BioMolecular Sciences; School of Pharmacy, 
The University of Mississippi, University, MS 38677, USA.
There is little information available on Monoamine oxidase isoform selec-
tivity of N-alkyl harmine analogs which exhibit a myriad of activities inclu-
ding MAO-A, tyrosine-phosphorylation-regulated- kinase (DYRK1A) and 
cytotoxicity to several select cancer cell lines. Keeping in mind the selecti-
ve inhibitory activity of harmine on MAO-A over MAO-B (>10,000-fold 
selectivity) we have designed the synthesis of single and double methyle-
ne bridged 1,2,3- triazole derivatives through simple ‘Click’ chemistry and 
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screened them for their MAO inhibitory potentials. The compounds 3e and 
4c exhibited an IC50 of 0.83 ± 0.03 and 0.43 ± 0.002 µM against MAO-A 
and an IC50 of 0.26 ± 0.04 and 0.36 ± 0.001 µM against MAO-B respective-
ly. The details on chemistry, computational results and biological assay will 
be disclosed. 
N
NO
H
N
NO
R1
N
NHO
R1
N
NO
R1
N
NO
R1
N
N N
Ar
1a -1d
N
NO
R1
N
N N
Ar
R1
 =
1
45
9
7 I
II
III
IV
IV
P-073
FIVE NEW STILBENES FROM THE STEM BARK OF 
ARTOCARPUS COMMUNIS 
Susanna T. Chan1, Wendy L. Popplewell1, Heidi R. Bokesch1,2, and Kirk R. 
Gustafson1
1Molecular Targets Program, Center for Cancer Research, National Cancer 
Institute, Frederick, MD, USA, 21702, 2Basic Science Program, Leidos 
Biomedical Research, Inc, Frederick National Lab, Frederick, MD, USA 
21702
Artocarpus communis J.R.Forst. & G.Forst. (Moraceae), synonymous with 
Artocarpus altilis, is a flowering tree that is native to Indonesia, Papua New 
Guinea, and Tropical Asia and the Pacific. It has been used in tradition-
al medicine in the Pacific Islands for a variety of ailments including liver 
cirrhosis, hypertension, diabetes, skin ailments, and tapeworm infection. 
Previous phytochemical investigations of this plant have yielded over 130 
compounds, of which flavonoids, aryl benzofurans, stilbenoids, and lectins 
are largely responsible for the pharmacological effects of the plant.  In our 
investigation, five new prenylated stilbenes, along with the known com-
pounds cudraflavone C, trans-4-isopentenyl-3,5,2´,4´-tetrahydroxystilbe-
ne, trans-4-(3-methyl-E-but-1-enyl)-3,5,2´,4´-tetrahydroxystilbene, pan-
nokin G, morusin, cycloartobiloxanthone, artonin P, artocarpin, artonin E, 
kuwanon C, artobiloxanthone, and artoindonesianin C were isolated from 
the stem bark of A. communis. The structures were established by NMR 
spectroscopic analysis, MS studies, and comparison of experimental data 
with spectral data reported in the literature. Although the organic extract of 
Artocarpus communis modulated the activity of the oncogenic transcription 
factor HIF-2α in preliminary testing, none of the isolated pure compounds 
had a significant inhibitory effect on the transcriptional activity of HIF-2α.
P-074
BIOMIMETIC TOTAL SYNTHESIS OF THE CYCLIC 
IMINE NATURAL PRODUCT SCYTONEMIDE A USING 
WEINREB AM SOLID PHASE RESIN
Tyler A. Wilson1, Robert J. Tokarski1, Jimmy E. Orjala2, L. Harinantenaina 
Rakotondraibe1, James R. Fuchs1
1Medicinal Chemistry and Pharmacognosy, The Ohio State University, 
Columbus, OH, USA, 2Medicinal Chemistry and Pharmacognosy, University 
of Illinois at Chicago, Chicago, IL, USA.
As part of a continued effort to identify novel compounds with anticancer 
properties, scytonemide A was isolated from the cyanobacterium Scyto-
nema hofmannii in 2010. This macrocyclic peptide contains a rare imine 
linkage previously seen in only a handful of other natural products, inclu-
ding the nostocyclopeptides and koranimine.  Scytonemide A displayed 
promising inhibition against human 20S proteasome chymotrypsin ca-
talytic activity, with an IC50 of 96 nM. However, further exploration and 
development of this unique natural product as a proteasome inhibitor was 
hindered due to the small quantities obtained from the cyanobacterium, 
necessitating an efficient synthetic route for sufficient quantities of the com-
pound. Therefore, inspired by the biosynthetic construction of cyclic pepti-
de imines using non-ribosomal peptide synthetases (NRPSs), a biomimetic 
solid-phase peptide synthesis (SPPS) approach was developed and execut-
ed using the Weinreb AM resin.  Thorough spectroscopic analysis was per-
formed to confirm the structure of the desired product, shedding light on 
the differences observed between the synthetic and natural samples. 
P-075
NATURE PRODUCT BASED ANTI-CANCER PROBE/LEAD 
DEVELOPMENT VIA SYNTHETIC DIVERSIFICATION 
STRATEGIES
Yang Liu1, Yinan Zhang1, Qing Ye2,3, Joseph Eckenrode1,  Xiachang 
Wang1, Yubin Guo2,3, Yanan Cao2,3, Weijia Cai2,3, Jamie Horn1, Larissa V. 
Ponomereva1, Khaled A. Shaaban1, Markos Leggas1, Qing-Bai She2,3, and 
Jon S. Thorson1. 
1Center for Pharmaceutical Research and Innovation, College of Pharmacy, 
University of Kentucky; 2Center for Applied Energy Research, University of 
Kentucky; 3Kentucky Geological Survey, University of Kentucky
Natural products are a productive source of leads for drug development. As 
part of our ongoing translational research and drug discovery and develop-
ment program at the Center for Pharmaceutical Research and Innovation 
(CPRI) at the University of Kentucky (UK), we carried out chemical probe 
synthesis, corresponding target identification, structure-activity relation-
ship (SAR) studies and in vivo evaluation of novel semi-synthetic analogs 
deriving pyranonaphthoquinones and mithramycin. We will report on key 
synthetic modification strategies, the discovery of the pyranonaphthoqui-
none molecular target, semi-synthetic mithramycin analogs with selectivity 
toward Ewing’s sarcoma and preliminary in vivo studies of optimized early 
potential lead candidates. 
P-076
Inspired by natural products, rational design 
and synthesis of novel steroidal LXR agonists 
as well as their biological evaluation
Derong Ding1,2, Rupinder Kaur1,2, Yaxia Yuan1,2, Gregory A. Graf1,2, Chang-
Guo Zhan1,2, David S. Watt1,3, Jon S. Thorson1,2
1Center for Pharmaceutical Research and Innovation, College of 
Pharmacy, University of Kentucky, Lexington, KY, USA; 2Department of 
Pharmaceutical Sciences, College of Pharmacy, University of Kentucky,  
Lexington, KY, USA ; 3College of Medicine, University of Kentucky, KY, 
USA,40508
Live X receptors (LXRs) are the ligand-activated transcription factors and 
have LXRα and LXRβ isoforms. They play an important role in lipid meta-
bolism and have been the useful target for treatment of cardiovascular di-
seases, Alzheimer`s disease, dermatological ailments and cancers. LXRβ is 
ubiquitously expressed and is a more attractive drug target owing to the he-
patic lipogenesis caused by the agonism of LXRα. Naturally occurring oxy-
sterols such as 24(S), 25-epoxycholesterol were identified as LXR ligands. 
To develop more potent LXRβ agonists for the treatment of cardiovascular 
disease, we embarked on a rational ligand design strategy. Specifically, using 
the crystal structure of LXRβ in complex with 24(S),25-epoxycholesterol, 
computational modeling predicted a series of novel structurally-realted li-
gands with putative high affinity for LXRβ. We report on the development 
of a 12-step synthetic strategy from lithocholic acid to enable the synthesis 
of the top computational target. In addition, preliminary biological evalua-
tion of the corresponding analog will be presented as the first step in valida-
ting and refining our current LXRβ computational model.
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P-077
CHARACTERIZATION OF IMMUNOMODULATORY 
POLYSACCHARIDES ISOLATED FROM PANAX 
QUINQUEFOLIUS (NORTH AMERICAN GINSENG) 
CALLUS CULTURES
Rajarshi Ghosh1,2, Shannon Smith1, Evidence Nwangwa2, Paul Kline2 and 
Anthony Farone1
1Department of Biology, Middle Tennessee State University, 2Department 
of Chemistry, Middle Tennessee State University, Murfreesboro, TN 37130, 
USA.
Botanical polysaccharides have been identified as attractive candidates for 
the development of novel therapeutics in recent years, mainly due to their 
ability to modulate the host immune system. However, there has been se-
veral challenges in the commercialization of such products because of high 
purification costs, erratic yields, and variable chemical characteristics. This 
study proposes the application of a plant tissue culture-based system for the 
production of pathogen-free natural immunomodulatory polysaccharides 
with consistent chemical characteristics. Four polysaccharide fractions were 
isolated from callus cultures of Panax quinquefolius, a well-known medi-
cinal herb with immunomodulatory properties. The heterogeneous frac-
tions ranged in molecular weight between 5 kDa and 50 kDa. The fractions 
displayed characteristics of arabinogalactan type II polysaccharide based 
on composition and linkage analysis data. The compounds were found to 
stimulate a range of pro-inflammatory markers (IL-6, TNF-α, MCP-1, GM-
CSF and nitric oxide) in vitro (RAW 264.7 murine macrophage cells) and 
ex vivo (mice splenocytes). The potency of the callus polysaccharides as 
immunostimulatory agents was comparable to mature Panax quinquefolius 
root polysaccharides. The results demonstrate the potential applicability of 
callus culture as a novel source of bioactive polysaccharides. 
P-078
SMALL MOLECULE CHEOENZYMATIC 
GLYCOSYLATION PLATFORM DEVELOPMENT AND 
APPLICATIONS
Ryan R. Hughes, Khaled A. Shaaban, Larissa Ponomareva, Jamie Horn, 
Markos Leggas,* Jon S. Thorson
* Center for Pharmaceutical Research and Innovation, Pharmaceutical 
Sciences, College of Pharmacy, University of Kentucky, Lexington, Kentucky 
40536; Department of Pharmaceutical Sciences, College of Pharmacy, 
University of Kentucky, Lexington, Kentucky 40536, United States
Glycosylation is a key process through which a glycosyltransferase (GT) 
attaches sugars to a wide variety of potential acceptors that include nucleic 
acids, polysaccharides, proteins, lipids, carbohydrates and medicinally rele-
vant secondary metabolites. While GT-catalyzed formation of O-glycosides 
is most common, corresponding GTs involved in the biosynthesis of C-, S-, 
and N-glycosides have also been characterized. OleD is an O- catalyzing GT 
from Streptomyces antibioticus that has been successfully engineered by the 
Thorson lab to give mutants that are more proficient and permissive in the 
context of both sugar donors and glycosyl substrates.  The corresponding 
engineered GTs serve as enabling catalysts for glycorandomization (a ro-
bust platform for small molecule differential glycosylation) and set the stage 
to assess the impact of glycosylation on basic physical properties, mecha-
nism and in vivo pharmacology of natural products, drugs, drug leads and/
or bioactive probes. As part of this broad effort, the extension of a 2-chloro-
4-nitrophenol glycoside-based high throughput screen to identify additio-
nal new GT substrates (including tertiary amines and hydroxamates) and 
new GT inhibitor pharmacophores will be presented. 
P-079
EVALUATION OF ANTIOXIDANT AND ANTI-CANCER 
ACTIVITY OF FUCOSE-CONTAINING SULFATED 
POLYSACCHARIDE FROM MARINE ALGAE
Priscilla Lin,1 Tamara Kondratyuk, 2 San Teh,1 Leng Kar Chang,1 Leng Chee 
Chang2
SKA Academy of Art and Design, 2645 North Berkeley Lake Road, Suite 
F142, Duluth, GA, 30096, USA. 2Department of Pharmaceutical Sciences, 
The Daniel K. Inouye College of Pharmacy, University of Hawai‘i at Hilo, 
Hilo, HI, 96720, USA.
Fucoidan, a sulfated polysaccharide purified from brown algae, possesses 
a variety of pharmacological effects, including anti-inflammatory, antioxi-
dant, and anticancer properties; however, different extraction method affect 
the biological activity and type of extracted fucoidan. The objectives of this 
study were to extract crude fucoidan and evaluate the medicinal properties 
found in Undaria pinnatifida and dried kelp with the aim to ascertain wh-
ether those  have these activities, as well as which functional groups confer 
them.  U. pinnatifida and dried kelp are common brown algae species eaten 
in soups. Both are easily accessible to consumers and are believed to have 
health benefits. Both specimens were pre-treated and extracted using two 
methods - the conventional method and a microwave-assisted extraction. 
Following extraction, samples were evaluated for antioxidant activity using 
the ferric ion-reducing antioxidant power (FRAP) assay. The structure of 
fucoidan was analyzed using NMR, and Fourier Transform Infrared Spec-
troscopy. Extracted fucose was tested for cytotoxicity using an in vitro sul-
forhodamine B (SRB) assay against human prostate (LNCaP, PC-3), breast 
(MCF-7), colon (Caco-2), and lung (Lu-1) cancer cell lines.  Analysis of 
data revealed activities with inhibitory concentrations greater than 50% 
against several cancer cell lines. These results demonstrated fucoidan iso-
lated from U. pinnatifida and dried Kelp does possess antioxidant and an-
ticancer properties.
P-080
GENOME MINING-GUIDED SCREENING FOR 
PSEUDOSUGAR-CONTAINING NATURAL PRODUCTS
Abdullah R. Alanzi, Michael J. Sieler Jr., and Taifo Mahmud*
Department of Pharmaceutical Sciences, Oregon State University, Corvallis, 
OR 97331-3507, U.S.A.
Sugar-containing compounds are ubiquitous in nature, and many of them 
have significant biological activities. The attachment of sugars to natural 
products is catalyzed by members of the glycosyltransferase (GT) super-
family. Similarly, pseudosugar-containing natural products have been re-
cognized to be important secondary metabolites with significant potential. 
The addition of pseudosugars to natural products is catalyzed by the vari-
ants of GTs known as pseudo-glycosyltransferases (PsGTs). Using bioinfor-
matic and genome mining approaches we discovered a number of promi-
sing gene clusters in different actinomycetes that are expected to produce 
pseudosugar-containing natural compounds. Inactivation of these gene 
clusters resulted in mutant strains that showed distinct secondary meta-
bolite profiles. Isolation, characterization, and biological activities of these 
natural products will be presented. 
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P-081
SILYMARIN PREVENTS MEMORY IMPAIRMENTS, 
ANXIETY, AND DEPRESSIVE-LIKE SYMPTOMS IN A RAT 
MODEL OF POSTTRAUMATIC STRESS DISORDER
Tamam El-Elimat1, Zeinab Y. Al Subeh2, Mahmoud Abu AlSamen1, Karem 
H. Alzoubi1, Tyler N. Graf2, and Nicholas H. Oberlies2
1Faculty of Pharmacy, Jordan University of Science and Technology, Irbid 
22110, Jordan; 2Department of Chemistry and Biochemistry, University of 
North Carolina at Greensboro, Greensboro, NC 27402, United States
Post-traumatic stress disorder (PTSD) is a debilitating psychopathological 
disease that is triggered by exposure or witnessing a traumatic event, and 
usually associated with substantial co-morbidities, such as cognitive im-
pairment, anxiety, and depression. Silymarin, from Silybum marianum (L.) 
Gaertn. (Asteraceae), has been reported to exhibit a neuroprotective activi-
ty against various neurodegenerative diseases. Herein, the beneficial effects 
of silymarin in ameliorating PTSD symptoms such as memory impair-
ments, anxiety- and depression-like behaviors were evaluated on a single 
prolonged stress (SPS) rat model of PTSD. Male Wistar rats were randomly 
assigned into four groups: control, silymarin, PTSD, and PTSD/silymarin 
groups. Rats were administered silymarin, 100 mg/kg i.p. for three weeks. 
Animals in all groups were tested for short- and long-term memory in the 
radial arm water maze, for anxiety behavior using open field and elevat-
ed plus maze tests, and for depressive symptoms using tail suspension test. 
Results showed that rats in PTSD group suffer from long-term memory 
impairment and depressive symptoms compared to the control group, and 
silymarin treatment prevents the development of memory impairments, 
anxiety, and depressive-like symptoms in PTSD rats.
P-082
APOPTOTIC INDUCTION BY (+)-BETULIN FROM 
SYZYGIUM CORTICOSUM ON MDA-MB-321 BREAST 
CANCER CELLS
Gerardo D. Anaya-Eugenio1,2, Yulin Ren1, A. Douglas Kinghorn1, Esperanza 
J. Carcache de Blanco1,2
1Division of Pharmacy Practice and Science, and 2Division of Medicinal 
Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State 
University, Columbus, Ohio, USA.
Betulin, one of the main secondary metabolites from Syzygium corticosum 
(Lour.) Merr. & Perry (Myrtaceae), has shown cytotoxic activity against 
MDA-MB-231 (triple negative) breast cancer cells1. However, its effect and 
mechanism of action remains unclear. The present study focuses on the 
study of the biological effects of betulin on MDA-MB-231 breast cancer 
cells, as well as its possible mechanisms underlying these effects. After 72 
hours of treatment with betulin, the growth of MDA-MB-231 cells were 
significantly inhibited (IC50= 1.5 µM) in the SRB assay. Betulin also reduced 
protein concentrations of NF-κB (p65 and p50/105), both IκB kinase (IKK) 
α and β in western blot analysis. However, betulin does not seem to modify 
the expression of PARP-1. These preliminary data suggest that betulin in-
duces apoptosis in MDA-MB-231 cancer cells by inhibition of the NF-κB 
complex.
Reference: Król SK, Kiełbus M, Rivero-Müller A, Stepulak A (2015). Com-
prehensive review on betulin as a potent anticancer agent. Biomed Res Int. 
2015: 584189.
P-083
DE-REPLICATION COUPLED WITH AMOEBIC BIOASSAY 
GUIDED FRACTIONATION IDENTIFIES BIOACTIVE 
SECONDARY METABOLITES IN EPIGENETIC 
MODULATED FUNGAL EXTRACTS
Santana Thomas,1 Christopher A. Rice,2 Dennis Kyle,2 Bill J. Baker1
1Department of Chemistry, University of South Florida, 4202 E Fowler 
Ave, Tampa, FL 33620; 2Center for Tropical and Emerging Global Diseases, 
University of Georgia, 500 D. W. Brooks Drive, Athens, Georgia, 30602
Fungal endophytes are suggested to be ubiquitous among plants to essenti-
ally provide a symbiotic relationship. The fungal bioactive natural products 
have profound effects on its host with provision of growth enhancement 
and competitiveness. As a good source of bioactive secondary metabolites 
fungal endophytes were collected and isolated from mangrove tissues. To 
encourage the production of these bioactive compounds, epigenetic modu-
lators were introduced to the cultures.  After a screen of over 8000 extracts 
against amoebic infections biologically active extracts were grown in a large 
scale for isolation and purification of the active components. Using anti-
amoebic activity and de-replication strategies in tandem several bioactive 
secondary metabolites were isolated from these fungal cultures.
P-084
INHIBITION OF THE 20S PROTEASOME: STRUCTURE-
ACTIVITY RELATIONSHIP OF SCYTONEMIDE A AND 
RELATED ANALOGUES
Robert J. Tokarski1, Tyler A. Wilson1, Jimmy E. Orjala2, Joanna E. Burdette2, 
L. Harinantenaina Rakotondraibe1, James R. Fuchs1.
1Medicinal Chemistry and Pharmacognosy, The Ohio State University, 
Columbus, OH 43210, USA; 2Medicinal Chemistry and Pharmacognosy, 
University of Illinois at Chicago, Chicago, IL 60607, USA
Scytonemide A (1), a unique cyclic peptide imine discovered from the cya-
nobacterium Scytonema hofmannii in 2010, shows promising 20S protea-
some inhibition, with an IC50 = 96 nM. Recently, the total synthesis of 1 was 
reported utilizing solid-phase peptide synthesis (SPPS) on Weinreb AM 
resin. To facilitate further development as a potential therapeutic, this syn-
thetic route has been modified to access structural analogues and establish 
structure-activity relationships. The syntheses and biological activities of a 
series of analogues of 1, including an alanine scan and imine modifications, 
will be presented. 
HN
N
O
HN O
N
H
OH
O H
N
O
HN O
HN
O
OH
NH2
O
H
Tyr1-Gly2-D-Gln3-Ile4-Ser5-Val6-Leu7
N C
Tyr1
Gly2
D-Gln3
Ile4
Ser5
Val6
Leu7
Ala1-Gly2-D-Gln3-Ile4-Ser5-Val6-Leu7
N C
Tyr1-Gly2-D-Ala3-Ile4-Ser5-Val6-Leu7
N C
Tyr1-Gly2-D-Gln3-Ala4-Ser5-Val6-Leu7
N C
Tyr1-Gly2-D-Gln3-Ile4-Ala5-Val6-Leu7
N C
Tyr1-Gly2-D-Gln3-Ile4-Ser5-Ala6-Leu7
N C
Tyr1-Gly2-D-Gln3-Ile4-Ser5-Val6-Ala7
N C
1
Alanine ScanImine
 
Modifications
Tyr1-Gly2-D-Gln3-Ile4-Ser5-Val6-Leu7
CN
H
Tyr1-Gly2-D-Gln3-Ile4-Ser5-Val6-Leu7
CN
O
Tyr1-D-Ala2-D-Gln3-Ile4-Ser5-Val6-Leu7
N C
P-085
NEW 1H-NMR BASED TECHNIQUE FOR THE DETECTION 
OF NOVEL NATURAL PRODUCTS
Asmaa Boufridi1, Dominique Gorse2, RuAngelie Edrada-Ebel3, Ronald J. 
Quinn1
1Griffith Institute for Drug Discovery, Griffith University, Brisbane, QLD, 
4111, Australia, 2QFAB Bioinformatics, Brisbane, QLD, 4072, Australia, 
3Strathclyde Institute of Pharmacy and Biomedical Sciences, University of 
Strathclyde, Glasgow G4 0RE, UK.
We have developed an untargeted 1H-NMR method in the R language. We 
have acquired and digitised 1H-NMR spectra of more than 4000 fractions 
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from plants and marine animals. The digitised 1H-NMR data were impor-
ted into the software R and processed (smoothing the intensity, removing 
the baseline and binning). Each detected peak was set to 1 to create a bar-
code related to each fraction. Each barcode is compared to the whole data-
set in order to detect unique peaks and the corresponding spectrum selec-
ted. Compounds are isolated by 1H-NMR guided isolation. 
  
P-086
NATIVE MASS SPECTROMETRY AS A DRUG 
DISCOVERY TOOL
Angela Di Capua1, Miaomiao Liu1, Asmaa Boufridi,1 Ali Elnaas,1 Tin Mak,1 
Yang Yang,1 Carl Nathan,2 Ruslana Bryk,2 Peter Myler3, and Ronald J. 
Quinn1
1Griffith Institute for Drug Discovery, Griffith University, Brisbane, 
Queensland 4111, Australia, 2Department of Microbiology and Immunology, 
Weill Cornell Medical College, New York, NY 10065 USA, 3Center for 
Infectious Disease Research, Seattle Structural Genomics Center for 
Infectious Disease (SSGCID) Seattle, WA 98109-5219 USA
We have reported the use of native mass spectrometry to investigate 62 
potential protein targets for malaria using a natural product-based frag-
ment library. 97 low molecular natural products were identified as binding 
partners of 32 of the putative malarial targets. Seventy-nine (79) fragments 
have direct growth inhibition on Plasmodium falciparum at concentrations 
that are promising for development of fragment hits. This adds a fragment 
library to the published HTS active libraries in the public domain.
As far as we are aware, the use of natural products as a fragment library 
has not been previously reported. The work should have broad impact as 
it can be applied to any therapeutic target. The use of a mass-spec based 
approach is novel as the vast majority of FBDD campaigns use either DSF 
or NMR as the primary screen. This work likely represents the largest single 
dataset disclosed for a FBDD campaign with data for 62 targets against 643 
unique fragments, providing a wealth of information on both ligand and 
target promiscuity. 
We will present an extension of this work applied to TB. We conducted a 
phenotypic HTS campaign against M. tuberculosis H37Rv and the TB tar-
get Lipoamide Dehydrogenase (Lpd). The phenotypic active fractions have 
been used for target identification using a panel of cloned and expressed 
Mycobacterium proteins. 
P-087
A MS/MS MOLECULAR NETWORKING BASED 
APPROACH TOWARD THE CHARACTERIZATION OF 
THE TRICHODESMIUM METABOLOME 
Christopher Via1, Evgenia Glukhov2, Samuel Costa1, William H. Gerwick2, 
and Matthew J. Bertin1 
1Department of Biomedical and Pharmaceutical Sciences, College 
of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA, 
2Center for Marine Biotechnology and Biomedicine, Scripps Institution 
of Oceanography, and Skaggs School of Pharmacy and Pharmaceutical 
Sciences, University of California at San Diego, La Jolla California 92093-
0212, USA
Trichodesmium species are highly adapted marine cyanobacteria, known 
for their beneficial role as nitrogen fixers in tropical and subtropical waters. 
Currently, there is little knowledge available with respect to the diversity 
and abundance of secondary metabolites. Using a MS/MS based molecular 
networking approach that clusters ions based on their similar MS2 fragmen-
tation patterns, we aimed to characterize the Trichodesmium metabolome. 
The approach led to the isolation and characterization of new smenamide 
analogs (1-3), which are structurally similar to the previously elucidated 
smenamides A and B, adding to a class of biosythetically interesting hybrid 
polyketide-peptide compounds. Among the newly described smenamides, 
1 and 3 showed potent cytotoxicity against neuro-2A cells. The isolation, 
characterization and cytotoxicity of these new smenamide molecules (1-3) 
will be presented. 
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P-088
EXPLORATION OF XANTHINE OXIDASE INHIBITORS 
FROM HYPTIS SUAVEOLENS
Fu-Chun Hsu, Yi-Li Lin, and Shoei-Sheng Lee*.
School of Pharmacy, College of Medicine, National Taiwan University, 33 
Lin-Sen South Rd., Taipei 10050, Taiwan
Bioassay-guided fractionation of the EtOH extract of the Hyptis suaveolens 
stems and seeds indicated both EtOAc- and n-BuOH- soluble fractions to 
be active against xanthine oxidase which catalyzes the formation of uric 
acid, a main cause of gout. Separation of these fractions via Sephadex LH-
20, centrifugal partition chromatography, and reversed-phase chromato-
graphy led to the isolation of 17 compounds from the stems and four from 
the seeds. Additional ten minors in the seeds were characterized via the 
assistance of HPLC-SPE-NMR. Of these isolates, nepetoidin B (7), 4,5-O-
dicaffeoylquinic acid (25), and methyl 3,5-O-dicaffeoylquinate (27) have 
been reported to display good inhibitory activity against xanthine oxidase.
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P-089
NEW NMR APPLICATIONS FOR BOTANICAL 
MIXTURES: THE USE OF HSQC TO DETERMINE LIGNAN 
CONTENT IN SAMBUCUS WILLIAMSII HANCE
Raymond Cooper1, Juan Lu2, Hui-Hui Xiao1,3, Daniel Mok1,3, Xin-Sheng 
Yao4 and Man-Sau Wong1,3
c
2Bruker (Beijing) Scientific Technology Co. Ltd., 8F, Tower C, Building 
B-6, No. 66, Xi Xiao Kou Road, Haidian District, 100192, Beijing, China, 
3State Key Laboratory of Chinese Medicine and Molecular Pharmacology 
(Incubation), Shenzhen Research Institute of The Hong Kong Polytechnic 
University, Shenzhen 518057, China, 4Institute of Traditional Chinese 
Medicine & Natural Products, College of Pharmacy, Jinan University, 
Guangzhou 510632, China
Lignans found in the botanical extract of the Traditional Chinese Medici-
ne, Sambucus williamsii Hance exhibit protective effects on trabecular bone 
mass and mechanical strength of cortical bone of ovariectomized (OVX) rats. 
A novel approach was adapted to standardize and determine quantities of 
the lignan content in the aqueous alcoholic extract of Sambucus williamsii 
using HSQC NMR methods and provides data to meet the registration re-
quirements for a Class 5 botanical drug in China. The assigned oxy-benzyl 
substituted carbon signal in the 13C NMR spectrum of a known lignan was 
compared to the equivalent carbon signal in the lignan mixture, observed in 
the botanical extract, under the same solvent and concentration conditions. 
A linear response curve was obtained for the peak height of the assigned oxy-
benzyl carbon at ~86ppm for the standard lignan at various dilutions. Results 
were obtained by comparing the correlation peak (oxy-benzyl substituted 
carbon signal in the HSQC for the 13C signal ~ 86ppm, and 1H signal at 
~4.6ppm) of pinoresinol in the HSQC spectrum with the equivalent corre-
lation peaks of lignans in the botanical extract. Using these data, the lignan 
amount in the extract was calculated to be approximately 60% of the total 
extract. The application of this simple and reliable method can be used to 
estimate other compound families in complex mixtures or botanical extracts.
P-090
ENHANCED LC–MS/MS MOLECULAR NETWORKING 
WORKFLOW FOR ACCELERATED AND MASSIVE 
DEREPLICATION OF NATURAL PRODUCTS 
Kyo Bin Kang1,2, Justin J.J. van der Hooft1,3, Madeleine Ernst1, Ricardo da 
Silva1, Marnix H. Medema3, Sang Hyun Sung2, and Pieter C. Dorrestein1.
1Skaggs School of Pharmacy and Pharmaceutical Sciences, University of 
California, San Diego, La Jolla, CA 92093, USA, 2College of Pharmacy and 
Research Institute of Pharmaceutical Sciences, Seoul National University, 
Seoul 08826, Republic of Korea, 3Bioinformatics Group, Department of Plant 
Sciences, Wageningen University, Wageningen 6708PB, The Netherlands.
MS/MS molecular networking, which groups and visualizes molecules 
based on their MS/MS spectral similarity suggesting structural similar-
ity, was previously presented by our group as a data analysis technique 
for accelerating dereplication processes. Here, we introduce an enhanced 
workflow that facilitates mapping and identifying massive specialized me-
tabolite spaces, based on enhancement of MS/MS molecular networking 
by two computational MS/MS data processing methods: network anno-
tation propagation (NAP) and MS2LDA substructure topic modeling. By 
combining these two processing tools, information about chemical scaf-
folds and substructures could be annotated automatically, even for spectral 
clusters without any spectral library matches. We demonstrate accuracy 
and efficiency of our integrative workflow in large-scale dereplication of 
natural products with a case of extracts from 71 Rhamnaceae plants. More 
than 1,000 compounds could be putatively annotated by NAP, and their 
substructures, for example, different phenolic moieties (e.g. vanilloyl or 
coumaroyl) of triterpenoid esters or aglycone types of flavonoid glycosides 
were easily recognized by MS2LDA.
P-091
CELLULAR MEMBRANE AFFINITY CHROMATOGRAPHY 
AND CELL MEMBRANE COATED NANOPARTICLES IN 
DRUG DISCOVERY FROM NATURAL MATRICES
Cayman Stephen1, Jennifer Sherwood2, Yuping Bao2, and Lukasz Ciesla1.
1Department of Biological Sciences, The University of Alabama, Tuscaloosa, 
AL 35487, USA, 2Department of Chemical and Biological Engineering, The 
University of Alabama, Tuscaloosa, AL 35487, USA
Identification of pharmacologically active compounds targeting transmem-
brane proteins (TMPs) is a challenging task that demands high resource 
commitment. Innovative approaches: cell membrane affinity chromatogra-
phy (CMAC) columns and cell membrane coated nanopartciles (nanog-
hosts) are proposed to screen complex natural matrices for biologically 
active, secondary metabolites. CMAC and ligand fishing with nanoghosts 
are robust approaches allowing for the immobilization of fully functional 
TMPs on the surface of either immobilized artificial membrane (IAM) sta-
tionary phase HPLC particles or magnetic nanoparticles. Both techniques 
allow for the identification of phytochemicals specifically interacting with 
TMPs, without the need to isolate any of the compounds present in the 
screened extract. These innovative techniques speed up the process of the 
identification of potential new drug leads and are ideally suited for building 
libraries of natural compounds, interacting with the specific protein targets. 
The preparation steps and application of both approaches in most recent 
drug discovery projects will be presented. 
P-092
NEW METHODS FOR THE DETECTION OF 
ADULTERANTS IN GINKGO BILOBA LEAF EXTRACT
Elizabeth Corwin, Meide Pan, PhD, and Michael Harvey
NSF International
A new reverse-phase HPTLC method combined with a dual-wavelength 
HPLC-UV fingerprint method (detection at 370 and 260 nm) has been de-
veloped in our laboratory to evaluate the quality of ginkgo products and to 
identify adulterants in ginkgo biloba leaf raw materials, leaf extract, and fi-
nished products.  More than 20 commercial ginkgo supplements from Nor-
th American and European markets were evaluated.  Of the ginkgo dietary 
supplements tested between 2015 and 2018, only three of the products con-
tained authentic ginkgo leaf extracts.  The adulterations included uncha-
racteristically high levels of rutin, quercetin, keampferol, or extracts from 
Japanese Sophora or green tea. The methods used will be presented, as well 
a systematic approach for determination of quality ginkgo biloba products. 
P-093
AN APPLICATION OF 19F NMR SPECTROSCOPY IN 
NATURAL PRODUCT CHEMISTRY TO INVESTIGATING 
THE EFFECT OF CHEMICAL ENVIRONMENT ON 
PARTITION COEFFICIENT
Laura Tyler, David C. Lankin, Shao-Nong Chen, Guido F. Pauli
UIC/NIH Center for Botanical Dietary Supplements Research, Department 
of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, 
University of Illinois at Chicago, IL.
In the context of pharmacokinetics, the absorption potential and membra-
ne permeability of natural products (NPs) can be reflected in the partiti-
on coefficient (Kp) between the lipid bilayer of phosphatidylcholine (PC) 
vesicles and a physiological buffer. However, measurement of Kp values in 
complex NP matrices is a major challenge. To fill this gap, a quantitative 
19F NMR (qFNMR) method was developed to determine the Kp of a semi-
synthetic, fluorinated NP (F-mimic) produced from a chalcone enriched 
fraction of Glycyrrhiza inﬂata (GI) rhizome extract. The qFNMR spectra of 
F-mimic in the presence of a PC unilamellar vesicle suspension showed a 
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single PC concentration dependent signal of varying shift and line broade-
ning related to fast exchange between the PC vesicles and buffer. GI extracts 
of variable preparation and polarity were applied to this methodology to 
investigate the effects of co-administered phytochemicals on the Kp of F-
mimic. The results are supported by Caco-2 biological assay and a second 
derivative spectrophotometric method. The proposed method leverages 
the highly selective nature of 19F NMR to exclude the signal interference of 
biological systems and extracts to investigate the effects of complex chemi-
cal environments on a target metabolite.
P-094
THE AXOLOTL AS A NEW MODEL FOR THE DISCOVERY 
AND VALIDATION OF CHEMICAL GENETICS TOOLS 
FOR REGENERATIVE BIOLOGY 
Larissa V. Ponomareva,1 Qingchao Qiu,2 Varun B Dwaraka,2 Khaled A. 
Shaaban,1 Jon S. Thorson,1 S. Randal Voss2
1Center for Pharmaceutical Research and Innovation, College of Pharmacy, 
University of Kentucky; 2College of Medicine, Spinal Cord and Brain Injury 
Research Center, University of Kentucky
Amphibian vertebrates are important models in regenerative biology be-
cause they present exceptional regenerative capabilities throughout life. 
However, it takes considerable effort to rear amphibians to adulthood for 
regeneration studies and the relatively large sizes that frogs and salaman-
ders achieve during development make them difficult to use in chemi-
cal screens. Here we develop a new tail regeneration model using early 
hatchling stage Mexican axolotl larvae. We show that axolotl hatchlings 
completely regenerate amputated tails in 7 days. Further, we show that 
axolotl hatchlings can be efficiently reared in microtiter plates to achie-
ve moderate throughput screening of chemicals to investigate toxicity and 
identify molecules that alter regenerative outcome. Importantly, the use of 
pre-feeding salamanders circumvents the need for an IACU protocol and 
the screen has also been adapted as an undergraduate student teaching la-
boratory exercise. Here we report results from screening of four compound 
collections: the Tocriscreen Stem Cell Toolbox (80 compounds), Selleck-
chem Epigenetics library (151 compounds), the representative sets from the 
MicroSource Discovery Systems Spectrum Collection (2650 compounds) 
and the Center for Pharmaceutical Research and Innovation (326 natu-
ral products). Several tail regeneration modulators were identified where 
subsequent dose response, expression-profiling for select agents have been 
pursued. Our study establishes the axolotl hatchling as a chemical scree-
ning model to investigate signaling pathways associated with tissue regene-
ration and implicates utility for toxicology screening.
P-095
INVESTIGATION OF THE CYTOTOXIC CONSTITUENTS 
OF GLYCOSMIS OVOIDEA COLLECTED IN VIETNAM
Peter J. Blanco Carcache1, Choon Y. Tan1, Austin A. Czarnecki3, Tran 
Ngoc Ninh2, Nelson Freitas Fernandes1, Gerardo D. Anaya-Eugenio1, Yulin 
Ren1, Djaja D. Soejarto3,4, H. Liva Rakotondraibe1, Joanna E. Burdette3, A. 
Douglas Kinghorn1.
1College of Pharmacy, The Ohio State University, Columbus, OH, 43210, 
2Institute of Ecology and Biological Resources, Vietnam Academy of Science 
of Technology, Hanoi, Vietnam, 3College of Pharmacy, University of Illinois 
at Chicago, Chicago, IL, 60612, 4Science and Education, Field Museum of 
Natural History, Chicago, IL, 60605
As part of a continuing effort to discover new anticancer agents, Glycosmis 
ovoidea Pierre (Rutaceae) was selected for further studies due to the cyto-
toxicity of the chloroform partition of its stems, fruits, and leaves against 
the HT-29 and MCF-7 cancer cell lines. No previous phytochemical studies 
have been reported on G. ovoidea. The chloroform extract has afforded thus 
far a potent flavonoid cytotoxic agent (1), a coumarin with a previously 
unassigned absolute configuration (2), and two known coumarins (3, 4). 
Compound 1 was tested against HeLa cells and displayed potent cytotoxici-
ty (IC50  = 2 nM). All compounds isolated have been evaluated in the present 
investigation against the MDA-MB-435, MDA-MB-231, OVCAR-3, and 
HT-29 human cancer cells.
P-096
HPLC-MS METHOD VALIDATION FOR SILVESTROL 
AND 5'''-EPISILVESTROL AND ITS APPLICATION IN 
DETECTING THEIR ANALOGS
Garima Agarwal1, Andrew C. Huntsman1, James R. Fuchs1, Esperanza 
Carcache de Blanco1, and A. Douglas Kinghorn1.
1Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, 
The Ohio State University, Columbus, Ohio 43210.
Silvestrol (1) and its analog 5'''-episilvestrol (2), first isolated from the twigs 
and barks of Aglaia foveolata Pannell,1 have garnered much interest due to 
their inhibitory activity against an array of cancer cell lines both in vitro and 
in vivo along with their ability to inhibit protein synthesis via binding to euka-
ryotic initiation factor (eIF) 4A.2 As part of our continuous effort to discover 
potential anticancer agents, the roots of Aglaia perviridis Hiern. were fractio-
nated and the chloroform partition was found to contain both 1 and 2. To aid 
in accurate identification and quantification of 1, 2, and their derivatives in a 
fraction, a LC-MS dereplication method has been developed and validated. 
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P-097
LABELING NATURAL PRODUCTS IN COMPLEX 
EXTRACTS
Gabriel Castro-Falcon, Grant S. Seiler, and Chambers C. Hughes.
Scripps Institution of Oceanography, University of California, San Diego, 
9500 Gilman Dr., La Jolla, CA 92093-0204 USA.
An enormous number of biologically-active natural products that could 
lead to new drugs have not been discovered because there is a shortage 
of innovative methods for their discovery. Reactivity-guided isolation is a 
novel approach to access natural product chemical space. It identifies bio-
logically-active metabolites based on their reactivity and has the potential 
to transform the way in which natural products chemists find new natural 
products. Chemical probes consisting of a prominent UV-MS (or fluoroge-
nic) tag and a chemoselective reagent are designed to label natural products 
with a specific pharmacophore or functional group in an unprocessed ex-
tract. The resulting derivatives are then readily detected by LC/MS, isolated, 
and characterized. The unlabeled metabolites are easily targeted for isola-
tion from the original extract on the basis of their calculated masses. We 
have developed an assortment of probes over the past five years for various 
purposes, which we will present in some detail.
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P-098
RAW NMR DATA: RESEARCH INTEGRITY AND NO 
MORE MULTIPLETS
James B. McAlpine,* Shao-Nong Chen,* Jonathan Bisson,* Charlotte 
Simmler,* David C. Lankin,* Matthias Niemitz,† Mark S. Butler,‡ Michael T. 
Crimmins,# Harald Gross,& Guido F. Pauli*
*Center for Natural Product Technologies (CENAPT), PCRPS & MCP, 
Coll. of Pharmacy, Univ. of IL at Chicago, Chicago, USA; †NMR Solutions, 
Kuopio, Finland; ‡UQ Centre Clin. Res.,Royal Brisbane& Women’s Hosp. 
Herston, 4029, Australia; #Kenan & Caudill Laboratories of Chemistry, Univ. 
of North Carolina, Chapel Hill, USA; &Dept. of Pharm, Biology, Eberhard 
Karls Univ., Tübingen, Germany
Whereas the role of NMR in natural product research is undisputed, what 
is still not appreciated is the fact that, surprisingly, it is underutilized. Al-
most invariably the first step in characterizing a new isolate is a simple 1H 
NMR spectrum, collected as a free induction decay (FID) from a broad 
band pulse. The 1H NMR incorporates a wealth of data on the electronic en-
vironment of each hydrogen and its relationship to nearby hydrogens and 
13C atoms. Unfortunately, FIDs are not human-readable and is submitted to 
a Fourier Transformation (FT) to give us the NMR spectrum that we can 
to some extent analyze. The result is commonly listed in tables, including 
frequent designation of signal patterns as multiplets, i.e., a loss of data and 
an invitation to typographical errors and misassignments. There are now 
programs which will analyze FIDs to reproduce the exact FT’ed spectrum 
and provide accurate chemical shifts, coupling constants, line widths, and 
peak areas. This and other developments make FIDs, the original raw data, 
invaluable for the integrity of science. They provide an avenue to structu-
ral correctness, purity analysis, build of databases, which can be used for 
dereplication, and enable reviewers to verify structures in submitted manu-
scripts. Examples of the use of these advanced FID analysis, deconvolution 
of “multiplets”, and of compounds whose published structures were shown 
to be erroneous by re-examination of their NMR spectra will be presented.
P-099
NATURAL PRODUCT DISCOVERY USING AUTOMATED 
HIERARCHICAL CLUSTERING AND PRINCIPAL 
COMPONENT ANALYSIS (HC-PCA) IN R
Shaurya Chanana1, Chris S. Thomas1, Tim S. Bugni1.
1Pharmaceutical Sciences Division, School of Pharmacy, University of 
Wisconsin, Madison, WI 53705, USA
Rediscovery of known natural products hinders discovery efforts aimed at 
identifying new and interesting structural scaffolds for drug discovery pur-
poses. Liquid chromatography / mass spectrometry in combination with 
principal component analysis (LC/MS-PCA) based metabolomics has been 
successfully used to address this challenge. However, the inherent complex-
ities of metabolomics data necessitate the development of a pre-processing 
step to determine appropriate group membership and manageable group 
sizes for computing informative PCA models. Datasets with large inherent 
diversity fare poorly in PCA since inter- and intra-group variance tends to 
be similar. Hierarchical clustering analysis (HCA) is able to group similar 
bacterial strains based on their LC/MS chromatograms after which PCA 
can be successfully employed on these smaller sub-groups for the discovery 
of putative novel compounds. We have developed a script that allows for a 
more robust automated analysis of large collections of bacterial strains. The 
script is written in R, and supports integration with other existing metabo-
lomics workflows and can be linked with automated mass matching using 
existing databases.
P-100
TARGETED ISOLATION OF NATURAL PRODUCTS 
USING IN SILICO MOLECULAR NETWORK 
ANNOTATION PROPAGATION: A CASE OF SAGERETIA 
THEEZANS
Kyo Bin Kang1,2, Eun Jin Park2, Ricardo R. da Silva1, Hyun Woo Kim2, Sang 
Hyun Sung2, and Pieter C. Dorrestein1.
1Skaggs School of Pharmacy and Pharmaceutical Sciences, University of 
California, San Diego, La Jolla, CA 92093, USA, 2College of Pharmacy and 
Research Institute of Pharmaceutical Sciences, Seoul National University, 
Seoul 08826, Korea.
Network Annotation Propagation (NAP) is a recently developed in sili-
co-based MS/MS spectra annotation tool, which takes an advantage of net-
work topology from MS/MS molecular networking. NAP improves accura-
cy of in silico fragmentation predictions by re-ranking candidate structures 
based on the network consensus of structural similarity, even when there is 
no match to a MS/MS spectrum in spectral libraries. In the present study, 
NAP was applied to annotate molecular families in the MS/MS spectral 
network of the Sageratia theezans (Rhamnaceae) twig extract for derepli-
cation. Based on the in silico dereplication results, molecules expected to 
be unknown were prioritized and isolated. In total, six dicoumaroyl 8-O-4’ 
neolignans (1–6) and three dicoumaroyl lignans (7–9) were isolated and 
structurally characterized by spectroscopic analyses. We also confirmed the 
feedback effect of expanding structural library to the improvement of NAP 
annotation; this highlights the importance of community contributions of 
structures to databases in addition to providing reference spectra. Among 
the isolates, compounds 7–9 showed potent protective effect against gluta-
mate-induced oxidative stress in mouse HT22 cells.
P-101
GENOMICS DRIVEN DISCOVERY AND ENGINEERING 
OF FUNGAL POLYCYCLIC POLYKETIDES
Karolina Subko1, Peter P. Wolff1, Sebastian Theobald1, Jens C. Frisvad1, 
Charlotte H. Gotfredsen2,  Mikael R. Andersen1, Uffe H. Mortensen1, and 
Thomas O. Larsen1.
1Department of Biotechnology and Biomedicine, Technical University of 
Denmark, Kgs. Lyngby, Denmark, 2Department of Chemistry, Technical 
University of Denmark, Kgs. Lyngby, Denmark
Polycyclic aromatic polyketides represent an important group of Natural 
Products (NPs) exhibiting a broad variety of antimicrobial and cytotoxic 
activities. In filamentous fungi their backbone structures are synthesised 
by iterative non-reducing polyketide synthases (NR-PKSs) that undergo 
regioselective cyclizations and are further altered by additional enzymatic 
modifications. In this study genome sequences of more than 300 species in 
genus Aspergillus were genome mined against selected polycyclic NR-PKS 
gene sequences to identify a hit list of species with homologous gene clus-
ters. The resulting hit strains were then grown under a number of growth 
media conditions and their crude extracts were dereplicated using HPLC-
DAD-HRMS, to separate the strains with expressed and silent polyketide 
pathways. The selected silent hit NR-PKSs, in association with the modifi-
cation enzymes encoded by their gene clusters, were overexpressed in their 
native strain, leading to isolation and structural elucidation of the result-
ing products and characterization of their biosynthetic pathways. The case 
study in Aspergillus sydowii will be presented.  
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P-102
EVALUATING A NEW TOOL TO AID IN STRUCTURE 
ELUCIDATION BY DOUBLE BOND PLACEMENT 
USING OZONE-INDUCED DISSOCIATION MASS 
SPECTROMETRY
Sonja L. Knowles1, Ngoc Vu1, Huzefa A. Raja1, Matthew E. Mead3, Jacob L. 
Steenwyk3, Antonis Rokas3, Qibin Zhang1,2, and Nicholas H. Oberlies1.
1Department of Chemistry and Biochemistry, University of North Carolina 
at Greensboro, Greensboro, NC 27412, 2 Center for Translational Biomedical 
Research, University of North Carolina at Greensboro, Kannapolis, NC 
28081, 3Department of Biological Sciences, Vanderbilt University, Nashville, 
TN, 37235. 
The location of double bonds can play a vital role in the activity of second-
ary metabolites. Most often, organic structures are solved by using NMR, 
but it can be challenging to locate double bond locations, particularly for 
fully substituted double bonds and compounds with multiple double bonds 
in similar chemical environments. Ozone-Induced Dissociation Mass 
Spectrometry (OzID-MS) serves as an orthogonal structure elucidative 
tool due to initiation of ozonolysis across a carbon-carbon double bond. 
Ozonolysis breaks a bond into an aldehyde/ketone and a Criegee ion, which 
produces unique fragments that can be detected. Using a Synappt G2 Mass 
Spectrometer, fungal secondary metabolites were analyzed to confirm the 
placement of double bonds, including, the structure elucidation of a new 
compound. To confirm that the unique fragment ions being observed 
were due to OzID-MS and can be used as indicative ions for character-
izing double bond placement, the compounds were also examined on the 
same instrument without the presence of ozone. In addition to serving as 
a complement to structure elucidation via NMR, we hypothesize that this 
technique could be valuable when analyzing the structures of secondary 
metabolites in situ.
P-103
STABLE ISOTOPE LABELING AND COMPARATIVE 
METABOLOMICS FACILITATE GENOME MINING IN 
CYANOBACTERIA
Daniel S. May1, Camila M. Crnkovic1,2, Aleksej Krunic1, Jimmy Orjala1.
1Department of Medicinal Chemistry & Pharmacognosy, College of 
Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA; 2CAPES 
Foundation, Ministry of Education of Brazil, Brasília, DF 70040-020, Brazil
Improvements in both sequencing and bioinformatic technologies have 
made genome mining a powerful approach for the identification of bac-
terial natural products.  Bioinformatic tools, such as AntiSMASH, can be 
used to identify biosynthetic gene clusters from genomic data and provide 
predictions on the structures of the produced compounds.  However, the 
predicted structures are often not complete, making identification of the 
produced compounds in a cell extract through mass spectrometry challen-
ging.  Taking advantage of the unique growth conditions for cyanobacteria, 
15N stable isotope labeling was used to match biosynthetic gene clusters to 
their produced compounds in a cyanobacterial cell extract.  Bioinformatic 
analysis with AntiSMASH was able to identify six biosynthetic gene clusters 
from the sequenced genome of the cyanobacterium UIC 10630 Nostoc sp. 
Three of the six biosynthetic gene clusters had high similarity to reported 
biosynthetic gene clusters, while three appeared to be orphan gene clusters. 
Stable isotope labeling with 15N labeled nitrate, and subsequent comparati-
ve metabolomic analysis, matched four of the six biosynthetic gene clusters 
with compounds in the cell extract.  Two of the identified compounds were 
new natural products and their structures were elucidated by NMR and 
mass spectrometry.
P-104
USING MALDI-TOF MS TO CREATE LOW-REDUNDANCY 
LIBRARIES FROM THE CULTIVABLE FRESHWATER 
SPONGE MICROBIOME
Chase M. Clark1, Dr. Michael Mullowney2, Antonio Hernandez1, Emma 
Ward1, Milan Patel1, Dr. Laura M. Sanchez1 and Dr. Brian T. Murphy1.
1University of Illinois at Chicago, Chicago, IL, USA, 2Northwestern 
University, Evanston, IL, USA
Our lab recently developed a mass spectrometry (MS) and bioinformat-
ics pipeline, IDBac, that allows MS fingerprinting of up to 384 microbial 
strains in four hours by a single user. We demonstrated IDBac’s capabilities 
by simultaneously extracting protein and specialized metabolite MS pro-
files from unidentified species of bacteria cultivated on an agar plate. With 
unsupervised machine learning and visualizations, IDBac created hierar-
chical groupings of protein MS fingerprints that accurately mirrored phylo-
genetic groupings and further distinguished isolates based on inter- and in-
tra-species differences in specialized metabolite production. While created 
for a broad range of applications, we are interested in IDBac’s application in 
creating bacterial strain libraries for drug discovery, a process that has seen 
little innovation in nearly 80 years of biomedical research. Current practice 
relies on colony morphology and/or limited gene sequencing analyses to 
prioritize strains, which has led to libraries plagued with a high degree of 
taxonomic and chemical redundancy and a general divestment in natural 
products by pharmaceutical companies and other agencies. To address this 
problem, we designed a detailed roadmap for creating a low-redundancy 
bacterial library, using the cultivable microbiomes of the understudied 
freshwater sponge Eunapius fragilis var. minuta as an example. Our pipe-
line is grounded in shareable data, and suitable for easily evaluating sam-
ple collection strategies. Built with collaborative efforts in mind, IDBac has 
potential in bringing a new paradigm to the front-end of microbial drug 
discovery.
P-105
IN VIVO AND IN VITRO ACTIVITY OF PERFOLIATIN 
A, AN Α-GLUCOSIDASE INHIBITOR ISOLATED FROM 
MELAMPODIUM PERFOLIATUM
Laura Flores-Bocanegra, José S. Calderón, Martín González-Andrade and 
Rachel Mata.
Universidad Nacional Autónoma de México, Ciudad de México, 04510, 
México.
 
The known melampolide, perfoliatin A (1) isolated from the aerial parts of 
Melampodium perfoliatum (Asteraceae) possessed antihyperglycemic acti-
vity in normal and hyperglycemic (NA/STZ, 50/130 mg/kg) mice during an 
oral sucrose tolerant test (3.1-31.6 mg/kg, Figure 1). Compound 1 exhibi-
ted in vitro inhibitory activity against rat small intestinal and Ruminococcus 
obeum α-glucosidases (IC50 = 6.5 ± 0.63 mM and 0.47 ± 0.01 mM, respec-
tively). Kinetic assays using the R. obeum enzyme showed that compound 1 
behaved as noncompetitive inhibitor, according with the Lineweaver Burk 
graphic (Figure 2). 
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P-106
MORE THAN THE SUM OF ITS PARTS: MONITORING 
ANTIVIRULENCE WITH DROPLET-LIQUID 
MICROJUNCTION-SURFACE SAMPLING PROBE
Diana Kao1, Huzefa A. Raja1, Daniel A. Todd1, Nadja B. Cech1, Nicholas H. 
Oberlies1.
1Department of Chemistry and Biochemistry, University of North Carolina 
at Greensboro, Greensboro, NC 27402, USA.
Methicillin-resistant Staphylococcus aureus (MRSA) is often the face of “su-
perbugs,” bacterial infections that develop antibiotic resistance.  To combat 
this, we turn our attention to alternative methods, such as antivirulence, to 
disrupt the quorum sensing pathway in MRSA and hinder its pathogenesis. 
One known quorum sensing inhibitor is ω-hydroxyemodin, which was iso-
lated from the fungal endophyte, Penicillium restrictum.  The antivirulence 
effect of ω-hydroxyemodin was observed in vitro and in vivo.  We have in-
corporated droplet-liquid microjunction-surface sampling probe (droplet 
probe), which applies an innocuous droplet to the surface of the bacteria 
and performs a microextraction of the metabolites.  We can couple this 
technique to UPLC-HRMS to broaden the scope of our analysis.  Previ-
ously this technique was used to sample fungi and some plants; we demon-
strate its use to measure the virulence of pathogenic bacteria by monitoring 
the inhibition of the virulent factor, δ-toxin, with the fungal metabolite, 
ω-hydroxyemodin, in situ. 
P-107
SMALL MOLECULE ACCURATE RECOGNITION 
TECHNOLOGY (SMART) TO ENHANCE NATURAL 
PRODUCTS RESEARCH
Chen Zhang1, Poornav S. Purushothama2, Nicholas Roberts2, Yashwanth 
Nannapaneni2, Vishal T. Vasudevan2, Garrison W. Cottrell2, William H. 
Gerwick1,3.
1Scripps Institution of Oceanography, 2Department of Computer Sciences 
and Engineering, 3Skaggs School of Pharmacy and Pharmaceutical Sciences, 
University of California San Diego, La Jolla, CA 92093, USA
We present the Small Molecule Accurate Recognition Technology 
(SMART), a system that integrates the benefits of Fast NMR with advances 
in deep learning to enhance and improve the efficiency of natural products 
discovery. This tool is highly effective in both assisting natural products dis-
covery efforts as well as the automatic identification of a new compound as 
belonging to a particular compound family. To effectively accomplish this 
goal, we first developed a state of the art protocol for the rapid accumula-
tion of this particular type of NMR data, and this involved an innovation 
in the data processing methodology. Next, a deep Convolutional Neural 
Network (CNN) with contrastive loss was trained on a database containing 
over 2,000 HSQC spectra as the training set. This resulted in a remarkable 
and highly accurate 3D clustering of different classes of molecules based 
on their respective HSQC spectra. To demonstrate the utility of SMART, 
several newly isolated compounds were automatically located with their 
known analogues in the embedded clustering space, thereby streamlining 
the discovery pipeline for new natural products. In addition, because white 
Gaussian noise, impurities, or solvent effects are often seen in experimental 
HSQC spectra, we investigated the robustness of the SMART to recognize 
HSQC spectra in the presence of significant noise or artifacts. 
P-108
DEVELOPMENT OF A BACTERIAL HOST FOR 
ANTIBIOTIC DISCOVERY AND PRODUCTION
Sylvia Kunakom1 and Alessandra S. Eustáquio1. 
1Department of Medicinal Chemistry and Pharmacognosy, University of 
Illinois at Chicago (UIC), 833 South Wood Street, Chicago, IL 60612
Microbial metabolites are remarkable starting points for antibiotic disco-
very and development. Bacterial genomes encode a large and mostly un-
tapped capacity for antibiotic biosynthesis. In order to realize the full ex-
tent of genome mining for antibiotic discovery is heterologous expression 
in a robust host. Burkholderia sp. FERM BP-3421, a β-Proteobacterium, is 
a non-pathogenic, industrial strain that offers the desired characteristics 
of a heterologous host.  FERM BP-3421 has a doubling time of ~1 hour, 
has genetic tractability, has been optimized to produce a drug lead in high 
yields, and has potential to produce complex metabolites of various biosyn-
thetic classes based on the >20 biosynthetic gene clusters (BGCs) encoded 
in its genome. We aim to test FERM BP-3421 as a heterologous host for the 
discovery and production of antibiotics identified by genome mining. We 
have established an electroporation protocol and have constructed suitable 
vectors for FERM BP-3421. This presentation will cover our latest results 
towards testing the host using model BGCs and selected orphan BGCs.
P-109
NEW APPROACHES FOR TARGET IDENTIFICATION OF 
NATURAL PRODUCTS
Corena Grant1, Shengxin Cai3,4, Tanja Grkovic5, Barry O’Keefe6,7, Robert 
Cichewicz3,4, April Risinger1,2, Susan Mooberry1,2
1Department of Pharmacology and 2Mays Cancer Center, UT Health 
San Antonio, San Antonio, TX, 78229. 3Department of Chemistry and 
Biochemistry and 4Natural Products Discovery Group, University of 
Oklahoma, Norman, OK, 73019. 5Natural Products Support Group, Leidos 
Biomedical Research Inc., Frederick National Laboratory for Cancer 
Research, Frederick, MD 21702. 6Natural Products Branch, Division of 
Cancer Treatment and Diagnosis, and 7Molecular Targets Laboratory, 
Center for Cancer Research, National Cancer Institute, Frederick, MD, 
21702.
Our mechanism-blind screening program aimed at identifying compounds 
targeting triple negative breast cancer (TNBC) subtypes from extracts and 
fractions of diverse source organisms has been successful and multiple 
compounds targeting different subtypes have been identified. A major be-
nefit of mechanism-blind drug discovery is the opportunity to identify new 
and unanticipated drug targets. This is critical for TNBCs because there 
are few defined molecular targets for this heterogeneous disease. A major 
challenge with this approach is identification of the biological targets. A 
CRISPR-Cas9 mediated genome-wide knockout screen is being used to 
identify the mechanisms of action of a compound with selective activity 
against the mesenchymal stem-like (MSL) subtype of TNBC. One gene per 
cell is knocked out by viral transduction of guide RNA (sgRNA). The cell 
population is treated with the compound of interest as a selection pressu-
re and sgRNAs are isolated and sequenced from surviving cells to iden-
tify gene disruptions that confer a survival advantage. A cytotoxin with no 
selectivity for the subtypes of TNBC is used as a control to discriminate 
genes that confer non-specific drug resistance, for example genes involved 
in apoptosis. The approach is expected to identify gene products critical for 
the sensitivity of MSL cells to the selective compound. This will inform on 
the compound’s mechanism of action and identify potential molecular tar-
gets that will be validated. Ultimately, these new targets will facilitate drug 
discovery for this challenging type of cancer. Funded by U01CA182740
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P-110
ACCURATE COMPOUND IDENTIFICATION OF 
COMPLEX TRADITIONAL HERBAL MEDICINE USING A 
NOVEL MASS SPECTROMETRY ACQUISITION METHOD 
Giorgis Isaac1, Jimmy Yuk1, Lee Gethings2, Rob Plumb1 and Rudolf Bauer3
1Waters Corporation, Milford, MA, USA; 2Waters Corporation, Wilmslow, 
UK; 3Department of Pharmacognosy, University of Graz, Graz, Austria
Yu Ping Feng San (YPFS) is a three herbs TCM formulation which has 
been traditionally used for treatment of immune system related diseases. 
The LC-MS data generated from such multiple herbs contain fragments 
from co-eluting multiple precursor ions. This makes the fragment data 
more complex and hence difficult to make correct compound identifica-
tion. Here we describe the application of a novel data independent acqui-
sition (DIA) approach called SONAR™ for improved spectral clarity and 
confident compound identification from a complex samples such as TCM. 
SONAR™ utilizes a low resolution quadrupole mass filter, which is scanned 
continuously and both precursor and MS/MS data are acquired. Data was 
also collected for comparison purposes using a traditional DIA method 
such as MSe which provides both precursor and fragment ion informati-
on but without a resolving quadrupole. From the results, the specificity of 
SONAR™ provides cleaner precursor and fragment ion spectra compared 
to the traditional DIA acquisition method. As an example, the identificati-
on of prim-O-glucosylcimifugin acquired using a traditional DIA and SO-
NAR™ was compared. When using the traditional DIA there are multiple 
co-eluting compounds which could confound the structural analysis.  The 
presence of these co-eluting precursor ions with prim-O-glucosylcimifugin 
provided a high complexity with 97 high energy fragment ions, making 
compound identification very complex and challenging. On the other hand 
when the data is acquired using SONAR™, cleaner precursor and fragment 
ion spectra were generated.  The selected narrow precursor mass window 
from SONARTM provided specific fragment ions and contains only the 
parent ions prim-O-glucosylcimifugin [M+H]+ and [M+Na]+. Eight clean 
relevant fragment ions generated only from the parent ion prim-O-gluco-
sylcimifugin which leads to correct and confident compound identificati-
on. In summary, compared to the traditional DIA method, the specificity of 
SONAR™ provides cleaner precursor and high energy fragment ion spectra, 
which results in confident compound identification.  
P-111
AUTHENTICATION OF AYURVEDIC HERBAL PRODUCTS 
AVAILABLE IN EUROPEAN MARKET USING DNA 
METABARCODING RAISES QUALITY CONCERNS
Gopalakrishnan Saroja Seethapathy1,2, Ancuta-Cristina Raclariu1, Jarl 
Andreas Anmarkrud1, Helle Wangensteen2, and Hugo J. de Boer1
1Natural History Museum, University of Oslo, P.O. Box 1172 Blindern, 
0318 Oslo, Norway, 2Department of Pharmaceutical Chemistry, School of 
Pharmacy, University of Oslo, P.O. Box 1068 Blindern, 0316 Oslo, Norway
Ayurveda is one of the oldest systems of medicine in the world, widely rec-
ognized as part of the complementary and alternative system of medicine. 
The growing commercial interest in Ayurvedic herbal products increases 
the incentive for adulteration and substitution in the medicinal plants mar-
ket. Such adulteration threatens the efficacy, safety and may seriously alter 
the consumer’s health. Most likely, fraudulent practices as the use of fill-
ers and plant materials of inferior quality is driven by the increasing level 
of consumption of herbal products which exceed the supply capacity for 
some plant species. Accidental substitutions may often occur, in addition 
to the deliberate fraudulent adulteration leading to an improper utilization 
of the plant material.  The quality of herbal products is directly reflected 
in their safety and efficacy, thereby proposing novel strategies to exhaus-
tively assess and monitor both the quality of the raw material and of the 
final marketed herbal product, is now a challenge in the herbal pharma-
covigilance. In this study we used DNA metabarcoding to authenticate the 
Ayurvedic products available on the European market, and to evaluate its 
feasibility to check the authenticity of the product. Seventy-nine Ayurvedic 
herbal products sold as tablets, capsules, powders and extracts were ran-
domly purchased via e-commerce and pharmacies in Europe, and analyzed 
using DNA metabarcoding approach. Our analysis reveals that only two 
out of 12 single ingredient products contained only one species, whereas six 
products contained the species listed on the label along with several other 
species, and four products did not contained any species listed on the label 
but contained several other species. Eight out of 27 multiple ingredient pro-
ducts, contained no species listed on the label, whereas the remaining 19 
products contained between of 1 to 5 of the species listed on the label along 
with many other species not specified on the label. The fidelity for single 
ingredient products was 67%, and the overall ingredient fidelity for multi 
ingredient products was 20% and for all products 23%. Also, detection of 
threatened species requiring conservation strategies raises concerns about 
illegal trade. The study highlights the necessity for quality control of the 
marketed herbal products, and shows that DNA metabarcoding is an effec-
tive analytical approach to authenticate complex multi ingredients herbal 
products. However, effort needs to be done to standardize the protocols 
for DNA metabarcoding for plant identification is necessary before this ap-
proach can be implemented as routine analytical approaches and approved 
by the competent authorities for use in regulated procedures.
P-112
PROGRESS TOWARD A BIOORTHOGONAL 
ALKYLATION PLATFORM: MODEL 
METHYLTRANSFERASE STUDIES
Brooke R. Johnson,1,2 Tyler D. Huber,1,2 Shanteri Singh,1,2,3 Jianjun Zhang,1,2,4 
Fengbin Wang,5,6 George N. Phillips Jr,5,7,8 and Jon S. Thorson1,2. 
1Center for Pharmaceutical Research and Innovation, University of 
Kentucky, Lexington, KY, 40536, USA; 2Department of Pharmaceutical 
Sciences, University of Kentucky, Lexington, KY, 40536, USA; current 
address: 3Department of Chemistry and Biochemistry, University 
of Oklahoma, Norman, OK, 73019, USA; current address: 4Alcami 
Corporation, Germantown, WI, 53022, USA; 5Department of Biosciences, 
Rice University, Houston, TX, 77251, USA; current address: 6Department of 
Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, 
VA, 22908, USA;  7Department of Biochemistry, University of Wisconsin-
Madison, Madison, WI 53706, USA;  current address: 8Department of 
Chemistry, Rice University, Houston, TX, USA
Methyltransferases (MTs) utilize S-adenosyl-L-methionine (AdoMet) 
as a cosubstrate and catalyze the methylation of nucleic acids, proteins, 
small molecules, macromolecules and natural products. These methylati-
on events are crucial for a number of important regulatory and metabolic 
reactions. These events are difficult to study, however, as MTs are highly 
prevalent within a cell, the AdoMet domains of which are highly conserved. 
Therefore, the development of bioorthogonal tools and strategies, which 
would allow us to study or exploit specific methylation events, would aid in 
our understanding of key biochemical reactions and further enable chemo-
enzymatic diversification of complex natural products. 
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CYTOTOXIC BISBENZYLISOQUINOLINE ALKALOIDS 
ISOLATED FROM THE LEAVES AND STEMS OF 
PACHYGONE ODORIFERA
Yulin Ren1, Austin A. Czarnecki2, Tran Ngoc Ninh3, Djaja D. Soejarto2,4, 
Joanna E. Burdette2, A. Douglas Kinghorn1.
1Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, 
The Ohio State University, Columbus, Ohio, USA. 2Department of Medicinal 
Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois 
at Chicago, Chicago, Illinois, USA. 3Institute of Ecology and Biological 
Resources, Vietnam Academy of Science and Technology, Hoang Quoc 
Viet, Cau Giay, Hanoi, Vietnam. 4Science and Education, Field Museum of 
Natural History, Chicago, Illinois, USA.
Bisbenzylisoquinoline alkaloids have been reported extensively for their 
promising antitumor potential. In a continuing search for anticancer agents 
from higher plants, a chloroform extract of the leaves and stems of Pachy-
gone odorifera Miers (Menispermaceae), collected in Vietnam, was found 
to be cytotoxic against the HT-29 colon, the MDA-MB-231 breast, the 
MDA-MB-435 melanoma, and the OVCAR3 ovarian human cancer cell 
lines. Fractionation of this extract guided by bioassay toward these cell lines 
yielded several new and known bisbenzylisoquinoline alkaloids. All these 
dimeric alkaloids contain a N,N’-dimethyl group and a methoxy group at 
the C-6 position, with two benzylisoquinoline alkaloid monomers connec-
ted through two oxygen bridges between the isoquinoline units and a single 
C-C linkage between the benzyl moieties. When tested toward the small 
panel of human cancer cell lines selected, all isolates obtained showed mo-
derate activity, with IC50 values in the range 3–10 µM. Investigation of these 
compounds and their activity showed that the configuration of the C-1 or 
C-1’ positions is not crucial for these bisbenzylisoquinoline alkaloids to 
mediate their cytotoxicity.
P-114
TOWARDS QUANTITATIVE SPATIAL PROFILING OF 
NATURAL PRODUCTS GINSENOSIDES FROM PANAX 
GINSENG ROOTS USING MASS SPECTROMETRY 
IMAGING
Bindesh Shrestha, Wei Rao, Giorgis Isaac, Jimmy Yuk, and Mark Ritchie
Waters Corporation, 34 Maple Street, Milford, MA 01757 
Panax ginseng C.A. Mey roots have been widely used as traditional herbal 
medicine in East Asia for several millennia. P. ginseng root contains diverse 
bioactive natural products, such as ginsenosides, that have been reported 
to show pharmacological effects on the tumor, immune system, diabe-
tes. Therapeutic utility of ginseng primarily depends on its ginsenosides 
contents. The effective use of ginsenosides requires profiling the types of 
ginsenosides and their quantitative distribution in ginseng roots. Mass 
spectrometry (MS) imaging is gaining momentum for profiling the spatial 
distribution of natural products in plant tissues. Here, we utilize desorption 
electrospray ionization (DESI) MS on a quadrupole Tof mass spectrom-
eter (Xevo G2-XS, Waters Corporation, MA, USA) to obtain the spatial 
distribution of ginsenosides within the ginseng root sections. The frozen 
transverse cross sections of the ginseng root at 20 μm thickness were pre-
pared for MS imaging. The MS image was plotted and analyzed by High 
Definition Imaging (HDI) software (Waters Corporation, MA, USA) at 100 
μm pixel size. MS images were overlaid with microscopic images to define 
regions of interest (ROI) for three sections in the root cross-section, perid-
erm, cortex, and stele. 
Fold-change analysis of ion counts in ROI of that section provided quan-
titative spatial distribution of the ginsenosides. Preliminary analysis shows 
ginsenosides Rg1/Rf were mostly found within the outer bark (periderm) 
and inner core (stele) of the root. While, ginsenosides Rd/Re Rs1/Rs2, 
Ra1/Ra2, and pseudoginsenoside Rc1 were more abundant in periderm. 
Ginsenoside Ra3 exhibited a diffuse distribution within the cross-section 
and a high concentration around the periderm. To distinguish between 
isomers, such as Rf/Rg1, tandem mass spectrometry (MS/MS) with DESI 
was employed. The characteristic separate fragmentation pattern showing 
monosaccharide or disaccharide group help discern between the spatial 
distributions of two ginsenosides. The spatial profile of ginsenosides may 
differ depending on the age, cultivar, year, geographic origin and quantita-
tive mass spectrometry imaging of ginsenosides from roots can be a helpful 
tool to study these variations.
Acknowledgement: Authors acknowledge the Institute of Chinese Materia 
Medica, China Academy of Chinese Medical Sciences in Beijing, China for 
generously proving the root samples.
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AN IMPROVED DEREPLICATION STRATEGY FOR 
NOVEL ACTIVE MARINE NATURAL PRODUCTS 
DISCOVERY
Jia-Xuan Yan,1 Fan Zhang1, Doug R. Braun,1 I-Wei Tsai,1 David R. Andes,2 
Kenneth Barns,3 Gene E. Ananiev3, and Tim S. Bugni1*.
1Pharmaceutical Sciences Division, University of Wisconsin–Madison, 
Madison, WI, 53705, USA, 2Department of Medicine, University of 
Wisconsin–Madison, Madison, WI, 53705, USA, 3Small Molecule Screening 
& Synthesis Facility, UW Carbone Cancer Center, Madison, WI, 53705, 
USA
Drug resistant infectious diseases continue to threaten global health as well 
as contemporary medical practices. There is an urgent call for novel anti-
biotics discovery. Mining novel sources, such as the marine bacteria, will 
clear the way for chemical and biological novelties. Our lab employed LC/
MS-principal component analysis (PCA) based strain selection followed by 
an automated, high-throughput LC/MS fractionation to generate marine 
bacterial natural product libraries for antimicrobial activities screening. 
Fractions with antibacterial or antifungal activities were analyzed by NMR 
and UHPLC/HRMS. The biological activity data and the spectroscopic 
data would provide information for dereplication efforts and further pu-
rification of active compounds. By utilizing this platform, a series of anti-
bacterial and antifungal compounds were discovered rapidly. Overall, our 
result highlights the advantages of applying modern analytical techniques 
in marine natural product libraries to accelerate novel antibiotics discovery.
P-116
DEVELOPMENT AND APPLICATION OF MAGNETIC 
MICROBEAD AFFINITY SELECTION SCREENING 
FOR NOVEL RETINOID X RECEPTOR-Α ANTI-
INFLAMMATORY AGENTS
Muchiri R, Rush M, Walker E, and Breemen RB.
Linus Pauling Institute, Oregon State University, Corvallis, Oregon.
With the aim of discovering new drugs, different methods have been deve-
loped to facilitate the screening of complex mixtures from natural products, 
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including for example, pulsed ultrafiltration mass spectrometry (PUF-MS) 
that was conceived in our lab. Though PUF-MS is superior to bioassay-
guided fractionation and the classical non MS-based bioassays that test 
compounds singly, its throughput is challenged by incompatibility with mi-
crotiter well plates and automation. Therefore, MS-based magnetic micro-
bead affinity selection screening (MagMASS) was designed and developed 
to overcome these challenges. The retinoid X receptor-α (RXR-α), a poten-
tial target for cancer treatment and prevention, and anti-inflammation was 
chosen to demonstrate the application of MagMASS. The protein-bound 
compounds from the extracts, after isolation using MagMASS, were analy-
zed by LCMS on a Shimadzu ion trap time-of-flight (IT-ToF) accurate mass 
tandem spectrometer. The MagMASS assay for RXR-α was developed with 
a throughput of at least 3 96-well plates per day which was an enhancement 
of over 100-fold compared to the previous PUF-MS RXR-α assay developed 
in our lab. Additionally, MagMASS was applied to screen complex mixtures 
of botanical extracts as well as synthetically derived compounds. New li-
gands of RXR-α were identified and characterized. The experimental details 
and results from this study will be presented.
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PREPARATIVE METABOLOMICS TO PROBE 
STRUCTURAL DIVERSITY OF RHODIOLA ROSEA BY 
COMBINED CPC, UHPLC, LC-MS, AND NMR
Yu Tang1,2, Bin Zhou2, Rasika S. Phansalkar3, Dejan Nikolic1,2, Richard 
B. van Breemen1,2,5, James B. McAlpine2,3, David C. Lankin1,2,4, Jonathan 
Bisson3,4, Guido F. Pauli1,2,3,4, and Shao-Nong Chen1,2,3,4
1UIC/NIH Center for Botanical Dietary Supplements Research, 2MCP, and 
3Inst. for Tuberculosis Research, 4CENAPT, College of Pharmacy, Univ. of 
Ill at Chicago, IL, USA; 5Linus Pauling Institute, Dept. of Pharmaceutical 
Sciences, College of Pharmacy, Oregon State Univ., Corvallis, OR, USA
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We are developing a combined analytical and preparative method using 
centrifugal partition chromatography (CPC), UHPLC, LC-MS, and NMR 
to analyze the metabolomic diversity of Rhodiola rosea phytoconstituents. 
This approach involves a proanthocyanidin (PAC) knock-out CPC proce-
dure, developed to remove the large amounts of PACs, which interfere with 
the analytical methods by causing UHPLC baseline issues and broad reso-
nances in 1H NMR spectra. Subsequently, 1D/2D NMR and qTOF experi-
ments were applied to investigate the PACs-free portion of the metabolome 
consisting of five types of compounds: phenylethanoid, phenylpropanoids, 
nitriles, flavonoids, and monoterpenes. Certain monoterpene glycosides 
were found to be sensitive to silica gel and their decomposition products 
were investigated. Collectively, this supports the use of liquid-liquid tech-
niques in preparative metabolomic analysis.
P-118
APPLICATION OF A PHYLOGENETIC-MOLECULAR 
NETWORKING STRATEGY TO IDENTIFY 
TRICHORMAMIDE-LIKE SECONDARY METABOLITES
Peter Sullivan, Wei-Lun Chen, Joanna Burdette, Jimmy Orjala
University of Illinois at Chicago, College of Pharmacy, Department of 
Medicinal Chemistry and Pharmacognosy, 833 South Wood St. Chicago, IL 
60612, United States
Cyanobacteria have emerged as a prominent source of biomedically rele-
vant natural products.  The accumulation of metabolites isolated from the 
phylum over the last few decades has resulted in the need to assess the nov-
elty of a compound at the onset of the drug discovery process to prevent 
rediscovery of known chemistry. Components extracted from UIC cya-
nobacterial strain 10484, found to be active against three cancer cell lines, 
were dereplicated by first identifying the taxonomic position of the strain 
using the 16S rRNA sequence.  The strain was found to clade with trichor-
mamide-producer UIC 10045.  Comparison of the MS/MS fragmentation 
profiles of the 10484 bioactive compounds to trichormamides using the 
Global Natural Products Social Molecular Networking (GNPS) platform 
confirmed the presence of novel trichormamide analogs.  Using 2D-NMR, 
MS/MS, and an advanced Marfey’s analysis, we were able to elucidate the 
structure of compounds found in the active HPLC subfractions. 
P-119
PURIFICATION OF PHENOLIC COMPOUNDS USING 
A COMBINATION OF FLASH AND PREPARATIVE 
CHROMATOGRAPHY
Jack E. Silver.
Teledyne ISCO, 4700 Superior Street, Lincoln, NE 68504, USA.
Phenolic flavonoids are common plant secondary metabolites. They occur 
as flavonoids, anthocyanidins, and anthocyanins. The interest in flavonoids 
is due to their anti-oxidant activity; they are also studied as potential nat-
ural food colorants that may also possess nutraceutical benefits. As the 
compounds are chemically similar to each other, obtaining pure material 
can be difficult. A simple three-step purification  procedure utilizing ion 
exchange chromatography for the initial separation, followed by purifica-
tion on polyamide resin, and final separation with C18 reverse phase chro-
matography is shown. The methanolic extract from Camellia sinensis, a rich 
source of phenolic flavonoids, is used as a model system for purification of 
these compounds.
P-120
A VALIDATED UNTARGETED METABOLOMICS 
METHOD FOR DIVERSITY SCREENING OF NATURAL 
PRODUCTS FROM ASTERACEAE
Annylory L. Rosa and Fernando B. Da Costa.
AsterBioChem Research Team, School of Pharmaceutical Sciences of 
Ribeirão Preto, University of São Paulo, 14040-903, Ribeirão Preto, SP, 
Brazil.
In natural products research, despite currently available state-of-the-art 
analytical techniques for the separation and detection of compounds, a 
bottleneck is to locate the desired or new compounds. The analysis of bio-
logical matrices remains a challenge while compound re-isolation is still a 
significant problem. LC-MS-based metabolomics combined with chemo-
informatics tools represent a rapid and efficient holistic approach for the 
large-scale analysis of plant material. In this work, we propose the develop-
ment and validation of an analytical methodology for diversity screening. 
Twelve compounds from a pure compound library were used to verify the 
efficiency and performance of reversed-phase UHPLC gradients. A full fac-
torial design, using extracts from 41 Asteraceae species, was used to select 
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chromatographic conditions. The resulting UHPLC-DAD-(ESI)-HRMS 
(Orbitrap) method was validated according to international analytical gui-
des. In total, 244 extracts were evaluated using this approach. As a result, 
a robust and efficient analytical method, which is capable of analyzing a 
broad range of secondary metabolites, was developed and their compound 
diversity could be verified by checking the similarity of known structures. 
This approach is also useful for finding novel compounds.
The authors are grateful for the financial support of the São Paulo Re-
search Foundation (FAPESP, grants #2014/26866-7, #2013/03024-8, and # 
2010/51454-3), CAPES, and CNPq.
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Chiral/achiral analysis of naturally occurring 
cannabinoids using a new sub-2 µm chiral 
stationary phase with ultra high performance 
SFC-MS
Melissa Wilcox1, Giulia Mazzoccanti2, Omar H. Ismail2, Alessia Ciogli2, 
Claudio Villani2, Francesco Gasparrini2
1Regis Technologies, Inc., 8210 Austin Avenue, Morton Grove, IL 60053, 
USA2Dipartimento di Chimica e Tecnologie del Farmaco - Sapienza 
Università di Roma, p.le Aldo Moro 5, 00185 Roma, Italy
The interest in the medical use of Cannabis Sativa L. is steadily increasing 
because of its therapeutic efficacy towards a wide variety of ailments, and 
its unique chemistry, characterized by the presence of cannabinoids that are 
concentrated in the female inflorescence. The fiber type of Cannabis Sativa 
L. has a low concentration of psychoactive (-)-Δ9-trans-tetrahydrocannab-
inol ((-)-Δ9-THC) that is typically less than 0.2%. The main cannabinoid 
in the fiber type of Cannabis Sativa L. is (-)-cannabidiol ((-)-CBD) but 
there is also (-)-cannabidivarin ((-)-CBDV), cannabigerol (CBG), cannabi-
nol (CBN) and the racemic cannabichromene (rac-CBC), each having var-
ious therapeutic actions. The analysis of the original composition of plant 
material is necessary for phenotype determination and quality control of 
medicinal cannabis used in therapeutic treatments.
The presence of natural racemic compounds (rac-CBC) in plant extract was 
investigated using Chiral Stationary Phases (CSPs) with Ultra High Per-
formance Supercritical Fluid Chromatography (UHPSFC). The Chiral Sta-
tionary Phase (CSP) allowed resolution of the racemic compound cannab-
ichromene (rac-CBC) in plant extract and the synthetic racemic (+/-)-Δ9-
trans-tetrahydrocannabinol. Good separation, in terms of chemio- and 
enantio- selectivity, was obtained with high resolution for all cannabinoids, 
and their acid forms, under isocratic conditions.
P-122
CHIRAL CHROMATOGRAPHIC RESOLUTION OF 
RACEMIC TERPENOIDS USING SFC WITH A TRIS-(3,5-
DIMETHYLPHENYL) CARBAMOYL AMYLOSE COATED 
STATIONARY PHASE
Melissa Wilcox, Ted Szczerba, Jeffrey Wheeler, Edward Franklin
Regis Technologies, Inc., 8210 Austin Avenue, Morton Grove, IL 60053, USA
Terpenes and terpenoids are secondary metabolites produced by a variety 
of plants and consist of two or more five-carbon isoprene units.  They are 
major constituents of essential oils, which are often used in fragrances and 
aromatherapies, and both natural and synthetic derivatives have been used 
as flavors in food additives.  Additionally, many terpenoids have shown a 
diverse range of biological activities, including anti-bacterial, anti-fungal, 
anti-viral, anti-imflammatory, anti-tumoral, and immunomodulatory 
functions.
Both enantiomeric forms of a particular terpenoid are often naturally oc-
curring, with each eliciting distinct biological responses.  For example, (R)-
(-)-linalool, known as licareol, has a woody, lavender-like scent, while (S)-
(+)-linalool, or coriandrol, has a sweet, floral aroma.  As such, enantiomeric 
profiling of terpenes in natural products is potentially important for both 
product formulation as well as cultivar determination.
Herein, the chromatographic resolution of two different naturally occur-
ring enantiomeric terpenoids, linalool and terpinen-4-ol, is shown on 
an analytical scale using supercritical fluid chromatography (SFC) and a 
polysaccharide coated chiral column [tris-(3,5-dimethylphenyl) carbamoyl 
amylase].  A small-scale purification of 250 mg of racemic linalool is also 
demonstrated.
P-123
APPLICATION OF CERTIFIED REFERENCE MATERIAL 
(CRM) IN NATURAL PRODUCTS
Shibiao Wu, Nick Hauser, Jenna Milliken, Andy Ommen, Christopher 
Rucinski
MilliporeSigma, 2931 Soldier Springs Rd, Laramie, WY 82070
MilliporeSigma Pharmaceutical Secondary Standards are Certified Refer-
ence Materials (CRM) that are considered to provide the highest level accu-
racy, uncertainty, and traceability to an SI unit as well as direct traceability 
to a Compendial Standard or other Primary Standard when available. In 
this presentation, we describe the best practices followed to accurately qual-
ify these Reference standards including mass balance approach and assay 
calculation by direct comparison techniques in these reference standards. 
The full characterization of the material for use as a Reference Standard 
gives confidence to the measured results for its intended purpose. Also, 
Snap-N-Shoot® reference solutions and mixes for common botanicals and 
other dietary supplements are available for improving laboratory efficien-
cy. These CRMs are prepared and certified to the highest industry stan-
dards including ISO Guide 34 and ISO/IEC 17025 and are accompanied by 
a comprehensive Certificate of Analysis which includes, as appropriate, a 
traceable assay and a mass balance assignment including water determina-
tion, residue analysis, and residual solvents. Additionally, the COA provides 
qualitative data for identity confirmation such as LC-QTOF-MS, optical ro-
tation, FTIR and NMR. This combination of a comprehensive COA and 
user-friendly CRMs  are highly applicable to the analytical requirements 
in phytochemical identification, minor component quantification, dietary 
supplement and food analyses, positive/negative control, and in vivo/vitro 
bioactivity tests. 
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ABSOLUTE STEREOSTRUCTURES OF CYCLOPENTA[G]
INDOLES FROM THE WEST AUSTRALIAN SPONGE 
TRIKENTRION FLABELLIFORME BY NMR AND ECD
Mariam N. Salib1, and Tadeusz F. Molinski1,2
1Department of Chemistry and Biochemistry, 2Skaggs School of Pharmacy 
and Pharmaceutical Sciences, University of California, San Diego, 9500 
Gilman Drive, La Jolla, California 92093-0358
Six new cyclopenta[g]indoles, trans-herbindole A (1), trikentramides E-H 
and I (2), were isolated from the sponge Trikentrion ﬂabelliforme collected 
in Exmouth Gulf, and their structures were elucidated by integrated spec-
troscopic analysis. Accurate scalar couplings (J) of the deceptively simple 
H-8 methine multiplet of 1 were secured through analysis of the resolution-
enhanced 1H NMR signal and simulations. The absolute configurations of 
the new compounds were established through interpretation of [a]D, ECD 
and comparison with known analogues. Chemical interconversion of five 
of the natural products reveal their stereochemical uniformity. A hypothe-
tical non-tryptophan biosynthesis is proposed based on a polyketide syn-
thase and pyrrole-2-carboxylic thioester as the starter unit.
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COMPREHENSIVE SPECTROSCOPIC 
CHARACTERIZATION OF A NEW FUSICOCCANE 
DITERPENE: APPLICATION OF NEW NMR STRUCTURE 
ELUCIDATION TOOLS 
Dongdong Wang1, Emily Smith1, David Durrant2, Deborah Morrison2, 
Robert H. Cichewicz3, Gary E. Martin4, Curtis J. Henrich1, Kirk R. 
Gustafson1, and John A. Beutler1
1Molecular Targets Program, CCR, NCI-Frederick. 2Laboratory of Cell and 
Developmental Signaling, CCR, NCI-Frederick 3Natural Products Discovery 
Group, University of Oklahoma 4Structure Elucidation Group, Process and 
Analytical Research and Development, Merck & Co. Inc.
A high-throughput screening assay for RAS/RAF pathway inhibitors iden-
tified a cultured fungal extract as a hit for further chemical investigation. 
Bioassay-guided isolation led to several different compound classes, in-
cluding new fusicoccane-type diterpenoids. In addition to conventional 2D 
NMR analyses, new NMR pulse sequences and experimental approaches 
were employed to assign and confirm the structure of compound 1. These 
included newly described pulse sequences such as LR-HSQMBC, which 
effectively extends the range of heteronuclear correlations to 4JCH, and 
1,1-HD-ADEQUATE, which provides the functional equivalent of unam-
biguous 2JCH correlations. Anisotropic NMR parameters such as residual 
chemical shift anisotropy (RCSA) and residual dipolar coupling (RDC) 
provide a powerful and complementary means to assign new small mol-
ecule structures. Anisotropy measurements are possible when compounds 
partially align within a gel or liquid crystaline medium. We obtained RCSA 
data for 1 in PBLG, a new liquid crystal that enhances molecular alignment 
and thus increases the RCSA values. Large RCSAs resulting from stronger 
molecular alignment improve structural analysis, especially in compounds 
rich in sp3-hybridized carbons. In addition to confirming the proposed 
structure of 1, RCSA data was particularly effective for assigning the rela-
tive configuration of a hemiketal carbon that was problematic to assign by 
other means.
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BIG-SCAPE/CORASON GENOME DATBASE MINING 
REVEALS NOVEL DETOXINS
Michael W. Mullowney1, Jorge C. Navarro-Muñoz2, Nelly Selem-Mojica3, 
Luciana Teresa Dias Cappelini1, James H. Tryon1, Satria Kautsar2, Elizabeth 
Parkinson4, Emmanuel L.C. De Los Santos5, William W. Metcalf4, Francisco 
Barona-Gomez3, Marnix H. Medema2, Regan J. Thomson1, and Neil L. 
Kelleher1
1Dept. of Chemistry, Northwestern University, Evanston, IL, 2Bioinformatics 
Group, Wageningen University, Wageningen, The Netherlands, 3Langebio, 
Guanajuato, Mexico, 4Institute of Genomic Biology, University of Illinois, 
Urbana, IL, 5Warwick Integrative Synthetic Biology Centre, University of 
Warwick, Coventry, United Kingdom
Using BGC identification tools in a new workflow with BiG-SCAPE and 
CORASON for gene cluster relatedness and phylogenomic analysis, respec-
tively, we mined a large actinomycete genome library to identify two new 
detoxin biosynthetic gene cluster subfamilies and discover three novel de-
toxin analogs. Detoxin N1 was purified, then characterized using metabolic 
labeling, tandem MS, and NMR, while detoxins P1 and P2 were identified 
using metabolic labeling and tandem MS.
P-127
SAR OF PENTACYCLIC TRITERPENES AND THEIR 
CYTOTOXICITY AND NF-ΚB AND MITOCHONDRIAL 
TRANSMEMBRANE POTENTIAL (MTP) INHIBITORY 
EFFECTS
Yulin Ren1, Gerardo D. Anaya-Eugenio1, Austin A. Czarnecki2, Chunhua 
Yuan3, Hee-Byung Chai1, Djaja D. Soejarto2,4, Joanna E. Burdette2, 
Esperanza J. Carcache de Blanco1, A. Douglas Kinghorn1
1Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, 
The Ohio State University, Columbus, Ohio, USA. 2Department of Medicinal 
Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois 
at Chicago, Chicago, Illinois, USA. 3Campus Chemical Instrument Center, 
The Ohio State University, Columbus, Ohio, USA. 4Science and Education, 
Field Museum of Natural History, Chicago, Illinois, USA.
Pentacyclic triterpenes of plant origin are attracting increasing interest, 
owing to their promising bioactivities. In a continuing search for antican-
cer agents from higher plants, (+)-ursolic acid was characterized as the 
main active compound from Syzygium corticosum (Lour.) Merr. & Perry 
(Myrtaceae), which showed potent NF-κB inhibitory activity, with an IC50 
value of 31 nM. Several (+)-ursolic acid analogues have been prepared in 
the present study, and their bioactivities were evaluated. A preliminary 
structure-activity relationship (SAR) study indicated that the substitution 
of the 19,20-dimethyl group plays a key role for (+)-ursolic acid to medi-
ate its cytotoxicity and NF-κB and mitochondrial transmembrane potenti-
al (MTP) inhibitory effects, and these activities were decreased greatly by 
esterification of the C-3 hydroxy group with 4-chlorobenzoic acid or reduc-
tion of the C-28 carboxy group to a primary alcohol. In addition, this same 
reduction increased the cytotoxicity of (+)-oleanolic acid and (+)-betulinic 
acid but decreased considerably the NF-κB and MTP inhibition of both 
compounds. Interestingly, esterification of the C-3 hydroxy group with a 
ferulic acid unit increased greatly the MTP inhibition of (+)-betulinic acid.
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PROBING DEVELOPMENTAL AND REPRODUCTIVE 
TOXICITY OF BOTANICALS USING IN VITRO 
TECHNIQUES
Karen M. VanderMolen1, Jorge Naciff2, Yuching Shan2, George P. Daston2, 
Timothy R. Baker3, Catherine Mahony4
1Global Product Stewardship, The Procter & Gamble Company, Winton 
Hill Business Center, 6110 Center Hill Ave, Cincinnati OH 45232, 2Global 
Product Stewardship, The Procter & Gamble Company, Mason Business 
Center, 8700 Mason-Montgomery Rd, Mason OH 45040, 3Research and 
Development, Corporate Functions Analytical, The Procter & Gamble 
Company, Mason Business Center, 8700 Mason-Montgomery Rd, Mason 
OH 45040, 4Global Product Stewardship, Procter & Gamble Company 
Technical Centres Ltd, Egham, Surrey, TW20 9NW, United Kingdom
As complex mixtures, botanicals present unique challenges when assessing 
safe use, particularly when endpoint gaps exist that cannot be fully resolved 
by existing toxicological literature. Obtaining data for developmental and 
reproductive toxicity can be particularly difficult, and so a weight of evi-
dence strategy for these endpoints is illustrated here which utilizes new in 
vitro approaches. Both receptor binding assays and gene expression studies 
have been explored as tools to inform on modes of action. Several extracts 
of both botanicals suspected to have reproductive effects and herbs with a 
significant history of use were tested against a suite of receptors and enzyme 
activity assays at biologically relevant doses to probe developmental and re-
productive activity at a molecular level. Additionally, gene expression chan-
ges in different cell types were analyzed using the connectivity mapping ap-
proach to identify major modes of action through a functional read-across 
approach. Together, these two data streams have been shown to increase 
confidence in predictions of botanical biological mode of action, and allow 
for assessment of relative potency in the decision-making process. 
P-129
QUANTITATIVE ANALYSIS OF SALVIA CIRCINATA 
AQUEOUS EXTRACT
Isabel Rivero, Laura Flores Bocanegra, and Rachel Mata
Facultad de Química, Universidad Nacional Autónoma de México, Mexico 
City 04510, Mexico
Salvia circinata Cavanillesii (Lamiaceae) is a medicinal Mexican plant wi-
dely commercialized for the treatment of diabetes, ulcers and parasites. Re-
cently the antidiabetic potential was confirmed using in vivo and in vitro 
experiments. Herein, a suitable validated UPLC−ESI/MS method to quan-
tify the most relevant active principles, amarisolide (1) and pedalitin (2), is 
described. UPLC analyses were carried out using a C18 column, a gradient 
elution [(H2O + 0.1% formic acid) and CH3CN] and a flow rate of 0.3 mL 
min−1. Detection wavelength was set at 270 and 330 nm and with an elec-
trospray source in negative mode. The method was successfully validated in 
terms of linearity, accuracy and precision. 
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UNEQUIVOCAL DETERMINATION OF A BREITFUSSIN 
ANALOG BY NMR ANISOTROPIC MEASUREMENTS
Ikenna E. Ndukwe,1 Yizhou Liu,2 Ryan D. Cohen,1 Colin Lam,1 Kirill A. 
Blinov,3 Edward R. Sherer,1  R. Thomas Williamson,1 Johan Isaksson1 and 
Gary E. Martin1
1 Process and Analytical Research and Development, Merck & Co., Inc., 
Rahway, NJ 07065. 2Analytical Research and Development, Pfizer, CT 
06340. 3MestReLab Research S. L., Santiago de Compostela, A Coruna, 
15706 Spain
Structural characterization of breitfussin analogs and compounds with si-
milar molecular features – vis-a-vis flat, sp2-hybridized, proton-deficient 
heterocycles – has been accomplished in the past by a combination of ana-
lytical/computational techniques including NMR spectroscopy, mass spec-
trometry (MS), Computer-Assisted Structure Elucidation (CASE) program 
utilization, DFT calculations and atomic force microscopy (AFM). The 
challenge of unequivocally determining the structure of the breitfussins 
by traditional NMR methodologies is exacerbated by the iodo-substituted 
oxazole ring. The molecules lack the requisite long-range heteronuclear 
correlations to enable unambiguous determination of its constitution while 
DFT calculation of carbon chemical shifts is adversely impacted by the rela-
tivistic effect of the iodine. Herein, we show the utility of NMR anisotropic 
measurements – Residual Dipolar Coupling (RDC) and Residual Chemical 
Shift Anisotropy (RCSA) – for the unambiguous constitutional definition 
of the breitfussin analogs.
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ADVANCES IN HIGH-THROUGHPUT AFFINITY 
EXTRACTION MASS SPECTROMETRY FOR 
CHARACTERIZING ACTIVE COMPOUNDS IN NATURAL 
PRODUCT MIXTURES
Richard B. van Breemen
Linus Pauling Institute, Oregon State University, 305 Linus Pauling Science 
Center, Corvallis, OR 97331
As faster alternatives to bioassay-guided fractionation, various affinity extrac-
tion mass spectrometry methods such as pulsed ultrafiltration (van Breemen 
1987), gel permeation chromatography (Kaur 1987) and magnetic microbead 
affinity selection (Choi and van Breemen, 2008) have been used for years for 
the isolation, characterization and identification of pharmacologically active 
compounds in complex natural product mixtures such as botanical and mi-
crobial extracts. Often requiring manual sample handling and data analysis, 
we enhanced the productivity of these MS-based methods by incorporating 
multichannel well plate format, automated sample preparation, substituting 
UHPLC for HPLC, and automating data analysis using metabolomics soft-
ware. Although all MS-based affinity selection screening approaches can 
benefit from the application of metabolomics software for data analysis and 
fast UHPLC, magnetic microbead affinity selection screening (MagMASS) 
was particularly compatible with automated multi-well plate technology. To-
gether, the application of these improvements enhanced the throughput of 
MagMASS mass spectrometry for natural products screening by over 100-
fold in applications using the estrogen receptors ER-alpha and ER-beta, RXR, 
lipoxygenase, and fructose-1,6-bisphosphatase.
Poster Presentations
77Abstracts | 2018 Annual Meeting of the ASP | July 21-25, 2018 | Lexington, Kentucky, USA
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ASSESSING THE EFFICIENCY OF CULTIVATION 
TECHNIQUES TO RECOVER NATURAL PRODUCT 
BIOSYNTHETIC GENE POPULATIONS FROM 
SEDIMENT.
Maryam Elfeki1, Mohammad Alanjary2, Stefan J. Green3, Nadine Ziemert2, 
Brian T. Murphy1
1Dept. of Medicinal Chemistry and Pharmacognosy, Center for Biomolecular 
Sciences, College of Pharmacy, 3DNA Services Facility, University of Illinois 
at Chicago, Chicago, IL 60607; 3Dept. Microbiology and Biotechnology, 
University of Tübingen, Auf der Morgenstelle 28, 72076 Tübingen, Germany
Despite decades of cultivating microorganisms for use in drug discovery, few 
attempts have been made to measure the extent to which common cultiva-
tion techniques have accessed existing chemical space. Metagenomic studies 
have shown that cultivable bacteria represent a fraction of those that exist in 
the environment, and that uncultivated populations in sediment have genes 
that encode for a high diversity of novel natural product (NP) biosynthetic 
enzymes. Quantifying these genes in both sediment and cultivatable bacteri-
al populations allows us to assess how much diversity is present on nutrient 
agar and is critical to guiding the trajectory of future NP discovery platforms. 
Herein we employed next generation amplicon sequencing to assess the NP 
biosynthetic gene populations present in two Lake Huron sediment samples, 
and compared these with populations from their corresponding cultivatable 
bacteria. We highlight three findings from our study: 1) after cultivation, we 
recovered between 7.7% and 23% of three common types of NP biosynthetic 
genes from the original sediment population; 2) between 76.3% and 91.5% 
of measured NP biosynthetic genes from nutrient agar have yet to be charac-
terized in known biosynthetic gene cluster databases, indicating that readily 
cultivatable bacteria harbor potential to produce new NPs; 3) even though 
the predominant taxa present on nutrient media represented some of the ma-
jor producers of bacterial NPs, the sediment harbored a significantly greater 
pool of NP biosynthetic genes that could be mined for structural novelty, and 
these likely belong to taxa that typically have not been represented in micro-
bial drug discovery libraries. 
P-133
ISOLATION OF NEW CASTANOPSININS FROM THE 
LEAVES OF CASTANOPSIS SIEBOLDII
Hyunwoo Kim and Sang Hyun Sung
College of Pharmacy and Research Institute of Pharmaceutical Sciences, 
Seoul National University, Gwanak-gu, Seoul 08826, Republic of Korea.
Castanopsis sieboldii (Fagaceae) is a species of evergreen tree that is widely 
distributed in East Asia. Castanopsis species has characteristic secondary 
metabolites, castanopsinins, which are the novel triterpene glycosides con-
taining a hexahydroxydiphenic acid (HHDP) group. They have only been 
isolated from castanopsis species, so these compounds are considered as 
chemotaxonomic makers for castanopsis species. In a search for this type 
of compounds from C. sieboldii, two new compounds, castanopsinins J (1) 
and K (2) were isolated. The structures of 1 and 2 were elucidated by inter-
preting their NMR, HRESIMS, and ECD spectra.
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NEUROPROTECTIVE EFFECT OF METHANOL EXTRACT 
OF ANNONA MURICATA IN HT22 CELLS
Ye Lim Son1, Lee Hyeon Woo1, Ma Choong Je1,2
1Department of Medical Biomaterials Engineering, College of Biomedical 
Science, Kangwon National University, Chuncheon 24341, Republic 
of Korea; 2Institute of Bioscience & Biotechnology, Kangwon National 
University, Chuncheon 24341, Republic of Korea
Annona muricata lives in tropics. It is known to be effective in anticancer, 
antioxidant properties, and strengthens immunity. Glutamate is an excita-
tory neurotransmitter, but excessive amounts of glutamate cause oxidative 
stress. And if oxidative stress causes damage to brain cells. The objective 
of this study was to establish the neuroprotective effect of 80% methanol 
extracts of Annona muricata. In this experiment, extracts of Annona mu-
ricata reduce the Ca2+, ROS levels and keep up the level of mitochondrial 
membrane potential. These results led to decrease the glutamate induced 
cell death. Annona muricata significantly subsist at the cell viability test, as a 
result Annona muricata seems to have a neuroprotective effect in HT22 cell. 
P-135
PROTECTIVE EFFECT OF METHANOL EXTRACT OF 
ORIGANUM VULGARE IN HT22 CELL
Ye Lim Son1, Lee Hyeon Woo1, Ma Choong Je1,2
1Department of Medical Biomaterials Engineering, College of Biomedical 
Science, Kangwon National University, Chuncheon 24341, Republic 
of Korea; 2Institute of Bioscience & Biotechnology, Kangwon National 
University, Chuncheon 24341, Republic of Korea
Origanum vulgare is a herb used as spice in Italian, Mexican and Spanish 
cuisine. Origanum vulgare contains a phenolic component, phenols have 
antioxidant, antibacterial, blood pressure reduction effect. Glutamate, an 
excitatory neurotransmitter, causes oxidative stress when released in large 
amounts. It leads to brain cell damage. This experiments showed Origanum 
vulgare rebating the level of intracellular ROS, Ca2+ and maintaining the 
mitochondrial membrane potential level. As a result, the glutamate indu-
ced cell death is decreased in HT22 cell. The purpose of this study was to 
identify the neuroprotective effect of 80% methanol extract of Origanum 
vulgare. It was effective at the cell viability test. Consequently, We confirm 
that Origanum vulgare has neuroprotective effect in HT22 cell. 
P-136
MEMORY IMPROVEMENT EFFECT OF METHANOL 
EXTRACT OF MAGNOLIA DENUDATA IN THE 
SCOPOLAMINE-INDUCED AMNESIA MOUSE MODEL
Ye Lim Son1, Hyeon Woo Lee1, Choong Je Ma1,2
1Department of Medical Bio Engineering, College of Biomedical 
science, Kangwon National University. Chuncheon 24341, Republic 
of Korea,2Institute of Bioscience & Biotechnology, Kangwon National 
University, Chuncheon 24341, Republic of Korea.
Magnolia denudata is known to have anti-oxidant, anti-inflammatory, anti-
cancer effect. But it has not been reported that it has memory improvement 
effect. We experimented whether the methanol extract of Magnolia denu-
data (50, 100 or 200 mg/kg) could improve memory improvement effect 
in scopolamine induced amnesia mouse model using the Morris water 
maze test and passive avoidance test. In the Morris water maze test, the 
extract of Magnolia denudata improved the impairment of memory ability 
by scopolamine. As well as it made cognitive dysfunction in mice better. 
These results show that methanol extract of Magnolia denudata decrease 
the cognitive dysfunction caused by scopolamine. Consequently, We expect 
that methanol extract of Magnolia denudata can be useful for improving 
memory impairment.
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INFLUENCE OF AÇAÍ BERRY CONSTITUENTS ON 
CELLULAR PROTECTION AND APOPTOSIS IN HEPG2 
CELLS: TO DEFEND OR SURRENDER.
Thomas Siff1, Bryan Berguson1, Noelle Addair1 Suneel Kandagatla2, José 
Rivera-Chávez2, Tyler N. Graf2, Nicholas H. Oberlies2, Gregory M. Raner1
1Department of Biology and Chemistry, Liberty University,  Lynchburg, VA 
24515, USA, 2Department of Chemistry and Biochemistry, The University of 
North Carolina at Greensboro, Greensboro, NC 27402
The Brazilian açaí berry (Euterpe oleracea) is one of the most highly mar-
keted and consumed natural products world-wide, with a projected market 
value of over $2 billion by 2025.  A variety of health benefits have been attri-
buted to this superfruit, however, studies linking these proposed effects to 
specific biochemical pathways are lacking.  Using an activity guided fractio-
nation approach, we have identified several compounds with distinct effects 
on biochemical pathways related to anti-oxidant activity, xenobiotic meta-
bolism and apoptosis in human hepatoma cells.  One of these compounds, 
a flavonoid called diosmetin, is active in multiple biochemical assays, which 
suggests a potential coordinated influence on cell death and protective pa-
thways in the cell.  This compound is an attenuator of the Nrf2 antioxidant 
pathway in human liver cells and has modest pro-apoptotic activity at low 
micromolar concentrations.  It is also a nanomolar inhibitor of several dif-
ferent human cytochrome P450 enzymes and appears to reduce induction 
of CYP enzymes following treatment with β-naphthoflavone. Combined, 
these findings present a coordinated biochemical model that may provide 
a missing element in our understanding of the true health effects of this 
popular product.
P-138
BIACTIVE COMPOUNDS ISOLATED FROM EPICOCCUM 
NIGRUM NFW7, AN ENDOPHYTIC FUNGUS FROM 
TAXUS FUANA.
Gerardo D. Anaya-Eugenio1, Hira Mehboob Mirza1, Safia Ahmed2, Masoom 
Yasinzai3, Esperanza J. Carcache de Blanco1
1Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, 
The Ohio State University, Columbus, Ohio, USA. 2Department of 
Microbiology, Quaid-i-Azam University, Islamabad, Pakistan. 3SA-CIRBS, 
International –Islamic University, Islamabad, Pakistan.
Endophytic fungi represent an important source of natural products with 
medicinal properties. In the present work, the endophytic fungus Epicoc-
cum nigrum was isolated from the plant Taxus fuana. Seven compounds 
were isolated from the ethyl acetate extract that showed growth inhibition 
against PC-3 prostate cancer cells. Structure identification and elucidation 
was completed using spectroscopy techniques (1D-NMR 1H and 13C, and 
2D-NMR such as HMBC, HSQC, COSY, and DEPT). Two compounds 
have been fully identified and tested, including ergosterol-5α, 8α-peroxide 
(1) and oleic acid (2), which have previously been reported with potenti-
al anticancer properties1-2. The anti-proliferative activity of all compounds 
isolated will be evaluated against a panel of cancer cell lines. They will also 
be tested against target-based assays such as NF-κB and mitochondrial 
trans-membrane potential (MTP).
      
P-139
SYNTHESIS AND BIOACTIVITY EVALUATION OF 
MILIUSANE ANALOGUES
Yu Zhu, Yi-Fu Guan, Ming-Yu Ye, Ni Shi, Siu Wai Tsang, and Hong-Jie 
Zhang*
School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, 
P.R. China.
Miliusanes are a cluster of compounds with a skeleton containing 18 car-
bons. They were identified from the Miliusa plants (Annonaceae), and 
showed cytotoxic activities against a panel of cancer cell lines (Zhang et al., 
J. Med. Chem. 2006, 49:693-708). To elucidate the structure-activity rela-
tionship (SAR), we have synthesized miliusane analogues by modifying the 
functional groups of the miliusane structures. Due to the bioactivity poten-
cy and structural novelty of this type of compounds, we have further car-
ried out total synthesis of miliusane-like compounds (Scheme 1). The bi-
ological activities of the synthetic compounds have been evaluated against 
different disease targets. Acknowledgements: The work described in this pa-
per was supported by the Research Grant Council of the Hong Kong Special 
Administrative Region, China (Project No. HKBU 12103014), the Hong Kong 
Baptist University (HKBU) Interdisciplinary Research Matching Scheme (RC-
IRMS/15-16/02) and the Hong Kong Baptist University, Knowledge Transfer 
Office, Matching Proof-of-Concept Fund (MPCF-003-2017/18).
OPG
O
HO
OH
OH
HO COOH
1a 1b
O
HO
O
O
Miliusane
OH
OPG
O
OR1
OR3
O
6 steps
R2
1c
(A)
(B)
 
Scheme 1. A) Synthetic design of the miliusane-like compounds. B) 
D-(-)-quinic acid (1a) was used as the starting compound toward the to-
tal synthesis. Through the key intermediate 1b, a series of miliusane-like 
compounds (1c) were synthesized.
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CHEMICAL COMPOSITION OF ESSENTIAL OILS, 
BIOLOGICAL ACTIVITY AND SECRETORY STRUCTURES 
OF SPECIES OF BACCHARIS FROM BRAZIL
Jane M. Budel1, Mei Wang2, Vijayasankar Raman2, Jianping Zhao2, Shabana 
I. Khan2, Junaid U. Rehman2, Luciane M. Monteiro1, Gustavo Heiden3, 
Paulo V. Farago1, Ikhlas A. Khan2
1Department of Pharmaceutical Sciences, State University of Ponta Grossa, 
Paraná, Brazil. 2National Center for Natural Products Research, School of 
Pharmacy, University of Mississippi, University, MS, USA, 3Embrapa Clima 
Temperado, Pelotas, RS, Brazil.
Chemical composition and biological activities of essential oils, and anat-
omy of leaves and stems of Baccharis microdonta, B. pauciﬂosculosa, B. 
punctulata, B. reticularioides, and B. sphenophylla growing in Brazil were 
studied. The essential oils extracted by hydrodistillation were analyzed by 
GC/MS and evaluated in vitro for their antimalarial and insecticidal activ-
ities. Anatomical analysis was performed by the usual light and scanning 
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microtechniques. Analyses of the essential oils from the five species showed 
significant differences in their chemical compositions. Some compounds 
are unique to some species hence can be used as chemical markers for spe-
cies identification. The major compounds of the essential oils were spathu-
lenol (23.27%) and kongol (22.43%) in B. microdonta, β-pinene (18.31%) 
and limonene (18.75%) in B. pauciﬂosculosa, α-bisabolol (23.63%) in B. 
punctulata, α-pinene (24.47%) in B. reticularioides, and β-pinene (15.20%), 
limonene (14.50%) and spathulenol (13.11%) in B. sphenophylla. Baccharis 
pauciﬂosculosa, B. reticularioides and B. sphenophylla exhibited antimalar-
ial activities. Baccharis microdonta and B. punctulata showed cytotoxicity. 
None of the oils showed insecticidal toxicity to bed bug assessed in using 
three different bioassays except B. sphenophylla with 66.67% and 83.33% 
mortality in insecticide resistant strain ‘Bayonne’ and susceptible strain‘Ft.
Dix’, respectively, only in fumigation bioassay at 250µg/125 mL of air. The 
vegetative aerial parts of all the five species showed glandular trichomes 
and ducts as secretory structures. This study was supported by Capes and 
Araucária Foundation (Brazil).
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NATURAL PRODUCTS FROM AUSTRALIAN 
CELASTRACEAE PLANTS AND THEIR LEUCINE 
TRANSPORT INHIBITION IN PROSTATE CANCER CELLS
Mario Wibowo,1 Qian Wang,2 Jeff Holst,2 Jonathan M. White,4 Andreas 
Hofmann,1 Rohan A. Davis1
1Griffith Institute for Drug Discovery, Griffith University, Brisbane, QLD 
4111, Australia, 2Centenary Institute, University of Sydney, Camperdown, 
NSW 2050, Australia, 4School of Chemistry and Bio21 Institute, The 
University of Melbourne, Melbourne, VIC 3010, Australia.
Australian endemic plants have been superficially explored for both their 
chemistry and pharmacology. Thus, the use of this unique bioresource for 
drug discovery and chemical biology research holds great promise for the 
identification of biologically active natural products. The Celastraceae fam-
ily is widely found in tropical and subtropical parts of the world, with some 
of the species endemic to Australia. These plants are a source of diverse 
chemical compounds with various bioactivities, one of which is inhibition 
of L-type amino acid transporters (LATs). This interesting biological activity 
has been recently identified during our research. LATs uptake neutral ami-
no acids such as leucine into cells and are vital for protein synthesis as well 
as stimulating the mammalian target of rapamycin complex 1 (mTORC1) 
signalling pathway. The mTORC1 pathway is a central regulator of cell pro-
liferation, growth, and metabolism. The LAT family is expressed in both 
normal and cancer cells, however the expression levels of LAT family mem-
bers are upregulated in various human cancers, including prostate cancer. 
Leucine plays an important role as a rate-limiting signalling molecule in the 
mTORC1 pathway; therefore, targeting LATs by inhibiting leucine uptake 
affects cancer. Accordingly, the inhibition of leucine transporters may be a 
novel therapeutic approach for treating a variety of cancers. This presenta-
tion will cover the chemical and pharmacological aspects of dihydro-β-aga-
rofurans from several Australian endemic Celastraceae plants.
P-142
CYTOTOXIC ANTHRACENONE C-GLYCOSIDES 
ISOLATED FROM THE LEAVES AND TWIGS OF 
ALVARADOA AMORPHOIDES
Yulin Ren1, Hee-Byung Chai1, Djaja D. Soejarto2,3, Juan Jose Castillo4, A. 
Douglas Kinghorn1
1Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, 
The Ohio State University, Columbus, Ohio, USA. 2Department of Medicinal 
Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois 
at Chicago, Chicago, Illinois, USA. 3Science and Education, Field Museum 
of Natural History, Chicago, Illinois, USA. 4Facultad de Agronomia, 
Universidad de San Carlos de Guatemala, Guatemala.
Previously, several anthracenone C-glycosides were isolated from the lea-
ves of Alvaradoa haitiensis Urb. (Simaroubaceae), and they were found to 
be potently cytotoxic against KB human oral epidermoid cancer cells. In a 
continuing search for anticancer agents from higher plants, a chloroform 
extract of the leaves and twigs of Alvaradoa amorphoides Liebm., collec-
ted in Guatemala (voucher specimen Soejarto et al. 7236 in deposit at the 
Herbarium of the Field Museum under accession number: F-2057539), 
was found to be cytotoxic against the HT-29 human colon cancer cell line. 
Fractionation of this extract guided by bioassay against HT-29 cells yiel-
ded several pairs of new and known isomeric anthracenone C-glycosides, 
as well their aglycone. The structures of these isolates were determined by 
analysis of their spectroscopic data, and their cytotoxicity was evaluated 
toward HT-29 cells. All the anthracenone C-glycosides were found to be 
active, with IC50 values in the range 2–6 µM, but their aglycone was inactive, 
indicating that the C-glycose unit plays an important role for these anthra-
cenones to mediate their cytotoxicity toward HT-29 cells. This is the first 
report of identification of anthracenone C-glycosides as the major cytotoxic 
components of A. amorphoides. 
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MOLLIC ACID, A CYCLOARTANE TRITERPENOID 
ISOLATED FROM MARKHAMIA TOMENTOSA LEAVES 
EXHIBITED ANTIPROLIFERATIVE ACTIVITY ON HELA 
CELLS
Mutiat Ibrahim1, Abimbola Sowemimo1, Luanne Venables2, Neil 
Koorbanally3, Gbojubola Awolola3, Margaret Sofidiya1, Olukemi Odukoya1, 
Trevor Koekemoer2, Maryna van de Venter2
1Department of Pharmacognossy, Faculty of Pharmacy, University of Lagos, 
College of Medicine campus, Idi-araba, Lagos, Nigeria, 2Department of 
Biochemistry and Microbiology, Nelson Mandela University, PO Box 77000, 
Port Elizabeth, South Africa, 3School of Chemistry and Physics, University of 
KwaZulu-Natal, Durban 4000, South Africa
Previous pharmacological investigations have reported the antiprolifera-
tive activity of Markhamia tomentosa (Benth.) K. Schum Ex Engl. (Bigno-
niaceae) leaf extract on HeLa cells [1]. In this study, the antiproliferative 
phytochemicals present in the plant were isolated and characterized using 
bioactivity-guided approach and spectroscopic techniques respectively. 
Bioassay-guided fractionation of the crude leaf extract of M. tomentosa re-
vealed that the dichloromethane (Mdf) and ethyl-acetate (Mef) fractions 
showed potent cytotoxicity activity against HeLa cells with IC50 values of 
83.26 and 104.5 μg/ml respectively in the MTT assay. From the isolation 
and purification of Mdf and Mef fractions by repeated column chroma-
tography, followed by characterization by 1D and 2D NMR spectroscopy, 
sitosterol, phytol, oleanolic acid and mollic acid were isolated for the first 
time from M. tomentosa. Mollic acid showed more potent antiproliferative 
activity. These results suggest that mollic acid isolated from Mef fraction of 
the crude extract may be responsible for the earlier reported antiprolifera-
tive activity of M. tomentosa on HeLa cells.
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P-144
CARDIOPROTECTIVE AND HYPOCHOLESTEROLEMIC 
EFFECT OF  ETHANOLIC EXTRACT OF  MORMODICAL 
CHARANTIAL  IN ISOPROTERENOL-INDUCED 
MYOCARDIAL INFARCTION IN ADULT WISTAR  RATS.
Ubhenin A. E.1, S. O. Innih, 2
1Department Biochemistry, Faculty of Medical science, Federal University  
Lafia. Nasarawa, Nigeria.2Department of Anatomy, School of Basic Medical 
sciences, College of Medical sciences, University of Benin, Benin City, 
Nigeria.
The ethanolic  extract of  the plant of  Mormodical charantial  and standard 
drug, metoprolol were prepared in normal saline and  then administered 
orally  to rats  at  the doses of 250 and 100mg/kg body weight ( b.wt) re-
spectively  for a period of  thirty  days .ISO was freshly prepared in normal 
saline and was then used to  induce MI by intraperitoneal  injection at the 
dose of 100mg/kg  to Wistar rats  on the 30th day.  Serum lipid profile and 
cardiac marker enzymes such as creatine phosphokinase (CK-MB) Iso-
enzyme , lactate dehydrogenase (LDH), Alanine transaminase (ALT)and 
Aspartate (AST) were obtained in the serum and in the heart homogenate 
of  the  experimental rats and  then measured calorimetrically.The results 
show that  isoproterenol-induced  myocardiac infarction  were associated 
with  significant (p<0.05) increase in the  activities of cardiac marker en-
zymes such as AST, ALT, CK-MB and LDH in the serum with concomitant 
decrease  in the activities of  these enzymes in the myocardial tissue  as 
compared to control group.  There were  also  significant   (p<0.05) increase 
in  serum level of   total cholesterol ( TC) ,trigyceride(TG),  low density 
lipoprotein(LDL) and  very low density lipoprotein(VLDL)  in the group 
injected with isoproterenol ( group ii)as compared with control  group . 
Pretreatment with leaf extract of Mormodical charantial at a dose of 250mg\
kg b.wt and also by Metoprolol  at dose 100 mg/kg body weight significantly 
(p<0.05) prevented this alteration of the  lipid profile and also of the activ-
ities of these  cardiac marker enzymes both in the serum and myocardial 
tissue  as compared  to isopreterenol-induced control group. The histolog-
ical examinations of the heart further confirmed the  cardioprotective  ef-
fect Mormodical charantial as there were absent of  swollen  myocardium 
whereas ISO induced groups were characterized with these  toxicological 
features . Mormodical charantial possesses  cardioprotective  and hypocho-
lesterolemic effects.
P-145
CHEMISTRY AND BIOAVAILABILITY OF THE 
FLAVONOIDS AND SAPONINS ISOLATED FROM 
GYNOSTEMMA PENTAPHYLLUM (THUNB.) MAKINO
Iftekhar Ahmed1, David Leach2,3, Hans Wohlmuth2,3, Joanne Blanchfield1 
and James De Voss1
1School of Chemistry & Molecular Biosciences, The University of 
Queensland, St Lucia 4072, QLD, Australia, 2Integria Healthcare, Logan 
Rd, Eight Mile Plains 4113, QLD, Australia, 3School of Health & Science, 
Western Sydney University, Locked Bag 1797, Penrith 2751 NSW, Australia.
Gynostemma pentaphyllum (Thunb.) Makino has been the focus of extensi-
ve research over the past decade. The work presented here encompasses the 
characterisation of total flavonoids and saponins (the principal active con-
stituents) in G. pentaphyllum. Two new flavonoids and five new dammara-
ne saponins, together with sixteen known compounds were isolated, puri-
fied and characterised from      G. pentaphyllum. The two new flavonoids, 
namely, kaempferol-3-O-α-rhamnopyranosyl-(1→2)-β-galactopyranoside 
and quercetin-3-O-α-rhamnopyranosyl-(1→2)-β-galactopyranoside and 
two new dammarane saponins, gypenoside LVI-acetate and gypenoside 
XLVI-acetate were isolated from the methanol extract of G. pentaphyllum 
leaves and the other three new saponins, namely, Damulin E, F and yixino-
side BI were isolated from the heat treated ethanol extract of Active-AMP ( 
a commercial preparation of G. pentaphyllum powder). A cell permeability 
assay, using Caco-2 cell model was performed on the isolated compounds 
resulting in compounds (both flavonoids and saponins) demonstrating 
moderate to good permeability across Caco-2 cell monolayer which can be 
considered for potential bioavailable drugs. To identify the potential bio-
activities of the isolated quercetin flavonoids, we did an enzyme inhibitor 
assay against PARP14, a key enzyme for inflammatory diseases and various 
cancer types. Two quercetin derivatives, quercetin-3-glucoside and querce-
tin-dirhamnoglucoside showed excellent inhibition of PARP14. 
P-147
CYTOTOXICITY OF EUPHOL, A TETRACYCLIC 
TRITERPENE
Flávio Luís Beltrame1, Luiza Stolz Cruz1, Thaís Latansio de Oliveira2, Carla 
Cristina Kanunfre3, and Kátia Sabrina Paludo3
1Department of Pharmaceutical Sciences, State University of Ponta Grossa, 
Ponta Grossa, Paraná, Brazil. 2Department of Medical Pathology, Federal 
University of Parana, Curitiba, Paraná, Brazil. 3Department of Structural 
and Molecular Biology and Genetics, State University of Ponta Grossa, Ponta 
Grossa, Paraná, Brazil.
Euphol, a tetracyclic triterpene alcohol, is one of the major compounds 
present in Euphorbia species, and cytotoxic activity has been attributed to 
this compound. The MTT reduction assay was used to evaluate the cytotox-
icity of euphol (7.30 to 234.30 µM) against cancer cell lines. The selectivity 
index was determinate by the ratio of IC50 of lymphocytes or monocytes 
and K-562 cells. To evaluate the death mechanisms, morphological and cell 
cycle assays in K-562 were done by fluorescence optical microscopy (acri-
dine orange and ethidium bromide staining) and flow cytometry (propidi-
um iodide), respectively. K-562 cells were more sensitive to the euphol with 
IC50 values of and 34.56±2.12 µM. Whereas, Jurkat, HL-60, HRT-18 and 
B16F10 showed an IC50 of 84.33±11.76 µM, 49.36±2.76 µM, 53.63±10.16 
µM and 69.80±7.31 µM. The selectivity index was 2.08 for lymphocytes and 
2.35 for monocytes. The morphological analysis showed a reduction in the 
total cell number and was possible to observe apoptotic cells. In the analy-
sis of the cell cycle it was observed that euphol promoted progression into 
S-phase and reduction of population cellular in G2/M-phase. This study 
demonstrated that euphol exhibited cytotoxic effects against a variety of 
cancer cells lines and suggest that the mechanism involved could be related 
with apoptosis.
P-148
DITERPENE ACIDS FROM GUTIERREZIA SAROTHREA 
AND G. MICROCEPHALA: CHEMICAL DIVERSITY, 
CHEMOTYPES AND IMPLICATIONS FOR 
ABORTIFACIENT ACTIVITY IN CATTLE.
Dale R. Gardner
USDA-ARS Poisonous Plant Research Laboratory, 1150 E. 1400 N., Logan, 
Utah, USA
Broom snakeweed (Gutierrezia sarothare) and threadleaf snakeweed (G. 
microcephala) are perennial plants found on western US rangelands.  If 
eaten, the plants can be toxic to cattle, sheep and goats.  In cattle they may 
cause premature parturition (abortions) in late term animals.  The toxic 
components are not known, but some propose that the diterpene acids may 
be both toxic and abortifacient.  A number (133) of plants were collected 
from Colorado, Oklahoma, New Mexico, Texas, Arizona and Utah.  Plants 
were identified by classical taxonomy and then analyzed by a general GC-
MS procedure to determine individual chemotypes.  The GC-MS finger-
prints were diverse showing a possible 15 different chemotypes.  There were 
four major chemotypes accounting for 73% of the samples from which the 
major diterpenes acids were determined by extraction, preparative chro-
matography and characterization by NMR, MS, IR and UV spectroscopy. 
The diterpene acids were found to be a mix of furano, lactone, di-acid and 
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labdane type acids.  Several of the diterpene acids appear to be new com-
pounds and most have not been previously described from G. sarothare 
or G. microcephala.  Chemotype BSW-2 is of particular interest because it 
was found to contain a compound identified as labd-7-en15,18-dioic acid, 
which is structurally similar to isocupressic acid and agathic acids which 
are known to cause abortions in cattle.
P-149
CYTOTOXIC CONSTITUENTS WITH NF-ΚB AND 
MITOCHONDRIAL TRANSMEMBRANE POTENTIAL 
(MTP) INHIBITORY EFFECTS FROM SYZYGIUM 
CORTICOSUM
Yulin Ren1, Gerardo D. Anaya-Eugenio1, Austin A. Czarnecki2, Tran Ngoc 
Ninh3, Chunhua Yuan4, Hee-Byung Chai1, Djaja D. Soejarto2,5, Joanna E. 
Burdette2, Esperanza J. Carcache de Blanco1, A. Douglas Kinghorn1
1Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, 
The Ohio State University, Columbus, Ohio, USA. 2Department of Medicinal 
Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois 
at Chicago, Chicago, Illinois, USA. 3Institute of Ecology and Biological 
Resources, Vietnam Academy of Science and Technology, Hoang Quoc Viet, 
Cau Giay, Hanoi, Vietnam. 4Campus Chemical Instrument Center, The 
Ohio State University, Columbus, Ohio, USA. 5Science and Education, Field 
Museum of Natural History, Chicago, Illinois, USA.
In a continuing search for anticancer agents from higher plants, a chloro-
form extract of the leaves and twigs of Syzygium corticosum (Lour.) Merr. & 
Perry (Myrtaceae), collected in Vietnam, was found to be cytotoxic against 
the HT-29 human colon cancer cell line. Fractionation of this extract guided 
by bioassay against HT-29 cells yielded a new hydroxylated lupane derivati-
ve and 18 known natural products. All isolates obtained were evaluated for 
their cytotoxicity toward the HT-29 colon, the MDA-MB-231 breast, the 
MDA-MB-435 melanoma, and the OVCAR3 ovarian human cancer cell 
lines. The pentacyclic triterpenoids, methylated 2,3-dihydroflavonoids, and 
ellagic acid derivatives purified were found to be the main active compon-
ents, but the megastigmanes did not contribute to this type of activity. The 
most abundant and cytotoxic compound, (+)-ursolic acid, exhibited also 
potent NF-κB (IC50 31 nM) and mitochondrial transmembrane potential 
(MTP) (IC50 3.5 µM) inhibitory activities. 
P-150
CHARACTERIZATION OF PHYTOPROGESTIN 
COMPOUNDS IN HERBAL SUPPLEMENTS
Julia Austin1, Matthew Dean1, Jeongho Lee1, Brian T. Murphy1, Joanna E. 
Burdette1
1Department of Medicinal Chemistry and Pharmacognosy, Center for 
Biomolecular Sciences, College of Pharmacy, University of Illinois at 
Chicago, Chicago, IL 60612
Progestins are used to treat gynecological diseases like uterine fibroids, en-
dometriosis, endometrial cancer, and ovarian cancer that result from ab-
normal levels of progesterone. Detrimental side effects like breast cancer, 
cardiovascular disease, and stroke are associated with progestin therapy. 
To prevent these side effects, alternative progestins that are selective for 
the progesterone receptor are necessary. Herbal supplement sales have in-
creased in recent years, although it is unclear what they contain since they 
are not tightly regulated. Previous studies have shown that some herbal sup-
plements contain compounds that modify steroid signaling and specifically 
our lab has identified molecules in herbal supplements that act similarly 
to progesterone, termed phytoprogestins. Phytoprogestin compounds were 
identified by bioassay guided fractionation using a luciferase reporter assay. 
The compounds were tested to see if they had agonist or antagonist effects. 
Apigenin, a flavonoid that is present in many herbal supplements and teas, 
was found to be a mixed agonist and had in vivo progestin-like effects by 
inhibiting genistein induced uterine proliferation. Surprisingly, irilone and 
cornuside, compounds isolated from red clover and dogwood respective-
ly, did not have agonist nor antagonist effects but potentiated progesterone 
mediated signaling without degrading the receptor. A natural product that 
potentiates progesterone mediated signaling has not been identified before, 
and this could be particularly useful for women who are afflicted with pro-
gesterone resistant gynecological diseases. 
P-151
UNVEILING THE IMPACT OF CRUDE OIL POLLUTION 
ON THE PHYTOCHEMICAL PROFILE OF VERNONIA 
AMYGDALINA
O.A. Diyaolu1, E.O. Oluwabusola1, A.A. Attah2, J.O. Moody2, M. Jaspars,1 R. 
Ebel1
1Department of Chemistry, University of Aberdeen, Scotland, 
U.K.2Department of Pharmacognosy, Faculty of Pharmacy, University of 
Ibadan. Nigeria.*Corresponding author: r.ebel@abdn.ac.uk
Vernonia amygdalina (VA) is used by traditional medical healers to treat 
pregnant indigenous women for the prevention of miscarriages. The pre-
sent study was aimed at investigating the effect of crude oil pollution on 
the phytochemical profile and safety of the use of VA during pregnancy. 
VA was collected from Kokori (affected by an oil-spill) and Abraka (oil-
free environment). Both samples were extracted with methanol followed by 
liquid–liquid separation. After repeated chromatography, the butanol frac-
tion gave two compounds which were characterized based on their NMR 
spectral data. In addition, ICPMS was carried out on the crude extracts of 
VA to assess the levels of heavy metal accumulation. The elemanolide-type 
sesquiterpene lactone, Vernodalol (1) was found in VA from both commu-
nities. However, the related Lasiopulide (2) which has never been reported 
from VA was exclusively found in VA collected from the oil-polluted com-
munity. Furthermore, ICP-MS revealed crude oil polluted VA to display 
elevated levels of lead, arsenic and cadmium. Our results thus show a mar-
ked difference in the phytochemical content of VA from Abraka (oil-free) 
and Kokori (oil-spill) communities, which may lend support to the respon-
dents’ claims that the medicinal plants in the crude oil spill community 
may lose their potency upon sustained oil exploration. Work is on-going to 
investigate the toxicity of the isolated compounds as well as plants extracts 
of both communities.
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P-153
PHYTOCHEMICAL SCREENING AND ANTIBACTERIAL 
STUDIES OF AN AUSTRALIAN NATIVE PLANT
1Manirujjaman, 1Peter L Katavic, 1Christopher Collet, 1Trudi Collet
1Indigenous Medicines Group, Institute of Health & Biomedical Innovation, 
School of Clinical Sciences, Queensland University of Technology, Brisbane, 
Australia.
This study aimed to evaluate the bactericidal efficacy of leaves obtained 
from an Australian native plant (denoted as 8479) against 19 bacteria. The 
antibacterial activity of 8479 was determined using the well diffusion assay, 
whilst broth microdilution assay was used to measure the minimum in-
hibitory concentration (MIC). Several chromatographic (i.e., normal phase 
flash column, reversed phase high performance liquid chromatography) 
and spectroscopic (i.e. nuclear magnetic resonance, mass spectroscopy) 
techniques were used to isolate and identify bioactive compounds derived 
from the plant. The crude methanolic extract at a concentration of 100 mg/
mL was bactericidal against numerous Gram-positive bacteria (B. cere-
Poster Presentations
82Abstracts | 2018 Annual Meeting of the ASP | July 21-25, 2018 | Lexington, Kentucky, USA
us, MSSA, MRSA isolates, S. pyogenes, B. subtilis and S. epidermidis) and 
vancomycin-resistant enterococci E. gallinarum, E casseliﬂavus, E. faecalis 
and E. faecium.  To date, phenolic compounds have been purified from the 
methanolic extract of 8479. The MICs of the compounds ranged between 
8-64 µg/mL. Further, current results demonstrate that crude methanolic 
extracts, as well as purified compounds have antibacterial activity against 
several common-wound colonising bacteria.
P-154
THREE NEW DITERPENOID ALKALOIDS FROM 
ACONITUM JAPONICUM
Mai Miyao1, Kazuki Hiramori1, Daisuke kobayashi1, Hiroshi Yamashita1, 
Masuo Goto2, Kuo-Hsiung Lee2,3, Koji Wada1. 
1Department of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, 
Hokkaido University of Science, 7-15-4-1, Maeda, Teine, Sapporo 006-8585, 
Japan, 2Natural Products Research Laboratories, UNC Eshelman School of 
Pharmacy, University of North Carolina, USA, 3Chinese Medicine Research 
and Development Center, China Medical University and Hospital, Taiwan
Three new C19-diterpenoid alkaloids, lipojesaconitine (1), 10-hydroxy-
chasmanine (2), and 8-demethylcrispulidine (3), have been isolated from 
Aconitum japonicum THUNB. subsp. subcuneatum (NAKAI) KADOTA 
together with two known C19-diterpenoid alkaloids, foresticine and neo-
linine, and four known C20-diterpenoid alkaloids, acomicarchamine A, 
9-hydroxynominine, kobusine and torokonine. The structures of these al-
kaloids were determined by their ms, 1D and 2D-nmr data. Two of the new 
C19-diterpenoid alkaloids (1, 3) and five of the known diterpenoid alkaloids 
were evaluated for cytotoxic activity against five human tumor cell lines 
(A549, MDA-MB-231, MCF-7, KB, and KB-VIN).
P-155
PHYTOCHEMICALS DERIVED FROM THE POPULAR 
SOUTH AFRICAN ROOIBOS TEA (ASPALATHUS 
LINEARIS) SPECIES AND THEIR DRUG INTERACTION 
POTENTIAL
Omer I. Fantoukh1,2,3, Olivia R. Dale1, Zulfiqar Ali1, Abidah Parveen1,2, 
Vamshi K. Manda1, Shabana I. Khan1,2, Amar G. Chittiboyina1, Alvaro 
Viljoen4, Ikhlas A. Khan1,2
1National Center for Natural Products Research, 2Division of 
Pharmacognosy, Department of BioMolecular Sciences, School of Pharmacy, 
University of Mississippi, University, MS 38677, USA, 3Department of 
Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi 
Arabia, 4Department of Pharmaceutical Sciences, Tshwane University of 
Technology, South Africa
Aspalathus linearis is a leguminous shrub endemic in South Africa, and 
used for production of the quaffable herbal rooibos tea. Although it is 
enjoyed in 37 countries, rooibos extracts were reported to inhibit CYP2C9, 
CYP2C8 and CYP3A4 isozymes. In our study, phytochemical investigation 
of unfermented rooibos tea leaves and seeds resulted in the isolation and 
characterization of eleven unique flavonoid C- and O-glycosides (1-11) in 
addition to syringin (12). This is the first study aims mainly to investigate 
the toxicity profile for the unfermented methanol extract of rooibos tea and 
its isolated unique secondary metabolites focusing on drug metabolizing 
enzymes and efflux transporters.
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P-156
INVESTIGATION OF THE CHEMICAL COMPOSITION 
AND ANTICANCER POTENTIAL OF ANDROCYMBIUM 
PALAESTINUM BAKER (COLCHICACEAE) LEAVES
Tamam El-Elimat1, Maram B. Alhawarri1, José Rivera-Chávez2, Joanna E. 
Burdette3, Austin Czarnecki3, Feras Alali4, and Nicholas H. Oberlies2
1Department of Medicinal Chemistry and Pharmacognosy, Faculty of 
Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan, 
2Department of Chemistry and Biochemistry, University of North Carolina 
at Greensboro, Greensboro, North Carolina 27402, USA, 3Department of 
Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University 
of Illinois at Chicago, Chicago, Illinois 60612, USA, 4Faculty of Pharmacy, 
Qatar University, Doha 2713, Qatar
Thirteen compounds were isolated from the methanolic extract of Andro-
cymbium palaestinum Baker (Colchicaceae) leaves. Of these, three were 
new, two were new natural products, and eight were known. The new isolat-
ed compounds were 1-demethyl-(+)-androcine (5), (-)-androcnizine (8), 
and 2-demethyl-β-lumicolchicone (10), while the new natural products 
were (+)-O-methylkreysigine-N-oxide (3) and 5´-methoxy-(+)-homo-
laudanosine (9). Moreover, (-)-colchicine (11), (-)-demecolcine (12), and 
3-demethyl-(-)-demecolcine (13) were reported for the first time from this 
species. The structures of the isolated compounds were elucidated using 
a series of spectroscopic and spectrometric techniques, principally HRES-
IMS, 1D-NMR (1H and 13C-NMR) and 2D-NMR (COSY, edited-HSQC, 
and HMBC). The cytotoxic activities of the isolated compounds were eval-
uated using the MDA-MB-435 (melanoma), MDA-MB-231 (breast), and 
OVCAR3 (ovary) cancer cell lines. Compound 11 was the most potent 
against all tested cell lines, with IC50 values of 12, 95, and 23 nM, respec-
tively.
P-157
REALTIME PCR ANALYSIS OF FLAVORNOID 
BIOSYNTHESIS GENES IN TIBETAN MEDICINAL PLANT 
SWERTIA MUSSOTII
Yue Liu1,2§, Yi Wang3§, Jiaqing Sun1, Fengxian Guo1, Lin Zhan1, Toni Mohr3, 
Prisca Cheng3, Naxin Huo3,4, Danning Pei1, Li Tang1, Chunlin Long1*, Luqi 
Huang2*, Yong Q. Gu3
1College of Life and Environmental Sciences, Minzu University of China, 
Beijing 100081, China, 2National Resource Center for Chinese Materia 
Medica, China Academy of Traditional Chinese Medicine, Beijing 100700, 
China, 3USDA-ARS, Western Regional Research Center, Albany, CA 94710, 
U.S.A., 4Department of Plant Science, University of California Davis, Davis, 
CA 95616, U.S.A.
Swertia mussotii Franch. is an important traditional Tibetan medicinal plant 
with pharmacological properties effective in the treatment of hepatitis. Fla-
vonoid are the major bioactive compounds in this plant. Transcriptome 
sequences of S. mussotii was used to mine the genes involved in flavonoid 
biosynthesis pathway. The expression profiles of 17 candidate transcripts 
encoding the key enzymes for flavonoid biosynthesis were examined in 
different S. mussotii tissues, root, stem, leaf, and flowers, validated by qRT-
PCR. We found that some allelic genes had different expression pattern. 
Maybe the allelic genes had the different role in the plant. Acknowledg-
ment: financial support by project of NSFC-81274185, 81373765, NCET-
13-0624, 111-B08044, and Yong Talent project 2016-3-1, sponsored by the 
State Ethnic Affairs Commission, China.
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P-158
THREE NEW TRITERPENOIDS FROM EUONYMUS 
ALATUS FORMA CILIATODENTATUS 
Yamashita H1, Matsuzaki M1, Kurokawa Y1, Nakane T2, Shibata T3, Bando 
H1 and Wada K1
1Hokkaido University of Science, Sapporo, Hokkaido 006-8590, Japan; 
2Showa College of Pharmaceutical Sciences, Machida, Tokyo 194-8543, 
Japan; 3Tukuba Division, Research Center for Medicinal Plant Resources, 
National Institute of Biomedical Innovation, Tukuba 305-0843, Japan
The bark of Euonymus alatus forma ciliato-dentatus (Celastraceae) has been 
used as an analgesic for toothache by the Ainu tribe (AINU-people), an 
indigenous people of Japan. In the course of our studies on natural drug 
resources used by the AINU-people, we became interested in chemical 
constituents and morphological differences among Euonymus species. 
Three new triterpenoids, 3β,17α−dihydroxy-28,30-bisnorlupan-20-one 
(1), 23,30-dihydroxylup-20(29)-en-3-one (2) and 24,24-dimethylcucurbi-
ta-7,26-dien-3β-ol (3) were isolated along with eight  known lupane deriv-
atives, 30-norlupane-3,20-dione (4), 28,30-dihydroxylup-20(29)-en-3-one 
(5), 23,30-dihydroxylup-20(29)-en-3-one (6), (20S)-30-norlupane-
3,20-diol (7), 3,28-dihydroxy-30-norlupan-20-one (8), 3,28-dihydroxy-
lup-20(29)-en-30-al (9), 3,23-dihydroxylup-20(29)-en-28-al (10) and lup-
20(29)-ene-3,23,28-triol (11) from an ethanol extract of the dried bark of E. 
alatus forma ciliato-dentatus. These known compounds were found in this 
plant for the first time. 
P-159
STRUCTURAL ELUCIDATION OF Ω-PHENYLPENTAENE 
FATTY ACID GLYCOSIDES FROM FRUITS OF TWO 
RHAMNACEAE PLANTS
Kyo Bin Kang1,2, Ming Gao3, Eun Jin Park1, Geum Jin Kim3, Jinwoong Kim1, 
Hyukjae Choi3, and Sang Hyun Sung1
1College of Pharmacy and Research Institute of Pharmaceutical Sciences, 
Seoul National University, Seoul 08826, Korea, 2Skaggs School of Pharmacy 
and Pharmaceutical Sciences, University of California, San Diego, La Jolla, 
CA 92093, USA,3College of Pharmacy, Yeungnam University, Gyeongsan 
38541, Korea.
Three 2-acetoxy-ω-phenylpentaene fatty acid triglycosides berchemiosides 
A–C (1–3) and two ω-phenylpentaene α,β-unsaturated fatty acid amide 
diglycosides rhamnellosides A (4) and B (5) were isolated and character-
ized from fruits of two Rhamnaceae plants Berchemia berchemiifolia and 
Rhamnella franguloides, respectively. Their structures were determined by 
spectroscopic analysis in combination with chemical derivatization; espe-
cially, 2D J-resolved and ROESY NMR analyses were applied to reveal the 
absolute configurations of pentaene groups. Compounds 1, 4, and 5 were 
found to have (6E,8E,10Z,12Z,14E)-geometry, whereas 2 and 3 exhibited 
all-E geometries.
P-160
NEW PREGNANE GLYCOSIDES ISOLATED FROM 
STAPELIA GIGANETEA
Hyeon Seok Jang1, Seong Yeon Choi1, Birang Jeong1, Jiho Lee1, Kiwon Ko1, 
Heejung Yang1
1Laboratory of Natural Products Chemistry, College of Pharmacy, Kangwon 
National University, Chuncheon 24341, Republic of Korea
Stapelia gigantea (Asclepiadaceae) is a succulent plant native to dry lands 
of South Africa and a popular garden in Korea. We isolated four new preg-
nane glycosides (1-4) from S.gigantea. The structures were determined by 
1D and 2D NMR spectral analysis. The absolute configuration of com-
pounds (1-4) were determined by NOESY and coupling constants analyses.
P-161
CYTOTOXIC COMPOUNDS FROM SEDUM 
MIDDENDORFFIANUM
Jiho Lee1, Seong Yeon Choi1, Hyeon Seok Jang1, Birang Jeong1, Kiwon Ko1, 
Heejung Yang1
1Laboratory of Natural Products Chemistry, College of Pharmacy, Kangwon 
National University, Chuncheon 24341, Republic of Korea
A new phenolic compound, belamphenone-5-O-β-D-glucoside (1), was 
isolated from S. middendorffianum along with eight flavonoids (2-9), two 
phenolic compounds (10 and 11) and two benzoic acid (12 and 13). Com-
pounds 8, 9, 11, 12 and 13 showed anti-proliferative activities against MCF-
7 than PC-3 cell line.
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P-162
ACAI EXHIBITS ANTI-DIABETIC AND OSTEOGENIC 
ACTIVITY IN FISH MODELS
Nicole A. Eggers-Woodard1, Sheila M. Wicks3, Nishikant Raut4,5, Yu 
Tingsheng5, Christoph Winkler5, Gail B. Mahady4, Esperanza J. Carcache de 
Blanco1,2
1Division of Medicinal Chemistry and Pharmacognosy, and 2Division of 
Pharmacy Practice and Science, College of Pharmacy, Ohio State University, 
Columbus, OH 43210 USA, 3Department of Cellular and Molecular 
Medicine, Rush University, 4Department of Pharmacy Practice, College 
of Pharmacy, University of Illinois at Chicago, Chicago, IL 60607, USA, 
5Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj 
Nagpur University, Nagpur, India. 
Acai berries from the Euterpe oleracea Martius (Arecaceae) palm tree, used 
in South American cultural medicine, have made a resurgence in popular 
culture for treating osteoarthritis, high cholesterol, weight loss, and obe-
sity. However, many of these claims have not yet been supported by sci-
entific evidence, so potential osteogenic and anti-diabetic effects of acai 
extract (AE) are being investigated. A methanol extract of dried organic 
acai berries was found active in several in vitro assays for anti-inflamm-
atory (NFκB), anti-diabetic (PPAR-γ), and osteogenic effects. AE increased 
osteoblast proliferation and reduced apoptosis in cultured human osteo-
blasts (hFOB). The AE was further tested in an osteogenesis medaka model 
and a diabetic zebrafish model. Double transgenic osterix/Sp7:mCherry 
medaka larvae treated with AE exhibited osteoblast proliferation and in-
creased osterix expression. In wildtype zebrafish with chemically-induced 
diabetes, HbA1C levels decreased upon treatment with AE, reversing hyper-
glycemia. In addition, PPAR-γ expression was increased at a level greater 
than positive control rosiglitazone, an FDA-approved anti-diabetes drug. 
Hence, acai is a promising lead.
P-163
VARIATION OF THE PRODUCTION OF 
4-NEROLIDYLCATECHOL BY PIPER UMBELLATUM 
Vanessa Raquel Greatti1, Fernando Bombarda Oda2 and Rosemeire Cristina 
Linhari Rodrigues Pietro1
1 Department of Drugs and Medicines, São Paulo State University-UNESP, 
Araraquara, SP, Brazil. Department of Natural Active Principles and 
Toxicology, São Paulo State University-UNESP, Araraquara, SP, Brazil.
Piper umbellatum, previously known by the popular name Pariparoba, has 
a high medicinal potential. The major compound is 4-nerolidylcatechol (4-
NC), responsible for several biological activities such as antioxidant, anti-
microbial, anti-edema and anti-malaria. The aim of the present study was 
to evaluate the yield of 4-NC produced by P. umbellatum collected at dif-
ferent times. Three isolations of 4-NC were performed, the first extraction 
being carried out at the beginning of August 2016, the second in January 
2017 and the third in October 2017. A dichloromethane extract was pre-
pared for each collect, using fresh leaves of P. umbellatum, obtained from 
the Garden of Medicinal Plants of the School of Pharmaceutical Sciences 
- Unesp, Araraquara, SP. After total evaporation of the solvent the extract 
was partitioned three times using hexane and acetonitrile. The acetonitrile 
phase was then fractionated on octadecylsilane column with isocratic elu-
tion of acetonitrile:water (50:50) and 20 fractions were collected. The frac-
tions were applied in thin layer chromatography eluting with hexane:ethyl 
acetate:acetic acid (60:28:2) and developing with sulfuric anisaldehyde and 
NMR (1H and 13C) analysis for confirmation of purity. The data obtained 
showed that in the first extraction the yield was 0.015%, followed by the se-
cond extraction with 0.010% and the third extraction with 0.006%, indica-
ting variation of the metabolite production in different collections perfor-
med in the same place. The results suggest that climatic and environmental 
factors may influence the increase or decrease of 4-NC production needing 
more attention to achieve higher levels.
P-165
A SINGLE ENZYME INTRODUCES BOTH C–O BONDS 
OF THE ETHER BRIDGE IN LOLINE ALKALOIDS. 
REGIO- AND STEREOCHEMICAL COURSE OF THE 
OXIDATIONS.
Juan Pan,1,2 Minakshi Bhardwaj,1 Bo Zhang,2 Wei-chen Chang,2 Christopher 
L. Schardl,1 Carsten Krebs,2 Robert B. Grossman,1 and J. Martin Bollinger, 
Jr.2
1Departments of Chemistry and Plant Pathology, University of Kentucky, 
Lexington, KY, USA. 2Department of Chemistry and Department of 
Biochemistry and Molecular Biology, Pennsylvania State University, 
University Park, PA, USA. 
The loline alkaloids, insecticidal natural products produced by fungal en-
dophytes of cool-season grasses, contain an ether bridge connecting two 
bridgehead C atoms, an unusual context for an ether in natural products. We 
show that a single nonheme Fe oxygenase, LolO, oxidizes two unactivated 
C–H bonds of 1-exo-acetamidopyrrolizidine (AcAP) to give N-acetylnorlo-
line (NANL). A stop-flow kinetics study and isolation and characterization 
of a hydroxylated intermediate show that LolO oxidizes the C2 position of 
AcAP first, and feeding of stereospecifically labeled precursors to live fungi 
shows that LolO selectively abstracts the endo H atoms from C2 and C7. 
These studies lay the groundwork for understanding the mechanism of the 
very unusual ether-forming event that leads to NANL. 
P-166
COMPARISON OF ANTIOXIDANT ACTIVITIES 
BETWEEN CRINUM ASIATICUM AND RICINUS 
COMMUNIS LEAVES EXTRACTS
Jitpisute Chunthorng-Orn1 and Arunporn Itharat1
1Department of Applied Thai Traditional Medicine, Faculty of medicine, 
Thammasat university, Pathumthani, 12120, Thailand.
Hot Salt-pot Compression is a method of postpartum care that has been 
widely used in Thai traditional medicine. The method is used for treating 
several symptoms of women’s postpartum. Crinum asiaticum (CA) leaf is 
the main component of this method. Ricinus communis (RC) leaf is also 
commonly used in the method instead of CA leaf. Therefore, in this work, 
we focuses on the comparison of antioxidant activities of the water and eth-
anolic extracts of CA and RC leaves. Antioxidant activities were assessed 
by DPPH and FRAP methods. The results demonstrated that the ethanolic 
extract of RC leaf showed the strongest antioxidant activity by using DPPH 
and FRAP assays (EC50 value of 17.37 µg/mL and FRAP value of 412.66 mg 
Fe(II)/g, respectively) while the lowest antioxidant activity was reported for 
the ethanolic extract of CA (EC50 value of > 100 µg/mL and FRAP value 
of 74.60 mg Fe(II)/g, respectively). From the findings, extracts from RC 
having better antioxidant activity than extracts from CA. However, these 
methods are fundamental assays which do not clearly indicate antioxidant 
effect. Thus, these extracts should further investigate for another antioxi-
dant methods.
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P-167
STRUCTURES AND BIOLOGICAL EVALUATION OF 
NEW COMPOUNDS FROM TRADITIONAL CHINESE 
MEDICINES (TCMS)
Jing-Fang Zhang, Gui-Yang Xia, Rui Li, Yu-Zhuo Wu, Ling-Yan Wang, Bo-
Lin Qiu, Huan-Xia, Sheng Lin* and Jian-Gong Shi*
State Key Laboratory of Bioactive Substance and Function of Natural 
Medicines, Institute of Materia Medica, Chinese Academy of Medical 
Sciences and Peking Union Medical College, Beijing 100050, People’s 
Republic of China
Guided by bioactivity-directed fractionation has resulted in discovery of 
new compounds (1-10) with chemical and/or biological diversity from six 
Traditional Chinese Medicines (TCMs), Paeonia lactiﬂora, Valeriana jata-
mansi, Litsea  cubeba, Fraxinus sieboldiana, Machilus yaoshansis, and red 
yeast rice [1-11]. Their structures were assigned via spectroscopic techni-
ques, and the absolute configurations were verified via chemical methods, 
specific rotation, electronic circular dichroism (ECD) data, and X-ray cry-
stallographic analysis. Compound 3 has an unusual 16,23:22,25-diepoxy 
unit. Compound 4 was a novel tricyclic spirolactones bearing long linear 
alkyl chains formed by Diels_Alder [4+2] cycloaddition of a molecule of 
each butenolide with β-phellandrene, and it showed cytotoxicity against the 
A549 cell lines with IC50 values of 5.1 μM. Compounds 7 and 8 are rare 
cage-like paeoniflorin derivatives comprising two monoterpenoidal moi-
eties. Compound 9 was an unusual γ-lactam with inhibitory activity against 
histone deacetylase 1 (HDAC1) with an IC50 of 3.7 µM.
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P-168
CRYSTAL STRUCTURE IN COMPLEX WITH CARRIER 
PROTEIN CHARACTERIZES PYRROLE BIOSYNTHESIS 
BY A TYPE II NRPS OXIDASE
Hem R. Thapa1 and Vinayak Agarwal1,2
1School of Chemistry and Biochemistry, 2School of Biological Sciences, 
Georgia Institute of Technology, Atlanta GA 30332
Sequential enzymatic reactions on payloads tethered to carrier proteins 
(CPs) generates non-proteogenic amino acids that are then delivered to 
non-ribosomal peptide synthetases (NRPSs) to generate peptidic natural 
products. The underlying diversity of non-proteogenic amino acid build-
ing blocks is the principal driver of the chemical diversity of NRPS-derived 
natural products. Structural insights into recognition of CPs by tailoring 
enzymes that generate these non-proteogenic amino acids is non-existent. 
Here, we present the crystal structure of FAD-dependent L-prolyl oxidase 
in complex with its cognate CP in the holo- and product bound states. The 
thiotemplated pyrrolyl product CP is a universal player in natural product 
biosynthetic pathways and our results delineate the interactions between 
the CP and the oxidase, while also providing insights into the stereospec-
ificity of the enzymatic reaction. Our results demonstrate that NRPSs rec-
ognize and bind to their CPs using interactions quite different to that from 
fatty acid and polyketide biosynthetic enzymes and that structural diversity 
in natural product biosynthesis can be, and is, derived from subtle modifi-
cations of primary metabolic enzymes.
P-169
PHYTOCHEMICAL AND BIOLOGICAL INVESTIGATION 
OF PILIOSTIGMA THONNINGII.
Chijoke Ezennaka1,2, Michael Afolayan1-4, Radhakrishnan Srivedavyasasri1, 
Olayinka Asekun2, Oluwole Familoni2, Margaret Sofidiya3, Abayomi 
Orishadipe4, Mohamed Ibrahim1, Samir Ross1,5,*
1National Center for Natural Products Research, University of Mississippi, 
University, MS 38677, USA. 2Department of Chemistry, 3Department of 
Pharmacognosy, University of Lagos, Lagos, Nigeria. 4Chemistry Advanced 
Research Center, Sheda Science and Technology Complex, PMB 186, 
Garki-Abuja, Nigeria. 5Department of BioMolecular Sciences, Division of 
Pharmacognosy, School of Pharmacy, University of Mississippi,  University, 
MS 38677, USA.
Piliostigma thonningii,  (Milne-Redhead, Fabaceae) is used for various 
medicinal purposes in African countries. The decoction of the leaves 
and bark is used for the treatment of ulcers, wounds, heart pain, arthritis, 
malaria, pyrexia, leprosy, sore throat, diarrhea, toothache, gingivitis, 
cough and bronchitis. Phytochemical investigation of P. thonningii yielded 
two new compounds: 2β-methoxyclovan-9α-ol (1), methyl-ent-3β-
hydroxylabd-8(17)-en-15-oate (2), and twenty known compounds which 
were identified by their NMR, MS and GC-MS spectral analyses as: 
clovane-2β,9α-diol (3), alepterolic acid (4), anticopalic acid (5), (3S,5R,6S)-
trihydroxy-7E -megastigmen-9-one (6),  β-amyrin (7), vitamin E (8), 
piliostigmin (9), (+)-epicatechin (10), quercetin (11), quercitrin (12), af-
zelin (13), 3-hexenyl-1-O-β-D-glucopyranoside (14), garcinielliptone Q 
(15), epoxydammarane-3α,25-diol (16),  palmitic acid, oleic acid, linoleic 
acid, stigmasterol, sitosterol and β-sitosterol glucoside. Compounds 1, and 
4 showed potential selectivity towards Trypanosoma brucei with IC50 7.89 
and 3.42 μM, respectively. Compound 2 showed moderate activity towards 
T. brucei and Leishmania donovani Amastigote with IC50 3.84 and 7.82 μM, 
respectively. The structure activity relationship of the isolated metabolites 
suggested that hydroxylation at C-2 enhances the activity towards T. 
brucei in sesquiterpenes 1 and 3. Similarly hydroxylation at C-3 in labdane 
diterpenes elevates the activity towards T. brucei. 
Acknowledgements: Supported by Association African Universities; 
SHESTCO, NG; NCNPR, USA. 
P-170
CONSITUTENTS OF FORSYTHIA KOREANA FLOWERS 
(OLEACEAE) AND THEIR FUNCTIONALITY AS 
PHARMACOLOGICAL AGENTS
Yeong-Geun Lee, Jung Su Ko, Jung Eun Gwag, Tong Ho Kang, Se Chan 
Kang, Hyoung-Geun Kim, Nam-In Baek
Graduate School of Biotechnology and Department of Oriental Medicine 
Biotechnology, Kyung Hee University, Yongin 17104, Korea.
Forsythia koreana (Oleaceae), a perennial shrub, is widely distributed in 
east Asia. From the F. koreana flowers, twenty phenolic compounds inclu-
ding four new ones were isolated through repeated column chromatogra-
phies and identified based on spectroscopic data such as 1D and 2D NMR, 
IR, FAB/MS, and CD. As well the examination of extracts, fractions, and 
isolated compounds was carried out for the functionality such as anti-dia-
betes, anti-oxidantion, and anti-inflammation. Some compounds showed 
significant anti-oxidant, anti-inflammatory, anti-diabetes, and whitening 
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activity without visible toxic effect. Quantitative analysis of active materials 
in F. koreana flowers was also conducted using LC/MS experiments.
P-171
A POLYKETIDE SYNTHASE TRIO LEADS TO ORTHO-
HYDROQUINONE BIOSYNTHESIS TO FACILITATE IRON 
ASSIMILATION BY ENDOPHYTIC FUNGI
Mengbin Chen1, Yi Tang1,2*
1Department of Chemical and Biomolecular Engineering, 2Department 
of Chemistry and Biochemistry, University of California, Los Angeles, 
California 90095, United States
Collaboration between iterative polyketide synthases (iPKS) represents 
an effective strategy to construct molecules of diverse functions. Through 
genome mining, we identified and characterized Tln cluster in biocontrol 
agent T. harzianum t-22 that synthesizes phenylpropanoid-like ortho-hy-
droquinone molecules, termed tricholignan, via a PKS trio followed by 
tailoring enzymes. Tricholignan, resembling coumarins in plant, can reduce 
Fe(III) to assimilate iron. The synthesis was initiated by sequential actions 
of a high-reduced polyketide synthase (HRPKS) and a non-reducing poly-
ketide synthase (NRPKS). An unusual pseudo acyl-carrier protein (ψACP) 
fused with methyltransferase (MT) in trans is essential to execute proper 
programming rules of the partner NRPKS, via inhibiting the KS domain in 
an ACP-specific manner.
P-172
ADDITIONAL α-GLUCOSIDASE INHIBITORS FROM 
MALBRANCHEA FLAVOROSEA (LEOTIOMYCETES, 
ASCOMYCOTA)
Daniela Rebollar, Martha Macías, Mario Figueroa, Huzefa A. Raja, Martín 
González, Rachel Mata
Facultad de Química, Universidad Nacional Autónoma de México, Mexico 
City 04510, Mexico
From the rice-based culture of Malbranchea ﬂavorosea three new com-
pounds, namely flavoroseoside B (1), 4-hydroxy-2-O-α-ribofuranosyl-5-
methylacetophenone (2), and (S)-3,4-dihydro-3-(1H-indol-3-ylmethyl)-
4-methyl-1H-1,4-benzodiazepine-2,5-dione (3); along with three known 
compounds, rosigenin, massarilactone B, and riboxylarinol B were 
obtained. The structures were determined by spectroscopic methods. 
Compound 3 and its synthetic analog (R)-3,4-dihydro-3-(1H-indol-3-
ylmethyl)-1-methyl-1H-1,4-benzodiazepine-2,5-dione inhibited the acti-
vity of Ruminococus obeum α-glucosidase enzyme.
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P-173
GENOME MINING GUIDED DISCOVERY OF BIOACTIVE 
NATURAL PRODUCTS FROM ENDOPHYTIC FUNGI
Qian Wei, Jian Bai, Daojiang Yan, and Youcai Hu*
State Key Laboratory of Bioactive Substance and Function of Natural 
Medicines,  Institute of Materia Medica, Chinese Academy of Medical 
Sciences & Peking Union Medical College, Beijing 100050, China
Filamentous fungi are prolific producers of bioactive natural products. Re-
cent genome sequencing efforts for many fungal species have revealed si-
gnificant biosynthetic potential, as represented by a large number of cryptic 
and diverse biosynthetic pathways. Endophytic fungi are increasingly reco-
gnized as significant underachievers in natural product biosynthesis. The 
high biosynthetic potential is a reflection of the complex natural ecological 
environment, in which small molecules play important roles in host-fungus 
interactions. These complex ecological interactions, which are difficult to 
replicate in the laboratory, also result in most gene clusters being silent in 
axenic cultures. 
Epigenetic modification, overexpression of transcription factor, heterolo-
gous expression of gene cluster in Aspergillus nidulans as well as combina-
tional strategies were used to active and overexpress the cryptic biosynthe-
tic genes, which provide a rapid approach to mine the chemical diversity of 
endophytic fungi.
P-174
PHENOLIC CONSTITUENTS FROM THE TWIGS OF 
BETULA SCHMIDTII REGEL AND THEIR BIOLOGICAL 
ACTIVITY 
Kyoung Jin Park1, Joon Min Cha1, Tae Hyun Lee1, Dong Hyun Kim1, Sun 
Yeou Kim2, Kang Ro Lee1
1Natural Products Laboratory, School of Pharmacy, Sungkyunkawn 
University, Suwon 16419, Republic of Korea, 2College of Pharmacy, Gachon 
University, 191, Hambakmoero, Yeonsu-gu, Incheon 21936, Republic of 
Korea.
As a part of our ongoing search for bioactive constituents from Korean 
medicinal sources, Betula schmidtii Regel (Betulaceae) twigs were studied. 
MeOH extract of B. schmidtii twigs was subjected to solvent-partitioning to 
yield n-hexane, CHCl3, EtOAc, and n-BuOH soluble fractions and repeated 
column chromatographic purification of the EtOAc-soluble and n-BuOH-
soluble fractions afforded four new phenolic glycosides (1-4), a new lignan 
glycoside (19), a new isoflavonoid glycoside (27), along with thirty-two 
known ones. The chemical structures of the new compounds (1-4, 19, and 
27) were elucidated by spectroscopic data analysis including 1D and 2D 
NMR (1H and 13C NMR, COSY, HSQC, and HMBC, and NOESY) and che-
mical methods. All the isolated compounds (1-38) were evaluated for their 
anti-inflammatory activity through the measurement of nitric oxide (NO) 
production levels in lipopolysaccharide (LPS)-stimulated murine microglia 
BV-2 cell line, for their neuroprotective effects via induction of nerve grow-
th factor (NGF) in C6 glioma cells, and for their cytotoxicity against four 
human cancer cell lines (A549, SK-OV-3, SK-MEL-2, and HCT15) were 
evaluated.
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P-175
SECURINEGA ALKALOIDS OF SECURINEGA 
SUFFRUTICOSA AND THEIR ANTIPROLIFERATIVE 
ACTIVITIES
Kyoung Jin Park1, Joon Min Cha1, Tae Hyun Lee1, Dong Hyun Kim1, Sang 
Un Choi2, Kang Ro Lee1
1Natural Products Laboratory, School of Pharmacy, Sungkyunkawn 
University, Suwon 16419, Republic of Korea, 2Korea Research Institute of 
Chemical Technology, Daejeon 34114, Republic of Korea
Securinega suffruticosa (Pall.) Rehder (Euphorbiaceae) is widely distributed 
in Korea, China, and Japan. The twigs of this plant have been used in Ko-
rean traditional medicine to treat infantile paralysis, rheumatic disease, and 
blood circulation disorder and its roots have been used to treat quadriple-
gia and acute ear infection. Previous phytochemical research on S. suffru-
ticosa repored alkaloid, flavonoid, tannin, and diterpenoid. As continuing 
search for bioactive secondary metabolites from Korean medicinal plants, 
the MeOH extract from the twigs of S. suffruticosa successively partitioned 
with n-hexane, CHCl3, EtOAc, and n-BuOH. Each fraction was assessed for 
their cytotoxic activities against four cancer cell lines (A549, SK-OV-3, SK-
MEL-2, and HCT15) in vitro using the SRB bioassay and the active fraction 
was shown to be the CHCl3 extract. The CHCl3-soluble fraction was sepa-
rated using repeated column chromatography to afford four new alkaloids 
(1-4) and five known compounds (5-9). The chemical structures of the new 
compounds (1-4) were established using diverse NMR techniques (1H and 
13C NMR, COSY, HSQC, HMBC, and NOESY) and HRMS data analysis. 
Cytotoxic study for the all isolates (1–9) is in progress.
P-176
CYTOTOXIC CONSTITUENTS FROM EUPHORBIA 
HUMIFUSA
Kyoung Jin Park, Won Se Suh, Joon Min Cha, Tae Hyun Lee, Dong Hyun 
Kim and Kang Ro Lee
Natural Products Laboratory, School of Pharmacy, Sungkyunkwan 
University, Suwon 16419, Republic of Korea
Euphorbia humifusa Willd. (Euphorbiaceae), an annual plant, is distributed 
widely in Korea, Japan and China. E. humifusa has been used to treat jaun-
dice, dysentery, enteritis, poisonous snake bites, and hepatitis caused by 
virus. A previous phytochemical investigation of E. humifusa reported pyr-
rolidinonoids, sesquiterpenoids, triterpenoids, and phenolic compounds. 
As a part of our continuing search for bioactive constituents from Korean 
medicinal plants, we investigated the MeOH extract of the whole plants of 
E. humifusa. The MeOH extract of E. humifusa were subjected to repeated 
column chromatography and semi-preparative HPLC to give a new mega-
stigmane glycoside (11), along with twenty one known compounds (1 – 10, 
and 12 – 22). The structures of isolated compounds were determined by 
spectroscopic methods, including 1D and 2D NMR analyses and chemi-
cal reaction.The cytotoxicities of the isolated compounds (1 – 22) against 
the A549, SK-OV-3, SK-MEL-2, and HCT15 human cancer cell lines were 
evaluated using the SRB assay in vitro. Compounds 3, 7, and 10 showed 
cytotoxic activity against the four human tumor cell lines with IC50 values 
in the range of 1.21 – 27.19 μM. 
P-177
A NEW PHENOLIC GLYCOSIDE FROM THE TWIGS OF 
QUERCUS ACUTISSIMA CARUTH
Joon Min Cha, Kyoung Jin Park, Tae Hyun Lee, Dong Hyun Kim, Seung Rak 
Lee, Jae Sik Yu, Seulah Lee, Hae Min So, Sil Kim, and Kang Ro Lee
School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of 
Korea
In the course of our continuing search for biologically active compounds 
from Korean medicinal plants, we investigated the twigs of Q. acutissima. 
Quercus acutissima Caruth (Fagaceae), known as Saw tooth oak, is widely 
distributed in Korea, Japan, and China. The edible fruits of Q. acutissima 
have been used in Korean traditional medicine to treat atopic dermati-
tis. Previous investigation of Q.acutissima reported several triterpenoids, 
flavonoids, lignans, tannins, and phenolic compounds with antioxidant, 
and antiviral activities. The MeOH extract of the twigs of Q. acutissima 
was partitioned with n-hexane, CHCl3, EtOAc, and n-BuOH. The EtOAc 
and n-BuOH-soluble fractions led to the isolation of a new diarylhepta-
noid glycoside, named acuttissioside A (1), together with thirteen known 
phenolic glycoside derivatives (2-14). The structure of new compound (1) 
was elucidated by spectroscopic methods including 1D and 2D NMR (1H 
and 13C NMR, COSY, HSQC, and HMBC). The isolated compounds (1-
14) were tested for their anti-inflammatory activity measuring nitric oxide 
(NO) production in lipopolysaccharide (LPS)-activated murine microbial 
cell line.
P-178
PHENOLIC COMPOUNDS FROM THE TWIGS OF 
ALEURITES FORDII AND THEIR CYTOTOXIC ACTIVITY
Joon Min Cha, Kyoung Jin Park, Tae Hyun Lee, Dong Hyun Kim, Seung Rak 
Lee, Jae Sik Yu, Seulah Lee, Hae Min So, Sil Kim, Kang Ro Lee
School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of 
Korea
Aleurites fordii Hemsl. (=Vernicia fordii Hemsl., Euphorbiaceae), known for 
tung oil tree, is widely distributed throughout northeast asia. The fruits, 
leaves and roots of this tree have been used in Korean traditional medi-
cine for treating sore throat, respiratory illness, constipation and dieresis. 
In the course of our continuing search for biologically active compounds 
from Korean medicinal sources, we investigated the MeOH extract of the 
twigs of A. fordii. From the MeOH extract, three new phenolic compounds 
(1, 10, and 11), including fourteen known phenolic compounds (2-9, and 
12-17) were isolated. The chemical structures of new compounds (1, 10, 
and 11) were determined through NMR (1H and 13C NMR, 1H-1H COSY, 
HMQC, HMBC, and NOESY), HRMS, and CD data. Cytotoxic activities 
of the isolated compounds (1-17) against the A549, SK-OV-3, SK-MEL-2, 
and HCT15 human cancer cell lines were evaluated using the SRB assay. 
Compound 11 exhibited weak cytotoxic activity against A549 cell line (IC50 
value = 13.76 μM).
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P-179
BIOASSAY-GUIDED ISOLATION OF CYTOTOXIC 
COMPONENTS FROM THE STEMS OF STREPTOCAULON 
GRIFFITHII
Ermias Mekuria Addo,1 Joshua M. Henkin,2 Austin A. Czarnecki,2 Tran 
Ngoc Ninh,3 Yulin Ren,1 Joanna E. Burdette,2 Djaja D. Soejarto,2,4 A. 
Douglas Kinghorn1 
1Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, 
The Ohio State University, Columbus, OH 43210. 2Department of Medicinal 
Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois 
at Chicago, Chicago, IL 60612. 3Institute of Ecology and Biological Resources, 
Vietnam Academy of Science and Technology, Hoang Quoc Viet, Cau Giay, 
Hanoi, Vietnam. 4Science and Education, Field Museum of Natural History, 
Chicago, IL 60605.
The cardenolides periplogenin (1) and alloperiplogenin (2) and their glyco-
sides periplocymarin (3), periplogen β-D-glucoside (4), periplocin (5), and 
corchorusoside C (6) were isolated as cytotoxic constituents of the stems of 
Streptocaulon griffithii Hook. f. (Apocynaceae), collected in Vietnam. Preli-
minary SAR observations based on the activity of 1, 3, 5, and 6 against four 
cancer cell lines (MDA-MB-435, OVCAR3, HT-29, and MDA-MB-231) 
can be summarized as: (1) the glycosides were ~20‒30 more potent than 
the aglycones (cardenolides), (2) selectivity may be reflected as to the extent 
of glycosylation for most of the glycosides, and (3) glycosides with a me-
thoxylated 2,6-dideoxy sugar unit were ~2‒3 times more potent than their 
non-methoxylated congeners. 
P-180
NEUROTHERAPEUTIC EFFECTS OF GINKGO BILOBA 
EXTRACT AND GINKGOLIDE B
Khaled Orabi1, Dalal Al-Adwani1, and Waleed Renno2
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy and 
2Department of Anatomy, Faculty of Medicine, Kuwait University, Kuwait
In addition to its documented use in traditional Chinese medicine, Ginkgo 
biloba  is used in modern herbal medicine. Its extract (GBE) is indicated 
in the treatment of many diseases such as Alzheimer, age-associated de-
mentia, and intermittent claudication. GBE, terpene trilactones-enriched 
extract (TTEE) and ginkgolide B (GB) were prepared via several chromato-
graphic processes and the identity of GB was confirmed based on its spec-
tral data. The potential of GBE, TTEE and GB to recover sciatic nerve crush 
injury in rat models was investigated. Six groups of Wistar male rats; naïve, 
sham, crush, crush + GBE (50 mg/kg), crush + TTEE (50 mg/kg) and crush 
+ GB (10 mg/kg) were prepared. The test extracts/compound were diluted 
with normal saline and administered intraperitoneally, one hour following 
the injury and daily for 14 days. Functional and sensory neurobehavioral 
tests, morphological, histological and immunohistochemistry analyses 
were performed at weeks 3 and 6. Results revealed that GBE, TTEE and 
GB enhance functional and sensory behavioral parameters and protected 
the histological and the ultrastructural elements in the sciatic nerve. Addi-
tionally, all treatments prevented spinal cord neurons from further deterio-
ration following sciatic nerve injury. Results demonstrated that GB has the 
most significant potential effects among other treatments.
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P-181
ETHNO-MEDICINAL AND PHARMACOGNOSICAL 
STUDY OF THE CHAKMA COMMUNITY OF JURACHARI 
UPAZILLA OF RANGAMATI DISTRICT, BANGLADESH
Sanjida Sultana and Shaikh Bokhtear Uddin
Department of Botany, University of Chittagong, Chittagong 4331, 
Bangladesh.
Investigation and documentation of the status of medicinal plants and associated 
knowledge was conducted of the Chakma community in Juraicchari upzilla of Ran-
gamati district, Bangladesh. The information has been documented by interviewing 
traditional herbalists, various elderly man and women following different recom-
mended ethnobotanical methods. A total of 144 vascular plants have been re-
corded which have been used to treat 80 diseases/illness. These species belonging 
to 127 genera under 62 families. The most used family in terms of number of 
species is Asteraceae (6.25%). Leaves (35.57%) have been found to be used fre-
quently in herbal formularies and the most frequently treated disease/illness is 
cough, dysentery, dermal disease, diarrohea, jaundice and fever.
To ascertain the level of agreement among the informants of the Chakma 
community regarding the use of plants to treat certain disease categories, 
informant consensus factors (FIC) values were determined. In the treat-
ment of neurological disorder, the highest FIC value (0.67) was observed, 
with 17 use-reports for 3 plant species. The fidelity level of Trevesia palma-
ta (Roxb. ex Lindl.)Vis. among the three plants is 54.17%. On the basis of 
FIC value and Fidelity level it is quite clear that the plant Trevesia palmata 
has a good medicinal background and selected for ethnopharmacognosical 
study.
In the present study, alkaloids were assessed qualitatively, indicates the pre-
sence of alkaloid in the fresh sample of Trevesia palmata leaf. The in vitro 
thrombolytic activity study revealed that the percentage of weight loss of clot 
after application of Trevesia palmata leaf extract solution was taken as the 
functional indication of thrombolytic activity. The herbal preparation may 
be incorporated as a thrombolytic agent for the improvement of the patient 
suffering from a therothrombotic diseases. Fresh leaves is also used to investiga-
te the sedative/anxiolytic effect using some recommended behavioral models, such 
as Tail suspension test (TST), Forced swimming test (FST), Elevated plus maze test 
(EPM), Hole cross test (HCT) and Open field test (OF). Observation of all implied 
methods and protocols help us to be enthusiastic enough to explain and 
anticipate that Trevesia palmata possesses significant level of neurological 
properties. Therefore, after analyzing the resultant findings it can be confi-
dently claim that, Trevesia palmata has satisfactory levels of anxiolytic and 
sedative capacity along with depressive domination. However the causative 
active ingredients isolation and modification probably can help with eradi-
cation of side effect like depression.
P-182
TRITERPENOIDAL SAPONINS ISOLATED FROM 
CAMELLIA JAPONICA ROOTS WITH NRF2-MEDIATED 
ANTIOXIDANT ACTIVATION
Kiwon Ko,1 Seong Yeon Choi,1 Sang Hyun Sung,2 Yong Soo Kwon,1 Jung-
Hwan Kim,3,* Heejung Yang1,*
1College of Pharmacy, Kangwon National University, Chuncheon 24341, 
Korea, 2College of Pharmacy and Research Institute of Pharmaceutical 
Sciences, Seoul National University, Gwanak-gu, Seoul 08826, Korea, 
3Department of Pharmacology, School of Medicine, Institute of Health 
Sciences, Gyeongsang National University, Jinju 52727, Korea
We isolated new triterpenoidal saponins (1-11) from the Camellia japon-
ica roots and investigated antioxidant response element (ARE) luciferase 
activities of compound 1-11 against human keratinocyte (HaCaT-ARE 
cells). Compound 1-11 increased ARE luciferase activities via nuclear fac-
tor erythroid 2-related factor 2 (Nrf2) accumulation in the nucleus. The 
ARE-luciferase activities of compounds 4, 5, 6, 8 and 11 significantly in-
creased more than two folds at 25 μM.
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P-183
DRUG DISCOVERY FROM NATURAL AND 
STRUCTURALLY MODIFIED BUFADIENOLIDES
Ren-Wang Jiang
Guangdong Province Key Laboratory of Pharmacodynamic Constituents 
of TCM and New Drugs Research, College of Pharmacy, Jinan University, 
Guangzhou 510632, P. R. China
Cardiotonic steroids (CTS), e.g. digoxin and ouabain, are clinically impor-
tant drugs for the treatment of heart failure owing to their potent inhibiti-
on of cardiac Na+,K+-ATPase (NKA). Bufadienolides constitute one of the 
two major classes of CTS, but no drug was discovered from pure bufadi-
enolides so far. We have performed systematic studies on bufadienolides. 
A number of novel bufadienolides were isolated from plants and animals, 
some of which displayed potent stereo-selective inhibition against NKA 
(J. Nat. Prod. 2017, 80, 1182-1186; Fitoterapia 2015; 105: 7-15 and  J. Nat. 
Prod. 2013, 76, 1842–1847). Structural modifications using both chemical 
and biosynthetic methods were performed to further improve the activities 
(Org Lett. 2018, 20(3):534-537 and  RSC Adv., 2018, 8, 5071–5078 ). Finally, 
the inhibition mechanism was investigated by molecular docking and solid 
state NMR (Sci. Rep. 2016; 6:29155). 
P-184
NEW SECONDARY METABOLITES ISOLATED FROM 
EPIGENETICALLY MODIFIED FUNGI FOR ANTI-
INFECTIVE DRUG DISCOVERY
Anne-Claire D. Limon,1 Jessie Adams,2 Rahmy Tawfik,2 Lindsey N. Shaw,2 
Bill J. Baker1
1Departments of Chemistry and 2Cell Biology, Microbiology, and Molecular 
Biology, University of South Florida, Tampa, FL 33620, USA
Whether from tropical or lower latitude ecosystems, the chemical survival 
mechanisms used by fungi offer a potential axis for research to find new 
drugs. Moreover, epigenetic regulation is a key mechanism to orchestrate 
the expression or suppression of gene activity; hence, manipulating these 
mechanisms offers new opportunities to express down-regulated secondary 
metabolite genes and has the potential to generate new potent and novel 
metabolites. In our lab, two kinds of epigenetic modifiers are used: sodium 
butyrate as a Histone Deacytalase (HDAC) inhibitor, and 5-azacytidine as 
a DNA Methyl Transferase (DNMT) inhibitor. Screening studies in the lab 
have shown that fungi from Floridian mangroves and from the coastal por-
tions of the Tapachula region of Mexico, cultured on rice in the presence 
of DNMT epigenetic regulators, exhibited activity against microbial agents 
such as ESKAPE, leishmaniasis and Naegleria fowleri pathogens. Through 
a bioassay-mass spectroscopy-guided sequence compiling extractions, par-
titions, and chromatographic methods, the separation of a crude extract 
material has shown potential new chemistry. Two different DNMT treated 
fungi were respectively active in leishmaniasis and ESKAPE screenings. 
After an ethyl acetate:water partition, the crude extracts were fractionated 
on normal phase MPLC. Then, stages of normal phase and reverse phase 
HPLC purifications have already brought forward known and new bioac-
tive compounds and the work is still ongoing and fruitful.  With the pool 
of isolated compounds, one and two-dimensional nuclear magnetic reso-
nance, mass spectroscopy, and X-ray crystallography are providing the data 
necessary to elucidate the structures and characterize the stereochemistry 
involved. Further biological testing is being performed to extend the scope 
of drug discovery potential. 
P-185
SECONDARY METABOLITE CAPACITY OF 
PSEUDONOCARDIA SYMBIONTS OF THE FUNGUS-
GROWING ANT TRACHYMYRMEX SEPTONTRIONALIS 
Sara P. Puckett1, Sarah L. Goldstein2, Jonathan L. Klassen2, and Marcy J. 
Balunas1,*
1Division of Medicinal Chemistry, Department of Pharmaceutical Sciences, 
University of Connecticut, Storrs, CT 06269 USA. 2Department of Molecular 
and Cell Biology, University of Connecticut, Storrs, CT 06269 USA
Trachymyrmex septentrionalis is a fungus-growing ant found primarily 
along the eastern coast of the United States. Like other fungus-growing 
ants, T. septentrionalis has adaptively incorporated Pseudonocardia bacteria 
onto its propleural plate, creating a symbiotic network in which bacterial 
secondary metabolites protect the fungus garden from pathogens, while the 
fungus garden provides a food source for the ants. In the current study, 
comparative metabolomic analyses of extracts of Pseudonocardia collected 
from geographically distinct colonies from New York to Florida were per-
formed to investigate evolutionary relationships along this geographic gra-
dient. Colonies from North Carolina, Georgia, and Florida had the largest 
diversity of secondary metabolites when comparing mass spectrometric 
(MS) data. Alongside this MS networking, genomic analysis of biosynthetic 
capacity for secondary metabolite production revealed that Pseudonocardia 
from Florida and North Carolina have the highest degree of similarity in 
their capacity for and production of secondary metabolites. These studies 
will be combined with antimicrobial and antiproliferative assays to direct 
isolation and identification of bioactive metabolites from this unique host-
microbe system. 
P-186
UNCOVERING NEW FUNGAL NATURAL PRODUCTS 
AND THEIR BIOSYNTHETIC PATHWAYS USING FAC-MS 
TECHNOLOGY
Matthew T. Robey1, Rosa Ye2, Jin Woo Bok3, Kenneth D. Clevenger4, Md 
Nurul Islam2, Cynthia Chen2, Raveena Gupta3, Michael Swyers2, Edward 
Wu2, Peng Gao4, Paul M. Thomas1,4, Chengcang C. Wu2,6, Nancy P. Keller3,6, 
and Neil L. Kelleher1,4,5,6
1Department of Molecular Biosciences, Northwestern University, Evanston, 
IL 60208, 2Intact Genomics, Inc., St Louis, MO 63132, 3Department of 
Medical Microbiology and Immunology and Department of Bacteriology, 
University of Wisconsin-Madison, Madison, WI 53706, 4Proteomics Center 
of Excellence, Northwestern University, Evanston, IL 60208, 5Department of 
Chemistry, Northwestern University, Evanston, IL 60208.
Filamentous fungi are prolific producers of secondary metabolites with 
drug-like properties, and their genome sequences have revealed an untap-
ped wealth of potential therapeutic leads. To better access these secondary 
metabolites and characterize their biosynthetic gene clusters, we have deve-
loped a new platform for large-scale screening and heterologous expression 
of intact gene clusters that uses fungal artificial chromosomes and metabo-
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lomic scoring (FAC-MS). We have utilized the FAC-MS platform to iden-
tify the biosynthetic machinery responsible for production of acu-dioxo-
morpholine, a metabolite produced by the fungus, Aspergilllus aculeatus. 
Using stable isotope labeling, MS, and bioinformatics analyses, we determi-
ne that the diketomorpholine scaffold is assembled from a tryptophan and 
phenyllactate by a highly unusual condensation domain. Acu-dioxomor-
pholine is highly related to orphan inhibitors of P-glycoprotein targets in 
multidrug-resistant cancers and identification of the biosynthetic pathway 
for this compound class enables genome mining for additional derivatives.
P-187
IDENTIFICATION OF A NOVEL DEPSIPEPTIDE FROM 
SHEEP FECES-DERIVED FUNGUS TALAROMYCES SP. 
CMB-NF091.
L. Nahar1, Z. Khalil1, and R. J. Capon1
1Division of Chemistry and Structural Biology, Institute for Molecular 
Bioscience, University of Queensland, QLD 4072, Australia.
To fully explore the secondary metabolite potential of a sheep feces-de-
rived fungus, Talaromyces sp. CMB-NF091, the strain was cultivated in a 
microbioreactor (MATRIX) array of ×33 different conditions, and solvent 
extracts subjected to chemical analysis. Optimised conditions were used to 
produce a hexa-depsipeptide, talaropyrine (shown) bearing a mixture of 
L (black) and D (blue) amino acid residues as determined by C3 Marfey’s 
analysis, and an unprecedented pyridinyl-acetamide moiety (red). 2D NMR 
and QTOF-MS/MS analysis supported the assignment of the amino acids 
sequences. Curiously talaropyrine appear to exist as different, equilibrating 
tautomers about the pyridinyl-acetamide moiety, prompts the synthesis of 
model compounds to better understand the phenomena.
P-188
FREE RADICAL SCAVENGING ABILITY OF THE 
SECONDARY METABOLITES PRODUCED IN THE 
SCLEROTIA AND MYCELIUM OF INONOTUS OBLIQUUS 
Riley Kirk, Matthew Bertin, Ph.D.
Department of Biomedical and Pharmaceutical Sciences, College of 
Pharmacy, University of Rhode Island, Kingston, RI 02881
The medicinal fungus Inonotus obliquus, commonly called Chaga, has been 
used in traditional Chinese medicine and Siberian folk medicine for cen-
turies. In the current study, Chaga specimens were collected on three Bet-
ulacae tree species, to evaluate the substrate effect on secondary metabolite 
production. This perennial fungus contains an outer protective layer, called 
the sclerotia which is rich in polysaccharides as well as an inner portion 
which is abundant in triterpenoid molecules. The water soluble, polysac-
charide portion has shown antioxidative activity in DPPH models, which 
is consistent with the common medicinal tea ingestion. However, certain 
triterpenoid molecules have shown to be good free radical scavengers and 
could augment the scavenging ability from oxidative damage. This would 
require extraction of Chaga biomass in a more lipophilic solvent such as 
alcohol, and ingestion in tincture form. Herein a combinatorial approach 
using the various molecules of Chaga will be investigated for maximum an-
tioxidant activity.  Furthermore, the permeability of these molecules will be 
explored using the parallel artificial membrane permeability assay (PAM-
PA) which uses membrane simulators in the human biological system such 
as the gut, the blood brain barrier, and the skin for uses in pharmaceuticals, 
nutraceuticals, and skincare. 
P-189
BIOASSAY GUIDED ISOLATION OF SECONDARY 
METABOLITES FROM PENICILLIUM 
AURANTIACOBRUNNEUM, A FUNGAL ASSOCIATE OF 
THE LICHEN NIEBLA HOMALEA
Choon Yong Tan1, Fengrui Wang1, Kristie D. Goughenour2, Chad Rappleye2, 
Harinantenaina L. Rakotondraibe1
1Division of Medicinal Chemistry & Pharmacognosy, College of Pharmacy, 
The Ohio State University, Columbus, OH 43210, 2Department of 
Microbiology, Center for Microbial Interface Biology, The Ohio State 
University, Columbus, OH 43210
Lichens are groups of organisms comprising photobionts (microalgae 
and cyanobacteria) and mycobionts (fungi) living symbiotically and have 
shown a myriad of biological activities attributable to their secondary me-
tabolites. As such, a preliminary cytotoxic screening on an extract of Peni-
cillium aurantiacobrunneum, a fungal associate of an endemic lichen of the 
U.S., Niebla homalea (Ach.) Rundel & Bowler, has elicited potent cytotoxic-
ities against human breast cancer (MCF-7, IC50 = 1.8 mg/mL) and human 
ovarian cancer (A2780, IC50 = 2.2 mg/mL) cells. Bioassay-guided isolation 
on this extract resulted in an identification of 1 with structure closely rela-
ted to the mycotoxin, citreoviridin (2). The structure elucidation including 
the stereochemistry of 1 and the isolation of other cytotoxic constituents 
produced by the fungus in various media, such as rice and barley, will be 
presented. 
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P-190
PERSEPHACIN, A NOVEL FUNGUS-DERIVED 
DEPSIPEPTIDE EXHIBITING BROAD-SPECTRUM 
ANTIFUNGAL ACTIVITY
Lin Du1,2, Jianlan You1,2, Allison O. Mattes1,2, Saikat Haldar1,2, Shikha 
Srivastava1,2, Jarrod B. King1,2, Robert H. Cichewicz1,2
1Natural Products Discovery Group, Institute for Natural 
Products Applications and Research Technologies, University of 
Oklahoma.2Department of Chemistry and Biochemistry, University of 
Oklahoma. 
Persephacin, a unique cyclic depsipeptide bearing a novel hydrophobic 
amino acid residue, was discovered from an endophytic fungal isolate, El-
sinoe sp. The bond-line structure of persephacin was ascertained through 
an analysis of its NMR and MS data, whereas its absolute configuration 
was determined by a combination of the Marfey’s analysis, acidic hydrolysis 
with amino acid modifications, and comparisons of experimental versus 
computational spectroscopic data (13C NMR chemical shifts, ECD spectra, 
and specific rotation values). Persephacin exhibited broad-spectrum anti-
fungal and fungicidal activities against a wide range of clinically important 
and drug-resistant fungal pathogens (yeasts and filamentous fungi). Details 
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pertaining to the structure analysis and bioactivity of persephacin are pre-
sented.
P-191
THE FRAGRANCE OF FUNGI: SPME-ASSISTED GC/MS 
HEADSPACE ANALYSIS OF VOLATILE METABOLITES
Mario Augustinovic1, Daniel A. Todd1, Ann Marie L. Lee1, Huzefa A. Raja1, 
Cedric J. Pearce2, Nicholas H. Oberlies1
1Department of Chemistry and Biochemistry, University of North 
Carolina at Greensboro, Greensboro, NC 27403, 2Mycosynthetix Inc., 505 
Meadowlands Dr. # 103, Hillsborough, NC 27278
Fungi produce a plethora of secondary metabolites, some of which have 
become drugs while others are toxins. They also produce volatiles, which 
evaporate easily under certain pressures and temperatures and are often 
lost through conventional extraction methods. The use of an alternative 
extraction method would allow for the elucidation of the missing volatile 
metabolites, and more importantly, further insight into the chemical ecol-
ogy of a fungus. Environmental pressures can influence the development 
of conventional secondary metabolites as well as volatile compounds. For 
headspace analysis, a solid phase microextraction is coupled to a GC/MS 
system, thereby allowing for real time collection of metabolites produced 
by a fungus. Penicillium restrictum unambiguously produced over 25 vola-
tiles over the course of extraction. Some of these are known to cause harm 
to humans, while others are used in perfumes. Further analysis of the P. 
restrictum will allow for complete description of its volatile metabolome, 
while the volatile metabolites of other fungi can subsequently be elucidated. 
P-192
ISOLATION AND STRUCTURE DETERMINATION OF 
ANTIVIRAL NATURAL PRODUCTS FROM FUNGI
Shinji Kamisuki1, Hiroki Matsunaga2, Shu Nishikori2, Kenji Takemoto2, 
Manabu Kaneko2,3, Syo Nakajima2,3, Makoto Murakami1, Hironobu 
Murakami1, Kouji Kuramochi2, Koichi Watashi2,3, and Fumio Sugawara2
1School of Veterinary Medicine, Azabu University, Sagamihara, Kanagawa 
252-5201, Japan, 2Department of Applied Biological Science, Tokyo 
University of Science, Noda, Chiba 278-8510, Japan, 3Department of 
Virology II, National Institute of Infectious Diseases, Tokyo 162-8640, Japan
We have focused on metabolites of fungi isolated from sand, seaweed, 
mosses, and plants to isolate novel antiviral natural products. In this study, 
we report the isolation and structural elucidation of anti-hepatitis B virus 
(HBV) compound, vanitaracin A, and anti-hepatitis C virus (HCV) com-
pound, peniciherquamide C. The chemical structures of these compounds 
were determined from spectroscopic data (1D/2D NMR, MS and IR). 
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P-193
CHEMICAL-ECOLOGICAL INVESTIGATION OF 
ACTINOBACTERIA ASSOCIATED WITH STINGLESS BEE 
MELIPONA SCUTELLARIS
Diego Rodríguez-Hernández1 and Mônica T. Pupo1
1School of Pharmaceutical Sciences of Ribeirão Preto, University of São 
Paulo, Ribeirão Preto-SP, Brazil. 
Social insects are frequently associated with symbiotic microorganisms that 
produce antimicrobial compounds to protect their colonies against patho-
gens. As part of an ongoing ICBG-Brazil project, we have studied the ability 
of bacterial symbionts associated with stingless bees and fungus growing 
ants to suppress pathogenic microbes. Six actinobacteria strains associated 
with the stingless bee Melipona scutellaris were isolated from nurse and fo-
raging bees. The strains ICBG1323 and ICBG1321 were identified as Strep-
tomyces pactum and Micromonospora tulbaghiae, respectively, using 16S 
rRNA sequencing. Both exhibited pronounced inhibitory activity against 
Paenibacillus larvae, the causative agent of American foulbrood. Strains 
were cultured in ISP-2 liquid medium and bioassay-guided HPLC fractio-
nation, led to the isolation of some compounds. NMR and MS data allowed 
the identification of spirotetronate (1) and anthracycline (2) families of me-
tabolites, known as potent antibiotics. The ecological role for this class of 
metabolites is being investigated. 
P-194
BIOLOGICALLY ACTIVE COMPOUNDS FROM THE 
ENDOPHYTIC FUNGUS PLECTANIA MILLERI NFL1, 
ISOLATED FROM TAXUS FUANA 
Hira Mehboob Mirza1,2, Ulyana Muñoz Acuña1, Karl A. Werbovetz2, Safia 
Ahmed3, Masoom Yasinzai4, Liva Rakotondraibe2, Esperanza J. Carcache de 
Blanco1,2
1Division of Pharmacy Practice and Science, and 2Division of Medicinal 
Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State 
University, Columbus, Ohio, USA. 3Department of Microbiology, Quaid-i-
Azam University, Islamabad, Pakistan. 4SA-CIRBS, International Islamic 
University, Islamabad, Pakistan.
Microbial natural products, particularly endophytes, have recently become 
primary targets in drug screening programs. Northern areas of Pakistan are 
considered biodiversity hotspots of medicinal plants with ethno-pharma-
cological importance (e.g Taxus fuana). In the present study, crude extracts 
obtained after solid state fermentation of endophytic fungus Plectania 
milleri NFL1 from Taxus fuana have been screened in a panel of bioassays. 
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Pestalotin (1), its analogue (2) and galiellalactone (3) were isolated from the 
ethyl acetate extract. Galiellalactone showed growth inhibition against the 
PC-3 prostate cancer cell line and promastigotes of Leishmania sp. Structu-
re identification and elucidation was completed using spectroscopy techni-
ques including 1D-NMR 1H, 13C, and DEPT, and 2D-NMR such as HMBC, 
HSQC, and COSY. In-silico studies will also be performed to optimize the 
activity of the active compound (s) and will serve as a foundation in the 
search for effective drugs against cancer and leishmaniasis.
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P-195
WIDESPREAD DISTRIBUTION OF A COMMON 
ANTIFUNGAL AGENT AMONG BRAZILIAN FUNGUS-
GROWING ANTS’ BACTERIAL SYMBIONT
Taise T. H. Fukuda1,2, Emily Mevers1, Weilan G. P. Melo2, Monica T. Pupo2, 
Jon Clardy1
1Department of Biological Chemistry and Molecular Pharmacology, Harvard 
Medical School, Boston, MA 02115 USA; 2School of Pharmaceutical Sciences 
of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, SP 14040-903 BR.
Attine ants cultivate a fungus with which they maintain a permanent 
and obligatory mutualistic association. To help prevent nest infection 
by parasites, especially by the specialized fungal pathogen Escovopsis sp., 
the ants have an association with symbiotic actinobacteria of the genus 
Pseudonocardia that produce protective secondary metabolites. Investiga-
tions of ants in a previously unstudied region, colonies from around Bra-
zil including the Amazon Forest, Atlantic Forest and Brazilian Cerrado 
(Savanna), led to an interesting ecological finding. Metabolomic analysis 
[HR-LCMS, MS/MS and Global Natural Products Social Molecular Net-
working (GNPS)] on over 100 Pseudonocardia strains representing five 
distinct collection sites revealed that a significant number of strains pro-
duced cahuitamycins and/or oxachelins, which are structurally related. 
Interestingly, in preliminary assays, many of these metabolites selective-
ly inhibited the parasite over the mutualistic fungus. Based on genomic 
analysis, it appears that the BGC was likely acquired by horizontal gene 
transfer as other cahuitamycin producers are distantly related strains. 
The geographically widespread production of oxachelins/cahuitamycins 
by distantly related Pseudonocardia sp. and the selective inhibition of the 
pathogenic fungus suggest that these metabolites have an important eco-
logical role in protecting the nest from infection.
P-196
UNUSUAL 19-NOR-PIMARANES FROM ICACINA 
TRICHANTHA
Brian Guo,1 Ming Zhao,1,2 Michael M. Onakpa,1,3 and Chun-Tao Che1
1Department of Medicinal Chemistry and Pharmacognosy, University of 
Illinois at Chicago, Chicago, IL 60612, USA, 2College of Pharmacy, Nanjing 
University of Chinese Medicine, Nanjing 210023, China, 3Department 
of Veterinary Pharmacology and Toxicology, University of Abuja, Abuja 
920001, Nigeria
The Niger Delta region of West Africa possesses a rich biodiversity of plants 
with various ethnobotanical uses, including Icacina trichantha Oliv. (Icaci-
naceae), a flowering shrub indigenous to Nigeria with a long history of tra-
ditional medicinal use that continues to this day. Our group has conducted 
the first phytochemical analysis of this species, leading to the identification 
of over 20 novel compounds. The current project presented here has re-
sulted in the isolation of five new pimarane derivatives from the EtOAc-
soluble fraction (1-5), including four rare 19-nor-pimaranes (2-5). 
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P-197
LIGNANS FROM FORSYTHIA VIRIDISSIMA ROOTS AND 
THEIR CYTOTOXIC EFFECTS IN HCT-116 COLON CANCER 
CELLS
Jungmoo Huh1, Eun Jin Park1, Heejung Yang2 and Sang Hyun Sung1
1College of Pharmacy and Research Institute of Pharmaceutical Sciences, 
Seoul National University, Gwanak-gu, Seoul 08826, Republic of Korea; 
2College of Pharmacy, Kangwon National University, Chuncheon 24341, 
Republic of Korea
Sixteen compounds, including eight dilignans (1−8) and eight lignan gly-
cosides (9−16), were isolated from the roots of Forsythia viridissima. Com-
pounds 1-6 and 16, which were newly isolated in nature, were unambig-
uously determined by 1D and 2D NMR analyses and chemical methods. 
Compounds 1−8 were dimers of dibenzylbutyrolactone lignan analogues. 
The cytotoxic activities of the isolates were examined against human colon 
cancer HCT-116 cells. Compounds 8 and 10 showed cytotoxic activities 
with IC50 values of 9.65 and 5.67 μM, respectively.
P-198
ANTIMICROBIAL ACTIVITIES OF TREGAYSORNMAS 
FORMULA 
Pathompong Phuaklee1, Bhanuz Dechayont1, Jitpisute Chunthorng-Orn1, 
and Arunporn Itharat1
1Department of Applied Thai Traditional Medicine, Faculty of Medicine, 
Thammasat University, Pathum Thani, 12120, Thailand
Tregaysornmas formula, including Jatropha multifida L., Nelumbo nucifera 
Gaertn. and Aegle marmelos L., was discovered in Thai Pharmacy scriptu-
re. This research aimed to investigate antimicrobial activities of the 95% 
ethanol and water extracts of Tregaysornmas formula using Disc diffusion 
method, Minimum Inhibitory Concentration (MIC) and Minimal Bacte-
ricidal/Fungicidal Concentration (MBC/MFC) assay. The results showed 
that 95%EtOH and water extracts of Tregaysornmas formula exhibited an-
tibacterial activity against Staphylococcus aureus with inhibition zone of 10 
and 6.5 mm., respectively. The 95%EtOH and water extracts showed MIC 
value of 0.625 and 1.25 mg/ml, respectively against S. aureus and MIC value 
of 5 and 1.25 mg/ml, respectively against Escherichia coli. However, both 
were not show antimicrobial activity against Pseudomonas aeruginosa and 
Candida albicans. We concluded that Tregaysornmas formula showed anti-
bacterial activities and it was related with the ethnomedical use as maintai-
ning body balance of patients in Thai traditional medicine.
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P-199
DISCOVERY OF NOVEL ANTIMALARIAL AGENTS FROM 
PLANTS
David G. I. Kingston1, Yongle Du1, Rolly Fuentes1, Namki Cho1, Ana Lisa 
Valenciano2, Maria B. Cassera2, Jason Clement3, and Michael Goetz3
1Department of Chemistry and the Virginia Tech Center for Drug 
Discovery, Virginia Tech, Blacksburg, Virginia 24061, USA, 2Department of 
Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia 
30602, USA, 3Natural Products Discovery Institute, 3805 Old Easton Road, 
Doylestown, Pennsylvania 18902, USA.
Malaria is one of the world’s most devastating diseases, with over 3.2 billion 
people at risk for contracting it, and an estimated 216 million malaria cases 
and over 440,000 deaths in 2016. The potent antimalarial drugs quinine and 
artemisinin are natural products, and natural products continue to make 
key contributions of new antimalarial agents. Recent work from our joint 
groups will be presented, leading to the isolation and structure elucidation 
of new antiplasmodial compounds as well as known compounds with pre-
viously unreported antiplasmodial activity.
IC50
 = 0.8 ± 0.1 µM
O
OHHO
OH
O
O
HO
OH
OCH3
H
IC50
 = 3.4 ± 0.4 µM
O
O N
AcO
H
H
IC50
 = 3.5 ± 0.3 µM
O
OH
O
OH
H
IC50
 
0.14 ± 0.01 µM
OH
P-200
ETHNOBOTANICAL AND PHYTOCHEMICAL STUDIES 
ON MAIANTHEMUM ATROPURPUREUM, A TIBETAN 
FOOD PLANT IN NORTHWEST YUNNAN 
Li Xu1, Yizhou Wang1, Shi-Biao Wu2, Edward J. Kennelly1,2,3*, Chunlin 
Long1,4,5*
1College of Life and Environmental Sciences, Minzu University of China, 
Beijing 100081, China, 2 Department of Biological Sciences, Lehman College 
City University of New York, New York 10468, USA, 3Ph.D. Programs 
in Biochemistry, Biology, and Chemistry, The Graduate Center, City 
University of New York, NY 10016 USA, 4Kunming Institute of Botany, 
Chinese Academy of Sciences, Kunming 650201, China, 5 Key Laboratory of 
Ethnomedicine (Minzu University of China), Ministry of Education, Beijing 
100081, China
Maianthemum atropurpureum (Asparagaceae), nibai in Tibetan or zhu-ye-
cai in local Chinese, is a wild vegetable commonly consumed by the Tibet-
an people in Northwest Yunnan, China. An ethnobotanical investigation 
had been carried out to understand its significance in traditional Tibetan 
diet. The phytochemical analysis involved multiple chromatographic and 
spectral methods including LC-TOF-MS analysis while the nutrient con-
tent for nibai was determined by the China National Standards (GB) meth-
ods. The phytochemical content of nibai was examined by conventional 
isolation strategies, as well as HR-ESI-TOF-MS to detect and identify 16 
compounds including nine steroid saponins and seven flavonoids. Dried 
nibai is a rich source of protein (24.6%), with 18 of the 20 common amino 
acids. The amino acid content of nibai can reach up to 17.9 g/100 g, with the 
essential amino acids as major contributors, corresponding to 42.3 % of the 
total amino acids. Nibai contains mineral elements, dietary fiber, vitamins, 
β-carotene, carbohydrates, and lipids. These results help to confirm that the 
local Tibetan practice of consuming Maianthemum atropurpureum is war-
ranted due to its high levels of vitamins, minerals, essential amino-acids, 
and other phytochemicals. Nibai may be further developed in Tibet and 
beyond as a health food and/or dietary supplement product.
P-201
EFFECTS OF ASSOCIATION OF PTERODON PUBESCENS 
AND CORDIA VERBENACEA ON CELL MIGRATION AND 
ANTI-INFLAMMATORY ACTIVITY IN HACAT CELLS
Rosanna Tarkany Basting1,2, Ilza Maria de Oliveira Sousa1, Veronika 
Butterweck3, Mary Ann Foglio1
1Faculty of Pharmaceutical Sciences – FCF/ 2Faculty of Medical Science – 
FCM/ State University of Campinas – Unicamp, 13083-887, Campinas – SP, 
Brazil, 3Institute for Pharma Technology, School of Life Sciences, University 
of Applied Sciences Northwestern Switzerland - FHNW, Muttenz, 4132, 
Switzerland. 
Pterodon pubescens (Pp) and Cordia verbenacea (Cv) are Brazilian folk me-
dicinal plants, known for anti-inflammatory effects. The extracts’ associ-
ation demonstrated a synergistic effect on in vivo inflammatory models. 
Herein the effects on cell migration is reported for the first evaluating sam-
ples [Association (A): Pp + Cv – ratio ½ : ½] effects in TNFαstimulated cells. 
Time-lapse microscopy detected a decrease in cell migration of A at 3.125 
and 12.5 µg/mL tested concentrations (at t= 24 h: 28.6 ± 1.3% for 3.125 
μg/mL and 46.3 ± 10.7% for 12.5 μg/mL) in comparison to the untreated 
control (at t=24 h 43.8 ± 3.5%). For 6.25 μg/mL, the cell migration was 
significantly higher, at t=24 h, a gap closure of 56.2 ± 11.0% was reached. In 
the TNFαstimulated cells, only A (12.5 μg/mL) increased the levels of vas-
cular endothelial growth factor (VEGF). All concentrations significantly 
reduced Interleukin 8 levels, demonstrating a potential anti-inflammatory 
effect and exerted inhibitory effects on cell migration. 
Acknowledgment: FAPESP grant #2016/23816-4; #2015/08600-2 
P-202
INVESTIGATION ON THE STRUCTURAL DIVERSE 
PROCYANIDINS FROM PINUS MASSONIANA
Bin Zhou1, Joo-Won Nam1,3, Rasika S. Phansalkar1, Yvette Alania2, Mariana 
C. dos Reis2, James McAlpine1, Shao-Nong Chen1, Ana K. Bedran-Russo2 
and Guido F. Pauli1
1Department of Medicinal Chemistry & Pharmacognosy, College of 
Pharmacy; 2Department of Restorative Dentistry, College of Dentistry, 
University of Illinois at Chicago, Illinois 60612, USA. 3College of Pharmacy, 
Yeungnam University, Gyeongsan, Gyeongbuk 712-749, Republic of Korea
Our previous studies of proanthocyanidin (PAC) action on dentin showed 
that the affinity of PACs to type-I collagen is directly correlated with their 
exact structural features and degree of polymerization. In order to explore 
the SARs of PACs, scaled-up phytochemical isolation from the bark of Pi-
nus massoniana was carried out. So far, 14 PACs have been isolated from 
enriched active fractions by means of previously developed countercurrent 
separation (CCS) protocols and identified by NMR and LC-MS: two resi-
dual monomers, epi-catechin and catechin (1 and 2); nine dimers including 
three seco-dimers (3−5); five A-type (6−10) and one 4,6-linked B-type di-
mer (11); two trimers (12 and 13); one tetramer (14). By including biosyn-
thetic considerations, the new seco-trimer, 12, is likely formed from EC(C) 
by oxidative ring opening, nucleophilic addition, and intramolecular este-
rification reactions. NOE evidence for its relative configuration will be pre-
sented. Two major dentin active components (13 and 14, purity ≥90% by 
qHNMR) were successfully enriched to near-gram levels by CCS, LH-20, 
and C-18 columns, ensuring sufficient quantities for biological studies.
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P-203
EFFECTS OF TOTAL FLAVONOIDS OF ASTRAGALUS 
SEEDS ON TG TTRANSPORT PATHWAY IN 
OVARIECTOMIZED HYPERLIPIDEMIA RATS
Jingxia Wang1, Lu Fu1, Junkai Yao1, Lan Jia1, Leilei Wang1, Wei Li1, Jianjun 
Zhang1.
1Beijing University of Chinese Medicine, 11 Bei San Huan Dong Lu, Beijing 
100029, China
Semen Astragali Complanati is a traditional Chinese medicine which could 
warm kidney-yang, commonly used for hyperlipermia. Previous studies 
indicate that the Total Flavonoids of Semen Astragali Complanati (TFA) 
could reduce TG synthesis of ovariectomized rats fed high-fat diet. This 
study aimed to explore the effects of TFA on TG transport pathways. Fe-
male SD rats were randomly divided into blank group, model group, pos-
itive control group, and TFA 28.5, 57, 114mg/kg groups. Furthermore, to-
tal cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol 
(LDL-C) and high density lipoprotein cholesterol (HDL-C) in serum and 
liver were detected. Tests of very low density lipoprotein (VLDL) and apoli-
poprotein B100 (ApoB100) in serum, and protein expression of MTP in liv-
er were applied. Results showed that TFA could significantly reduce lipids 
in blood and liver, increase the levels of VLDL and ApoB100 in serum and 
upregulate protein expression of MTP. Thereby, TG transport from liver to 
blood was increased while TG deposition in liver was reduced. However, 
blood lipid was not up but down. It might be related to fat hydrolysis me-
tabolism, which is needed to further research. 
P-204
PREPARATION OF RED CLOVER (TRIFOLIUM 
PRATENSE) ISOFLAVONE KNOCKOUT AND ENRICHED 
DESIGNER EXTRACTS FOR IN VIVO STUDIES
Gonzalo R. Malca-Garcia1, J. Brent Friesen2, David C. Lankin1, James B. 
McAlpine1, Shao-Nong Chen1, and Guido F. Pauli1
1UIC/NIH Center for Botanical Dietary Supplements Research, Dept. of 
Med. Chemistry and Pharmacognosy, College of Pharmacy, University of 
Illinois at Chicago, Chicago, IL 60612, USA. 2Dominican University, Physical 
Science Dept. River Forest, IL 60305, USA. 
Focusing on isoflavone-rich red clover extract (RCE), this study expands on 
the DESIGNER approach to Deplete and Enrich Select Ingredients to Gene-
rate Normalized Extract Resources using countercurrent separation (CCS). 
Knockout and highly-enriched RCEs for biochanin A (1) and formonone-
tin (2) were prepared by centrifugal partition chromatography (CPC). The 
biphasic solvent system n-hexane-ethyl acetate-methanol-water (HEMWat 
5.5/4.5/5/5) yielded the target K values of 1.25 and 1.18 for 1 and 2, respec-
tively. The qHNMR characterization and quantitation of 81 CPC fractions 
identified 11 major isoflavonoids, including the target compounds with 
sufficient resolution for the preparation of knockout and highly-enriched 
extracts. To prepare sufficient quantities for animal studies, it was necessary 
to improve RCE solubility and loading capacity to 1.0 g per run by additi-
on of DMSO. This did not disrupt the separation profile. The preparation 
of knockout extracts was performed with two sequential CPC separations. 
The first CPC separation afforded 93.8% pure 1 with 0.6% of prunetin as a 
residual component. The second CPC step used HEMWat 4/6/4/6 and pro-
duced high purity 2. The isoflavone metabolome can resolved preparatively 
with high resolution by CPC technology large-scale DESIGNER extract 
preparation. Gravimetric investigations demonstrated the high efficiency 
of CPC technology for full and unbiased sample recovery (99.8%). 
P-205
DISCOVERY OF PHYTOPROGESTINS WITH MIXED 
AGONIST AND SYNERGISTIC ACTIVITY FROM 
TRIFOLIUM PRATENSE AND CORNUS OFFICINALIS
Jeongho Lee, Matthew Dean, Julia Austin, Joanna E. Burdette, Brian T. 
Murphy
Department of Medicinal Chemistry and Pharmacognosy, Center for 
Pharmaceutical Biotechnology, College of Pharmacy, 833 S. Wood St., 
University of Illinois at Chicago, Chicago, IL 60612, United States
The use of botanical dietary supplements is becoming increasingly popu-
lar for the alleviation of hormonal-based conditions such as hot flashes, 
premenstrual syndrome, and fertility. Estrogen and progesterone recep-
tors (ER and PR) play an essential role in these processes. However, despi-
te the fact that many therapies used to alleviate gynecological conditions 
act through PR-mediated mechanisms, few studies have investigated or 
identified any herbal natural product components that act on this recep-
tor, particularly when comparing literature focused on estrogenic con-
stituents. In the current study, we used a progesterone response element 
(PRE)-luciferase reporter assay to identify seven phytoprogestins present in 
red clover (Trifolium pratense) and dogwood (Cornus officinails) extracts. 
While looking for compounds in both plants, irilone (1), cornuside (5), 
(7α)-7-O-methylmorroniside (6), and a new derivative, demethoxycornu-
side (7) exhibited a synergistic interaction with progesterone. Prunetin (2), 
formononetin (3) and biochanin A (4) exhibited mixed agonist activity. 
Collectively these results suggest that the effects of red clover and dogwood 
extracts repeatedly observed in cultured cells, and the inverse correlation 
between risk of various cancers and flavonoid intake may be due, in part, to 
altered progesterone signaling.
P-206
INDOLE DITERPENES IN IPOMOEA ASARIFOLIA AND 
IPOMOEA MUELLERI 
Stephen T. Lee1, Dale R. Gardner1, Daniel Cook1, Kevin D. Welch1
1USDA ARS Poisonous Plant Research Laboratory, 1150 East, 1400 North, 
Logan, UT, 84341
Ipomoea asarifolia and Ipomoea muelleri have been associated with a tre-
morgenic syndrome in livestock in Brazil and Australia, respectively.  Ipo-
moea asarifolia and I. muelleri were investigated by high-performance li-
quid chromatography–high-resolution mass spectrometry (HPLC–HRMS) 
and high-performance liquid chromatography–tandem mass spectrometry 
(HPLC–MS/MS) for indole diterpene composition. The high-resolution 
mass spectrometric data in combination with MS/MS fragmentation mass 
spectral data provided valuable information for indole diterpene characte-
rization.  Several indole diterpenes were detected in each species.    Three 
new indole diterpenes were isolated and their structures determined by 
1D and 2D NMR spectroscopy and given the names 11-hydroxy-12,13-
epoxyterpendole K, 6,7-dehydroterpendole A, and 6,7-Dehydro 11-hydro-
xy-12,13-epoxyterpendole A.  The tremorgenic potential of the new indole 
diterpenes were evaluated in a mouse model.  
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P-207
PHYTOCHEMICAL AND ANTIPROLIFERATIVE ACTIVITY 
INVESTIGATIONS OF THE LICHEN NIEBLA HOMALEA 
Yan Zhang1, Choon Yong Tan1, Richard Spjut2, L. Harinantenaina 
Rakotondraibe1
Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, 
The Ohio State University, Columbus, OH 43210, 2World Botanical 
Associates, P.O. Box 81145, Bakersfield, CA 93380 
Lichens are symbiosis organisms composed of fungi (mycobionts) and one 
or more algae and/or cyanobacteria (photobionts). Triterpenes, phenolic 
compounds (e.g. depsides, depsidones, quinones, xanthones, diphenyl 
ethers), and sesquiterpenes were reported from lichens and their mycobi-
onts. Lichen metabolites have been shown to display biological activities 
such as cytotoxicity, antiviral, and antimicrobial activities. During our sys-
tematic search for antiproliferative (against A2780, ovarian and MCF-7, 
breast cancer cell lines) compounds from lichens and their mycobionts, we 
selected a lichen identified Niebla homalea (Ach.) Rundel & Bowler (Ra-
malinaceae) for further studies on cytotoxicity. N. homalea is a species of 
fruticose lichen endemic to the coastal fog regions California and Baja Cal-
ifornia. To date, no bioactive chemical investigation has been reported on 
the lichen genus Niebla. To determine the unknown chemotaxonomy of the 
genus and to identify secondary metabolites that can display antiprolifera-
tive activity, we carried out the phytochemical investigation of the present 
N. homalea. We discovered eight stictane triterpenoids (including five new, 
1-5) and isolated four known phenolic compounds. The structure elucida-
tion, antiproliferative evaluation of the secondary metabolites as well as the 
chemotaxonomy of the genus Niebla will be presented.  
P-208
UP480P, AS A NATURAL PRESERVATIVE
Ping Jiao1, Mei Hong1, Misun Oh2, Qi Jia1 
1Unigen USA, 3005 1st Avenue, Seattle, WA 98121, USA, 2Naturetech, 200-1 
Songjung-Ri, Byeongcheon-Myeon, Cheonam-Si, Chungnam 330-863, South 
Korea 
There is a need for natural compositions with broad antimicrobial activity 
to be utilized as safer and more environment-friendly natural preservatives 
for cosmetic and personal care products. UP480P, a unique combination 
of two plant extracts of Albizia amara seeds and Magnolia officinalis barks, 
has been developed as a natural preservative with proven anti-microbial 
activities. Magnolia officinalis barks contains two major lignans - Magnolol 
and Honokiol, which are responsible for the antibacterial and antifungal 
activities. The Albizia amara seed extract showed potent inhibition against 
both Gram-positive and Gram-negative bacteria with macrocyclic alkalo-
ids - budmunchiamines identified as active components. UP480P showed 
potent antimicrobial activities with unexpected synergistic effect by com-
bining Magnolia and Albizia extracts with MIC values determined against 
five microorganisms including E. coli, P. aeruginosa, S. aureus, A. brasilien-
sis, and C. albicans. UP480P were also evaluated following USP <51> gui-
deline at two concentrations of 0.5% and 0.1% in a non-ionic Oil/Water 
emulsion system. The safety of UP480P has been demonstrated by both in 
vitro and human safety tests. 
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P-209
PHYTOTOXIC NEW FURANOCOUMARIN AND 
ANALOGS FROM LEAVES OF AMYRIS ELEMIFERA 
Kumudini M. Meepagala1, Amy K. Bracken1,2, and Stephen O. Duke1
1USDA-ARS, Natural Products Utilization Research Unit, University, 
MS 38677, 2Sally McDonnell Barksdale Honors College, University of 
Mississippi, University, MS 38677
Plants produce secondary metabolites to compete with other fungi, plants, 
and insects. Thus, these secondary metabolites can have various biologi-
cal activities such as antifungal, insecticidal, and phytotoxic activities. The 
plants in the Rutaceae family are especially enriched in these compounds. 
We investigated Amyris elemifera, a plant in the Rutaceae family in search 
of such compounds. Chromatographic fractionation of the ethyl aceta-
te extract of the leaves of A. elemifera afforded a novel furanocoumarin, 
2-(9-((3-methylbut-2-en-1-yl)oxy)-7-oxo-2,3-dihydro-7H-furo[3,2-g]
chromen-2-yl)propan-2-yl acetate with phytotoxic and antifungal activi-
ties. In the seedling development bioassay for evaluating phytotoxic activi-
ty, this compound was more active against the monocot Agrostis stolonifera 
than the dicot Lactuca sativa. This novel compound is the major constituent 
in the ethyl acetate extract of the leaves. Isolation of the active metabolite, 
elucidation of structure and biological activities, and synthesis of analogs 
will be discussed. 
P-210
EVALUATION OF MACA AND AÇAÍ FOR CYP3A4 
INHIBITION AND INDUCTION AND THEIR POTENTIAL 
TO PRODUCE BOTANICAL-DRUG INTERACTIONS
Yilue Zhang1, Elizabeth Lopez1,2, Da Jung1,2, Kodye Abbott3, Satyanarayana 
R. Pondugula3, Jingjing Qian 4, Richard A. Hansen4, Angela I. Calderón1
1Department of Drug Discovery and Development, Harrison School of 
Pharmacy, Auburn University, Auburn, AL 36849, 2College of Science and 
Math, Auburn University, Auburn, AL 36849, 3Department of Anatomy, 
Physiology and Pharmacology, Auburn University, Auburn, AL 36849, 
4Department of Health Outcomes Research and Policy, Auburn University, 
Auburn, AL 36849
The consumption of botanical dietary supplements (BDS) is a common 
practice among the US population, but potential of metabolic botani-
cal-drug interactions exists and its mechanism has not been well studied. 
CYP3A4 is an important enzyme that contributes to the metabolism of 60% 
clinically used drugs, including most anticancer agents.  This study focused 
on Lepidium meyenii Walpers (maca) root and Euterpe oleracea Mart. (açaí) 
berries since they are commonly used BDS that may be co-administered 
with CYP3A4-metabolized drugs. Parallel artificial membrane permea-
bility assay (PAMPA) was conducted to filter intestinal passively diffused 
compounds of maca and açaí extracts that were subsequently screened for 
liver CYP3A4 inhibition and induction.  Passively diffused constituents of 
methanol açaí extract with IC50 of 28.03 µg/µL and non-passively diffused 
constituents of acidic methanol açaí extract with IC50 of 0.49 µg/µL demon-
strated the highest inhibition potential. Moreover, both passively diffused 
and non-passively diffused compounds in methanol açaí extract at 1.5 µg/
µL displayed the most significant hepatic CYP3A4 induction. This study 
suggests more potential of açaí to produce metabolic CYP3A4 interactions 
than maca extracts.
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P-211
TWO NEW SERRATANE-TYPE TRITERPENES FROM 
HUPERZIA SERRATA
Byeol Ryu1, Mina Lee2, Sang Hyun Sung1,*
1College of Pharmacy and Research Institute of Pharmaceutical Science, 
Seoul National University, Seoul 08826, Republic of Korea. 2College of 
Pharmacy, Sunchon National University, Jeonnam 57922, Republic Korea
Huperzia serrata (Thunb.) Trev. (Huperziaceae, also named Lycopodium 
serratum) is a traditional Chinese herbal medicine used for the treatment 
of contusion, strain, swelling, and schizophrenia. To search for structural-
ly interesting and bioactive serratane-type triterpenes, we have focused on 
nonalkaloidal fraction and two new compounds (1 and 2) along with four 
known compounds (3 - 6) were isolated. The chemical structures of isolates 
were determined by spectroscopic data interpretation, particularly by 1D- 
and 2D-NMR studies. Thereafter all the isolated compounds (1 - 6) were 
evaluated for cytotoxicity against hepatic stellate cells (HSC-T6).
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P-212
NEW LIGNANS AND SECOIRIDOID 
GLYCOSIDES FROM JASMINUM SINENSE 
Ya-Ching Shen1
1School of Pharmacy, College of Medicine, National Taiwan University, 
Taipei, Taiwan 
Three new lignans and secoiridoid glycosides were isolated by chromato-
graphic fractionation of alcoholic extract of Jasminum sinense and named 
jasminolignans A-C (1-3). They were identified as 2α-(4β-D-glucosyloxy-
3-methoxy-phenyl)-4α-(3-methoxy-4-hydroxy-phenyl)-3,7-dioxabicyclo 
[3.3.0]-octane (1), 2α-(4β-D-glucosyloxy-3-methoxy-phenyl)-4α-[3-me-
thoxy-4-O- (5-ethylidene- 6β-D-glucosyloxy-5,6-dihydro-2H-pyran-3-car-
boxylic acid methyl ester-7-oxoyloxy)- 2-acetyl- phenyl]-1β-hydroxy-3,7-
dioxabicyclo[3.3.0]-octane (2), and 3β-[(4β-D-glucosyloxy-3-methoxy- 
phenyl)-α-hydroxy]-methyl-4β-hydroxy-4α-(3-methoxy-4-hydroxy-
phenyl)-tetrahydro-4H-pyran (3). The structures and the relative configu-
rations of the new metabolites were elucidated through extensive spectro-
scopic analyses.  
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P-213
NEW TRITERPENOIDS FROM STEMS OF SCHISANDRA 
ARISANENSIS  
Chan–Han Hsieh1, Ching-Te Chien2 and Ya-Ching Shen1,*
1School of Pharmacy, College of Medicine, National Taiwan University, 
Taipei, Taiwan; 2Division of Silviculture, Taiwan Forestry Research Institute, 
Taipei, Taiwan
Schisandra arisanensis is an endemic medicinal plant grown in mountai-
nous area of Taiwan. Previously, many new triterpenoids have been isolated 
from the fruits of this species. Chemical investigation of triterpenoids from 
the stems of S. arisanensis revealed 22 triterpenoids including eight new 
compounds. The new compounds are classified into four types according 
to their carbon skeleton patterns, 14(13→12)16(17→13)–diabeoschiarta-
ne–type, wuweiziartane–type, lancischiartane–type and preschisanartane–
type. All the isolated triterpenoids will be discussed in the meeting.
14(1312):16(1713)-diabeoschiartane   wuweiziartane   
 
lancischiartane     preschisanartane
P-214
BLACK COHOSH (ACTAEA RACEMOSA) EXTRACTS 
AND COMPOUNDS ENHANCE OSTEOBLASTOGENESIS 
IN HFOB OSTEOBLASTS BY ACTING AS HDAC 
AGONISTS
Nishikant Raut1, Zhitao Ren2, Temitope O. Lawal3, Sheila M. Wicks4, 
Shitalben Patel5, Gail B. Mahady5
1Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj 
Nagpur University, Nagpur, India, 2Univerity of Macau, Macau, China, 
3Department of Pharmaceutical Microbiology, University of Ibadan, Ibadan, 
Nigeria, 4Department of Cellular and Molecular Medicine, Rush University, 
Chicago, IL 60607. 4Department of Pharmacy Practice, College of Pharmacy, 
PAHO/WHO Collaborating Centre, University of Illinois at Chicago, 
Chicago, IL 60607, USA.
Extracts of the roots and rhizomes of Actaea racemosa, commonly known 
as black cohosh are widely used for the management of menopausal symp-
toms and bone health. In mouse myoblasts, extracts of black cohosh (EBC) 
enhanced osteoblast differentiation and increased trabecular bone struc-
ture and BMD in mice, however the mechanisms have not been entirely 
elucidated. In this work, we investigate the effects of EBC, actein (Ac) and 
deoxyactein (Dc) in hFOB cultured human osteoblasts. The extract, Ac and 
Dc all enhanced osteoblast proliferation and reduced apoptosis. EBC, Ac 
and Dc increased osteoblast proliferation and reduced apoptosis in cultured 
human osteoblasts (hFOB) by reducing the Bax/Bcl-2 ratio, and acting as 
HDCA agonists by concentration dependently increasing SIRT1, HDAC1, 
and HDAC3. Ac and Dc (5-20 ng/ml) also induce mitochondrial biogenesis 
in hFOB osteoblasts by increasing the expression of PGC1α mRNA. These 
data support the hypothesis that black cohosh enhances bone formation by 
increasing osteoblastogenesis through epigenetic regulation of HDACs and 
mitochondrial biogenesis. 
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BLACKCURRANT (RIBES NIGRUM L., 
GROSSULARIACEAE) EXTRACTS ENHANCE 
OSTEOBLASTOGENESIS IN HFOB OSTEOBLASTS AND 
TELEOST FISH 
Nishikant Raut1, Zhitao Ren2, Temitope O. Lawal3, Sheila M. Wicks4, 
Shitalben Patel5, Gail B. Mahady5
1Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj 
Nagpur University, Nagpur, India, 2Univerity of Macau, Macau, China, 
3Department of Pharmaceutical Microbiology, University of Ibadan, Ibadan, 
Nigeria, 4Department of Cellular and Molecular Medicine, Rush University, 
Chicago, IL 60607. 4Department of Pharmacy Practice, PAHO/WHO 
Collaborating Centre, University of Illinois at Chicago, Chicago, IL 60607, 
USA.
Blackcurrants (Ribes nigrum) are native to Central and Eastern Europe and 
Northern Asia and are used in traditional medicine for the treatment of 
cardiovascular disease, diabetes, viral infections and inflammation. The 
berries contain four major anthocyanins: delphinidin-3-O-glucoside, del-
phinidin-3-O-rutinoside, cyanidin-3-O-glucoside, cyanidin-3-O-rutino-
side. We have previously shown that blackcurrant extracts (BCE) increase 
myoblastogenesis, and in this work, we investigate its effects in cultured 
hFOB human osteoblasts and osterix/Sp7:mCherry transgenic medaka. 
BCE and delphinidin-3-glucose increased osteoblast proliferation and re-
duced apoptosis in cultured human osteoblasts (hFOB) by reducing Bax 
and p53 expression and increasing HDAC1, HDAC3 and PGC1α mRNA 
expression. In osterix/Sp7:mCherry medaka, BCE treatment (10 µg/ml) in-
creased osteoblast proliferation by increasing osterix/Sp7 expression. These 
data suggest that BCE and D3G increase osteoblastogenesis through epi-
genetic regulation of HDACs and mitochondrial biogenesis. 
P-216
CHEMICAL INVESTIGATION OF BOEHMERIA 
FORMOSANA ASSISTED BY HPLC-SPE-TT-NMR/MS
Wan-Ting Huang, Shoei-Sheng Lee and Chia-Chuan Chang
School of Pharmacy, College of Medicine, National Taiwan University, 33 
Lin-Sen S. Rd., Taipei 10050, Taiwan
Chemical investigation of the constituents from the EtOAc-soluble fraction 
of Boehmeria formosana root via Sephadex LH-20, reversed phase HPLC, 
and centrifugal partition chromatography led to the isolation of nine com-
pounds (1—9). As the hyphenated HPLC-SPE-TT-NMR/MS technique 
can provide much more information for structural elucidation of the minor 
compounds than the general approaches, this hyphenation was applied in 
this study to characterize the minor natural constituents. This approach led 
to characterization of four additional compounds (10—13) from a partially 
purified mixture, about 2 mg at most. Among these isolates, compound 13 
is a novel tetrameric phenylpropanoid. Its structural elucidation, based on 
extensive spectroscopic analysis, was presented.
P-217
MASS SPECTROMETRY DETECTION OF BOTANICAL 
SECONDARY METABOLITE MODIFICATIONS BY THE 
GUT MICROBIOME
Heather L. Winter1, Daniel A. Todd1, Stephen J. Polyak2, William R. 
DePaolo3, Nicholas H. Oberlies1, Nadja B. Cech1
1Department of Chemistry and Biochemistry, University of North Carolina 
at Greensboro, Greensboro, NC, 27412, 2Department of Laboratory 
Medicine, University of Washington, Seattle, WA, 98195, 3Center for 
Microbiome Sciences & Therapeutics, University of Washington Medicine, 
Seattle, Washington, 98185
Secondary metabolites derived from botanical sources have historically 
been utilized in the medical community due to their extensive exhibition of 
beneficial effects on human health. The potential role of the gut microbiome 
in dictating or altering biological activity of such secondary metabolites has 
recently become a topic of great interest. Modifications to already active 
components of botanicals may serve as a source of new drug candidates, 
or may explain the beneficial health effects that result from consumption 
of plant based foods or medicines. We have conducted experiments to ex-
plore the influence of gut microbes on the compound parthenolide, isolated 
from the botanical medicine Tanacetum parthenium. Mass spectrometry 
was used as a tool to detect structural modifications to parthenolide after 
in vitro exposure to gut microbes. Several unique compounds derived from 
parthenolide, including methylated and methoxylated forms, were detected 
by mass spectrometric analysis in these studies.
P-218
ENERGY METABOLISM AND IMMUNOMODULATORY 
MECHANISM OF MACA BASED ON SPLEEN-
DEFICIENCY SYNDROME MICE
Wenting Fei1, Yujie Wang1, Yan Hou1, Xue Zhou1, Na Yue1, Aimin Li2, 
Linyuan Wang1, Jianjun Zhang1*
1 Beijing University of Chinese Medicine, 11 Beisanhuandonglu, Chaoyang 
District, Beijing 100029, China, 2 New Era Health Industry(Group) Co., Ltd., 
Beijing 102206, China
Maca (Lepidium meyenii Walp.), native to Peru, is quite popular used with a 
variety of traditional Chinese medicinal materials in China. However, its us-
age is still lack of theoretical basis on the issue of Traditional Chinese Med-
icine(TCM). This study put forward TCM properties of Maca and aimed 
to verify it by investigating the mechanism of energy metabolism and im-
munomodulatory on spleen-deficiency mice. Ginseng, a major strengthen 
spleen herb, as control. Maca significantly increased the numbers of periph-
eral blood cells and reversed the atrophy of thymus and spleen. In addition, 
Maca increased lymphocyte proliferation inhibition rate and lymphocytes 
cycle were detected by flow cytometry. The proportion of cells in G2/M 
phase and S phase increased, but the proportion of cells in G0/G1 phase 
decreased. The levels of IL-2, IL-4, TNF-β, IFN-γ in serum increased, mea-
sured by RIA. Then study of hot and cold property indexes, the differences 
in the thermotropism behaviors of mice after administration showed that 
Maca has the warm property. Furthermore, the ratio of cAMP/cGMP in se-
rum and the level of mitochondrial energy metabolism enzymes increased. 
This study revealed the mechanism of improving the immune system and 
promoting energy metabolism by Maca. Our results suggest that Maca has 
the function of strengthen spleen and the TCM property of warm.
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ABSOLUTE CONFIGURATION AND CONFORMATION 
OF TWO ISOPRENYLATED FLAVONOIDS 
FROM DODONAEA VISCOSA BY NMR AND ECD 
SPECTROSCOPIC ANALYSIS
Ahmad E.Mostafa1, Khaled Elokely2, Atef A. El-Hela1, Abd-Elsalam 
I.Mohammad1, Stephen J.Cutler3, Samir A.Ross4,5*
1Department of Pharmacognosy, Faculty of Pharmacy, University of Al-
Azhar, Cairo 11371, Egypt, 2Institute for Computational Molecular Science 
and Moulder Center for Drug Discovery Research, Temple University, 
Philadelphia, PA 19122, USA, 3Dean, Collage of Pharmacy, University 
of South Carolina, 772, 700 Sumter St, Columbia, S.C. 29208, USA, 
4Department of BioMolecular Sciences, and 5National Center for Natural 
Products Research,  School of Pharmacy, The University of Mississippi, 
University, MS 38677, USA.
Two isoprenylated flavonoids from Dodonaea viscosa have been isolated, 
previously, without determination of their configuration. The present study 
shows that a combination of NMR and electronic circular dichroism (ECD) 
techniques are a relatively straightforward method to determine the abso-
lute configuration of isomer compounds. HREMS values, 1H-NMR and 
13C-NMR chemical shifts, are the same for the two isomers, except their 
stereocenters and their adjacent atom. we complement our study by car-
rying out (ECD) spectral simulations for the two models and the related 
diastereomers. The calculated ECD spectra was consistent with the experi-
mental results for both isomers. 
P-220
DETERMINATION OF ANTHRAQUINONES FROM 
BULBINE NATALENSIS (BULBINE LATIFOLIA) AND 
DIETARY SUPPLEMENTS USING UHPLC-PDA-MS 
Ji-Yeong Bae1, Bharathi Avula1, Yan-Hong Wang1, Mei Wang1, Alvaro M. 
Viljeon2,3 and Ikhlas A. Khan1,4
1National Center for Natural Products Research, School of Pharmacy, 
University of Mississippi, University, MS 38677, USA, 2Department of 
Pharmaceutical Sciences and 3SAMRC Herbal Drugs Research Unit, 
Tshwane University of Technology, Pretoria, South Africa, 4Division of 
Pharmacognosy, Department of BioMolecular Sciences, School of Pharmacy, 
University of Mississippi, University, MS 38677, USA
Bulbine natalensis Baker (synonym Bulbine latifolia (L.f.) Spreng.), family 
Xanthorrhoeaceae, is widely distributed in South Africa and traditionally 
used as an aphrodisiac and skin remedies. A validated ultra-high perfor-
mance liquid chromatography-photodiode-array method was developed 
for the quantification of seven anthraquinone type of compounds. The sep-
aration was achieved using a reversed phase (C-18) column, photodiode ar-
ray detection, and a gradient of water/acetonitrile as the mobile phase. The 
seven compounds could be separated within 15 minutes using the devel-
oped UHPLC method with detection limits of 25 ng/mL with 2 µL injection 
volume. The analytical method was validated for linearity, repeatability, ac-
curacy, limits of detection (LOD) and limits of quantification (LOQ). The 
Relative Standard Deviations (RSD) for intra- and inter-day experiments 
were less than 5%, and the recovery efficiency was 98-101%. Nine supple-
ments labeled as containing B. natalensis were available for sale, five prod-
ucts showed for the profile of B. natalensis with total content ranging from 
11.3 to 90.4 mg per recommended daily dose. Compounds of B. natalensis 
were not detected in four of nine supplements. The developed method is 
simple, economic, rapid and especially suitable for quality control analysis 
of B. natalensis. LC-mass spectrometry coupled with electrospray ioniza-
tion (ESI) method is described for the identification and confirmation of 
compounds in plant samples and dietary products. 
P-221
 EXTRA-VIRGIN OLIVE OIL C-MET INHIBITOR 
OLEOCANTHAL-LAPATINIB: A NOVEL SYNERGISTIC 
COMBINATION FOR THE CONTROL OF HER2+ BREAST 
MALIGNANCIES
Abu Bakar Siddique1, Hassan Ebrahim1, Mohamed Akl1, Nehad M. Ayoub2, 
Amira Goda1, Mohamed Mohyeldin1, Wael M. Hananeh2, Yong-Yu Liu1, 
Khalid El Sayed1*
1Department of Basic Pharmaceutical Sciences, School of Pharmacy, 
University of Louisiana at Monroe, Monroe, Louisiana 71201,2Department 
of Pathology and Public Health, Faculty of Veterinary Medicine, Jordan 
University of Science and Technology, Irbid 22110, Jordan.
Dysregulation of EGFR/HER2 family is a hallmark of aggressive breast 
cancer (BC). Small-molecule tyrosine kinase inhibitors (TKIs) are among 
the most effective cancer targeted treatments. (-)-Oleocanthal (OC) is a 
naturally occurring phenolic secoiridoid lead from extra-virgin olive oil 
(EVOO) with documented anti-cancer activities via targeting c-Met. Dys-
regulation of c-Met promotes resistance to BC targeted therapies. Lapati-
nib (LP) is a dual EGFR/HER2 inhibitor for HER2-amplified BC. Combi-
ned OC-LP treatment was hypothesized to be mechanistically synergistic 
against HER2-overexpressing BC. Combined sub-effective concentrations 
of OC-LP resulted in synergistic anti-proliferative effects against the HER2-
positive BT-474 and SK-BR-3 BC cell lines. Antibody Array and Western 
blot analysis showed that combined OC-LP treatment inhibited EGFR, 
HER2, and c-Met receptor activation as well as multiple downstream signa-
ling proteins. OC-LP combination significantly inhibited BC cell invasion, 
migration, and reduced activation of FAK, and paxillin. Combined treat-
ment of OC (5 or 10 mg/kg) with LP (50 or 12.5 mg/kg) suppressed BT-474 
tumor growth by more than 90% in a nude mice xenograft model. c-Met, 
EGFR, HER2 were significantly suppressed in treated mice tumors. This 
study reveals OC translational potential for use to sensitize HER2-overex-
pressing BC and synergize with chemotherapeutics targeting HER family. 
P-222
INTER-KINGDOM BEACH WARFARE: A TALE OF TWO 
MICROBES. 
Zeinab G. Khalil,1 Pablo Cruz-Morales,2 Cuauhtemoc Licona-Cassani,2 
Esteban Marcellin,2 Robert J. Capon1
1Institute for Molecular Bioscience and 2Australian Institute for 
Bioengineering and Nanotechnology, The University of Queensland, St 
Lucia, Queensland 4072, Australia. 
Inter-kingdom beach warfare between Streptomyces sp. CMB-StM0423 and 
Aspergillus sp. CMB-AsM0423, co-isolated from beach sand collected on 
Heron Island, Australia, sees the Aspergillus metabolite cyclo-(L-Phe-trans-
4-hydroxy-L-Pro) (DKP) stimulate the Streptomyces to produce nitric oxide 
(NO), which mediates transcriptional activation of silent biosynthetic gene 
clusters (BGCs) for heronapyrrole B, and in turn prompts the Aspergillus 
to upregulate DKP.  Structure activity relationship studies, coupled with 
the use of NO synthase inhibitors, NO donors and scavengers, and chemi-
cal, biochemical, microscopic, genomic and transcriptomic analyses, con-
firmed the specificity of DKP as an NO activator. These findings highlight 
the importance of inter-kingdom chemical cues (particularly NO) in regu-
lating silent BGCs. We have since determined NO mediated transcriptional 
activation (NOMETA) has a broader ecological footprint, and has potential 
application in microbial biodiscovery.
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IN-VITRO AND IN-VIVO ANALYSIS OF FORMULATED 
COLA NITIDA TABLET AND CREAM IN THE 
TREATMENT OF DERMATOPHYTE INFECTION
Olakunle Olayinka Mebude1, Bolanle A. Adeniyi1*
1 Department of Pharmaceutical Microbiology, University of Ibadan, Ibadan.
This study assessed the formulation and evaluation of anti-dermatophyt-
ic activities of tablets and creams prepared from ethanol extract of Cola 
nitida stem bark and Avicel by direct compression with simple ointment 
B.P.C. The tablet in synergy with the simple ointment as a combination 
therapy for the treatment of dermatophyte infection by Trichophyton ru-
brum and Trichophyton tonsurans in-vitro was evaluated. The variables used 
in the formulation of the cream and tablet elicited synergistic potency of 
Cola nitida for the treatment of dermatophyte infection with varied zones 
of inhibition. The statistical ratio obtained from this study indicated that 
H (2.5% extract + 10% glycerine + 87.5% base) and F (5% extract + 5% 
propyleneglycol + 90% base) in combination with 200 mg of CNSB (Cola 
nitida stem bark) tablet elicited the greatest efficacy with zones of inhibition 
of 25±0.2 and 20± 0.2. While for the non-combination treatment, zones of 
inhibition were 14±0.1 and 10± 0.1. The in-vivo analysis revealed histo-
logically and hematologically that though the control drug, ketoconazole 
and 5-fluorouracil were active against the tested dermatophytes, there is 
rupturing of cells at the site of infection after treatment. In treatment with 
formulated Cola nitida stem bark; there were no obvious rupturing of the 
cells of the wistar rats after treatment.  This affirmed the fear of medical 
practitioners in prescribing oral drugs when patients present with derma-
tophyte infection because they are eukaryotic in nature.
P-224
NONTUBERCULOUS MYCOBACTERIA SPECIES ARE 
INHIBITED BY METHANOL EXTRACTS OF COLA NITIDA 
(VENT.) SCHOTT
T. O. Lawal., T. S. Agidigbi and *B. A. Adeniyi
Department of Pharmaceutical Microbiology, Faculty of Pharmacy, 
University of Ibadan, Nigeria.
Cola nitida (Vent.) Schott. used in traditional medicine to treat asthma, 
whooping cough and other respiratory tract diseases including tuberculosis 
was investigated for antimycobacterial activities in five nontuberculous my-
cobacteria species viz: Mycobacterium fortuitum ATCC 684, Mycobacterium 
smegmatis ATCC 19420, Mycobacterium phlei ATCC 19240, Mycobacterium 
abscessus and Mycobacterium smegmatis. Preliminary antimycobacterial 
screening was done by the agar diffusion method. The minimum inhibitory 
concentration (MIC) of the methanol extract was determined by the agar di-
lution method while the bactericidal activity was studied by the viable count-
ing technique. Phytochemical screening for the detection of secondary me-
tabolites revealed the presence of saponins, tannins, reducing sugar, phenol 
and glycoside in the bark while alkaloids, tannins, reducing sugar, phenolics, 
glycoside, resin and terpernoids were detected in the leaf sample. Alkaloids, 
tannins, reducing sugar and resin were the secondary metabolites detected 
in the seed. The methanol extracts of the bark at 100 mg/mL demonstrated 
highest activity with diameter of zone of inhibition between 14±0.2 mm and 
24±0.4 mm. The MIC for the bioactive extracts was in the range of 12.5 – 50 
mg/mL while the minimum bactericidal concentration (MBC) ranged from 
75 mg/mLto 200 mg/mL. Time-kill assay revealed a drastic decline (> 50%) 
in population after 6 hours of exposure to methanol extracts of seed and bark 
at concentrations equivalent to 2 x MIC and 4 x MIC accompanied with a 
total kill (100%) of the population at 24 hour
P-225
COMBINATION THERAPY WITH β-GLUCAN AND 
COENZYME Q10 IN MURINE EXPERIMENTAL 
AUTOIMMUNE DISEASE AND CANCER
Vaclav Vetvicka*, Jana Vetvickova
University of Louisville, Department of Pathology, Louisville, KY, USA
Coenzyme Q10 (CoQ10), also known as ubiquinone or ubidecarenone, is an 
essential substance for electron transport in oxidative phosphorylation and 
also serves as an important anti-oxidant. CoQ10 is recently gaining attention 
as a substance with significant anti-inflammatory properties. In addition to 
the effects on various aspects of immune system, CoQ10 was also found to 
positively affect fatigue, have positive effects on type 1 and type 2 diabetes 
mellitus and serve as a preventive agent against toxicity acting via modula-
tion of oxidative stress. 
In our study, we decided to evaluate the possibility that Q10 effects will be 
potentiated by simultaneous addition of well-established immune modula-
tor β-glucan. A Q10 and β-glucan were used both in vivo and in vitro and 
their effects were evaluated using phagocytosis, cytokine secretion, two types 
of experimentally-induced inflammatory problems and cancer. Our study 
confirmed strong anti-inflammatory effects of CoQ10 and showed that the-
se effects were further potentiated by addition of β-glucan. The anti-cancer 
effects of CoQ10 were less pronounced, but again, stronger with added β-glu-
can. Based on our studies, we can conclude that there is significant synergy 
between CoQ10 and β-glucan, suggesting that this combination has a poten-
tial for further development in anti-inflammatory and anti-cancer treatment.
P-227
GASTROPROTECTIVE EFFECTS OF CARVONE 
ENANTIOMERIC PAIR.
Lucia Elaine de Oliveira Braga 1,2, Karin Maia Monteiro 2, Gisele Goulart da 
Silva 1,2, Mary Ann Foglio 1,3, Ana Lúcia Tasca Gois Ruiz 1,2,3
1 FOP/UNICAMP, Piracicaba – SP, Brazil; 2 CPQBA/UNICAMP, Paulínia – 
SP, Brazil;3 FCF/UNICAMP, Campinas – SP, Brazil, University of Campinas 
- UNICAMP.
Mentha aquatica (Lamiaceae) essential oil contains almost 60% of carvone. 
This study evaluated the gastroprotective effects of both R-(-)-carvone (R-
C) and S-(+)-carvone (S-C). The carvone enantiomeric pair was purchased 
from Merck. The Ethics Committee (CEUA/UNICAMP) approved the in 
vivo protocols using male Wistar rats. The anti-ulcer activity was evaluated 
in ethanol-induced gastric ulcer; the animals (n = 7) were treated (v.o.) with 
PBS (10 ml/kg, vehicle), Carbenoxolone (200 mg/kg, positive control), R-C 
or S-C (10, 30, 100 mg/kg) 1 h before ethanol administration (4 mL/Kg). 
After 1 h, the stomachs were removed, opened along the greater curvature, 
photographed at a fixed distance and the relative ulcerative areas (%) were 
analyzed using ImageJ®. The anti-secretory activity was evaluated in pylorus 
ligation model; the animals (n = 7) were treated (intraduodenal) with PBS 
(2.5 ml/kg, vehicle), Cymetidine (100 mg/kg, positive control), R-C or S-C 
(10, 30, 100 mg/kg) immediately after pylorus ligation. After 4 h, the gastric 
content was collect to volume, pH and hydrogenionic concentration evalu-
ations. All results were submitted to statistic evaluation (ANOVA followed 
by Tuckey). Both R-C (ED50 = 25.6 mg/kg). and S-C (ED50 = 16.2 mg/kg) 
prevented ethanol-induced ulcers. 
Acknowledgment: CAPES, FOP/UNICAMP, CPQBA/UNICAMP.
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TARGETED DEREPLICATION OF MICROBIAL 
NATURAL PRODUCTS BY HIGH-RESOLUTION MS AND 
PREDICTED LC RETENTION TIME
Mary McKee1, Justine Chervin2, Marc Stierhof2, Ming H. Tong2, Doe Peace2, 
Kine Ø. Hansen3, Dagmar S. Urgast2, Jeanette H. Andersen3, Yi Yu4, Rainer 
Ebel2, Kwaku Kyeremeh5, Veronica Paget1, Gabriela Cimpan1, Albert Van 
Wyk1, Hai Deng2, Marcel Jaspars2, and Jioji N. Tabudravu2
1Advanced Chemistry Development, Inc., 8 King Street East - Suite 107, 
Toronto, ON, Canada, M5C 1B5, 2The Marine Biodiscovery Centre, 
Department of Chemistry, University of Aberdeen, AB24 3UE, Aberdeen, 
Scotland, UK, 3Marbio, UiT The Arctic University of Norway, Breivika, 
N-9037, Tromsø, Norway, 4Key Laboratory of Combinatory Biosynthesis and 
Drug Discovery (Ministry of Education), School of Pharmaceutical Sciences, 
Wuhan University, 185 East Lake Road, Wuhan 430071, People’s Republic 
of China, 5Marine and Plant Research Laboratory of Ghana, Department of 
Chemistry, University of Ghana, P.O. Box LG 56, Accra, Ghana
A new strategy for identification of known compounds in Streptomyces 
was developed via combined screening of two natural product databases. 
StrepDB contains LCMS data for 5555 natural products, and was screened 
using a high-throughput processing algorithm that rapidly identifies 
known compounds using HRMS data and predicted LC retention times. 
MbcDB contains structures and analytical data for 665 natural products 
and was generated using the ACD/Spectrus DB Platform. StrepDB was 
used to screen a mutant Streptomyces albus extract, which led to the identi-
fication of two new compounds, legonmaleimides A and B. Their proposed 
structures were then confirmed by computer-assisted structure elucidation 
methods using ACD/Structure Elucidator Suite. This strategy suggests an 
extract dereplication pipeline approach that can be applied to natural prod-
uct discovery.
P-229
THE MIXTURE OF DAUCOSTEROL AND LUPEOL 
AMELIORATE DSS-INDUCED INFLAMMATORY BOWOL 
DISEASE BY ENHANCING IMMUNE RESPONSES
Jin Jang1,*, Su-Man Kim1, Geung-Joo Lee2, Won-Kyung Yang3, Han-Young 
Kim4, Kun-Hoae Kim4, Hyung-Sik Kang1,† and Seung-Hyung Kim3,†
1School of Biological Sciences and Technology, Chonnam National 
University, 77 Yongbong-ro, Buk-gu, Gwangju 61186, Republic of Korea; 
2Department of Horticultural Science, Chungnam National University, 
Daejeon 34134, Korea; 3Institute of Traditional Medicine and Bioscience, 
Daejeon University, Daejeon 34520, Republic of Korea; 4Central Research 
Laboratories of Aekyung industrial Co.Ltd., Daejeon, Republic of Korea.
Inflammatory bowel disease (IBD) is known to be associated with inflam-
mation and ulceration in intestinal environment, but its pathogenesis is 
not clearly yet. Canavalia gladiata (CG) and Arctium lappa (AL) are wide-
ly used in traditional medicine and food, and have been demonstrated to 
have anti-inflammatory effects. Although CG and AL are popularly used 
in traditional medicine and food, the CGAL prevented the clinical signs 
of IBD and restored excessive production of ROS and IgA in DSS-induced 
IBD mice. The marker compounds of CG and AL mixture were identified 
as daucosterol (DA) and lupeol by HPLC. This study demonstrated that 
LPS-induced reactive oxygen species (ROS) and nitric oxide (NO) were 
measured after treatment with CG, AL, CGAL, lupeol, DA, and the mixture 
(lupeol+DA) of marker compounds such as DA and lupeol in Raw264.7 
cell. And the enhancing immune responses including increased population 
and activation of immune cells, up-regulation of cell cycle and induction of 
IgA and IgG production were observed in WT mice after administration 
of lupeol+DA. Furthermore, the lupeol+DA also ameliorated the clinical 
signs of IBD and improved the population and activation of immune cells 
in DSS-induced IBD mice. Moreover, the functional defects of NK cells and 
amplified production of IgA were reversed by the mixture of lupeol+DA. In 
conclusion, the lupeol+DA ameliorate the progression of DSS-induced IBD 
by enhancing the immune responses and recovering the functional defects 
of immune cells. 
P-230
A BACTERIAL PRODUCT INDUCES MATING IN 
ANIMAL’S CLOSEST RELATIVE
Joseph P. Gerdt1, Arielle Woznica2, Ryan E. Hulett2, Nicole King2, Jon Clardy1
1Department of Biological Chemistry and Molecular Pharmacology, 
Harvard Medical School, Boston, MA 02115, 2Howard Hughes Medical 
Institute, and Department of Molecular and Cell Biology, University of 
California, Berkeley, Berkeley, CA 94720
Choanoflagellates are the closest living relatives of animals, and thus serve 
as an excellent evolutionary model for the common ancestor of the animal 
kingdom. Notably, choanoflagellates share many signaling and cell-cell ad-
hesion proteins with animals. Furthermore, many choanoflagellate species 
can exist in both single celled and multicellular forms. The choanoflagellate 
Salpingoeca rosetta’s unicellular-to-multicellular transition is regulated by 
specific lipids produced by its prey bacteria (Algoriphagus machipongon-
ensis and other Bacteroidetes). In our search for new multicellularity-in-
ducing lipids, we serendipitously discovered that choanoflagellates begin 
to mate when exposed to a secreted product from a different environmen-
tal and symbiotic bacterium (Vibrio fischeri). To our surprise, the secret-
ed product was an enzyme. Bioassay-guided fractionation revealed the 
enzyme to be a chondroitinase. The chondroitinase digests chondroitin in 
the choanoflagellate proteoglycan coating, which is reminiscent of sperm 
cells releasing hyaluronidase to penetrate the egg coat in animal fertiliza-
tion. Significantly, this discovery revealed that (a) chondroitin is present in 
choanoflagellates—suggesting for the first time that this glycosaminoglycan 
preceded the evolution of animals, and (b) bacteria can induce fertilization 
in choanoflagellates via a mechanism similar to animal fertilization—sug-
gesting that bacteria may induce fertilization in primitive animals.
P-231
METABONOMICS STUDY OF MECHANISM OF 
PAEONIFLORIN ON CHRONIC RESTRAINT STRESS AND 
RADIOTHERAPY-INDUCED MYELOSUPPRESSION RATS
Danping Zhao, Ruying Tang, Zinan Zhao, Cheng He, Wei Li, JingxiaWang, 
Jianjun Zhang, Linyuan Wang*
Beijing University of Chinese Medicine, Beijing 100029, China
Paeoniflorin (PF) is considered as an effective ingredient of Paeoniae Radix 
Alba(PRA), in this study a novel approach using metabonomics was used 
to investigate the mechanism of PF on nourishing blood and anti-depress 
effect. The Chronic restraint stress and Radiotherapy-induced myelosup-
pression model rats were established by solitary and chronic restraint stress 
combined with radiation, a metabonomic approach based on LC-MS was 
used to profile metabolic pathway changed of the serum samples. The re-
sults showed that the changes in the levels of endogenous metabolites in 
the serum of model rats included higher levels of Phosphatidylcholine, L-
Kynurenine, L-Glutamine and other 11 metabolites, and a lower concen-
tration of Triglyceride, Butyrylcarnitine and other 9 metabolites, while PF 
group regulated insignificantly in the 11 metabolites. Five key metabolic 
pathways including ether lipid metabolism, glycerophospholipid metabo-
lism, alanine, aspartate and glutamate metabolism, arginine and proline 
metabolism and tryptophan metabolism were the most relevant pathways 
involved in the model rats, the mechanism of the efficiency of PF on nou-
rishing blood and anti-depress may be related  to  the  regulation of  these 
metabolic pathways.
Acknowledgements: The National Natural Science Foundation of Chi-
na(81173569, 81473370).
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STUDY ON ANTIOXIDANT AND IMMUNE 
REGULATIONEFFECTS OF DENDROBIUM 
HUOSHANENSE ON DEFICIENCY OF KINDEY-YIN MICE
Yan Hou, Ruying Tang, Yujie Wang, Wenting Fei, Na Yue, Xue Zhou, 
Linyuan Wang, Jianjun Zhang*
Beijing University of Chinese Medicine, No. 11, Bei San Huan Dong Lu, 
Chaoyang District, Beijing 100029
Dendrobium huoshanense (DH) is a species of Dendrobium, which is not 
included in the Chinese Pharmacopoeia clearly but has a history of several 
thousand years of application. Shennong Bencao Jing, the earliest mono-
graph of Chinese medicine, records that Dendrobium have the efficacies of 
replenishing the deficiency and reinforcing yin essence. In order to explore 
the antioxidant and immune regulation effects of DH, the kidney-yin de-
ficiency mice were set up with thyroxine under the guidance of the TCM 
theory in this study, both Dendrobium candidum, a collected in Chinese 
Pharmacopoeia and commonly used Dendrobiumand in clinic, and Liuwei 
Dihuang pills were used as control drugs, and the changes of hair, food in-
take, autonomous activity in mice were observed, and the body weight, thy-
mus index and spleen index were measured, and the level of IL-6 and IL-2 
in serum, the content of SOD, GSH-Px, CAT and MDA in liver tissues were 
detected separately. The results showed that DH can obviously alleviate the 
yin deficiency symptoms of mice, such as yellowing dull hair, dry stool, ye-
llow urine, restlessness, irritability, gain body weight of mice, increase the 
thymus index and spleen index, reduce the secretion of IL-6 and increa-
se IL-2 in serum, enhance the content of SOD,GSH-Px,CAT and decrease 
MDA in liver tissues, which indicates that DH has the abilities to improve 
the antioxidant ability and enhance immunity, and its mechanism may be 
related to nourish kidney-yin deficiency. This study not only further clari-
fies the pharmacological effect of DH, but also provides experimental basis 
for the rational clinical application and the development of health products. 
P-233
HUNTING FOR NEW CLASSES OF PANCREATIC CANCER 
THERAPEUTIC LEADS FROM CYANOBACTERIA
Jayanti Bhandari Neupane1, Wesley Yoshida1, Tedros Bezabeh2, Philip 
Williams1
1 Department of Chemistry, University of Hawaii at Manoa, Honolulu, HI 
96822, 2 Department of Chemistry, University of Guam, Mangilao, Guam, 
96923.
Pancreatic cancer is the twelfth most abundant form of cancer and yet has 
the third highest mortality rate in the United States.1 The high mortality 
rate from pancreatic cancer may be attributed to difficulties in early dia-
gnosis and the lack of effective therapeutic agents.2 To address the latter 
issue, we aim to discover new classes of pancreatic cancer therapeutic leads 
from the secondary metabolites, including exo-metabolomes, produced by 
various strains of cyanobacteria. We also seek to generate preliminary hy-
potheses on mechanisms of action of these active natural products from the 
principal component analyses of the whole cell NMR spectra of pancreatic 
carcinoma cells treated with these compounds, as well as with drugs with 
known mechanisms of action.
Extracts of Leptolyngbya sp. and Phormidium corium exhibited significant 
inhibition of proliferation of Panc-1 cells. Bioactivity guided separation 
of the media extract of Leptolyngbya sp. resulted in the isolation of a few 
chlorinated metabolites. Structure elucidation and evaluation of biological 
activity of these compounds will be discussed 
P-234
BOTANICALS CONTAIN MITOCHONDRIALLY-ACTIVE 
COMPOUNDS
Sandipan Datta1, Fakhri Mahdi2, Kelly Komachi3, Zulfiqar Ali4, Mika B. 
Jekabson5, Ikhlas A. Khan4,6, Owen Hughes3, Yu-Dong Zhou8,10, Dale G. 
Nagle9,10, Gino Cortopassi.1
1Dept. of Molecular Biosciences, School of Veterinary Medicine, U. of 
California, Davis, CA 95616, USA, 2Dept. of Biomolecular Sciences, School 
of Pharmacy, U. of Mississippi, Oxford MS, 38677, 3Eon Corporation, 1729 
Hampton Drive, Davis, CA 95616, 4National Center for Natural Products 
Research, School of Pharmacy, 5Dept. of Biology, 6Dept. of BioMolecular 
Sciences and RIPS, School of Pharmacy, 7Dept. of Chemistry and 
Biochemistry, U. of Mississippi, University, Mississippi, MS, 38677, 9Institute 
of Interdisciplinary Integrative Biomedical Research, Shanghai U. of TCM, 
Shanghai, 201203, China.
Mitochondrial agonism and antagonism are both viable therapeutic stra-
tegies in different contexts. Botanical dietary supplements (BDS) were 
evaluated for mitochondria-targeting molecules. Human T47D breast 
cancer cells, and osteosarcoma cytoplasmic hybrids carrying a pathogenic 
mitochondrial mutation [complex I-driven ATP synthesis] were exposed 
to BDS crude extracts and O
2 consumption, ATP synthesis, and cell via-bility were measured. Guggul (Commiphora wightii) and 11 other extracts 
inhibited cellular respiration by ≥50%. Guggulsterol III and sesamin from 
guggul suppressed cellular respiration by inhibiting mitochondrial electron 
transport chain (ETC) complex I. Both compounds inhibited hypoxic acti-
vation of hypoxia-inducible factor-1 (HIF-1) and exhibited antiproliferative 
effects against T47D cells [IC50 values (95% CI) 3.4 (3.06–3.73) μM and 22.2 (19.78–24.81) μM, respectively]. Twelve BDS extracts stimulated rotenone-
inhibited mitochondrial complex I-driven ATP synthesis. Three Colchicum 
spp. compounds from the NCI natural product library stimulated mito-
chondrial O2 consumption. About 4% of BDS evaluated contained mito-chondrial agonists or antagonists, with the antagonists being three-times 
more prevalent. Depending on their potency/concentration, consumption 
of BDS mitochondrial antagonists and agonists could either produce organ 
toxicity or act therapeutically.
P-235
LOBARIC ACID AND PSEUDODEPSIDONES FROM THE 
LICHEN STEREOCAULON PASCHALE INHIBITS NF-ΚB 
SIGNALING PATHWAY 
Claudia Carpentier1, Xavier Barbeau1,2, Jabrane Azelmat3, Daniel Grenier3, 
Patrick Lague2, Normand Voyer1
1Département de Chimie, Université Laval, Québec, QC G1V 0A6, 
2Département de Biochimie, Université Laval, Québec, QC G1V 0A6, 
3Groupe de Recherche en Écologie Buccale, Faculté de Médecine Dentaire, 
Université Laval, Québec, QC G1V 0A6
Lichens produce a vast diversity of highly bioactive defence compounds in 
response to environmental stress to protect the symbiotic partners. There-
fore, lichens of Northen Quebec represent a source of potential bioactive 
natural products due to the extreme growing conditions in the Nunavik 
region. Chemical investigation of the lichen Stereocaulon paschale has led 
to the isolation and identification of two new dibenzofurans and 11 knowns 
lichen metabolites.2 Six pseudodepsidone-type metabolites were identified 
and derived from the cleavage of the depsidone linkage of lobaric acid, the 
major compound of the crude extract. Lobaric acid and the pseudodep-
sidones metabolites demonstrated significant in vitro inhibitory activity 
against major pro-inflammatory targets (NF-κB, TNF-α and IL-1β). Dock-
ing simulations were performed to investigate the mechanism involved. To 
further investigate their anti-inflammatory potency, we have developed a 
synthetic methodology to give access to a variety of lichens metabolites. 
Phytochemical investigation, inhibitory activity against pro-inflammatory 
targets and the synthetic methodology will be presented.
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SUPPLEMENTAL CAFFEIC ACID SUPPRESSES ROS 
ACCUMULATION AND HSC SENESCENCE IN THE BONE 
MARROW OF TBI-EXPOSED MICE
Sung-Ho Kook1, Dong-Woon Lee2, and Jeong-Chae Lee1
1Research Center of Bioactive Materials, Chonbuk National University 
School of Dentistry, Jeonju 54896, South Korea, 2College of Ecology and 
Environmental Science, Kyungpook National University, Sangju 37224 
Repetitive total body irradiation (TBI) irreversibly accumulated radioto-
xic stress in bone marrow (BM) HSPCs, induced hematopoietic stem cell 
(HSC) senescence, and decreased hematopoietic function greater than 
single TBI did. Supplemental caffeic acid (CA) ameliorated TBI-medi-
ated long-term BM injury by inhibiting ROS accumulation and HSC se-
nescence. Supplementation with CA also exhibited a radioprotection effect 
on the survival of mice exposed only to single TBI. Collectively, our results 
indicate that supplemental CA ameliorates HSC senescence-accompanied 
long-term BM injury in TBI-exposed mice. 
P-237
CHEMOSELECTIVE DEHYDRATION OF GLUTAMINES 
TO EXPLORE STRUCTURE-ACTIVITY RELATIONSHIPS 
OF THE PEPTAIBOL ALAMETHACIN F50
José Rivera-Chávez,1,2 Mohammed H. Al-Huniti,1 Katsuya L. Colón,1 Jarrod 
L. Stanley,1 Joanna E. Burdette,3 Cedric J. Pearce,4 Nicholas H. Oberlies,1 and 
Mitchell Croatt.1
1Department of Chemistry and Biochemistry, University of North Carolina 
at Greensboro, Greensboro, NC 27402. 2Instituto de Química, Universidad 
Nacional Autónoma de México, Mexico City, 04510. 3Department of 
Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 
Chicago, IL 60607. 4Mycosynthetix, Inc., Hillsborough, NC 27278. 
The reactions of primary amides to chemoselectively generate nitriles was 
accomplished via the Selectfluor modification of a palladium (II) catalyst. 
Illustration of the utility of this process was demonstrated via using this 
reaction with alamethicin F50, a peptaibol that has three different glutami-
ne groups. Conditions were optimized to generate a mixture of all seven 
possible products in a single reaction. Separation protocols were used to 
purify them for examination of structure-activity relationships, and process 
rapidly determined which amides were important for the peptaibol’s cyto-
toxic activity. Thus, this dehydration protocol can act similar to an alanine 
scan for the glutamines in a peptide.
P-238
DEVELOPING NEW SOURCES OF ANTICANCER DRUGS: 
ENDEMIC COASTAL MACROLICHENS AND THEIR 
MICROBIAL ASSOCIATES 
L. Harinantenaina Rakotondraibe1, Choon Y. Tan1, Yan Zhang1, Joanna E. 
Burdette2, Nicholas H. Oberlies3, A. Douglas Kinghorn1
1Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, 
The Ohio State University, Columbus, OH 43210, 2Department of Medicinal 
Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois 
at Chicago, Chicago, IL 60612, 3Department of Chemistry and Biochemistry, 
University of North Carolina at Greensboro, NC 27402
Natural product compounds derived from plants and microbes have been 
frequently used as anticancer leads and chemical probes for validation of new 
pharmacological targets in anticancer drug discovery during the last decade. 
This is due to their biologically relevant chemical space that can be utilized 
not only to fight against recently discovered drug resistant cancers but also 
to contribute to the challenging drug discovery work of synthetic chemists 
by giving insights for the design of new lead molecules that better mimic the 
chemical space of natural products. As part of our effort to keep the discovery 
of new anticancer candidates that originate from natural products moving 
forward, we investigate the antiproliferative activity of unexplored and high-
ly stressed endemic lichens (and their myco- and photobionts) growing on 
rocks of the west coast of the U.S. The results of bioassay-guided isolation and 
structure determination of antiproliferative compounds from an U.S. ende-
mic lichen, Niebla homalea (Ach.), Ramalinaceae, the isolation of the fungal 
associates, and bioassay-guided isolation studies that led to the identification 
of new and bioactive compounds will be presented.
P-239
CLINICAL EVALUATION OF INTERACTION OF A HOP 
BOTANICAL DIETARY SUPPLEMENT WITH DRUG 
METABOLISM IN WOMEN
Luying Chen1,2, Alyssa Tonsing-Carter2, Suzanne Banuvar2, Elena 
Barengolts2, Marlos Viana2, Richard B. van Breemen1,2*
1Linus Pauling Institute, College of Pharmacy, Oregon State University, 
Corvallis, OR 97331, 2UIC/NIH Center for Botanical Dietary Supplements 
Research, Chicago, IL 60612
Extracts of hops (Humulus lupulus L.) containing prenylated flavanones are 
being used as botanical dietary supplements consumed by women for the 
management of menopausal symptoms. Our previous phase I clinical data 
(1) indicate that the half-lives of hop compounds exceed 20 hours. Addi-
tionally, our in vitro data suggest that hops might inhibit certain cytochro-
me P450 enzymes involved in drug metabolism (2). To evaluate this safety 
issue in the clinic, we tested a botanically authenticated and chemically 
and biologically standardized hop dietary supplement in 16 peri- and post-
menopausal women for possible interactions with the pharmacokinetics of 
four FDA-approved drugs (caffeine, tolbutamide, dextromethorphan, and 
alprazolam) as probe substrates for cytochrome P450 enzymes using UH-
PLC-MS/MS. Data suggest no clinically relevant interactions of hop dietary 
supplement with drug metabolism.
P-240
CHLOROPHYLL CLEAN-UP AND KNOCK-OUT MAY 
ENHANCE REPRODUCIBILITY OF BOTANICAL 
RESEARCH
Seon Beom Kim, Jonathan Bisson, Khang Nguyen, Guido F. Pauli and 
Charlotte Simmler*
Center for Natural Product Technologies, Department of Medicinal 
Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois 
at Chicago, 833 S. Wood Street, Chicago, IL 60612, USA.
Chlorophylls, present in virtually all phytochemical extracts of aerial plant 
materials, can act as nuisance compounds, preventing reproducible and 
meaningful measurement of bioassay readouts via fluorescence interference 
and possible precipitation in aqueous media. To our knowledge, no detailed 
report comparing the specificity and reproducibility of chlorophyll clean-up 
methods exists. Therefore, a collection of scientific literature and web re-
sources were mined systematically in order to evaluate existing chlorophyll 
removal methods, and thus, offer comprehensive protocols. Frequently re-
ported are the use of (1) charcoal; (2) gel permeation, mainly using Sepha-
dex LH-20; (3) adsorption resins, mainly Diaion HP-20; (4) the QuEChERS 
method; (5) liquid/liquid partitioning. Herein, we report a single step coun-
tercurrent separation (CCS) method that utilizes a biphasic solvent system 
for the targeted removal of chlorophyll from crude botanical extracts, thereby 
leading to the production of chlorophyll knock-out extracts (KOEs). The pro-
posed CCS method was evaluated using two well-identified and chemically 
characterized plant materials, Epimedium koreanum and Senna alexandrina, 
both chosen for their mainstream usage as dietary supplements and for their 
substantial chlorophyll content. The extent of chlorophyll removal, as well as 
the preservation of the KOE chemical integrity were both evaluated by means 
of orthogonal 1H NMR fingerprinting and UHPLC-UV/fluorescence.
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QUANTIFICATION OF IRIDOID AND PHENOLIC 
COMPOUNDS FROM ROOTS AND AERIAL PARTS OF 
FADOGIA AGRESTIS AND DIETARY SUPPLEMENTS 
Bharathi Avula1, Ji-Yeong Bae1, Vijayasankar Raman1, Yan-Hong Wang1, 
Fantoukh Omer1, Ahmed Galal Osman1, Mei Wang1, Zulfiqar Ali1, Ikhlas A. 
Khan1,2
1National Center for Natural Products Research, Research Institute of 
Pharmaceutical Sciences, University of Mississippi, University, MS 38677, 
USA. 2Division of Pharmacognosy, Department of BioMolecular Sciences, 
School of Pharmacy, The University of Mississippi, University, MS 38677, 
USA. 
An UHPLC-PDA-MS method was developed for the determination of one 
iridoid and ten phenolic compounds from roots and aerial parts of Fadogia 
agrestis Schweinf. ex Hiern (synonym  Vangueria agrestis (Schweinf. ex Hi-
ern) Lantz). The separation was achieved within 7 minutes by using C-18 
column material, a water/acetonitrile mobile phase, both containing 0.1% 
formic acid gradient system. The method was validated for linearity, re-
peatability, limits of detection (LOD) and limits of quantification (LOQ). 
The limits of detection of compounds was found to be in the range from 
0.025-0.1 µg/mL. The wavelengths used for quantification with the diode 
array detector were 238, 254, 291 and 325 nm. Twelve of 17 dietary supple-
ments contained phenolic compounds in the range from 0.3-2.5 mg/day. 
The phenolic compounds were not detected in five dietary supplements. 
LC-mass spectrometry coupled with electrospray ionization (ESI) interface 
method is described for the identification and confirmation of compounds 
from plant samples and dietary supplements claiming to contain Fadogia. 
This method involved the use of [M+H]+ and [M+Na]+ ions in the positive 
ion mode and [M-H]- ions in the negative ion mode with extractive ion 
monitoring (EIM). The developed method is simple, economic, rapid and 
especially suitable for quality control analysis of Fadogia. 
P-242
CHEMICAL PROFILING AND CHARACTERIZATION 
OF PRENYLFLAVONES FROM AERIAL PARTS OF 
EPIMEDIUM SPECIES USING UHPLC-QTOF-MS
Ji-Yeong Bae1*, Bharathi Avula1*, Fazila Zulfiqar1, Jianping Zhao1, Yan-Hong 
Wang1, Mei Wang1, Wei Feng2, Zulfiqar Ali1, Ikhlas A. Khan1,3
1National Center for Natural Products Research, School of Pharmacy, 
University of Mississippi, University, MS 38677, USA, 2Division of 
Chinese Materia Medica, National Institutes for Food and Drug Control, 
China Food and Drug Administration, 2 TiantanXili, Beijing 100050, P. 
R. China, 3Division of Pharmacognosy, Department of BioMolecular 
Sciences, School of Pharmacy, University of Mississippi, University, MS 
38677, USA. 
Epimedium, also known as horny goat weed, is a genus of flowering plants 
in the family Berberidaceae. The majority of the species are endemic to 
northeastern Asia. The dried aerial parts of Epimedium brevicornu Maxim., 
Epimedium sagittatum Maxim., Epimedium pubescens Maxim., Epimedium 
wushanense T.S. Ying, and Epimedium koreanum Nakai contain the highest 
concentrations of prenylflavonoids, which are the major compounds pre-
sent in Epimedium, and have shown multiple beneficial therapeutic effects 
in vitro. UHPLC coupled with PDA is used for the quantitative determina-
tion of 15 components from different species of Epimedium (Epimedium 
brevicornu Maxim., Epimedium sagittatum Maxim., and Epimedium gran-
diﬂorum C.Morren) and dietary supplements claiming to contain Epime-
dium. These three species of Epimedium showed distinct chemical profile 
and icariin is found to be a major compound in Epimedium grandiﬂorum. 
LC-mass spectrometry coupled with electrospray ionization (ESI) interface 
method is described for the identification of compounds and involved the 
use of [M+H]+, [M+Na]+ and [M-H]+ ions in the positive and negative ion 
mode with extracted ion chromatogram (XIC).
P-243
BIOASSAY-GUIDED ISOLATION AND STRUCTURE 
ELUCIDATION OF FUNGICIDAL AND HERBICIDAL 
COMPOUNDS FROM AMBROSIA SALSOLA 
(ASTERACEAE).
Wilmer H. Perera1, Kumudini M. Meepagala2, David E. Wedge2 and 
Stephen O. Duke2
1ORISE fellow-Agricultural Research Service, U.S. Department of 
Agriculture, Natural Product Utilization Research Unit, University 
of Mississippi, MS, 38677, USA. 2Agricultural Research Service, U.S. 
Department of Agriculture, Natural Product Utilization Research Unit, 
University of Mississippi, MS, 38677, USA.
Plant species are a vast reservoir of biologically active compounds that have 
been used for agrochemical applications. The genus Ambrosia L. comprises 
more than 40 species and belongs to one of the most extensive botanical 
family, Asteraceae. Species of the genus or compounds isolated has been 
reported for its allelopathic, anti-inflammatory and antiprotozoal activities, 
among others. Ambrosia salsola (Torr. & A. Gray) Strother & B. G. Baldw 
(synonym Hymenoclea salsola Torr. & A. Gray), a species that thrives in the 
United States of America, was chosen for the discovery of phytotoxic and 
fungitoxic compounds.  Dried and powdered leaves and twigs of A. salsola 
were extracted successively with hexane, ethyl acetate and methanol. The 
bioactive ethyl acetate extract was subjected to flash chromatography, and 
fractions eluted were screened for their phytotoxic and fungitoxic poten-
tial. Confertin and some methylated quercetin derivatives were identified, 
most of them described for the first time from this species. Bioassays for 
phytotoxic compounds showed that confertin inhibited the germination 
and growth of Lactuva sativa L. and Agrostis stolonifera L. Confertin was 
also active against the fungal plant pathogen Colletotrichum fragariae A.N. 
Crooks. with a thin layer chromatography bioautography assay. 
P-244
CHEMICAL DIVERSITY OF FUNGAL METABOLITES 
VIA EPIGENETIC MODIFICATION AND PRECURSOR 
DIRECTED BIOSYNTHESIS.
Chiraz Soumia M. Amrine1, Michael G. Doyle1, Huzefa A. Raja1, Cedric J. 
Pearce2, Nicholas H. Oberlies1
1Department of Chemistry and Biochemistry, University of North Carolina 
at Greensboro, Greensboro, NC 27402, USA. 2Mycosynthetix, Inc., 505 
Meadowlands Drive, Suite 103, Hillsborough, NC 27278, USA.
Beauvericin is a well known mycotoxin that belongs to the ennitiatin anti-
biotic family and the cyclic depsipeptide class. It was first discovered from 
Beauveria bassiana, which is a commercial entomopathogenic mycoinsec-
ticide fungus. The fungal strain MSX61576 from the Mycosynthetix library 
showed the production of beauvericin as the main secondary metabolite. 
A series of strategies was used to generate new chemical diversity, includ-
ing OSMAC, epigenetic modifiers, and precursor directed biosynthesis. In 
this study we screened growth conditions, adding epigenetic modifiers and 
precursor units to the media to explore the new chemical diversity biosyn-
thesized by the fungus. The experiments were analyzed in situ via droplet 
probe, and then a scale up of the selected culture conditions was prepared 
for isolation purposes. 
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CHEMICAL PROFILING AND CHARACTERIZATION OF 
ANNONACEOUS ALKALOIDS AND ACETOGENINS 
FROM ASIMINA SPECIES USING UHPLC-QTOF-MS
Bharathi Avula1, Ji-Yeong Bae1, Tung-Ying Wu2, Yan-Hong Wang1, Taghreed 
Majrashi1, Mei Wang1, Zulfiqar Ali1, Yang-Chang Wu3,4, Ikhlas A. Khan1,5
1National Center for Natural Products Research, School of Pharmacy, 
University of Mississippi, University, MS 38677, USA. 2Chinese Medicine 
Research and Development Center, China Medical University Hospital, 
Taichung 40447, Taiwan. 3Research Center for Natural Products and Drug 
Development, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. 
4Department of Medical Research, Kaohsiung Medical University Hospital, 
Kaohsiung 80708, Taiwan. 5Division of Pharmacognosy, Department of 
BioMolecular Sciences, School of Pharmacy, University of Mississippi, 
University, MS 38677, USA.
Alkaloids and acetogenins were reported to be the major physiologically 
active constituents in Asimina species. Chemical profiling of alkaloids and 
acetogenins from methanolic extracts of Asimina species (A. triloba and A. 
parviﬂora) have been analyzed using UHPLC-QToF in positive ion mode. 
These compounds were tentatively characterized based on the accurate 
mass of mass spectra and fragment ions. The fragments produced by col-
lision induced dissociation (CID) revealed the characteristic cleavage and 
the fragmentation pattern provided structural information. The alkaloids 
of the aporphine, oxoaporphine and benzylisoqionolines type represent the 
predominant group found in Asimina species. Acetogenins are an impor-
tant group of long-chain fatty acid derivatives containing one to three tetra-
hydrofuran (THF) rings and have a long aliphatic chain on one side (belon-
ging to a series of C35-C38 compounds) and aliphatic chain ending in an α, 
β-unsaturated γ-lactone on the other side. These compounds can be used to 
distinguish Asimina species. It also provides an excellent approach for rapid 
screening of chemical components from plant extracts. Magnoflorine was 
used as an example to discuss the fragmentation patterns. The fragment 
ions at m/z 297.1127 [M+H-(CH3)2NH]+, 282.0886 [M+H-(CH3)3NH]+, 
265.0865 [M+H-(CH3)2NH-CH3OH]+, 237.0916 [M+H-(CH3)2NH-
CH3OH-CO]+, and 222.0681 [M+H-(CH3)2NH-CH3OH-CO-CH3]+ resul-
ted from the protonated molecular ion. A total of 120 compounds were 
identified from the different parts of A. triloba and A. parviﬂora samples. 
However, for definite identification of these unknown components, further 
investigation is required. This may provide a model for the rapid scree-
ning and structural characterization of bioactive constituents from plant 
extracts. 
P-246
EXAMINATION OF CHEMICAL IONIZATION MASS 
SPECTRAL CALIBRATION METHODS FOR THE 
ANALYSIS OF ALKALOIDS IN POISON FROGS
Richard W. Fitch, Kimberly Gleason, Jacqueline Smith, and Chinonye 
Olumba
Department of Chemistry and Physics, Indiana State University, Terre 
Haute, IN 47809. 
The quantitation of compounds in analytical samples typically relies on ca-
libration curves of known analytes in order to provide reliable data.  Unfor-
tunately, for most published natural products, standards of analytically pure 
materials are not readily available and for novel compounds, no such stan-
dards could exist.  Various modes of chromatography-mass spectrometry 
are commonly used for identifying natural products in extracts.  However, 
mass spectrometry is generally viewed as being unreliable as an a priori 
quantitation method due to variation in ion yields and/or propensity for 
fragmentation or ion-molecule reactions. We have examined the feasibility 
of obtaining reliable quantitation based on the use of commercially avai-
lable surrogate calibration compounds in structural classes (pyrrolizidines, 
indolizidines and quinolizidines) that are representative of the majority of 
poison frog alkaloids.  Chemical ionization methods (ammonia chemical 
ionization in GC-MS and electrospray and atmospheric pressure chemical 
ionization in LC-MS) were evaluated.  Our results to date will be presented, 
including a discussion of structural influences on response factors and the 
effects of post-column additives in LC-ESI-MS.  
P-247
CHLORELLA SP. MODULATES CHOLINESTERASE 
ACTIVITY AND Β-AMYLOID AGGREGATION AND DIS-
AGGREGATION IN VITRO
Tosin A. Olasehinde1, Leonard V. Mabinya1, Ademola O. Olaniran2, and 
Anthony I. Okoh1
1Applied and Environmental Microbiology Research Group, Department of 
Biochemistry and Microbiology, University of Fort Hare, Alice, South Africa, 
2Discipline of Microbiology, School of Life Sciences, College of Agriculture, 
Engineering and Science, University of Kwazulu-Natal, Durban, South 
Africa2
The antioxidant, anti-cholinesterase and anti-amyloidogenic activities of 
extracts of Chlorella sorokiniana and Chlorella minutissima were investiga-
ted in this study. The extracts showed antioxidant activity through their 
radical and metal chelating abilities. Furthermore, the ethanol extract of C. 
sorokiniana exhibited highest acetylcholinesterase inhibitory activity while 
dichloromethane extract of C. minutissima showed the highest butyrylcho-
linesterase activity. Results of Thioflavin-T assay and electron microscopy 
study revealed that incubation of β-amyloid protein increased the aggre-
gation of fibrils after 96 hours. However, ethanol extracts of C. sorokiniana 
induced disaggregation of β-amyloid fibrils. This study reveals the effective 
action of C. sorokiniana and C. minutissima extracts on some mediators of 
Alzheimer’s disease and gives insights into their potential benefits as func-
tional food or source of therapeutic agents relevant for the management of 
this disease.
P-248
CHEMICAL DEFENSE OF THE COMMON EUROPEAN 
GLOWWORM LAMPYRIS NOCTILUCA
Stephen T. Deyrup1, Nicole R. Howells1, Faizan U. Rahim1, David A. Posner1, 
and Raphael De Cock2.
1 Department of Chemistry and Biochemistry, Siena College, Loudonville, 
New York 12211  USA; 2 Evolutionary Ecology Group, Campus Drie Eiken, 
University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.
Chemical investigations of several genera of fireflies have demonstrated the 
presence of steroidal pyrones known as lucibufagins (LBGs, example struc-
tures shown below).  These compounds have been shown to be the primary 
chemical defense mechanisms of these taxa, as they affect Na+/K+−ATPase, 
an enzyme essential to all animals.  A prior HPLC-MS study of the Com-
mon European Glowworm Lampyris noctiluca, indicated that this species 
contains LBGs, but was unable to determine which of the many LBGs were 
present.  Using specimens collected from Belgium and separated by life-
stage and sex, we describe here HPLC-MS and NMR studies that are part 
of our ongoing efforts to determine the precise chemical structures of the 
LBG components of L. noctiluca.  We also provide evidence that L. noctiluca 
larvae contain at least 11 different LBGs. 
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SELECTIVE DEGALLOYLATION AND GALLIC ACID 
KNOCK-OUT OF PROANTHOCYANIDIN-RICH PLANT 
EXTRACTS WITH DENTIN BIOMODIFYING PROPERTIES
Bin Zhou1, Yvette Alania2, Mariana C. dos Reis2, James McAlpine1, Shao-
Nong Chen1, Ana K. Bedran-Russo2, and Guido F. Pauli1*
1Department of Medicinal Chemistry & Pharmacognosy, College of 
Pharmacy, 2Department of Restorative Dentistry, College of Dentistry, 
University of Illinois at Chicago, Illinois 60612, USA 
Long-term dental bioassays have shown that plant extracts containing gal-
lated procyanidins (PACs) lose a significant amount of their bioactivity 
over time. Thus, the gallic acid (GA) moiety is thought to be a major con-
tributors to the relative instability PACs dentin complexes, making galloyl 
degradation in PACs a critical factor in abating their activities in dental 
applications. In order to produce more stable and active dentin biomod-
ifiers, an efficient and mild hydrolysis reaction was pursued. Preliminary 
data identified tannase as capable of hydrolyzing galloyl moiety of EGCG 
rapidly and under mild conditions. Applied to Green Tea Extract (GTE), 
the liberated GA was removed by countercurrent separation (CCS) using 
n-hexane-EtOAc-MeOH-H2O (1/9/1/9, K = 0.697). Processing an aqueous 
solution (8 mL) of GTE (200 mg) and enzyme (20:1 w/w) at 37 oC for 20 
hrs yielded 22.0 mg of GA (15% of GTE, w/w, purity ≥ 98% by HPLC at 280 
nm), which was knocked-out from the extract by CCS. The same protocol 
was applied to witch hazel and grape seed extracts. Their phytochemical 
profiles and the dentin strengthen activities of all three GA knock-out ex-
tracts will be presented.
P-250
ALKALOIDS FROM MALBRANCHEA ALBOLUTEA SIGLER 
& CARMICHAEL (MYXOTRICHACEAE)
Miriam Díaz, Manuel Rangel-Grimaldo, Mario Figueroa, Isabel Rivero, and 
Rachel Mata
Facultad de Química, Universidad Nacional Autónoma de México, Mexico 
City 04510, Mexico
Extensive fractionation of an extract from the rice-based culture of the fun-
gus Malbranchea albolutea Sigler & Carmichael (Myxotrichaceae) led to 
the isolation of 5- N- acetyl- 8- β- isopropyl- ardeemin (1) and 5- N- acetyl-15-
β-hydroxy- 8-β- isopropyl- ardeemin (2), along with 1H-indole-3-carboxal-
dehyde (3). The structures of 1 and 2 were elucidated by spectroscopic and 
molecular modeling methods. The absolute configuration at the stereoge-
nic centers of 1 and 2 was established by comparison of their experimental 
CD spectra with those calculated using DFT at the B3LYP/6-311G+(2d,p) 
level of theory.
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P-251
ANTI-MICROBIAL AND ANTI-INFLAMMATORY 
ACTIVITIES OF BIOACTIVE CONSTITUENTS FROM 
BOCCONIA FRUTESCENS
Elizabeth Lough,1,3 Tamara Kondratyuk,1Julian Hurdle,2 and Leng Chee 
Chang1
1Department of Pharmaceutical Sciences, The Daniel K. Inouye College 
of Pharmacy, University of Hawai‘i at Hilo, Hilo, HI 96720. 2Center 
for Infectious and Inﬂammatory Diseases, Institute of Biosciences and 
Technology, Texas A &M Health Science Center, Houston, TX, 77030. 
3Department of Biology, University of Hawai‘i Hawaii at Hilo, Hilo, HI, 
96720. 
The number of infectious disease cases and the threat of drug-resistant bac-
teria is globally increasing. Some bacteria on the list of “biggest threats” 
compiled by the Centers for Disease Control and Prevention, such as me-
thicillin-resistant Staphylococcus aureus (MRSA), are increasingly viewed 
as community- acquired (CA). While the sources of CA-infections are not 
precisely known, evidence suggests that environmental exposures in rural 
areas puts these communities at greater risk: Hawai‘i was identified as the 
state with the highest prevalence of MRSA as compared with the national 
average. Treatment for MRSA is challenging due to development of drug 
resistance thus requiring novel treatment approaches. During the course 
of research on new natural product-derived antimicrobials, B. frutescens 
extracts of roots and seeds collected in Hawai‘i exhibited potent activity 
against methicillin-sensitive S. aureus Newman with MIC values of IC50 
of 0.8, 3.25 µg/mL, respectively. B. frutescens has been used in traditional 
medicine to treat respiratory and skin infections in human. Following a 
chemically-guided approach, several alkaloids, including 8-hydroxydihy-
dro sanguinarine, and chelerythrine were isolated. Their structures are de-
termined using NMR spectroscopy and mass spectrometry. Compounds 
were tested evaluated against inflammation by following decreasing pro-
inflammatory cytokines tumor necrosis factor (TNF)-α that are exacerba-
ted by S. aureus in vitro. Indeed, extracts inhibited TNF-induced nuclear 
factor (NF-κB) activity by 95% without cytotoxicity. NF-κB pathways are 
known to play a vital role in regulating the activity of cyclooxygenase-2 and 
pro-inflammatory cytokines. The structure elucidation of alkaloids, their 
biological activity will be presented.
P-252
FORSYTHIA OVATA INHIBITS 
LIPOPOLYSACCHARIDE-INDUCED NITRIC 
OXIDE PRODUCTION IN RAW 264.7 CELLS VIA 
MODULATION OF NF-ΚB AND NRF2-MEDIATED 
HO-1 PATHWAYS
Jong Hwan Kwak, Yeon Jeong Jang, Suhkneung Pyo
School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea
Forsythia ovata Nakai is a deciduous shrub in the family Oleaceae, and dis-
tributed in the central area of Korea. Inflammation is an essential defensive 
response to harmful stimuli including pathogens, irritants, and inflamma-
tory cytokines, which interact with other cells. Although the inflammato-
ry process is a beneficial physiologic reaction, excessive or persistent in-
flammation causes serious inflammatory diseases including septic shock, 
rheumatoid arthritis, and autoimmune diabetes. Lipopolysaccharide (LPS), 
a bacterial endotoxin, induces the production of inflammatory media-
tors such as iNOS, COX-2, TNF-α, IL-1, and IL-6 in macrophages. In this 
study, we established anti-inflammatory effects of the 70% EtOH extract 
of F. ovata leaves in LPS-stimulated RAW 264.7 macrophage cells. F. ovata 
suppressed the LPS-induced expression of iNOS, COX-2, and proinflam-
matory cytokines in RAW 264.7 cells. F. ovata inhibited NO production in 
LPS-stimulated RAW 264.7 cells through suppression of their regulatory 
genes. The anti-inflammatory effects are associated with suppression of NF-
κB and enhancement of Nrf2-mediated HO-1 activation. To characterize 
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the 70% EtOH extract of F. ovata leaves, we used reverse phase HPLC and 
UPLC-QTof MS. Major peaks were identified, and contents of major peaks 
were determined in the extract.     
P-253
STRUCTURAL DIVERSITY AND ANTICANCER ACTIVITY 
OF MARINE-DERIVED ELASTASE INHIBITORS: KEY 
FEATURES AND MECHANISMS MEDIATING THE 
ANTIMETASTATIC EFFECTS IN INVASIVE BREAST 
CANCER
Fatma H. Al-Awadhi1,2,  Valerie J. Paul3 and Hendrik Luesch1
1Department of Medicinal Chemistry, Center for Natural Products, Drug 
Discovery and Development (CNPD3), University of Florida, Gainesville. 
2Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kuwait 
University, P.O. Box 24923, Safat 13110, Kuwait. 3Smithsonian Marine 
Station, Fort Pierce, Florida, USA.
Three new 3-amino-6-hydroxy-2-piperidone (Ahp)-containing cyclic dep-
sipeptides named loggerpeptins A‒C (1‒3) along with molassamide (4) 
were discovered from a marine cyanobacterium, extending the structural 
diversity of this prevalent scaffold of cyanobacterial serine protease inhibi-
tors. Molassamide (4), containing the 2-amino-butenoic (Abu) unit in the 
cyclic core, was the most potent and selective analogue against human neu-
trophil elastase (HNE). Given the growing evidence supporting the role of 
HNE in breast cancer progression and metastasis, we assessed the cellular 
effects of compounds 3 and 4 in the context of targeting invasive breast can-
cer. Both compounds inhibited the cleavage of the elastase substrate CD40 
in biochemical assays; however, only 4 exhibited significant cellular activi-
ty. As CD40 and other receptor proteolytic processing culminates in NFKB 
activation, we assessed the effects on the expression of target genes, inclu-
ding ICAM-1. ICAM-1 is also a direct target of elastase, and in our studies 
compound 4 attenuated both elastase-induced ICAM-1 gene expression 
and ICAM-1 proteolytic processing by elastase, revealing a potential dual 
effect on migration through modulation of gene expression and proteolytic 
processing. Molassamide (4) specifically inhibited the elastase-mediated 
migration of highly invasive triple negative breast cancer cells.
P-254
ACTIVATION OF SILENT BIOSYNTHETIC GENES OF 
RARE-ACTINOMYCETES BY COMBINED-CULTURE 
WITH MYCOLIC ACID-CONTAINING BACTERIUM
Shotaro Hoshino1, Takayoshi Awakawa1, Hiroyasu Onaka2, and Ikuro Abe1
1Graduate School of Pharmaceutical Sciences, The University of Tokyo, 
Bunkyo-ku, Tokyo 113-0033, Japan. 2Graduate School of Agricultural and 
Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-8657, Japan.
Mycolic acid-containing bacterium (MACB) could interact with broad-spec-
trum of actinobacteria and induce the gene expression responsible for natural 
products biosynthesis. The co-culture method using MACB was described 
as “combined-culture”. Because rare-actinomycetes (=non-Streptomyces) are 
less-exploit resources for natural product discovery than Streptomyces spe-
cies, we targeted the rare-actinomycetes for the combined-culture method. 
As a result, MACB induced the secondary metabolites production in 11 out 
of the 40-tested rare-actinomycetes by co-culture, and we finally obtained 11 
novel compounds with unique and diverse structures and bioactivities.  
P-255
MICROBIAL NATURAL PRODUCTS DISCOVERY FROM 
UNIQUE TERRESTRIAL ENVIRONMENTS
Khaled A. Shaaban,1,* Larissa V. Ponomareva,1 Xiachang Wang,1 Sherif 
I. Elshahawi,1 Gregory C. Copley,2 James C. Hower,2 Stephen F. Greb,3 
J. Richard Bowersox,3 Madan K. Kharel,1 S. Randal Voss,4 and Jon S. 
Thorson1,*
1Center for Pharmaceutical Research and Innovation, College of Pharmacy, 
University of Kentucky; 2Center for Applied Energy Research, University of 
Kentucky; 3Kentucky Geological Survey, University of Kentucky; 4College of 
Medicine, University of Kentucky
Natural products remain a major inspiration and source for drug leads and 
bioactive probes. While the trends in microbial natural products discov-
ery over the last decade have moved away from terrestrial microbes, we 
seek to explore the microbial diversity (and corresponding biosynthetic 
potential) of untapped terrestrial microbes from environments. As part of 
our ongoing natural product discovery program at the Center for Phar-
maceutical Research and Innovation (CPRI) at the University of Kentucky 
(UK), we examined soil samples collected from different sites in Kentucky 
(including thermal vents from underground coal mine fires, coal and lead 
mine reclamation sites, active underground and surface coal mines, and 
deep subterranean drilling sites as unique access to the rich biodiversity 
of Appalachian Kentucky and throughout the Commonwealth) with a fo-
cus upon culturable actinomycetes capable of producing novel secondary 
metabolites. Cumulatively, this program has led to the deposition of >900 
non-redundant bacterial strains and >360 pure bacterial metabolites (near-
ly half of which are new natural products exclusive to the CPRI collection). 
This CPRI natural product repository represents broad chemical diversity 
(terpenes, macrolides, coumarins, peptides, phenazines, glycosides, etc.). 
CPRI has enabled UK investigators with novel biochemical, cell-based and/
or animal-model based assays access to the repository and this broad col-
laborative effort has led to discoveries of relevance to chemical probe in 
the areas of cancer, infectious disease, neurodegenerative diseases, regener-
ation and drug addiction.
P-256
RACEMIC X-RAY STRUCTURES OF JATROPHA’S 
ORBITIDES 
Suelem D. Ramalho1, Conan K. Wang2, Gordon J. King2, Yen-Hua Huang2, 
Vanderlan S. Bolzani1, and David J. Craik2
1Institute of Chemistry, State University of São Paulo, Araraquara, SP 
14800-060, Brazil, 2Institute for Molecular Bioscience, The University of 
Queensland, Brisbane, QLD 4072, Australia
Orbitides are plant-derived cyclic peptides that have a range of therapeu-
tically-relevant bioactivities. They are typically of low molecular weight, 
comprising 5 to 12 standard L-amino acids amino acid residues, ribosomal-
ly synthesized and have a head-tail cyclization as a post-translational mo-
dification1. Among the wide range of plant species that contain orbitides, 
Jatropha species (Euphorbiaceae) are one of the most promising sources 
of biologically active orbitides. Our objective was to elucidate the three-
dimensional structures of these cyclic peptides to provide a basis for further 
functional or drug design studies. To determine their tertiary structures, 
we used racemic crystallography, an emerging structural technique that 
enables rapid crystallization of biomolecules by combining equal amounts 
of each stereo-isomer2. It has recently been successfully applied to determi-
ne structures of several cyclic disulfide-rich peptides that were previously 
recalcitrant to crystallization3. In this study, we synthesized both L- and 
D-enantiomeric forms of three Jatropha’s orbitides: ribifolin, pohlianin C 
and jatrophidin, and determined their X-ray structures by direct methods. 
Overall, our results highlight the utility of racemic crystallography for ob-
taining high-resolution structures and also a useful approach to design new 
orbitides analogues.
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P-257
INTERACTION-DRIVEN MOLECULE DISCOVERY LEADS 
TO ISOLATION OF A NEW LINCOMYCIN DERIVATIVE 
FROM LABRENZIA SP. ANG18, A BACTERIAL SYMBIONT
Samantha M. Gromek1, Andrea M. Suria2, Spencer V. Nyholm2, and Marcy 
J. Balunas1,*
1Division of Medicinal Chemistry, Department of Pharmaceutical Sciences, 
University of Connecticut, 69 North Eagleville Road, Storrs, CT 06269, 
USA, 2Department of Molecular and Cell Biology, University of Connecticut, 
Storrs, CT 06269, USA
Host-microbe symbioses are emerging as promising sources for drug dis-
covery, with many bacterial symbionts producing biologically active com-
pounds designed to interact with their host and/or protect against patho-
gens and prey. We utilize the Hawaiian bobtail squid, Euprymna scolopes, as 
a model system for the discovery and development of novel antimicrobial 
drug leads. Our previous research has shown that bacteria associated with 
the accessory nidamental gland (ANG) and the egg jelly coat (JC) of E. 
scolopes produce defensive metabolites that inhibit fungal fouling and/or 
bacterial growth. Labrenzia sp. ANG18 was isolated from an E. scolopes 
ANG and exhibited potent antifungal activity against three phylogenetical-
ly related Fusarium keratoplasticum strains. Using a suite of mass spectro-
scopic (MS) and nuclear magnetic resonance (NMR) techniques, we identi-
fied known lincomycins and isolated a new lincomycin derivative. Genom-
ic sequencing confirmed the presence of key lincomycin biosynthesis genes 
in Labrenzia sp. ANG18. Lincomycin A, an FDA-approved antibiotic, was 
originally isolated from an actinomycete, Streptomyces lincolnensis var. lin-
colnensis. To our knowledge this is the first report of lincomycin derivatives 
produced by a bacterial isolate within Alphaproteobacteria. 
P-258
MANUMYCIN-A IS A POTENT INHIBITOR OF 
MAMMALIAN CYTOPLASMIC THIOREDOXIN 
REDUCTASE AND AN ACTIVATOR OF 
MITOCHONDRIAL THIOREDOXIN REDUCTASE
Anupama Tuladhar1, Kathleen Rein1
1Department of Chemistry and Biochemistry, Florida International 
University, Miami, Fl, 33199
The thioredoxin system is the major cellular reductant system present in 
the cell, whose role is to maintain cellular redox homeostasis. It does this 
in part, by regulating the activity of many other enzymes including ribo-
nucleotide reductase, which is essential for DNA synthesis. It also acts as 
an antioxidant, reducing destructive reactive oxygen species. The thiored-
oxin system is comprised of thioredoxin (Trx) which reduces target prote-
in disulfide bridges by thiol-disulfide exchange and thioredoxin reductase 
(TrxR) which reduces Trx back to its active state. TrxR is a common target 
for many cancer drugs including cisplatin and auranofin. Recently we have 
shown that the Florida red tide toxin, brevetoxin can inhibit mammalian 
TrxR. Several compounds which are similar to brevetoxin in size and func-
tionality have a similar effect on TrxR. These compounds include antitumor 
and antibiotics such as manumycin A (Man-A), geldanamycin and algal 
toxins such as nodularin and microcystin-LR. Man-A behaves as a typical 
TrxR1 (cytoplasmic) inhibitor.  Other compounds screened activate the re-
duction of small disulfides such as DTNB (5,5’-dithiobis-(2-nitrobenzoic 
acid). Inhibition of TrxR at the C-terminal redox center produces a pro-
oxidant known as SecTRAP (Selenium Compromised Thioredoxin Reduc-
tase-derived Apoptotic Proteins), which uses NADPH to produce super-
oxide radical anion. This might explain the observed burst of ROS in cells 
exposed to these compounds. We have also tried to characterize the mole-
cular mechanism of action by using site-specific mutant enzymes which 
allow us to determine the specific site of interaction between enzyme and 
the compounds. The use of mutant enzymes has revealed that Man-A in-
teracts in very different ways with mitochondrial TrxR by activating DTNB 
reduction similar to other compounds but still inhibiting the reduction of 
Trx. Our attempt to evaluate such activation observed in DTNB reduction 
due to these compounds will also be discussed. This study will thus identify 
a novel mechanism of action of these compounds.
P-259
THE STRUCTURE-ACTIVITY RELATIONSHIP OF 
NATURAL AND SEMI-SYNTHETIC CINNAMODIAL 
ANALOGUES AGAINST THE AEDES AEGYPTI 
MOSQUITO
Preston K. Manwill1, Megha Kalsi2, Peter M. Piermarini2 and 
Harinantenaina L. Rakotondraibe1.
1Division of Medicinal Chemistry and Pharmacognosy, College of 
Pharmacy, The Ohio State University, Columbus, OH 43210, 2Department 
of Entomology, The Ohio State University, Ohio Agricultural Research and 
Development Center, Wooster, OH 44691
The Aedes aegypti mosquito serves as a major vector for viral diseases, 
such as dengue, chikungunya, and Zika, which continue to spread across 
the globe and threaten public health. In addition to increased vector 
transmission, the prevalence of insecticide-resistant mosquitoes is on the 
rise. Thus, new, safe and effective insecticides to control mosquito popu-
lations are needed. Cinnamodial, an unsaturated drimane sesquiterpene 
dialdehyde isolated from the Madagascan medicinal plant Cinnamosma 
fragrans, was recently shown to exhibit significant larval and adult toxici-
ty to Ae. aegypti and outperformed DEET – the gold standard for insect 
repellents – at repelling adult female Ae. aegypti from feeding. In this stu-
dy, a library of natural and semisynthetic analogues of cinnamodial were 
used to probe the structure-activity relationship for larvicidal, adulticidal 
and antifeedant activity against Ae. aegypti. Initial efforts were focused on 
modification of the unsaturated dialdehyde, aimed at probing the impor-
tance of the 1,4-dialdehyde and the α,ß-unsaturated carbonyl functiona-
lities in the observed bioactivity of cinnamodial. Previous studies have 
highlighted the antifeedant and toxicant activity of drimane sesquiterpe-
nes against agricultural pests, but this study represents the first compre-
hensive investigation into the SAR of cinnamodial against the medically 
important Ae. aegypti mosquito.
P-260
BRAZILIAN GREEN PROPOLIS: IN VITRO 
SCHISTOSOMICIDAL PROPERTIES 
Sergio R. Ambrósio1, Rodrigo C. S. Veneziani1, Carly H. Borges1, Aline N. 
Silva1, Juliana A. Silva1, Danieli Lemes1, Lizandra G. Magalhães1, Jairo K. 
Bastos2
1Universidade de Franca, Franca, Brazil, 2School of Pharmaceutical Sciences 
of Ribeirão Preto, USP, Ribeirão Preto, Brazil; 
Brazilian green propolis produced by Apis mellifera has great economic 
importance due to their biological activities, including the activity against 
several parasites causing human diseases. Thus, the hydroalcoholic extract 
of Brazilian green propolis (HEGP), as well as their fractions obtained from 
partitions of the crude extract in aqueous methanol with hexanes (GPH), 
methylene chloride (GPMC) and n-butanol (GPB), in sequence, were te-
sted in vitro against male and female worms of Schistosoma mansoni. The 
results revealed that both, HEGP and GPMC, showed potent schistosomi-
cidal effect with LC50 values of 57.5 and 28.2 µg.mL-1, respectively. Then, 
three metabolites isolated from GPMC (compounds 1-3) were also evalu-
ated, and baccharin (1) was the most effective one with LC50 value of 52.7 
µM. In addition, 1 at 12.5 and 25.0 µM abolished the in vitro egg produc-
tion, thus denoting its capability of efficiently cease the S. mansoni life cycle. 
In this context, the results described here pointed out baccharin as a natural 
prototype for further medicinal chemical studies against S. mansoni. 
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P-261
NEW HYDROXYOLEOSIDE-TYPE SECO-IRIDOIDS WITH 
INSULIN MIMETIC ACTIVITY FROM SYMPLOCOS 
COCHINCHINENSIS
Ba Wool Lee1, Van On Tran2 and Won Keun Oh1
1Korea Bioactive Natural Material Bank, Research Institute of 
Pharmaceutical Sciences, College of Pharmacy, Seoul National University, 
Seoul 151-742, Republic of Korea, 2Department of Botany, Hanoi University 
of Pharmacy, Hanoi, Vietnam
To find active constituents with insulin mimetic activity from Symplocos 
cochinchinensis (Lour.) S. Moore, dereplication application using the EtO-
Ac fraction of S. cochinchinensis resulted in ten new hydroxyoleoside-type 
compounds conjugated with a phenolic acid and monoterpene (1-6 and 
8-11), as well as four known compounds (7 and 12-14). The absolute con-
figuration of isolates were determined by ECD analysis of derivatives ob-
tained after a series of reactions, such as those with dirhodium tetrakis and 
dimolybdenum tetraacetate. Compounds 3, 7 and 8 exhibited moderate 
2-NBDG uptake increasing activity in differentiated 3T3-L1 adipocytes by 
GLUT4 translocation. Selected compounds also showed moderate inhibi-
tory activity on PTP1B. 
P-262
CYTOTOXIC VERAGUAMIDES SELECTIVELY INDUCE 
APOPTOSIS IN TRIPLE NEGATIVE BREAST CANCER 
CELLS
Andrea Rague1, Stacy-Ann J. Parker1, Thomas Wright2, Neil Lax3, Benedict J. 
Kolber3, Jane E. Cavanaugh2 and Kevin J. Tidgewell1
1Department of Medicinal Chemistry, Graduate School of Pharmaceutical 
Sciences, 2Department of Pharmacology, Graduate School of Pharmaceutical 
Sciences, 3Department of Biological Sciences, Bayer School of Natural 
and Environmental Sciences, Duquesne University, 600 Forbes Avenue, 
Pittsburgh, PA 15282, United States
One in eight women will be diagnosed with breast cancer in their lifetime. 
Of these women, 15%-20% will be diagnosed with triple negative breast 
cancer (TNBC), which is characterized by a lack estrogen receptors, pro-
gesterone receptors, and human epidermal growth factor 2 receptors. The 
treatment options for TNBC are limited to radiation, chemotherapy, and 
surgery, so there is dire need for small molecule drugs to treat this disease. 
One known and two new veraguamides were isolated from the extracts of 
an Okeania sp cyanobacteria collected in the Las Perlas Archipelago of Pa-
nama, and showed cytotoxicity for TNBC cells (MDA-MB-231). The novel 
linear analogues, veraguamides M and N showed minimal  (>100 µM)  cy-
totoxicity against ER positive cells (MCF-7) with low micromolar (12 and 3 
µM) toxicity against TNBC cells. This suggests that the compounds may act 
through a mechanisms unique to TNBC cells, and for this reason could be 
used as molecular probes for the mechanisms of action. 
P-263
DEGRADATION PRODUCTS OF ARTEPILLIN C AND 
P-COUMARIC ACID IN BRAZILIAN GREEN PROPOLIS
Caroline Arruda, Victor Pena Ribeiro, Jennyfer Andrea Aldana Mejía, Jairo 
Kenupp Bastos. 
Department of Pharmaceutical Sciences, University of São Paulo, Av. Café, 
s/n, 14040-903, Ribeirão Preto – SP, Brazil.
In Brazilian green propolis, artepillin C (1) and p-coumaric acid (2) are 
responsible, along with other compounds, for several of its biological ac-
tivities. Their stability as single compounds and in the crude propolis raw 
material were evaluated by exposure to heat, air oxygen and light. A full 
factorial experimental Design with two levels and eight experiments was 
selected, in which lower levels corresponded to absence or presence of light 
and oxygen and temperatures of -20ºC or 40ºC in the higher levels. To es-
tablish the best storage conditions, a Central Composite Design was select-
ed. The two factors evaluated were temperature, from -20 to 50ºC, and time 
from zero to 30 days. Light is the main factor responsible for degradation of 
both 1 and 2, and temperature also causes moderate loss of 1. Combination 
of light and heat caused the degradation of 100% of 1 and 20% of 2, in 30 
days. Aiming to establish the best storage conditions, samples were pro-
tected from the ambient light. According to these experiments, when the 
compounds are isolated, by increasing the temperature the concentration 
decreases. The desirability of 1 states that a temperature of -2ºC is enough 
to reduce its degradation. Regarding 2, between 15 and 25ºC, no signifi-
cant degradation was observed. Both compounds, in the crude propolis, 
showed degradation of approximately 20% at 50ºC after 20 days. Therefore, 
to decrease degradation, the best storage and transport conditions include 
protection from the light, the use of dark packing and low temperatures.  
P-264
(-)- EPICATECHIN MODULATES VASOREACTIVITY AND 
CELLULAR SIGNALING IN ENDOTHELIAL CELLS
Amy C. Keller1,2, Sara E. Hull1,2, Leslie A. Knaub1,2, Aspen Johnston1, Jane 
E.B. Reusch1,2,3
1Division of Endocrinology, University of Colorado Anschutz Medical 
Campus, Aurora, Colorado 80045 2Department of Medicine, Rocky 
Mountain Regional VA Medical Center, Aurora, Colorado 80045, 3Center 
for Women’s Health Research, University of Colorado School of Medicine, 
Aurora, Colorado 80045
Vascular dysfunction heralds the onset of diabetic cardiovascular disease. 
The botanical compound (-)- epicatechin (EPICAT) is a known vasodilator. 
We hypothesized that EPICAT restores vasodilation in the diabetic vascula-
ture by bolstering mitochondrial function via support of endothelial nitric 
oxide synthase (eNOS) activity and mitigation of reactive oxygen species 
(ROS). We examined the impact of EPICAT on vasoreactivity ex situ and 
endothelial cell function in vitro. EPICAT increased endothelium depen-
dent vasodilation in rat aortic vessels (64.74%, p=0.002). HUVEC cells 
were incubated with 7 mM (NG) or 30 mM glucose (HG) with or without 
0.1 or 1.0 µM EPICAT for 2 hours. Mitochondrial superoxide was detected 
via electron spin resonance spectroscopy, respiration was measured using 
Oroboros Oxygraph 2k, and cellular signaling was assessed by protein ex-
pression. Superoxide concentration was significantly elevated in HG cells 
but not in cells with HG and 1.0 µM EPICAT (p=0.008). EPICAT at 1.0 µM 
stimulated peNOS protein expression (p=0.006), and both concentrations 
stimulated protein expression of mitochondrial complexes I and II (p=0.02 
for both). No changes in respiration were detected. We surmise that EPI-
CAT potentiates vasodilation by activating eNOS and increasing mito-
chondrial complex expression, while attenuating excess ROS production. 
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P-265
SCREENING OF A NATURAL PRODUCT LIBRARY 
FOR ANTIMICROBIAL ACTIVITY TARGETING METAL 
HOMEOSTASIS
Charles A. Veltri1, Jennifer Foster2, Genna Gallas2, Maria Loyoza1, Pete 
Manchen2, Cynthia Reck3, and Jose Hernandez2
1Midwestern University College of Pharmacy-Glendale; 2Midwestern 
University Arizona College of Osteopathic Medicine; 3Midwestern University 
College of Health Sciences
Plants such as Fouquieria splendens and Larrea tridentata have been used 
by natives to treat several ailments such as fluid congestion, influenza, and 
bacterial infections. As antibiotic resistance in bacterial pathogens contin-
ues to become a more and more serious problem, new strategies for anti-
bacterial control become more important to investigate. Zinc and iron are 
essential micronutrients for all living organisms due to their role in cata-
lytic, regulatory, and structural proteins. We have explored the chemistry 
of Sonoran Desert plants for their ability to disrupt the metal homeostasis 
by targeting proteins in the zinc or iron physiological pathways. The leaves, 
bark, inner tissue, and flowers of F. splendens and L. tridentata were ex-
tracted and used to generate 88 enriched fractions for each tissue type. The 
crude extracts and enriched fractions were screened for activity testing us-
ing lux, lacZ, or xylE reporter systems expressed in E. coli and Klebsiella sp. 
Crude extracts of L. tridentata inner core, leaf, and flower and F. splendens 
flower extracts showed significant suppression of PzntA-lux and were con-
firmed by PzntA-xylE assay. Enriched fractions of these samples continued 
to show suppression of both reporter systems. Addition of crude and en-
riched extracts of F. splendens flowers also led to impaired PznuA-lux and 
PfepA-lux expression. Results were further confirmed with growth curves 
and microbial viability assays. These data strongly suggest the presence of 
small molecules impairing metal homeostasis.
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AN ANTIPLASMODIAL COUMARIN AND A 
NORNEOLIGNAN FROM ANIBA CITRIFOLIA
Yongle Du1, Yumin Dai1, Ana Lisa Valenciano2, Maria B. Cassera2, Jason 
Clement3, Michael Goetz3, and David G. I. Kingston1
1Department of Chemistry and the Virginia Tech Center for Drug 
Discovery, Virginia Tech, Blacksburg, Virginia 24061, USA, 2Department of 
Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia 
30602, USA, 3Natural Products Discovery Institute, 3805 Old Easton Road, 
Doylestown, Pennsylvania 18902, USA.
An extract of Aniba citrifolia from the Natural Products Discovery Institute 
was found to have good antimalarial activity, with an IC50 value of <1.25 μg/
mL. After purification by liquid-liquid partition, chromatography on Seph-
adex LH-20, diol open column and C-18 reverse phase HPLC, the new cou-
marin 1, the new neolignan 2 and six known neolignans were isolated. The 
structures of the new and known compounds were determined by NMR 
spectroscopy, MS and ECD. Among these compounds, the new coumarin 1 
displayed the strongest antiplasmodial activity.
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NCI PROGRAM FOR NATURAL PRODUCTS DISCOVERY: 
BUILDING AN INFORMATICS PLATFORM TO 
FACILITATE DISCOVERY OF BIOACTIVE NATURAL 
PRODUCTS
Jason Evans1,3, Tanja Grkovic2, and Barry R. O’Keefe1,4
1Natural Products Branch, Developmental Therapeutics Program, National 
Cancer Institute; 2Natural Products Support Group, Leidos Biomedical 
Research Inc., Frederick National Laboratory for Cancer Research; 3DMS 
Inc., FNLCR; 4Molecular Targets Program, NCI, Frederick, MD 21702.
The NCI Program for Natural Product Discovery (NPNPD) is a new, pri-
ority initiative for the NCI. The program is tasked with generating up to 
1 million pre-fractionated samples from the existing repository of crude 
extracts at the NCI Natural Products Branch for the purposes of modern 
high-throughput targeted screening technologies. This effort will also en-
compass the development of integrated analytical resources for the isola-
tion and structure elucidation of biologically active natural products. Here 
we present an informatics system for rapid identification of bioactive com-
ponents that combines analytical, historical and source material informa-
tion in a unified platform. Aspects of the system will eventually be publicly 
available, serving as a central repository of data on natural product samples 
derived from NCI collections.
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NCI PROGRAM FOR NATURAL PRODUCTS DISCOVERY: 
RAPID ISOLATION AND IDENTIFICATION OF 
BIOLOGICALLY ACTIVE NATURAL PRODUCTS FROM A 
PRE-FRACTIONATED LIBRARY
Tanja Grkovic1, Rhone K. Akee1, Christopher C. Thornburg1, Spencer K. 
Trinh1, Jason R. Evans2,3, John R. Britt,1 and Barry R. O’Keefe3,4
1Natural Products Support Group, Leidos Biomedical Research Inc., 
Frederick National Laboratory for Cancer Research, Frederick, MD 
21702, 2Data Management Services Inc., Frederick, MD 21702, 3Natural 
Products Branch, Developmental Therapeutics Program, Division of Cancer 
Treatment and Diagnosis, National Cancer Institute, Frederick, MD 21702. 
4Molecular Targets Program, Center for Cancer Research, National Cancer 
Institute, Frederick, Maryland 21702
The NCI Program for Natural Products Discovery (NPNPD) is a newly 
launched, priority program for the NCI. The new initiative aims to genera-
te pre-fractionated extracts (up to 1,000,000) for modern high-throughput 
targeted screening technologies, and develop integrated analytical resour-
ces for the isolation and structure elucidation of biologically active natural 
products. Here we present a high-throughput, high capacity HPLC-based 
method for the isolation and identification of natural products sourced 
from the NPNPD prefractionated library. The methodology is capable of 
processing 44 fractions in 12 hours to generate 968 sub-fractions in an assay 
ready-format. Examples of rapid isolation and identification of biological-
ly active natural products from plant, marine and microbial biota will be 
presented. 
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EXPLORING SOUTH CHINA SEA CYANOBACTERIAL 
DIVERSITY FOR THE DISCOVERY OF NEW MARINE 
DRUG LEAD MOLECULES
Fang Fang1, Te Li1, Weiyan Zhang1, Bin Zhang1, Ye Yuan1, Lijian Ding1, 
Shan He1, C. Benjamin Naman*,1,2 
1. Li Dak Sum Marine Biopharmaceutical Research Center, College of 
Marine Sciences, Ningbo University, Ningbo, Zhejiang 315211, China.  2. 
Scripps Institution of Oceanography, University of California, San Diego, La 
Jolla, California 92093, United States
The structures of many cyanobacterial compounds differ significantly from 
marine natural products from other producers, and the discovery of new 
molecules from this source continues to be productively achieved especially 
when investigations focus on genetically and geographically diverse sam-
ples. The efficiency of this research has been demonstrated to be greatly 
improved by using targeted isolation methods after dereplication, for ex-
ample guided by comparative metabolomics and cheminformatics, which 
is further supported here. It was observed during a dive trip near Hainan 
Province in the South China Sea, in the Tropic of Cancer, that this region 
maintains a biodiverse collection of marine filamentous cyanobacteria. 
Small- and medium-scale samples were there collected for chemical analy-
sis, research prioritization, and preliminary isolation experiments. This has 
informed the decision to re-visit several nearby dive sites for larger-scale 
collection of cyanobacteria samples, where plausible and responsible to do 
so, as well as permitting the targeted isolation of a few prevalent second-
ary metabolites that, after MS, NMR, and chemical degradation structure 
elucidation studies, have been determined to be new bioactive marine nat-
ural products. The continued investigation of this underexplored natural 
resource is expected to provide further lead molecules for drug discovery 
and development.
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ANTITUMOR AND ANTIMETASTATIC ACTIVITIES OF 
ESCULETIN BY TARGETING AXIN2/E-CADHERIN AXIS IN 
COLON CANCER
Won Kyung Kim1, Woong Sub Byun1, Hwa-Jin Chung2, Jedo Oh1, Hyen Joo 
Park1, Jae Sue Choi3 and Sang Kook Lee1
1College of Pharmacy, Seoul National University, Seoul 08826, Korea; 2Jaseng 
Spine and Joint Institute, Jaseng Medical Foundation, Seoul 06017, Korea; 
3Departmemt of Science and Nutrition, Pukyong National University, Busan 
608-737, Korea
Colorectal cancer (CRC) is the most common malignant disease world-
wide due to its metastasis via the epithelial-mesenchymal transition (EMT) 
process. E-cadherin and Wnt signaling are emerging as potential targets for 
suppressing the EMT. In this context, Axin2 has been recognized as a nega-
tive regulator that inhibits glycogen synthase kinase 3β (GSK3β)-mediated 
degradation of Snail1, a transcriptional repressor of E-cadherin. However, 
Axin2 can also impede Wnt signaling via β-catenin degradation. Therefore, 
Axin2 may serve as either a promoter or suppressor of tumors, and the ef-
fects of its inhibition on the cell proliferation and metastasis of CRC require 
further elucidation. Here, esculetin (ES), a coumarin, was found to have 
the most potential effects on both β-catenin-responsive transcriptional and 
E-cadherin promoter activities. ES also showed anti-proliferative and an-
ti-invasive activities in CRC cells. Mechanistically, Axin2 suppression by ES 
contributed to E-cadherin-mediated Wnt signaling inhibition. Moreover, 
the ability of ES to inhibit tumor growth and metastasis via Axin2 suppres-
sion was further supported in an HCT116-implanted orthotopic mouse 
model. Collectively, these findings suggest that targeting the Axin2/E-cad-
herin axis by ES may be an attractive therapeutic strategy for the treatment 
of metastatic CRC.
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A STRUGGLE FOR FUNGAL SURVIVAL: ANALYSIS 
OF THE CO-CULTURE OF ASPERGILLUS FISHERI AND 
XYLARIA CUBENSIS
Ann Marie L. Lee1, Sonja L. Knowles1, Huzefa A. Raja1, Matthew E. Mead2, 
Jacob L. Steenwyk2, Antonis Rokas2, and Nicholas H. Oberlies1
1Department of Chemistry and Biochemistry, University of North Carolina 
at Greensboro, Greensboro, NC 27412, 2Department of Biological Sciences, 
Vanderbilt University, Nashville, TN, 37235.
Fungi naturally grow in competitive environments, and in order to prosper 
they have evolved the ability to biosynthesize a wide range of secondary 
metabolites. Co-culturing is one way to capitalize upon the fact that they 
have evolved to respond to a wide range of chemical stimuli. In turn, this 
could produce secondary metabolites that are not typically observed in mo-
no-culture. To illustrate this, Xylaria cubensis, which is a known producer 
of griseofulvin, was grown in co-culture with Aspergillus fischeri in order 
to induce new secondary metabolite production. The co-culture grown on 
oatmeal agar was analyzed in situ via microextractions (droplet probe) on 
the surface of the fungi. The junction between the two fungi was observed 
to have a different chromatographic profile than that of the mono culture, 
suggesting the stimulation of cryptic biosynthesis. Isolation and structure 
elucidation was performed and other griseofulvin analogues as well as my-
cotoxins not previously see in the mono-culture were observed.
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A NEW TETRANORLABDANE DITERPENE FROM 
BOTRYOSPHAERIA PARVA AN ENDOPHYTIC FUNGUS 
IN EUGENIA JAMBOLANA (LAM.)
Angela R. Araujo1, Júlia D. Monfardini1, Vanessa M. Chapla2, Alberto J. 
Cavalheiro1, Vanderlan da S. Bolzani1.
1Nucleus of Bioassays, Biosynthesis and Ecophysiology of Natural 
Products (NuBBE], Institute of Chemistry, São Paulo State University 
(UNESP),14800-900, Araraquara, São Paulo, Brazil; 2 Environmental 
Chemistry, Federal University of Tocantins (UFT), 77402-970 Gurupi-TO, 
Brazil
Tetranorlabdanes diterpenes are well-known secondary metabolites of 
both fungi and higher plants, and members of this class display several ac-
tivities. As part of our ongoing screening for bioactive compounds from 
endophytic fungi, we have investigated the endophytic fungus Botryosphae-
ria parva, isolated from Eugenia jambolana (Lam.). B. parva was cultured 
in maize (90 g) for 21 days at 26oC in static mode. The culture was extrac-
ted with methanol (7 days) furnishing the crude CH3OH extract, which 
was dissolved in CH3CN and defatted with hexane by liquid partitioning. 
The CH3CN fraction was evaporated to give 3.0 g of the crude extract. The 
CH3CN extract was fractionated by CC using reversed-phase silica gel and 
eluted with H2O:CH3OH (70:30→100%) to afford eight fractions (A-H). The 
fraction B (168.3 mg) was subjected to HPLCprep. (40-63µm) using a gradi-
ent of H2O:CH3OH (63:37) yielding six known tetranorlabdane diterpene 
1, 3-7 and one new 2. the structure of these compounds was established by 
extensive spectroscopic data analysis including NMR 1D and 2D and HRE-
SIMS analysis, while the relative stereochemistry of 1-7 were determined by 
NOESY. To the best of our knowledge this is the first reporter of chemical 
studies of B. parva. The biological activities of these compounds are under 
investigation.
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P-274
A BIOBRICKS SYNTHETIC BIOLOGY TOOLBOX FOR 
BIOSYNTHESIS OF ANTHRACYCLINONES
S. Eric Nybo1 and Jennifer Tran1
1Department of Pharmaceutical Sciences, Ferris State University, Big Rapids, 
MI 49307.
BioBricks® is a synthetic biology standard for interchangeable genetic parts 
including promoters, genes, noncoding sequences, and terminators. We 
have developed a BioBricks® toolbox of codon-optimized genes, strong 
promoters, and chromosomal integrating vectors for the metabolic engi-
neering of anthracyclinone biosynthetic pathways in Streptomyces coelicolor 
M1146. Here, we report the initial assessment of a BioBricks® polyketide 
synthase pathway (module 1) and post-PKS tailoring genes (module 2) for 
production of aklanonic acid, aklanonic acid methyl ester, aklaviketone, ak-
lavinone, and ε-rhodomycinone using HPLC-UVvis, HRMS-QTOF analy-
sis, and 1H- and 13C-NMR spectroscopy.
P-275
MAMMOSPHERES AS MODELS FOR PREDICTING P450 
1A1/1B1 METABOLISM
Caitlin E. Howell, Ryan Hitzman, Birgit M. Dietz, and Judy L. Bolton*
UIC/NIH Center for Botanical Dietary Supplements Research, Department 
of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, 
University of Illinois at Chicago, 833 S. Wood St. Chicago, IL. 60612. 
Since the Women’s Health Initiative reported that hormone replacement 
therapy directly correlated with increased risk of breast cancer and heart 
disease, many American women have turned to botanical supplements to 
seek relief from menopausal symptoms. Little is known about how these 
extracts modulate the chemical carcinogenic effects of estrogens. In the 
genotoxic pathway, P450 1B1 performs 4-hydroxylation of estrone/es-
tradiol whereas P450 1A1 catalyzes detoxification of estrogen through 
2-hydroxylation. These pathways are classically regulated by the aryl hy-
drocarbon receptor (AhR), and estrogen receptor alpha (ERα) regulates 
P450 1A1 epigenetically. Botanical supplements can affect both ERα and 
AhR, causing differential effects within the same supplement. The ethoxy-
resorufin-O-dealklase (EROD) assay measures activity of P450 1 family of 
enzymes. Unfortunately, in 2D MCF-7 cells, EROD signal was low and the 
AhR-mediated effect could not be separated from the ERα-mediated effect. 
3D-Mammospheres are considered to be better models of humans than 2D 
monolayers. qPCR showed increased CYP1A1, but not CYP1B1 expression 
in 3D models, and with the P450 1B1 selective inhibitor, 2,3’,4,5’-tetrame-
thoxystilbene (TMS), ERα-mediated effects can be separated from those 
mediated by AhR. These results indicate that MCF-7 mammospheres, not 
monolayers, can be utilized to screen for modulation of estrogen chemi-
cal carcinogenesis and should be investigated in other assays as a way to 
achieve in vitro results more similar to humans. Supported by NIH Grant 
P50AT000155.
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